{"cells":[{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":13637,"status":"ok","timestamp":1702836980897,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"5g94qsJBCTHm","outputId":"465cf0fb-5609-4277-8c6a-d7af3be4328e"},"outputs":[{"output_type":"stream","name":"stdout","text":["Cloning into 'pubmed-rct'...\n","remote: Enumerating objects: 39, done.\u001b[K\n","remote: Counting objects: 100% (14/14), done.\u001b[K\n","remote: Compressing objects: 100% (9/9), done.\u001b[K\n","remote: Total 39 (delta 8), reused 5 (delta 5), pack-reused 25\u001b[K\n","Receiving objects: 100% (39/39), 177.08 MiB | 18.33 MiB/s, done.\n","Resolving deltas: 100% (15/15), done.\n","PubMed_200k_RCT\t\t\t\t       PubMed_20k_RCT_numbers_replaced_with_at_sign\n","PubMed_200k_RCT_numbers_replaced_with_at_sign  README.md\n","PubMed_20k_RCT\n"]}],"source":["!git clone https://github.com/Franck-Dernoncourt/pubmed-rct.git\n","!ls pubmed-rct"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"3MIEVNkMFTHM"},"outputs":[],"source":["data_dir = \"/content/pubmed-rct/PubMed_20k_RCT_numbers_replaced_with_at_sign/\""]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":17,"status":"ok","timestamp":1702836980898,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"6FfdkuQjFe35","outputId":"2667d4ff-5053-4ea6-a0be-5c631efff772"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["['/content/pubmed-rct/PubMed_20k_RCT_numbers_replaced_with_at_sign/train.txt',\n"," '/content/pubmed-rct/PubMed_20k_RCT_numbers_replaced_with_at_sign/dev.txt',\n"," '/content/pubmed-rct/PubMed_20k_RCT_numbers_replaced_with_at_sign/test.txt']"]},"metadata":{},"execution_count":3}],"source":["import os\n","filenames = [data_dir+filename for filename in os.listdir(data_dir)]\n","filenames"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"tHlhtTZmFqQG"},"outputs":[],"source":["def get_lines(filename):\n","  with open(filename,\"r\") as f:\n","    return f.readlines()"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":14,"status":"ok","timestamp":1702836980898,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"ui9q2_7_Lb3d","outputId":"a68d0929-54e3-4f1a-dd7f-ef3fe6376e2d"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["['###24293578\\n',\n"," 'OBJECTIVE\\tTo investigate the efficacy of @ weeks of daily low-dose oral prednisolone in improving pain , mobility , and systemic low-grade inflammation in the short term and whether the effect would be sustained at @ weeks in older adults with moderate to severe knee osteoarthritis ( OA ) .\\n',\n"," 'METHODS\\tA total of @ patients with primary knee OA were randomized @:@ ; @ received @ mg/day of prednisolone and @ received placebo for @ weeks .\\n',\n"," 'METHODS\\tOutcome measures included pain reduction and improvement in function scores and systemic inflammation markers .\\n',\n"," 'METHODS\\tPain was assessed using the visual analog pain scale ( @-@ mm ) .\\n',\n"," 'METHODS\\tSecondary outcome measures included the Western Ontario and McMaster Universities Osteoarthritis Index scores , patient global assessment ( PGA ) of the severity of knee OA , and @-min walk distance ( @MWD ) .\\n',\n"," 'METHODS\\tSerum levels of interleukin @ ( IL-@ ) , IL-@ , tumor necrosis factor ( TNF ) - , and high-sensitivity C-reactive protein ( hsCRP ) were measured .\\n',\n"," 'RESULTS\\tThere was a clinically relevant reduction in the intervention group compared to the placebo group for knee pain , physical function , PGA , and @MWD at @ weeks .\\n',\n"," 'RESULTS\\tThe mean difference between treatment arms ( @ % CI ) was @ ( @-@ @ ) , p < @ ; @ ( @-@ @ ) , p < @ ; @ ( @-@ @ ) , p < @ ; and @ ( @-@ @ ) , p < @ , respectively .\\n',\n"," 'RESULTS\\tFurther , there was a clinically relevant reduction in the serum levels of IL-@ , IL-@ , TNF - , and hsCRP at @ weeks in the intervention group when compared to the placebo group .\\n',\n"," 'RESULTS\\tThese differences remained significant at @ weeks .\\n',\n"," 'RESULTS\\tThe Outcome Measures in Rheumatology Clinical Trials-Osteoarthritis Research Society International responder rate was @ % in the intervention group and @ % in the placebo group ( p < @ ) .\\n',\n"," 'CONCLUSIONS\\tLow-dose oral prednisolone had both a short-term and a longer sustained effect resulting in less knee pain , better physical function , and attenuation of systemic inflammation in older patients with knee OA ( ClinicalTrials.gov identifier NCT@ ) .\\n',\n"," '\\n',\n"," '###24854809\\n',\n"," 'BACKGROUND\\tEmotional eating is associated with overeating and the development of obesity .\\n',\n"," 'BACKGROUND\\tYet , empirical evidence for individual ( trait ) differences in emotional eating and cognitive mechanisms that contribute to eating during sad mood remain equivocal .\\n',\n"," 'OBJECTIVE\\tThe aim of this study was to test if attention bias for food moderates the effect of self-reported emotional eating during sad mood ( vs neutral mood ) on actual food intake .\\n',\n"," 'OBJECTIVE\\tIt was expected that emotional eating is predictive of elevated attention for food and higher food intake after an experimentally induced sad mood and that attentional maintenance on food predicts food intake during a sad versus a neutral mood .\\n',\n"," 'METHODS\\tParticipants ( N = @ ) were randomly assigned to one of the two experimental mood induction conditions ( sad/neutral ) .\\n',\n"," 'METHODS\\tAttentional biases for high caloric foods were measured by eye tracking during a visual probe task with pictorial food and neutral stimuli .\\n',\n"," 'METHODS\\tSelf-reported emotional eating was assessed with the Dutch Eating Behavior Questionnaire ( DEBQ ) and ad libitum food intake was tested by a disguised food offer .\\n',\n"," 'RESULTS\\tHierarchical multivariate regression modeling showed that self-reported emotional eating did not account for changes in attention allocation for food or food intake in either condition .\\n',\n"," 'RESULTS\\tYet , attention maintenance on food cues was significantly related to increased intake specifically in the neutral condition , but not in the sad mood condition .\\n',\n"," 'CONCLUSIONS\\tThe current findings show that self-reported emotional eating ( based on the DEBQ ) might not validly predict who overeats when sad , at least not in a laboratory setting with healthy women .\\n',\n"," 'CONCLUSIONS\\tResults further suggest that attention maintenance on food relates to eating motivation when in a neutral affective state , and might therefore be a cognitive mechanism contributing to increased food intake in general , but maybe not during sad mood .\\n',\n"," '\\n',\n"," '###25165090\\n',\n"," 'BACKGROUND\\tAlthough working smoke alarms halve deaths in residential fires , many households do not keep alarms operational .\\n',\n"," 'BACKGROUND\\tWe tested whether theory-based education increases alarm operability .\\n',\n"," 'METHODS\\tRandomised multiarm trial , with a single arm randomly selected for use each day , in low-income neighbourhoods in Maryland , USA .\\n',\n"," \"METHODS\\tIntervention arms : ( @ ) Full Education combining a health belief module with a social-cognitive theory module that provided hands-on practice installing alarm batteries and using the alarm 's hush button ; ( @ ) Hands-on Practice social-cognitive module supplemented by typical fire department education ; ( @ ) Current Norm receiving typical fire department education only .\\n\",\n"," 'METHODS\\tFour hundred and thirty-six homes recruited through churches or by knocking on doors in @-@ .\\n',\n"," 'METHODS\\tFollow-up visits checked alarm operability in @ homes ( @ % ) @-@ @ years after installation .\\n',\n"," 'METHODS\\tnumber of homes with working alarms defined as alarms with working batteries or hard-wired and number of working alarms per home .\\n',\n"," 'METHODS\\tRegressions controlled for alarm status preintervention ; demographics and beliefs about fire risks and alarm effectiveness .\\n',\n"," 'RESULTS\\tHomes in the Full Education and Practice arms were more likely to have a functioning smoke alarm at follow-up ( OR = @ , @ % CI @ to @ ) and had an average of @ more working alarms per home ( @ % CI @ to @ ) .\\n',\n"," 'RESULTS\\tWorking alarms per home rose @ % .\\n',\n"," 'RESULTS\\tFull Education and Practice had similar effectiveness ( p = @ on both outcome measures ) .\\n',\n"," 'CONCLUSIONS\\tWithout exceeding typical fire department installation time , installers can achieve greater smoke alarm operability .\\n',\n"," 'CONCLUSIONS\\tHands-on practice is key .\\n',\n"," 'CONCLUSIONS\\tTwo years after installation , for every three homes that received hands-on practice , one had an additional working alarm .\\n',\n"," 'BACKGROUND\\thttp://www.clinicaltrials.gov number NCT@ .\\n',\n"," '\\n',\n"," '###24633056\\n',\n"," 'OBJECTIVE\\tTo evaluate the performance ( efficacy , safety and acceptability ) of a new micro-adherent absorbent dressing ( UrgoClean ) compared with a hydrofiber dressing ( Aquacel ) in the local management of venous leg ulcers , in the debridement stage .\\n',\n"," 'METHODS\\tA non-inferiority European randomised controlled clinical trial ( RCT ) was conducted in @ centres , on patients presenting with venous or predominantly venous , mixed aetiology leg ulcers at their sloughy stage ( with more than @ % of the wound bed covered with slough at baseline ) .\\n',\n"," 'METHODS\\tPatients were followed over a @-week period and assessed weekly .\\n',\n"," 'METHODS\\tThe primary judgement criteria was the relative regression of the wound surface area after the @-week treatment period .\\n',\n"," 'METHODS\\tSecondary endpoints were the relative reduction of sloughy tissue and the percentage of patients presenting with a debrided wound .\\n',\n"," 'RESULTS\\tAltogether , @ patients were randomised to either UrgoClean ( test group ; n = @ ) or Aquacel ( control group ; n = @ ) dressings .\\n',\n"," 'RESULTS\\tRegarding the wound healing process predictive factors ( wound area , duration , ABPI value , recurrence ) , at baseline , the two groups were well balanced , for both wound and patient characteristics .\\n',\n"," 'RESULTS\\tCompression therapy was administered to both groups and after a median @-day treatment period , the percentage of relative reduction of the wound surface area was very similar ( -@ % vs -@ % in the UrgoClean and control groups , respectively ) .\\n',\n"," 'RESULTS\\tWhen considering the secondary criteria at week @ , the relative reduction of sloughy tissue was significantly higher in the UrgoClean group than in the control group ( -@ % vs -@,@ % ; p = @ ) .\\n',\n"," 'RESULTS\\tThe percentage of debrided wounds was also significantly higher in the test group ( @ % vs @ % ; p = @ ) .\\n',\n"," \"CONCLUSIONS\\tThis ` EARTH ' RCT confirmed that the UrgoClean dressing has similar efficacy and safety compared to Aquacel .\\n\",\n"," 'CONCLUSIONS\\tHowever , UrgoClean also showed better autolytic properties than the control group in the management of venous leg ulcers at the sloughy stage .\\n',\n"," 'CONCLUSIONS\\tThe new UrgoClean dressing therefore represents a promising therapeutic option within the current range of autolytic dressings available .\\n',\n"," 'BACKGROUND\\tThis study was sponsored by a grant from the pharmaceutical company Laboratoires Urgo .\\n',\n"," 'BACKGROUND\\tS. Bohbot and O. Tacca are employees of Laboratoires Urgo .\\n',\n"," 'BACKGROUND\\tS. Meaume , J. Dissemond and G. Perceau have received monetary compensation as presenters for Laboratoires Urgo .\\n',\n"," 'BACKGROUND\\tData management and statistical analyses were conducted independently by Vertical ( Paris , France ) .\\n',\n"," '\\n',\n"," '###24814304\\n',\n"," 'OBJECTIVE\\tEye movements ( EM ) during recall of an aversive memory is a treatment element unique to Eye Movement Desensitization and Reprocessing ( EMDR ) .\\n',\n"," 'OBJECTIVE\\tExperimental studies have shown that EM reduce memory vividness and/or emotionality shortly after the intervention .\\n',\n"," 'OBJECTIVE\\tHowever , it is unclear whether the immediate effects of the intervention reflect actual changes in memory .\\n',\n"," 'OBJECTIVE\\tThe aim of this study was to test whether immediate reductions in memory vividness and emotionality persist at a @h follow up and whether the magnitude of these effects is related to the duration of the intervention .\\n',\n"," \"METHODS\\tSeventy-three undergraduates recalled two negative autobiographical memories , one with EM ( `` recall with EM '' ) and one without ( `` recall only '' ) .\\n\",\n"," 'METHODS\\tHalf of participants recalled each memory for four periods of @s , the other half for eight periods of @s .\\n',\n"," 'METHODS\\tMemory vividness/emotionality were self-rated at a pre-test , an immediate post-test , and a @h follow-up test .\\n',\n"," 'RESULTS\\tIn both duration groups , recall with EM , but not recall only , caused an immediate decrease in memory vividness .\\n',\n"," 'RESULTS\\tThere were no immediate reductions in memory emotionality .\\n',\n"," \"RESULTS\\tFurthermore , only the ` eight periods ' group showed that recall with EM , but not recall only , caused a decrease in both memory emotionality and memory vividness from the pre-test to the follow-up .\\n\",\n"," 'CONCLUSIONS\\tOnly self-report measures were used .\\n',\n"," 'CONCLUSIONS\\tThe findings suggest that recall with EM causes @-hchanges in memory vividness/emotionality , which may explain part of the EMDR treatment effect , and these effects are related to intervention duration .\\n',\n"," '\\n',\n"," '###25825539\\n',\n"," 'OBJECTIVE\\tFew studies have tested the impact of motivational interviewing ( MI ) delivered by primary care providers on pediatric obesity .\\n',\n"," 'OBJECTIVE\\tThis study tested the efficacy of MI delivered by providers and registered dietitians ( RDs ) to parents of overweight children aged @ through @ .\\n',\n"," 'METHODS\\tForty-two practices from the Pediatric Research in Office Settings Network of the American Academy of Pediatrics were randomly assigned to @ of @ groups .\\n',\n"," 'METHODS\\tGroup @ ( usual care ) measured BMI percentile at baseline and @ - and @-year follow-up .\\n',\n"," 'METHODS\\tGroup @ ( provider only ) delivered @ MI counseling sessions to parents of the index child over @ years .\\n',\n"," 'METHODS\\tGroup @ ( provider + RD ) delivered @ provider MI sessions plus @ MI sessions from a RD. .\\n',\n"," 'METHODS\\tThe primary outcome was child BMI percentile at @-year follow up .\\n',\n"," 'RESULTS\\tAt @-year follow-up , the adjusted BMI percentile was @ , @ , and @ for groups @ , @ , and @ , respectively .\\n',\n"," 'RESULTS\\tThe group @ mean was significantly ( P = @ ) lower than group @ .\\n',\n"," 'RESULTS\\tMean changes from baseline in BMI percentile were @ , @ , and @ across groups @ , @ , and @ .\\n',\n"," 'CONCLUSIONS\\tMI delivered by providers and RDs ( group @ ) resulted in statistically significant reductions in BMI percentile .\\n',\n"," 'CONCLUSIONS\\tResearch is needed to determine the clinical significance and persistence of the BMI effects observed .\\n',\n"," 'CONCLUSIONS\\tHow the intervention can be brought to scale ( in particular , how to train physicians to use MI effectively and how best to train RDs and integrate them into primary care settings ) also merits future research .\\n',\n"," '\\n',\n"," '###24507941\\n',\n"," 'BACKGROUND\\tAntithrombin ( AT ) concentrations are reduced after cardiac surgery with cardiopulmonary bypass compared with the preoperative levels .\\n',\n"," 'BACKGROUND\\tLow postoperative AT is associated with worse short - and mid-term clinical outcomes .\\n',\n"," 'BACKGROUND\\tThe aim of the study is to evaluate the effects of AT administration on activation of the coagulation and fibrinolytic systems , platelet function , and the inflammatory response in patients with low postoperative AT levels .\\n',\n"," 'METHODS\\tSixty patients with postoperative AT levels of less than @ % were randomly assigned to receive purified AT ( @ IU in three administrations ) or placebo in the postoperative intensive care unit .\\n',\n"," 'METHODS\\tThirty patients with postoperative AT levels greater than @ % were observed as controls .\\n',\n"," 'METHODS\\tInterleukin @ ( a marker of inflammation ) , prothrombin fragment @-@ ( a marker of thrombin generation ) , plasmin-antiplasmin complex ( a marker of fibrinolysis ) , and platelet factor @ ( a marker of platelet activation ) were measured at six different times .\\n',\n"," 'RESULTS\\tCompared with the no AT group and control patients , patients receiving AT showed significantly higher AT values until @ hours after the last administration .\\n',\n"," 'RESULTS\\tAnalysis of variance for repeated measures showed a significant effect of study treatment in reducing prothrombin fragment @-@ ( p = @ ; interaction with time sample , p = @ ) and plasmin-antiplasmin complex ( p < @ ; interaction with time sample , p < @ ) values but not interleukin @ ( p = @ ; interaction with time sample , p = @ ) and platelet factor @ ( p = @ ; interaction with time sample , p = @ ) .\\n',\n"," 'RESULTS\\tNo difference in chest tube drainage , reopening for bleeding , and blood transfusion was observed .\\n',\n"," 'CONCLUSIONS\\tAntithrombin administration in patients with low AT activity after surgery with cardiopulmonary bypass reduces postoperative thrombin generation and fibrinolysis with no effects on platelet activation and inflammatory response .\\n',\n"," '\\n',\n"," '###24976083\\n',\n"," 'OBJECTIVE\\tWe evaluated patients at tertiary -LSB- both percutaneous coronary intervention ( PCI ) and coronary artery bypass grafting ( CABG ) capable -RSB- and primary hospitals in the EARLY-ACS trial .\\n',\n"," 'BACKGROUND\\tEarly invasive management is recommended for high-risk non-ST-segment elevation acute coronary syndromes .\\n',\n"," \"METHODS\\tWe evaluated outcomes in @,@ patients presenting to : tertiary sites , primary sites with transfer to tertiary sites ( `` transferred '' ) and those who remained at primary sites ( `` non-transfer '' ) .\\n\",\n"," 'RESULTS\\tThere were @ tertiary ( n = @,@ patients ) and @ primary hospitals -LSB- n = @,@ patients ( @ transferred ; @,@ non-transfer ) -RSB- .\\n',\n"," 'RESULTS\\tSignificant delays occurred in time from symptom onset to angiography ( @ hr ) , PCI ( @h ) , and CABG ( @ hr ) for transferred patients ( P < @ ) .\\n',\n"," 'RESULTS\\tNon-transfer patients had less @-day death/myocardial infarction -LSB- @ % vs. @ % ( tertiary ) ; adjusted odds ratio ( OR ) : @ ( @-@ @ ) , P = @ -RSB- ; transferred ( @ % ) and tertiary patients were similar -LSB- adjusted OR : @ ( @-@ @ ) , P = @ -RSB- .\\n',\n"," 'RESULTS\\tNon-transfer patients had lower @-year mortality -LSB- @ % vs. @ % ( tertiary ) ; adjusted hazard ratio ( HR ) : @ ( @-@ @ ) , P = @ -RSB- : there was no difference between transferred and tertiary patients -LSB- @ % vs. @ % ; adjusted HR : @ ( @-@ @ ) , P = @ -RSB- .\\n',\n"," 'RESULTS\\tDespite similar rates of catheterization , GUSTO severe/moderate bleeding within @ hr was less in non-transfer -LSB- @ % vs. @ % ( tertiary ) ; adjusted OR : @ ( @-@ @ ) , P < @ -RSB- , whereas transferred ( @ % ) and tertiary patients were similar -LSB- adjusted OR : @ ( @-@ @ ) , P = @ -RSB- .\\n',\n"," 'RESULTS\\tThere was no difference in non-CABG bleeding .\\n',\n"," 'CONCLUSIONS\\tTimely angiography and revascularization were often not achieved in transferred patients .\\n',\n"," 'CONCLUSIONS\\tNon-transferred patients presenting to primary sites had the lowest event rates and the best long-term survival .\\n',\n"," '\\n',\n"," '###25001475\\n',\n"," 'OBJECTIVE\\tWe hypothesized that a targeted temperature of @ C as compared to that of @ C would increase survival and reduce the severity of circulatory shock in patients with shock on admission after out-of-hospital cardiac arrest ( OHCA ) .\\n',\n"," 'METHODS\\tThe recently published Target Temperature Management trial ( TTM-trial ) randomized @ OHCA patients with no difference in outcome between groups and no difference in mortality at the end of the trial in a predefined subgroup of patients with shock at admission .\\n',\n"," 'METHODS\\tShock was defined as a systolic blood pressure of < @ mm Hg for > @ min or the need of supportive measures to maintain a blood pressure @ mmHg and/or clinical signs of end-organ hypoperfusion .\\n',\n"," 'METHODS\\tIn this post hoc analysis reported here , we further analyzed the @ patients with shock at admission ; all had been randomized to receive intervention at @ C ( TTM@ ; n = @ ) or @ C ( TTM@ ; n = @ ) .\\n',\n"," 'METHODS\\tPrimary outcome was @-day mortality .\\n',\n"," 'METHODS\\tSecondary outcomes were intensive care unit ( ICU ) and @-day mortality , severity of circulatory shock assessed by mean arterial pressure , serum lactate , fluid balance and the extended Sequential Organ Failure assessment ( SOFA ) score .\\n',\n"," 'RESULTS\\tThere was no significance difference between targeted temperature management at @ C or @ C on @-day mortality -LSB- log-rank test , p = @ , hazard ratio @ , @ % confidence interval ( CI ) @-@ @ -RSB- or ICU mortality ( @ vs. @ % , p = @ ; relative risk @ , @ % CI @-@ @ ) .\\n',\n"," 'RESULTS\\tSerum lactate and the extended cardiovascular SOFA score were higher in the TTM@ group ( p < @ ) .\\n',\n"," 'CONCLUSIONS\\tWe found no benefit in survival or severity of circulatory shock with targeted temperature management at @ C as compared to @ C in patients with shock on admission after OHCA .\\n',\n"," '\\n',\n"," '###25406902\\n',\n"," 'BACKGROUND\\tYouths with a family history of alcohol and other drug use disorders ( FH + ) are at a greater risk of developing substance use disorders than their peers with no such family histories ( FH - ) , and this increased risk may be related to impaired maturation of forebrain circuitry .\\n',\n"," 'BACKGROUND\\tFH + individuals have shown altered forebrain activity at rest and while performing cognitive tasks .\\n',\n"," 'BACKGROUND\\tHowever , it is not fully understood how forebrain activity is altered in FH + individuals , and ultimately how these alterations may contribute to substance use disorder risk .\\n',\n"," 'METHODS\\tIn this study , we tested @ FH + and @ FH - youths performing a go/no-go task and examined activations in blocks with only go trials ( Go Only ) , blocks with @ % go and @ % no-go trials ( Go/NoGo ) , and a contrast of those @ blocks .\\n',\n"," 'RESULTS\\tFH + youths had significantly greater cerebral activations in both the Go and Go/NoGo blocks than FH - youths in regions including the posterior cingulate/precuneus , bilateral middle/superior temporal gyrus , and medial superior frontal gyrus with no significant group differences in the subtraction between Go Only and Go/NoGo blocks .\\n',\n"," 'RESULTS\\tAdditionally , FH + youths had moderately slower reaction times on go trials in the Go Only blocks .\\n',\n"," 'CONCLUSIONS\\tOur findings suggest that global activation increase in FH + youths are modulated by FH density and are not specific to the inhibitory components of the task .\\n',\n"," 'CONCLUSIONS\\tThis pattern of increased activations in FH + youths may be at least partially due to impaired forebrain white matter development leading to greater activations/less efficient neural communication during task performance .\\n',\n"," '\\n',\n"," '###25471989\\n',\n"," 'BACKGROUND\\tRisk factors have been proposed for running injuries including ( a ) reduced muscular strength , ( b ) excessive joint movements and ( c ) excessive joint moments in the frontal and transverse planes .\\n',\n"," \"BACKGROUND\\tTo date , many running injury prevention programs have focused on a `` top down '' approach to strengthen the hip musculature in the attempt to reduce movements and moments at the hip , knee , and/or ankle joints .\\n\",\n"," 'BACKGROUND\\tHowever , running mechanics did not change when hip muscle strength increased .\\n',\n"," \"BACKGROUND\\tIt could be speculated that emphasis should be placed on increasing the strength of the ankle joint for a `` ground up '' approach .\\n\",\n"," 'BACKGROUND\\tStrengthening of the large and small muscles crossing the ankle joint is assumed to change the force distribution for these muscles and to increase the use of smaller muscles .\\n',\n"," 'BACKGROUND\\tThis would be associated with a reduction of joint and insertion forces , which could have a beneficial effect on injury prevention .\\n',\n"," 'BACKGROUND\\tHowever , training of the ankle joint as an injury prevention strategy has not been studied .\\n',\n"," 'BACKGROUND\\tAnkle strengthening techniques include isolated strengthening or movement-related strengthening such as functional balance training .\\n',\n"," 'BACKGROUND\\tThere is little knowledge about the efficacy of such training programs on strength alteration , gait or injury reduction .\\n',\n"," 'METHODS\\tNovice runners will be randomly assigned to one of three groups : an isolated ankle strengthening group ( strength , n = @ ) , a functional balance training group ( balance , n = @ ) or an activity-matched control group ( control , n = @ ) .\\n',\n"," 'METHODS\\tIsokinetic strength will be measured using a Biodex System @ dynamometer .\\n',\n"," 'METHODS\\tRunning kinematics and kinetics will be assessed using @D motion analysis and a force platform .\\n',\n"," 'METHODS\\tPostural control will be assessed by quantifying the magnitude and temporal structure of the center of pressure trace during single leg stance on a force platform .\\n',\n"," 'METHODS\\tThe change pre - and post-training in isokinetic strength , running mechanics , and postural control variables will be compared following the interventions .\\n',\n"," 'METHODS\\tInjuries rates will be compared between groups over @months .\\n',\n"," 'CONCLUSIONS\\tAvoiding injury will allow individuals to enjoy the benefits of participating in aerobic activities and reduce the healthcare costs associated with running injuries .\\n',\n"," 'BACKGROUND\\tCurrent Controlled Trial NCT@ .\\n',\n"," '\\n',\n"," '###24694205\\n',\n"," 'BACKGROUND\\tVitamin B@ deficiency causes neurologic and psychiatric disease , especially in older adults .\\n',\n"," 'BACKGROUND\\tSubacute combined degeneration is characterized by damage to the posterior and lateral spinal cord affecting the corticospinal tract .\\n',\n"," 'OBJECTIVE\\tTo test corticospinal tract projections using motor evoked potentials ( MEPs ) by transcranial magnetic stimulation ( TMS ) in asymptomatic older adults with low vitamin B@ ( B@ ) levels .\\n',\n"," 'METHODS\\tCross-sectional study of @ healthy older adults ( > @ years ) .\\n',\n"," 'METHODS\\tMEPs were recorded in the abductor pollicis brevis and tibialis anterior muscles , at rest and during slight tonic contraction .\\n',\n"," 'METHODS\\tCentral motor conduction time ( CMCT ) was derived from the latency of MEPs and peripheral motor conduction time ( PMCT ) .\\n',\n"," 'METHODS\\tNeurophysiological variables were analyzed statistically according to B@ status .\\n',\n"," 'RESULTS\\tMedian age was @ years ( @ % women ) .\\n',\n"," 'RESULTS\\tTwenty-six out of the @ subjects had low vitamin B@ levels ( B@ < @pmol/l ) .\\n',\n"," 'RESULTS\\tMEPs were recorded for all subjects in upper and lower extremities .\\n',\n"," 'RESULTS\\tThere were no significant differences in either latency or amplitude of MEPs and CMCT between low and normal B@ groups .\\n',\n"," 'RESULTS\\tThere was a significant PMCT delay in the lower extremities in the low B@ group ( p = @ ) .\\n',\n"," 'CONCLUSIONS\\tNo subclinical abnormality of the corticospinal tract is detected in asymptomatic B@-deficient older adults .\\n',\n"," 'CONCLUSIONS\\tThe peripheral nervous system appears to be more vulnerable to damage attributable to this vitamin deficit .\\n',\n"," 'CONCLUSIONS\\tThe neurophysiological evaluation of asymptomatic older adults with lower B@ levels should be focused mainly in peripheral nervous system evaluation .\\n',\n"," '\\n',\n"," '###24576512\\n',\n"," 'BACKGROUND\\tUncontrolled hypertension ( HTN ) is a significant public health problem among blacks in the United States .\\n',\n"," 'BACKGROUND\\tDespite the proven efficacy of therapeutic lifestyle change ( TLC ) on blood pressure ( BP ) reduction in clinical trials , few studies have examined their effectiveness in church-based settings-an influential institution for health promotion in black communities .\\n',\n"," 'METHODS\\tUsing a cluster-randomized , @-arm trial design , this study evaluates the effectiveness of a faith-based TLC intervention vs health education ( HE ) control on BP reduction among hypertensive black adults .\\n',\n"," 'METHODS\\tThe intervention is delivered by trained lay health advisors through group TLC sessions plus motivational interviewing in @ black churches .\\n',\n"," 'METHODS\\tParticipants in the intervention group receive @ weekly TLC sessions targeting weight loss , increasing physical activity , fruit , vegetable and low-fat dairy intake , and decreasing fat and sodium intake , plus @ monthly individual motivational interviewing sessions .\\n',\n"," 'METHODS\\tParticipants in the control group attend @ weekly classes on HTN and other health topics delivered by health care experts .\\n',\n"," 'METHODS\\tThe primary outcome is change in BP from baseline to @ months .\\n',\n"," 'METHODS\\tSecondary outcomes include level of physical activity , percent change in weight , and fruit and vegetable consumption at @ months , and BP control at @ months .\\n',\n"," 'CONCLUSIONS\\tIf successful , this trial will provide an alternative and culturally appropriate model for HTN control through evidence-based lifestyle modification delivered in churches by lay health advisors .\\n',\n"," '\\n',\n"," '###24807407\\n',\n"," 'BACKGROUND\\tThe classification of clinical severity of Ebstein anomaly still remains a challenge .\\n',\n"," 'BACKGROUND\\tThe aim of this study was to focus on the interaction of the pathologically altered right heart with the anatomically-supposedly-normal left heart and to derive from cardiac magnetic resonance ( CMR ) a simple imaging measure for the clinical severity of Ebstein anomaly .\\n',\n"," 'RESULTS\\tTwenty-five patients at a mean age of @ years with unrepaired Ebstein anomaly were examined in a prospective study .\\n',\n"," 'RESULTS\\tDisease severity was classified using CMR volumes and functional measurements in comparison with heart failure markers from clinical data , ECG , laboratory and cardiopulmonary exercise testing , and echocardiography .\\n',\n"," 'RESULTS\\tAll examinations were completed within @ hours .\\n',\n"," 'RESULTS\\tA total right/left-volume index was defined from end-diastolic volume measurements in CMR : total right/left-volume index = ( RA + aRV + fRV ) / ( LA+LV ) .\\n',\n"," 'RESULTS\\tMean total right/left-volume index was @ ( normal values : @ ) .\\n',\n"," 'RESULTS\\tThis new total right/left-volume index correlated with almost all clinically used biomarkers of heart failure : brain natriuretic peptide ( r = @ ; P = @ ) , QRS ( r = @ ; P = @ ) , peak oxygen consumption/kg ( r = -@ ; P = @ ) , ventilatory response to carbon dioxide production at anaerobic threshold ( r = @ ; P = @ ) , the severity of tricuspid regurgitation ( r = @ ; P = @ ) , tricuspid valve offset ( r = @ ; P = @ ) , and tricuspid annular plane systolic excursion ( r = @ ; P = @ ) .\\n',\n"," 'RESULTS\\tPreviously described severity indices ( -LSB- RA + aRV -RSB- / -LSB- fRV + LA+LV -RSB- ) and fRV/LV end-diastolic volume corresponded only to some parameters .\\n',\n"," 'CONCLUSIONS\\tIn patients with Ebstein anomaly , the easily acquired index of right-sided to left-sided heart volumes from CMR correlated well with established heart failure markers .\\n',\n"," 'CONCLUSIONS\\tOur data suggest that the total right/left-volume index should be used as a new and simplified CMR measure , allowing more accurate assessment of disease severity than previously described scoring systems .\\n',\n"," '\\n',\n"," '###24947717\\n',\n"," 'OBJECTIVE\\tThis study sought to investigate the association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction ( STEMI ) after primary percutaneous coronary intervention ( PCI ) .\\n',\n"," 'BACKGROUND\\tLimited data are available on the efficacy of beta-blocker therapy for secondary prevention in STEMI patients .\\n',\n"," 'METHODS\\tBetween November @ , @ and September @ , @ , @,@ patients were enrolled in nationwide , prospective , multicenter registries .\\n',\n"," 'METHODS\\tAmong these , we studied STEMI patients undergoing primary PCI who were discharged alive ( n = @,@ ) .\\n',\n"," 'METHODS\\tWe classified patients into the beta-blocker group ( n = @,@ ) and no-beta-blocker group ( n = @,@ ) according to the use of beta-blockers at discharge .\\n',\n"," 'METHODS\\tPropensity-score matching analysis was also performed in @,@ patient triplets .\\n',\n"," 'METHODS\\tThe primary outcome was all-cause death .\\n',\n"," 'RESULTS\\tThe median follow-up duration was @ days ( interquartile range : @ to @ days ) .\\n',\n"," 'RESULTS\\tAll-cause death occurred in @ patients ( @ % ) of the beta-blocker group versus @ patients ( @ % ) of the no-beta-blocker group ( p < @ ) .\\n',\n"," 'RESULTS\\tAfter @:@ propensity-score matching , beta-blocker therapy was associated with a lower incidence of all-cause death ( @ % vs. @ % , adjusted hazard ratio : @ , @ % confidence interval : @ to @ , p = @ ) .\\n',\n"," 'RESULTS\\tThe association with better outcome of beta-blocker therapy in terms of all-cause death was consistent across various subgroups , including patients with relatively low-risk profiles such as ejection fraction > @ % or single-vessel disease .\\n',\n"," 'CONCLUSIONS\\tBeta-blocker therapy at discharge was associated with improved survival in STEMI patients treated with primary PCI .\\n',\n"," 'CONCLUSIONS\\tOur results support the current American College of Cardiology/American Heart Association guidelines , which recommend long-term beta-blocker therapy in all patients with STEMI regardless of reperfusion therapy or risk profile .\\n',\n"," '\\n',\n"," '###24281275\\n',\n"," 'OBJECTIVE\\tLocal anesthetic wound infiltration is widely used as an effective adjunct during multimodal postoperative pain management .\\n',\n"," 'OBJECTIVE\\tThe aim of this study was to evaluate the effectiveness of continuous wound infusion of ropivacaine in postoperative pain relief , opioid sparing , incidence of nausea and vomiting , and bowel and liver function improvement in patients undergoing open hepatectomy .\\n',\n"," 'METHODS\\tForty patients undergoing open hepatectomy were enrolled in this prospective , randomized , double-blinded , placebo-controlled trial .\\n',\n"," 'METHODS\\tPatients were divided into @ groups : the @ % saline continuous infusion group ( the control group ; n = @ ) and the ropivacaine continuous infusion group ( the Ropi group ; n = @ ) .\\n',\n"," 'METHODS\\tOutcomes measured postoperatively were pain score at rest and on movement , sufentanil consumption , incidence of nausea and vomiting , and sedation score across @ postoperative hours .\\n',\n"," 'METHODS\\tTime to bowel recovery , liver function change , mean length of hospitalization , patient satisfaction , and other data after @ postoperative hours were collected until hospital discharge .\\n',\n"," 'RESULTS\\tPain scores at rest were lower for the ropivacaine group and reached significance after @ and @ hours ( P < @ ) .\\n',\n"," 'RESULTS\\tSufentanil consumption ( @ vs. @ g ; P < @ ) after @ hours , time to bowel recovery ( @ vs. @ d ; P < @ ) , incidence of nausea and vomiting ( @ vs. @ ; P < @ ) , and mean length of hospitalization ( @ vs. @ d ; P < @ ) were significantly reduced , and the sedation score and liver function change were also comparable between the @ groups .\\n',\n"," 'RESULTS\\tThere was no difference with respect to pain scores on movement , nor with respect to patient satisfaction .\\n',\n"," 'CONCLUSIONS\\tSurgical wound infusion with ropivacaine after hepatectomy can improve pain relief at rest and accelerate recovery and discharge .\\n',\n"," '\\n',\n"," '###24911353\\n',\n"," 'OBJECTIVE\\tTuberculosis ( TB ) is highly prevalent among HIV-infected people , including those receiving combination antiretroviral therapy ( cART ) , necessitating a well tolerated and efficacious TB vaccine for these populations .\\n',\n"," 'OBJECTIVE\\tWe evaluated the safety and immunogenicity of the candidate TB vaccine M@/AS@ in adults with well controlled HIV infection on cART .\\n',\n"," 'METHODS\\tA randomized , observer-blind , controlled trial ( NCT@ ) .\\n',\n"," 'METHODS\\tHIV-infected adults on cART in Switzerland were randomized @:@:@ to receive two doses , @ month apart , of M@/AS@ , AS@ or @ % physiological saline ( N = @ , N = @ and N = @ , respectively ) and were followed up to @ months postdose @ ( D@ ) .\\n',\n"," 'METHODS\\tIndividuals with CD@ cell counts below @ cells/l were excluded .\\n',\n"," 'METHODS\\tAdverse events ( AEs ) including HIV-specific and laboratory safety parameters were recorded .\\n',\n"," 'METHODS\\tCell-mediated ( ICS ) and humoral ( ELISA ) responses were evaluated before vaccination , @ month after each dose ( D@ , D@ ) and D@ .\\n',\n"," 'RESULTS\\tThirty-seven individuals -LSB- interquartile range ( IQR ) CD@ cell counts at screening : @-@ cells/l ; undetectable HIV-@ viremia -RSB- were enrolled ; @ % of individuals reported previous BCG vaccination , @ % tested negative for the QuantiFERON-TB assay .\\n',\n"," 'RESULTS\\tFor M@/AS@ recipients , no vaccine-related serious AEs or cART-regimen adjustments were recorded , and there were no clinically relevant effects on laboratory safety parameters , HIV-@ viral loads or CD@ cell counts .\\n',\n"," 'RESULTS\\tM@/AS@ was immunogenic , inducing persistent and polyfunctional M@-specific CD@ T-cell responses -LSB- medians @ % ( IQR @-@ @ ) at D@ -RSB- and @ % ( @-@ @ ) at D@ , predominantly CD@LIL-@TNF - , CD@LIL-@ and CD@LIL-@TNF-IFN - -RSB- .\\n',\n"," 'RESULTS\\tAll M@/AS@ vaccines were seropositive for anti-M@ IgG after second vaccination until study end .\\n',\n"," 'CONCLUSIONS\\tM@/AS@ was clinically well tolerated and immunogenic in this population , supporting further clinical evaluation in HIV-infected individuals in TB-endemic settings .\\n',\n"," '\\n',\n"," '###25318787\\n',\n"," 'OBJECTIVE\\tThe aim of this study was to investigate whether remedial hydration ( RH ) reduces the incidence of contrast-induced nephropathy ( CIN ) and short-term adverse events in ST-elevation myocardial infarction ( STEMI ) patients undergoing primary percutaneous coronary intervention ( PCI ) .\\n',\n"," 'METHODS\\tA total of @ consecutive STEMI patients were prospectively and randomly assigned into two groups : @ patients in the RH group and @ patients in the no RH ( control ) group .\\n',\n"," 'METHODS\\tThe serum creatinine ( SCr ) and creatinine clearance ( CCr ) levels were measured on admission and at @ , @ and @ hours after primary PCI .\\n',\n"," 'METHODS\\tThe rates of CIN and short-term adverse events were analyzed for each group .\\n',\n"," 'METHODS\\tAfter surgery , the patients were categorized into four groups according to the Mehran risk score : low ( @ , n = @ ) , moderate ( @-@ , n = @ ) , high ( @-@ , n = @ ) or very high ( @ , n = @ ) .\\n',\n"," 'RESULTS\\tThe incidence of CIN in the RH group was lower than that observed in the control group ( @/@ ; @ % vs. @/@ ; @ % , p < @ ) .\\n',\n"," 'RESULTS\\tThe subgroup analysis showed that the rate of CIN was lower in the moderate ( @/@ ; @ % vs. @/@ ; @ % , p < @ ) and significantly lower in both the high ( @/@ ; @ % vs. @/@ ; @ % , p < @ ) and very high score groups ( @/@ ; @ % vs. @/@ ; @ % , p < @ ) among the RH patients compared to the controls .\\n',\n"," 'RESULTS\\tAt @ , @ and @ hours after PCI , the patients in the RH group exhibited lower SCr levels and higher CCr levels than the patients in the control group ( both p < @ ) .\\n',\n"," 'RESULTS\\tA lower incidence of in-hospital clinical events was also observed in the RH group .\\n',\n"," 'CONCLUSIONS\\tRemedial hydration decreases the occurrence of CIN and improves the short-term prognosis of STEMI patients undergoing primary PCI .\\n',\n"," '\\n',\n"," '###24396280\\n',\n"," 'BACKGROUND\\tAn increased production of oxidizing species related to reactive oral diseases , such as chronic apical periodontitis , could have systemic implications such as an increase in cardiovascular morbidity .\\n',\n"," 'BACKGROUND\\tBased on this consideration , we conducted a prospective study to assess whether subjects affected by chronic periodontitis presented with higher values of oxidative stress than reference values before endodontic treatment , and whether endodontic treatment can reduce the oxidative imbalance and bring it back to normal in these subjects .\\n',\n"," 'METHODS\\tThe authors recruited @ groups of patients from private studies and dental clinics : these patients were recruited randomly .\\n',\n"," 'METHODS\\tThe oxidative balance in both patients with chronic apical periodontitis ( CAP ) and healthy control patients was determined by measuring the oxidant status , using an identification of the reactive oxygen metabolites ( d-ROMs ) test , while the antioxidant status in these patients was determined using a biological antioxidant potential ( BAP ) test .\\n',\n"," 'METHODS\\tBoth these tests were carried on plasma samples taken from enrolled patients .\\n',\n"," 'METHODS\\tValues were measured both before the endodontic treatment of the patients with chronic apical periodontitis , and @ and @ days after treatment , and compared to those obtained from healthy control patients .\\n',\n"," 'RESULTS\\tIt was found that , on recruitment , the patients with chronic apical periodontitis exhibited significantly higher levels of oxidative stress than control patients , as determined by the d-ROMs and BAP tests .\\n',\n"," 'RESULTS\\tFurthermore , the d-ROMs test values were shown to decrease and the BAP test values to increase over time in patients with chronic apical periodontitis following endodontic therapy .\\n',\n"," 'RESULTS\\tAs the levels of oxidative stress in these patients tended to reduce and return to normal by @ days following treatment .\\n',\n"," 'CONCLUSIONS\\tThis study has demonstrated a positive association between chronic apical periodontitis and oxidative stress .\\n',\n"," 'CONCLUSIONS\\tSubjects affected by chronic apical periodontitis are exposed to a condition of oxidative stress , which is extremely dangerous to general health .\\n',\n"," 'CONCLUSIONS\\tMoreover , one can infer from these findings that through proper endodontic therapy , a good oxidative balance can be restored , thereby avoiding the risk of contracting the abovementioned diseases .\\n',\n"," '\\n',\n"," '###24731889\\n',\n"," 'BACKGROUND\\tPlacebo effect has been largely studied and debated in medicine .\\n',\n"," 'BACKGROUND\\tResearch focused mainly on children and adults but not on newborns .\\n',\n"," 'BACKGROUND\\tIn osteopathy , few studies documented this effect and no research has been conducted in newborns .\\n',\n"," 'OBJECTIVE\\tTo assess the presence of placebo effect in newborns using sham osteopathic manipulative treatment .\\n',\n"," 'METHODS\\tRandomized control trial .\\n',\n"," 'METHODS\\tNeonatal Intensive Care Unit in Italy .\\n',\n"," 'METHODS\\tTwo groups ( @ patients each ) of preterm infants aged @-@ weeks without medical complications received routine pediatric care and osteopathic sham therapy was administrated to the study group only for the entire period of hospitalization .\\n',\n"," 'METHODS\\tPrimary end point was the mean reduction of length of stay at discharge .\\n',\n"," 'METHODS\\tSecondary objective was the change in daily weight gain .\\n',\n"," 'RESULTS\\t@ newborns entered the study .\\n',\n"," 'RESULTS\\tNo difference between sham and control group was found for the primary outcome length of stay ( @ ; @ ; p = @ ) .\\n',\n"," 'RESULTS\\tMultivariate analysis showed no difference between study and control group on length of stay .\\n',\n"," 'RESULTS\\tA negative association was found for gestational age ( -@ ; @ % CI -@ to -@ ; p = @ ) , birth weight ( -@ ; @ % CI -@ to -@ ; p < @ ) and milk volume at study enrollment ( -@ ; @ % CI -@ to -@ ; p = @ ) .\\n',\n"," 'CONCLUSIONS\\tTo the best of our knowledge , this study is the first in the field showing no placebo effect on newborns .\\n',\n"," 'CONCLUSIONS\\tFurther discussions are opened concerning the age when placebo effect starts .\\n',\n"," '\\n',\n"," '###25880933\\n',\n"," 'BACKGROUND\\tClostridium difficile infection ( CDI ) is a leading cause of diarrhoea in health care settings with symptoms ranging from mild and self-limiting to life threatening .\\n',\n"," 'BACKGROUND\\tSMT@ is a novel , non-absorbable antibiotic currently under development for the treatment of CDI .\\n',\n"," 'BACKGROUND\\tHere we report the results from a Phase I study .\\n',\n"," 'METHODS\\tA double-blind , randomized , placebo-controlled study assessing safety and tolerability of single and multiple oral doses of SMT@ in healthy volunteers .\\n',\n"," 'METHODS\\tPharmacokinetic assessments included blood and faecal sampling .\\n',\n"," 'METHODS\\tThe effect of food on systemic exposure and analysis of the gut microbiota were also included .\\n',\n"," 'RESULTS\\tFifty-six healthy male subjects were enrolled .\\n',\n"," 'RESULTS\\tFollowing single oral doses of up to @,@ mg in the fasted state , plasma concentrations of SMT@ were generally below the lower limit of quantification .\\n',\n"," 'RESULTS\\tIn the fed state levels ranged from @ to @ ng/mL after single dosing and after repeat dosing at Day @ from @ to @ ng/mL .\\n',\n"," 'RESULTS\\tFollowing single and multiple oral doses of SMT@ , mean daily faecal concentrations increased with increasing dose level and were significantly above the typical MIC range for C. difficile ( @-@ @ g/mL ) .\\n',\n"," 'RESULTS\\tAt @ mg BID , mean ( SD ) faecal concentrations of @,@ ( @ ) g/g and @,@ ( @ ) g/g were determined on days @ and @ of dosing respectively .\\n',\n"," 'RESULTS\\tNo notable metabolites were detected in faeces .\\n',\n"," 'RESULTS\\tOverall , all doses of SMT@ were well tolerated both as single oral doses or BID oral doses for @ days .\\n',\n"," 'RESULTS\\tThe majority ( @ % ) of adverse events ( AEs ) were classified as gastrointestinal disorders and were mild in severity , resolving without treatment .\\n',\n"," 'RESULTS\\tThe gut microbiota was analysed in the multiple dose groups with minimal changes observed in the bacterial groups analysed except for total clostridia which were reduced to below the limit of detection by day @ of dosing .\\n',\n"," 'CONCLUSIONS\\tOral administration of SMT@ was considered safe and well tolerated and was associated with negligible plasma concentrations after single and multiple doses .\\n',\n"," 'CONCLUSIONS\\tIn addition , minimal disruption of normal gut microbiota was noted , confirming the highly selective spectrum of the compound .\\n',\n"," 'CONCLUSIONS\\tThese results support the further clinical development of SMT@ as an oral therapy for CDI .\\n',\n"," 'BACKGROUND\\tCurrent Controlled Trials .\\n',\n"," 'BACKGROUND\\tISRCTN@ .\\n',\n"," '\\n',\n"," '###25231496\\n',\n"," 'BACKGROUND\\tWhile overall survival for most common cancers in Australia is improving , the rural-urban differential has been widening , with significant excess deaths due to lung , colorectal , breast and prostate cancer in regional Australia .\\n',\n"," 'BACKGROUND\\tInternationally a major focus on understanding variations in cancer outcomes has been later presentation to healthcare and later diagnosis .\\n',\n"," 'BACKGROUND\\tApproaches to reducing time to diagnosis of symptomatic cancer include public symptom awareness campaigns and interventions in primary care to improve early cancer detection .\\n',\n"," 'BACKGROUND\\tThis paper reports the protocol of a factorial cluster-randomised trial of community and general practice ( GP ) level interventions to reduce the time to diagnosis of cancer in rural Western Australia ( WA ) .\\n',\n"," 'METHODS\\tThe community intervention is a symptom awareness campaign tailored for rural Australians delivered through a community engagement model .\\n',\n"," 'METHODS\\tThe GP intervention includes a resource card with symptom risk assessment charts and local referral pathways implemented through multiple academic detailing visits and case studies .\\n',\n"," 'METHODS\\tParticipants are eligible if recently diagnosed with breast , colorectal , lung or prostate cancer who reside in specific regions of rural WA with a planned sample size of @ .\\n',\n"," 'METHODS\\tThe primary outcome is the Total Diagnostic Interval , defined as the duration from first symptom ( or date of cancer screening test ) to cancer diagnosis .\\n',\n"," 'METHODS\\tSecondary outcomes include cancer stage , healthcare utilisation , disease-free status , survival at @ and @years and cost-effectiveness .\\n',\n"," 'BACKGROUND\\tEthics approval has been granted by the University of Western Australia and from all relevant hospital recruitment sites in WA .\\n',\n"," 'RESULTS\\tResults of this trial will be reported in peer-reviewed publications and in conference presentations .\\n',\n"," 'BACKGROUND\\tAustralian New Zealand Clinical Trials Registry ( ANZCTR ) .\\n',\n"," 'BACKGROUND\\tACTRN@ .\\n',\n"," '\\n',\n"," '###26024687\\n',\n"," 'BACKGROUND\\tThis study aimed to evaluate whether incidental CT findings of emphysema , airway thickening and bronchiectasis , as seen on CT scans performed for other non-pulmonary clinical indications , are associated with future acute exacerbations of COPD resulting in hospitalisation or death .\\n',\n"," 'METHODS\\tThis multicentre prospective case-cohort study comprised @ subjects who underwent routine diagnostic chest CT for non-pulmonary indications .\\n',\n"," 'METHODS\\tUsing a case-cohort approach , we visually graded CT scans from cases and a random sample of @ % of the baseline cohort ( n = @ ) for emphysema severity ( range @-@ ) , airway thickening ( range @-@ ) and bronchiectasis ( range @-@ ) .\\n',\n"," 'METHODS\\tWe used weighted Cox proportional hazards analysis to assess the independent association between CT findings and hospitalisation or death due to COPD exacerbation .\\n',\n"," 'RESULTS\\tDuring a median follow-up of @ years ( maximum @ years ) , @ COPD events were identified .\\n',\n"," 'RESULTS\\tThe risk of experiencing a future acute exacerbation of COPD resulting in hospitalisation or death was significantly increased in subjects with severe emphysema ( score @ ) and severe airway thickening ( score @ ) .\\n',\n"," 'RESULTS\\tThe respective HRs were @ ( @ % CI @ to @ ) and @ ( @ % CI @ to @ ) .\\n',\n"," 'RESULTS\\tSevere bronchiectasis ( score @ ) was not significantly associated with increased risk of adverse events ( HR @ ; @ % CI @ to @ ) .\\n',\n"," 'CONCLUSIONS\\tMorphological correlates of COPD such as emphysema and airway thickening detected on CT scans obtained for other non-pulmonary indications are strong independent predictors of subsequent development of acute exacerbations of COPD resulting in hospitalisation or death .\\n',\n"," '\\n',\n"," '###24851690\\n',\n"," 'OBJECTIVE\\tTo explore the feasibility of making a preoperative diagnosis of lung adenocarcinoma shown as ground-glass nodule ( GGN ) on computed tomography ( CT ) .\\n',\n"," 'METHODS\\tA total of @ GGN lesions proved pathologically were divided randomly into A and B groups .\\n',\n"," 'METHODS\\tThen each group was further divided pathologically into preinvasive lesion , minimal invasive adenocarcinoma ( MIA ) and invasive adenocarcinoma ( IAC ) subgroups .\\n',\n"," 'METHODS\\tGroup A ( n = @ ) , size of lesion , proportion of ground glass opacity ( GGO ) composition of lesion , long diameter , longest diameter and size of solid component in lesion were measured on CT so as to establish the CT diagnostic standard of lung adenocarcinoma shown as GGN on CT. .\\n',\n"," 'METHODS\\tGroup B ( n = @ ) was employed to evaluate the accuracy of the above CT diagnostic standard .\\n',\n"," 'METHODS\\tSPSS @ software was used for statistical analysis .\\n',\n"," 'RESULTS\\tSignificant statistic significance existed in all parameters among all groups ( P < @ ) .\\n',\n"," 'RESULTS\\tAll parameters were correlated the pathologic type of lesion .\\n',\n"," 'RESULTS\\tThe differences were statistically significant ( P = @ ) .\\n',\n"," 'RESULTS\\tThrough the receiver operating characteristic ( ROC ) curve , between groups of preinvasive lesion and MIA , each parameter had a medium diagnostic value of @-@ @ ; between groups of MIA and IAC , size of lesion and long diameter of solid component in lesion had a medium diagnostic value of @-@ @ , longest diameter of solid component , size of solid component in lesion and proportion of GGO composition of lesion had a high diagnostic value with an AUC of > @ .\\n',\n"," 'RESULTS\\tThe CT diagnostic standard , derived from group A , was used to analyze the pathologic type of group B. And t no significant statistic significance existed between CT preoperative diagnosis and operative pathologic diagnosis ( P > @ ) .\\n',\n"," 'RESULTS\\tThe correct diagnosis rates of size of lesion , proportion of GGO composition of lesion , long diameter , longest diameter and size of solid component in lesion were @ % , @ % , @ % , @ % and @ % respectively .\\n',\n"," 'CONCLUSIONS\\tBased upon size of lesion , proportion of GGO composition of lesion , long diameter , longest diameter and size of solid component in lesion , preoperative CT examination may be used to determine the pathological types of lung adenocarcinoma shown as GGN .\\n',\n"," '\\n',\n"," '###25883103\\n',\n"," 'OBJECTIVE\\tTonsillectomy surgery is associated with severe postoperative pain that usually requires analgesics including opioids .\\n',\n"," 'OBJECTIVE\\tPain control is still a big problem after tonsillectomy surgery .\\n',\n"," 'OBJECTIVE\\tWe aimed to evaluate the efficacy of preemptive analgesia using montelukast for pediatric post-tonsillectomy pain management .\\n',\n"," 'OBJECTIVE\\tThis is the first-time use of montelukast in post-tonsillectomy pain .\\n',\n"," 'METHODS\\tDouble-blind , controlled-randomized study .\\n',\n"," 'METHODS\\tUniversity teaching and research hospital .\\n',\n"," 'METHODS\\tA total of @ children , aged @ to @ years , American Society of Anesthesiologist class I-II , scheduled for elective tonsillectomy were enrolled in this clinical trial study .\\n',\n"," 'METHODS\\tThe patients were randomized into @ groups : the montelukast group ( group M , n = @ ) and control group ( group C , n = @ ) .\\n',\n"," 'METHODS\\tGroup M recieved an oral montelukast tablet and group C recieved placebo at @pm on the morning before surgery .\\n',\n"," 'METHODS\\tPost-tonsillectomy pain was evaluated with the Wong-Baker FACES Scale during the @ hours after surgery .\\n',\n"," \"METHODS\\tPatients ' intraoperative hemodynamic parameters and intraoperative and postoperative complications were recorded .\\n\",\n"," 'RESULTS\\tThere were statistically significant differences between group C and group M for Wong-Baker FACES pain rating scale scores ( P < @ ) .\\n',\n"," 'RESULTS\\tIn the @ hours after surgery , the total number of patients using rescue analgesics was higher in group C than in group M , and the difference was statistically significant ( P < @ ) .\\n',\n"," 'RESULTS\\tThere was no significant difference in demographic parameters ( P > @ ) .\\n',\n"," 'RESULTS\\tThere were no significant differences in postoperative nausea and vomiting , otalgia , trismus , fever , or halitosis between the groups ( P > @ ) .\\n',\n"," 'CONCLUSIONS\\tPreemptive montelukast can be used safely to reduce the serious pain caused by tonsillectomy in children .\\n',\n"," '\\n',\n"," '###24318863\\n',\n"," 'OBJECTIVE\\tMetastatic colon cancer patients are treated with the chemotherapy regimens , FOLFOX and FOLFIRI , in either order .\\n',\n"," 'OBJECTIVE\\tSo far , we can not predict the response of chemotherapeutic agent , so it is necessary to find which regimen is adequate before starting chemotherapy .\\n',\n"," 'METHODS\\tEnrolled patients are randomized into either conventional treatment or planned treatment preceded by pretreatment genetic analysis .\\n',\n"," 'METHODS\\tBlood samples of patients in planned treatment group ( N = @ ) were analyzed for the genetic polymorphism before selection of chemotherapeutic agents .\\n',\n"," 'METHODS\\tTarget genes were XPD-@ , GSTP-@-@ , XRCC@-@ for oxaliplatin , UGT@A@ for irinotecan .\\n',\n"," 'METHODS\\tThe response was measured by computed tomographic scan after completion of three cycles of chemotherapy .\\n',\n"," 'RESULTS\\tOverall response rate was significantly higher in planned group ( @ % vs. @ % , P = @ ) .\\n',\n"," 'RESULTS\\tIn FOLFOX group , response rate was significantly improved in the planned patients ( @ % vs. @ % , P = @ ) .\\n',\n"," \"RESULTS\\tIn FOLFIRI group , the difference did n't reach statistical significance ( @ % vs. @ % , P = @ ) .\\n\",\n"," 'CONCLUSIONS\\tWe found significantly improved response rates in the chemotherapy of metastatic colon cancer by pretreatment genetic analysis , especially in FOLFOX group .\\n',\n"," '\\n',\n"," '###25872502\\n',\n"," 'BACKGROUND\\tCardiac arrest causes ischaemic brain injury .\\n',\n"," 'BACKGROUND\\tArterial carbon dioxide tension ( PaCO@ ) is a major determinant of cerebral blood flow .\\n',\n"," 'BACKGROUND\\tThus , mild hypercapnia in the @ h following cardiac arrest may increase cerebral blood flow and attenuate such injury .\\n',\n"," 'BACKGROUND\\tWe describe the Carbon Control and Cardiac Arrest ( CCC ) trial .\\n',\n"," 'METHODS\\tThe CCC trial is a pilot multicentre feasibility , safety and biological efficacy randomized controlled trial recruiting adult cardiac arrest patients admitted to the intensive care unit after return of spontaneous circulation .\\n',\n"," 'METHODS\\tAt admission , using concealed allocation , participants are randomized to @ h of either normocapnia ( PaCO@ @ to @ mmHg ) or mild hypercapnia ( PaCO@ @ to @ mmHg ) .\\n',\n"," 'METHODS\\tKey feasibility outcomes are recruitment rate and protocol compliance rate .\\n',\n"," 'METHODS\\tThe primary biological efficacy and biological safety measures are the between-groups difference in serum neuron-specific enolase and S@b protein levels at @ h , @ h and @ h. Secondary outcome measure include adverse events , in-hospital mortality , and neurological assessment at @ months .\\n',\n"," 'CONCLUSIONS\\tThe trial commenced in December @ and , when completed , will provide clinical evidence as to whether targeting mild hypercapnia for @ h following intensive care unit admission for cardiac arrest patients is feasible and safe and whether it results in decreased concentrations of neurological injury biomarkers compared with normocapnia .\\n',\n"," 'CONCLUSIONS\\tTrial results will also be used to determine whether a phase IIb study powered for survival at @ days is feasible and justified .\\n',\n"," 'BACKGROUND\\tAustralian New Zealand Clinical Trials Registry ACTRN@ .\\n',\n"," '\\n',\n"," '###24226487\\n',\n"," 'BACKGROUND\\tFor decades thiopental has been considered as the hypnotic drug of choice for intracranial surgery .\\n',\n"," 'BACKGROUND\\tHowever , total intravenous anesthesia performed with thiopental is associated with delayed recovery , whereas early post-operative neurological evaluation is critical .\\n',\n"," 'BACKGROUND\\tFor this reason , target controlled infusion ( TCI ) of propofol is increasingly used for maintenance of anesthesia .\\n',\n"," 'BACKGROUND\\tHowever , a thiopental TCI has never been assessed for this purpose .\\n',\n"," 'BACKGROUND\\tWe tested the hypothesis that a thiopental TCI provides an acceptable way to achieve early recovery compared to a propofol TCI during supratentorial surgery .\\n',\n"," 'METHODS\\tEighty patients undergoing elective craniotomy for a supratentorial tumor were randomized to receive either a propofol TCI ( group P ) or a thiopental TCI ( group T ) .\\n',\n"," 'METHODS\\tBoth groups received a sufentanil TCI and the bispectral index was monitored .\\n',\n"," 'METHODS\\tThe primary end-point was time to tracheal extubation .\\n',\n"," 'METHODS\\tSecondary end-points were per - and post-operative hemodynamics as well as respiratory and recovery parameters .\\n',\n"," 'METHODS\\tAssessment of study end-points was performed by an intensive care specialist blinded ( like the patient ) to the received hypnotic .\\n',\n"," 'RESULTS\\tTime to extubation was significantly ( P < @ ) shorter in group P ( median @ minutes ; interquartile range @-@ minutes ) than in group T ( median @ minutes ; interquartile range @-@ minutes ) .\\n',\n"," 'RESULTS\\tSimilarly , the recovery parameters were significantly better in group P than in group T.\\n',\n"," 'RESULTS\\tThere was no difference between groups in terms of patient characteristics and hemodynamic parameters .\\n',\n"," 'CONCLUSIONS\\tEven with TCI and bispectral index monitoring , thiopental is associated with an inappropriate delayed recovery from supratentorial surgery compared to propofol TCI .\\n',\n"," '\\n',\n"," '###25539560\\n',\n"," 'OBJECTIVE\\tTo investigate the effects of conservative therapy applied before arthroscopic subacromial decompression on the clinical outcome in patients with stage @ shoulder impingement syndrome .\\n',\n"," 'METHODS\\tSixty-eight patients having stage @ shoulder impingement syndrome and treated with arthroscopic subacromial decompression were included in the study .\\n',\n"," 'METHODS\\tWe divided these patients into @ groups , whereby @ ( @ % ) patients received conservative therapy before arthroscopic subacromial decompression and @ ( @ % ) patients did not receive conservative therapy .\\n',\n"," 'METHODS\\tWe compared both groups in terms of the the Constant , UCLA , and VAS scores for shoulder pain before and after arthroscopic subacromial decompression .\\n',\n"," 'RESULTS\\tConstant , UCLA , and VAS scores were statistically significantly improved in both groups after arthroscopic subacromial decompression ( P < @ ) .\\n',\n"," 'RESULTS\\tConstant , UCLA , and VAS scores before arthroscopic subacromial decompression were statistically better in Group @ than in Group @ ( P < @ ) .\\n',\n"," 'RESULTS\\tNo statistically significant difference was found between the groups in terms of Constant , UCLA , and VAS scores after arthroscopic subacromial decompression ( P > @ ) .\\n',\n"," 'CONCLUSIONS\\tConservative therapy applied in patients with stage @ shoulder impingement syndrome before arthroscopic subacromial decompression does not have a positive contribution on the clinical outcome after arthroscopic subacromial decompression .\\n',\n"," '\\n',\n"," '###24401051\\n',\n"," 'BACKGROUND\\tObstructive sleep apnea is associated with considerable health risks .\\n',\n"," 'BACKGROUND\\tAlthough continuous positive airway pressure ( CPAP ) can mitigate these risks , effectiveness can be reduced by inadequate adherence to treatment .\\n',\n"," 'BACKGROUND\\tWe evaluated the clinical safety and effectiveness of upper-airway stimulation at @ months for the treatment of moderate-to-severe obstructive sleep apnea .\\n',\n"," 'METHODS\\tUsing a multicenter , prospective , single-group , cohort design , we surgically implanted an upper-airway stimulation device in patients with obstructive sleep apnea who had difficulty either accepting or adhering to CPAP therapy .\\n',\n"," 'METHODS\\tThe primary outcome measures were the apnea-hypopnea index ( AHI ; the number of apnea or hypopnea events per hour , with a score of @ indicating moderate-to-severe apnea ) and the oxygen desaturation index ( ODI ; the number of times per hour of sleep that the blood oxygen level drops by @ percentage points from baseline ) .\\n',\n"," 'METHODS\\tSecondary outcome measures were the Epworth Sleepiness Scale , the Functional Outcomes of Sleep Questionnaire ( FOSQ ) , and the percentage of sleep time with the oxygen saturation less than @ % .\\n',\n"," 'METHODS\\tConsecutive participants with a response were included in a randomized , controlled therapy-withdrawal trial .\\n',\n"," 'RESULTS\\tThe study included @ participants ; @ % were men .\\n',\n"," 'RESULTS\\tThe mean age was @ years , and the mean body-mass index ( the weight in kilograms divided by the square of the height in meters ) was @ .\\n',\n"," 'RESULTS\\tThe median AHI score at @ months decreased @ % , from @ events per hour to @ events per hour ( P < @ ) ; the ODI score decreased @ % , from @ events per hour to @ events per hour ( P < @ ) .\\n',\n"," 'RESULTS\\tSecondary outcome measures showed a reduction in the effects of sleep apnea and improved quality of life .\\n',\n"," 'RESULTS\\tIn the randomized phase , the mean AHI score did not differ significantly from the @-month score in the nonrandomized phase among the @ participants in the therapy-maintenance group ( @ and @ events per hour , respectively ) ; the AHI score was significantly higher ( indicating more severe apnea ) among the @ participants in the therapy-withdrawal group ( @ vs. @ events per hour , P < @ ) .\\n',\n"," 'RESULTS\\tThe ODI results followed a similar pattern .\\n',\n"," 'RESULTS\\tThe rate of procedure-related serious adverse events was less than @ % .\\n',\n"," 'CONCLUSIONS\\tIn this uncontrolled cohort study , upper-airway stimulation led to significant improvements in objective and subjective measurements of the severity of obstructive sleep apnea .\\n',\n"," 'CONCLUSIONS\\t( Funded by Inspire Medical Systems ; STAR ClinicalTrials.gov number , NCT@ . )\\n',\n"," '\\n',\n"," '###26126563\\n',\n"," 'OBJECTIVE\\tTo identify facilitators and barriers to clinical trial implementation in Aboriginal health services .\\n',\n"," 'METHODS\\tIndepth interview study with thematic analysis .\\n',\n"," 'METHODS\\tSix Aboriginal community-controlled health services and one government-run service involved in the Kanyini Guidelines Adherence with the Polypill ( KGAP ) study , a pragmatic randomised controlled trial that aimed to improve adherence to indicated drug treatments for people at high risk of cardiovascular disease .\\n',\n"," 'METHODS\\t@ health care providers and @ Aboriginal and Torres Strait Islander patients .\\n',\n"," 'RESULTS\\tA fundamental enabler was that participants considered the research to be governed and endorsed by the local health service .\\n',\n"," 'RESULTS\\tThat the research was perceived to address a health priority for communities was also highly motivating for both providers and patients .\\n',\n"," 'RESULTS\\tEnlisting the support of Aboriginal and Torres Strait Islander staff champions who were visible to the community as the main source of information about the trial was particularly important .\\n',\n"," 'RESULTS\\tThe major implementation barrier for staff was balancing their service delivery roles with adherence to often highly demanding trial-related procedures .\\n',\n"," \"RESULTS\\tThis was partially alleviated by the research team 's provision of onsite support and attempts to make trial processes more streamlined .\\n\",\n"," 'RESULTS\\tAlthough more intensive support was highly desired , there were usually insufficient resources to provide this .\\n',\n"," 'CONCLUSIONS\\tDespite strong community and health service support , major investments in time and resources are needed to ensure successful implementation and minimal disruption to already overstretched , routine services .\\n',\n"," 'CONCLUSIONS\\tTrial budgets will necessarily be inflated as a result .\\n',\n"," 'CONCLUSIONS\\tFunding agencies need to consider these additional resource demands when supporting trials of a similar nature .\\n',\n"," '\\n',\n"," '###24693629\\n',\n"," 'OBJECTIVE\\tTo compare the effect of incomplete caries removal ( ICR ) and indirect pulp capping ( IPC ) with calcium hydroxide ( CH ) or an inert material ( wax ) on color , consistency and contamination of the remaining dentin of primary molars .\\n',\n"," 'METHODS\\tThis double-blind , parallel-design , randomized controlled trial included @ children presenting one primary molar with deep caries lesion .\\n',\n"," 'METHODS\\tChildren were randomly assigned after ICR to receive IPC with CH or wax .\\n',\n"," 'METHODS\\tAll teeth were then restored with resin composite .\\n',\n"," 'METHODS\\tBaseline dentin color and consistency were evaluated after ICR , and dentin samples were collected for contamination analyses using scanning electron microscopy .\\n',\n"," 'METHODS\\tAfter @ months , restorations were removed and the three parameters were re-evaluated .\\n',\n"," 'METHODS\\tIn both groups , dentin became significantly darker after @ months .\\n',\n"," 'RESULTS\\tNo cases of yellow dentin were observed after @ months with CH compared to @ % of the wax cases ( P < @ ) .\\n',\n"," 'RESULTS\\tA statistically significant difference over time was observed only for CH regarding consistency .\\n',\n"," 'RESULTS\\tCH stimulated a dentin hardening process in a statistically higher number of cases than wax ( @ % vs. @ % ; P = @ ) .\\n',\n"," 'RESULTS\\tContamination changed significantly over time in CH and wax without significant difference between groups .\\n',\n"," 'RESULTS\\tIt was concluded that CH and wax arrested the carious process of the remaining carious dentin after indirect pulp capping , but CH showed superior dentin color and consistency after @ months .\\n',\n"," '\\n',\n"," '###24996519\\n',\n"," 'BACKGROUND\\tIn literature there is a general consensus that the use of the mirror improves proprioception .\\n',\n"," 'BACKGROUND\\tDuring rehabilitation the mirror is an important instrument to improve stability .\\n',\n"," 'BACKGROUND\\tIn some sports , such as dancing , mirrors are widely used during training .\\n',\n"," 'BACKGROUND\\tThe purpose of this study is to evaluate the effectiveness of the use of a mirror on balance in young dancers .\\n',\n"," 'BACKGROUND\\tSixty-four young dancers ( ranging from @-@ years ) were included in this study .\\n',\n"," 'BACKGROUND\\tThirty-two attending lessons with a mirror ( mirror - group ) were compared to @ young dancers that attended the same lessons without a mirror ( non-mirror group ) .\\n',\n"," 'BACKGROUND\\tBalance was evaluated by BESS ( Balance Error Scoring System ) , which consists of three stances ( double limb , single limb , and tandem ) on two surfaces ( firm and foam ) .\\n',\n"," 'BACKGROUND\\tThe errors were assessed at each stance and summed to create the two subtotal scores ( firm and foam surface ) and the final total score ( BESS ) .\\n',\n"," 'BACKGROUND\\tThe BESS was performed at recruitment ( T@ ) and after @months of dance lessons ( T@ ) .\\n',\n"," 'RESULTS\\tThe repeated measures ANOVA analysis showed that for the BESS total score there is a difference due to the time ( F = @ ; p < @ ) .\\n',\n"," 'RESULTS\\tNo other differences due to the group or to the time of measurement were found ( p > @ ) .\\n',\n"," 'RESULTS\\tThe analysis of the multiple regression model showed the influence of the values at T@ for every BESS items and the dominance of limb for stability on an unstable surface standing on one or two legs .\\n',\n"," 'CONCLUSIONS\\tThese preliminary results suggest that the use of a mirror in a ballet classroom does not improve balance acquisition of the dancer .\\n',\n"," 'CONCLUSIONS\\tOn the other hand , improvement found after @months confirms that at the age of the dancers studied motor skills and balance can easily be trained and improved .\\n',\n"," '\\n',\n"," '###25440306\\n',\n"," 'OBJECTIVE\\tLong-term follow-up studies documenting maintenance of treatment effects are fewin adolescent anorexia nervosa ( AN ) .\\n',\n"," 'OBJECTIVE\\tThis exploratory study reports relapse from full remission and attainment of remission during a @-year open follow-up period using a convenience sample of a subgroup of @ % ( n = @ ) from an original cohort of @ participants who completed a randomized clinical trial comparing family-based therapy ( FBT ) and adolescent-focused individual therapy ( AFT ) .\\n',\n"," 'METHODS\\tFollow-up assessments were completed up to @years posttreatment ( average , @ years ) .\\n',\n"," 'METHODS\\tAvailable participants completed the Eating Disorder Examination as well as self-report measures of self-esteem and depression at @ to @ years posttreatment .\\n',\n"," 'RESULTS\\tTwo participants ( @ % ) relapsed ( FBT : n = @ , @ % ; AFT : n = @ , @ % ) , on average @ years ( SD = @ years ) after remission was achieved at @-year follow-up .\\n',\n"," 'RESULTS\\tTen new participants ( @ % ) achieved remission ( FBT : n = @ , @ % ; AFT : n = @ , @ % ) .\\n',\n"," 'RESULTS\\tMean time to remission for this group was @ years ( SD = @ years ) from @-year follow-up .\\n',\n"," 'RESULTS\\tThere were no differences based on treatment group assignment in either relapse from full remission or new remission during long-term follow-up .\\n',\n"," 'RESULTS\\tOther psychopathology was stable over time .\\n',\n"," 'CONCLUSIONS\\tThere were few changes in the clinical presentation of participants who were assessed at long-term follow-up .\\n',\n"," 'CONCLUSIONS\\tThese data suggest that outcomes are generally stable posttreatment regardless of treatment type once remission is achieved .\\n',\n"," 'CONCLUSIONS\\tClinical trial registration information-Effectiveness of Family-Based Versus Individual Psychotherapy in Treating Adolescents With Anorexia Nervosa ; http://www.clinicaltrials.gov/; NCT@ .\\n',\n"," '\\n',\n"," '###24754891\\n',\n"," 'BACKGROUND\\tCoronary artery bypass grafting using the radial artery has , since the @s , gone through a revival .\\n',\n"," 'BACKGROUND\\tObservational studies have indicated better long-term patency when using radial arteries .\\n',\n"," 'BACKGROUND\\tTherefore , radial artery might be preferred especially in younger patients where long time patency is important .\\n',\n"," 'BACKGROUND\\tDuring the last @years different endoscopic techniques to harvest the radial artery have evolved .\\n',\n"," 'BACKGROUND\\tEndoscopic radial artery harvest only requires a small incision near the wrist in contrast to open harvest , which requires an incision from the elbow to the wrist .\\n',\n"," 'BACKGROUND\\tHowever , it is unknown whether the endoscopic technique results in fewer complications or a graft patency comparable to open harvest .\\n',\n"," 'BACKGROUND\\tWhen the radial artery has been harvested , there are two ways to use the radial artery as a graft .\\n',\n"," 'BACKGROUND\\tOne way is sewing it onto the aorta and another is sewing it onto the mammary artery .\\n',\n"," 'BACKGROUND\\tIt is unknown which technique is the superior revascularisation technique .\\n',\n"," 'METHODS\\tThe NEO Trial is a randomised clinical trial with a @ factorial design .\\n',\n"," 'METHODS\\tWe plan to randomise @ participants into four intervention groups : ( @ ) mammario-radial endoscopic group ; ( @ ) aorto-radial endoscopic group ; ( @ ) mammario-radial open surgery group ; and ( @ ) aorto-radial open surgery group.The hand function will be assessed by a questionnaire , a clinical examination , the change in cutaneous sensibility , and the measurement of both sensory and motor nerve conduction velocity at @months postoperatively .\\n',\n"," 'METHODS\\tAll the postoperative complications will be registered , and we will evaluate muscular function , scar appearance , vascular supply to the hand , and the graft patency including the patency of the central radial artery anastomosis .\\n',\n"," 'METHODS\\tA patency evaluation by multi-slice computer tomography will be done at one year postoperatively.We expect the nerve conduction studies and the standardised neurological examinations to be able to discriminate differences in hand function comparing endoscopic to open harvest of the radial artery .\\n',\n"," 'METHODS\\tThe trial also aims to show if there is any patency difference between mammario-radial compared to aorto-radial revascularisation techniques but this objective is exploratory .\\n',\n"," 'BACKGROUND\\tClinicalTrials.gov identifier : NCT@.Danish Ethics committee number : H-@-@-@ .\\n',\n"," 'BACKGROUND\\tDanish Data Protection Agency : @-@-@ / jr. n :@ -@ .\\n',\n"," '\\n',\n"," '###24284437\\n',\n"," 'BACKGROUND\\tKnowledge of essential amino acid requirements in infants is important because excessive intake of protein can lead to increased long-term morbidity such as obesity .\\n',\n"," 'BACKGROUND\\tA deficient intake may lead to suboptimal growth and impaired neurodevelopment .\\n',\n"," 'BACKGROUND\\tThe current recommended branched-chain amino acid requirements in infants aged @-@ mo are based on the amino acid content of human milk .\\n',\n"," 'OBJECTIVE\\tWe quantified the requirements for isoleucine , leucine , and valine for term neonates by using the indicator amino acid oxidation method with -LSB- @ - ( @ ) C -RSB- phenylalanine as the indicator .\\n',\n"," 'METHODS\\tFully enterally fed term infants received randomly graded amounts of isoleucine ( @-@ mg kg ( -@ ) d ( -@ ) ) , leucine ( @-@ mg kg ( -@ ) d ( -@ ) ) , or valine ( @-@ mg kg ( -@ ) d ( -@ ) ) as part of an elemental formula .\\n',\n"," 'METHODS\\tData are expressed as means SDs .\\n',\n"," 'RESULTS\\tEighty-three Asian , term neonates ( mean SD birth weight : @ @ kg ; gestational age : @ @ wk ) were studied at a postnatal age of @ @ d. Mean requirements for isoleucine , leucine , and valine ( measured in boys only ) were @ mg kg ( -@ ) d ( -@ ) ( r ( @ ) = @ , P < @ ) , @ mg kg ( -@ ) d ( -@ ) ( r ( @ ) = @ , P < @ ) , and @ mg kg ( -@ ) d ( -@ ) ( r ( @ ) = @ , P = @ ) , respectively .\\n',\n"," 'CONCLUSIONS\\tCurrent human milk-based recommendations for isoleucine and valine in term infants aged @-@ mo are correct .\\n',\n"," 'CONCLUSIONS\\tHowever , the current recommendation for leucine ( @ mg kg ( -@ ) d ( -@ ) ) is higher than the mean requirement of @ mg kg ( -@ ) d ( -@ ) that we determined in this study .\\n',\n"," 'CONCLUSIONS\\tThis trial was registered at www.trialregister.nl as NTR@ .\\n',\n"," '\\n',\n"," '###25585779\\n',\n"," 'OBJECTIVE\\tWe wanted to confirm the benefit of mometasone furoate ( MF ) in preventing acute radiation reactions , as shown in a previous study ( Bostrm et al , Radiother Oncol @ ; @:@ -@ ) .\\n',\n"," 'METHODS\\tThe study was a double-blind comparison of MF with D ( Diprobase ) , administered daily from the start of radiation therapy for @ weeks in patients receiving breast radiation therapy , @ Gy in @-Gy fractions daily over @ weeks .\\n',\n"," 'METHODS\\tThe primary endpoint was mean modified Radiation Therapy Oncology Group ( RTOG ) score .\\n',\n"," 'RESULTS\\tMean RTOG scores were significantly less for MF than for D ( P = @ ) .\\n',\n"," 'RESULTS\\tMaximum RTOG and mean erythema scores were significantly less for MF than for D ( P = @ and P = @ , respectively ) .\\n',\n"," 'RESULTS\\tThe Dermatology Life Quality Index ( DLQI ) score was significantly less for MF than for D at weeks @ and @ when corrected for Hospital Anxiety and Depression ( HAD ) questionnaire scores .\\n',\n"," 'CONCLUSIONS\\tMF cream significantly reduces radiation dermatitis when applied to the breast during and after radiation therapy .\\n',\n"," 'CONCLUSIONS\\tFor the first time , we have shown a significantly beneficial effect on quality of life using a validated instrument ( DLQI ) , for a topical steroid cream .\\n',\n"," 'CONCLUSIONS\\tWe believe that application of this cream should be the standard of care where radiation dermatitis is expected .\\n',\n"," '\\n',\n"," '###24332668\\n',\n"," 'OBJECTIVE\\tTo compare the interstage cardiac catheterization hemodynamic and angiographic findings between shunt types for the Pediatric Heart Network Single Ventricle Reconstruction trial .\\n',\n"," 'OBJECTIVE\\tThe trial , which randomized subjects to a modified Blalock-Taussig shunt ( MBTS ) or right ventricle-to-pulmonary artery shunt ( RVPAS ) for the Norwood procedure , demonstrated the RVPAS was associated with a smaller pulmonary artery diameter but superior @-month transplant-free survival .\\n',\n"," 'METHODS\\tWe analyzed the pre-stage II catheterization data for the trial subjects .\\n',\n"," 'METHODS\\tThe hemodynamic variables and shunt and pulmonary angiographic data were compared between shunt types ; their association with @-month transplant-free survival was also evaluated .\\n',\n"," 'RESULTS\\tOf @ randomized subjects , @ underwent pre-stage II catheterization .\\n',\n"," 'RESULTS\\tA smaller size , lower aortic and superior vena cava saturation , and higher ventricular end-diastolic pressure were associated with worse @-month transplant-free survival .\\n',\n"," 'RESULTS\\tThe MBTS group had a lower coronary perfusion pressure ( @ vs @ mm Hg ; P < @ ) and greater pulmonary blood flow/systemic blood flow ratio ( @ vs @ , P = @ ) .\\n',\n"," 'RESULTS\\tA greater pulmonary blood flow/systemic blood flow ratio increased the risk of death or transplantation only in the RVPAS group ( P = @ ) .\\n',\n"," 'RESULTS\\tThe MBTS group had fewer shunt ( @ % vs @ % , P = @ ) and severe left pulmonary artery ( @ % vs @ % , P = @ ) stenoses , larger mid-main branch pulmonary artery diameters , and greater Nakata indexes ( @ vs @ , P < @ ) .\\n',\n"," 'CONCLUSIONS\\tCompared with the RVPAS subjects , the MBTS subjects had more hemodynamic abnormalities related to shunt physiology , and the RVPAS subjects had more shunt or pulmonary obstruction of a severe degree and inferior pulmonary artery growth at pre-stage II catheterization .\\n',\n"," 'CONCLUSIONS\\tA lower body surface area , greater ventricular end-diastolic pressure , and lower superior vena cava saturation were associated with worse @-month transplant-free survival .\\n',\n"," '\\n',\n"," '###24379356\\n',\n"," 'OBJECTIVE\\tIt has been hypothesized that the development of diabetic polyneuropathy ( DPN ) is due to swelling of the nerve , as well as thickening and stiffening of the surrounding ligaments , causing chronic compression of nerves .\\n',\n"," 'OBJECTIVE\\tWe aimed to examine the effect of surgical decompression of the tibial nerve on the mean cross-sectional area ( CSA ) .\\n',\n"," 'METHODS\\tWe performed a randomized controlled trial of @ subjects with painful DPN diagnosed using the Diabetic Neuropathy Score .\\n',\n"," 'METHODS\\tA computer randomized for the surgery arm of the study .\\n',\n"," 'METHODS\\tA control group consisting of @ healthy subjects was included .\\n',\n"," 'METHODS\\tAn experienced sonographer measured the CSA and thickness-to-width ( T/W ) ratio of the tibial nerve , as well as the thickness of the flexor retinaculum .\\n',\n"," 'RESULTS\\tCSA is significantly larger in patients with painful DPN ( @ @ mm ( @ ) ) than in control subjects ( @ @ mm ( @ ) ) , P = @ .\\n',\n"," 'RESULTS\\tThe T/W ratio in patients with painful DPN is @ and in control subjects @ , P = @ .\\n',\n"," 'RESULTS\\tPatients with DPN have a significantly thicker retinaculum ( @ mm ) than control subjects ( @ mm ) , P < @ .\\n',\n"," 'RESULTS\\tMean follow-up was @ weeks ( range @-@ ) .\\n',\n"," 'RESULTS\\tDifference between baseline and follow-up in the operated leg was @ mm ( @ ) and in the control leg @ mm ( @ ) , P = @ .\\n',\n"," 'CONCLUSIONS\\tDecompression of the tibial nerve does not result in a significant difference between baseline and follow-up in CSA using ultrasound between the operated and control leg .\\n',\n"," 'CONCLUSIONS\\tUltrasound measurements show a significantly increased CSA , a significantly thicker retinaculum , and a significantly increased T/W ratio in patients with painful DPN compared with healthy control subjects .\\n',\n"," 'CONCLUSIONS\\tClinical trial reg .\\n',\n"," 'CONCLUSIONS\\tno .\\n',\n"," 'CONCLUSIONS\\tNTR@ , www.trialregister.nl .\\n',\n"," '\\n',\n"," '###25018097\\n',\n"," 'BACKGROUND\\tA community-based randomized trial was conducted in Costa Rica to evaluate the HPV-@ / @ AS@-adjuvanted vaccine ( NCT@ ) .\\n',\n"," 'BACKGROUND\\tThe primary objective was to evaluate efficacy of the vaccine to prevent cervical intraepithelial neoplasia @ or more severe disease ( CIN@ + ) associated with incident HPV-@ / @ cervical infections .\\n',\n"," 'BACKGROUND\\tSecondary objectives were to evaluate efficacy against CIN@ + associated with incident cervical infection by any oncogenic HPVs and to evaluate duration of protection against incident cervical infection with HPV-@ / @ .\\n',\n"," 'BACKGROUND\\tVaccine safety and immunogenicity over the @-year follow-up were also evaluated .\\n',\n"," 'METHODS\\tWe randomized ( @ HPV arm ; @ control arm ) , vaccinated ( HPV-@ / @ or Hepatitis A ) and followed ( median @ months ) @ healthy women aged @-@ years .\\n',\n"," 'METHODS\\t@ women ( @ HPV arm ; @ control arm ) were included in the according to protocol analysis for efficacy .\\n',\n"," 'METHODS\\tThe full cohort was evaluated for safety .\\n',\n"," 'METHODS\\tImmunogenicity was considered on a subset of @ ( HPV-@ ) and @ ( HPV-@ ) women .\\n',\n"," 'METHODS\\tHPV type was assessed by PCR on cervical specimens .\\n',\n"," 'METHODS\\tImmunogenicity was assessed using ELISA and inhibition enzyme immunoassays .\\n',\n"," 'METHODS\\tDisease outcomes were histologically confirmed .\\n',\n"," 'METHODS\\tVaccine efficacy and @ % confidence intervals ( @ % CI ) were computed .\\n',\n"," 'RESULTS\\tVaccine efficacy was @ % ( @ % CI : @-@ @ ; N = @ events total ) against HPV-@ / @ associated CIN@ + , @ % ( @ % CI : @-@ @ ; N = @ events total ) against CIN@ + associated with non-HPV-@ / @ oncogenic HPVs and @ % ( @ % CI : @-@ @ ; N = @ events total ) against CIN@ + irrespective of HPV type .\\n',\n"," 'RESULTS\\tThe vaccine had an acceptable safety profile and induced robust and long-lasting antibody responses .\\n',\n"," 'CONCLUSIONS\\tOur findings confirm the high efficacy and immunogenicity of the HPV-@ / @ vaccine against incident HPV infections and cervical disease associated with HPV-@ / @ and other oncogenic HPV types .\\n',\n"," 'CONCLUSIONS\\tThese results will serve as a benchmark to which we can compare future findings from the ongoing extended follow-up of participants in the Costa Rica trial .\\n',\n"," 'BACKGROUND\\tRegistered with clinicaltrials.gov : NCT@ .\\n',\n"," '\\n',\n"," '###24736930\\n',\n"," 'BACKGROUND\\tThere is a long-held concept among spine surgeons that endoscopic lumbar discectomy procedures are reserved for small-contained disc herniation ; @-year follow-up has not been reported .\\n',\n"," 'BACKGROUND\\tThe purpose of this study is to assess microendoscopic discectomy ( MED ) in patients with large uncontained lumbar disc herniation ( the antero-posterior diameter of the extruded fragment is @-@ mm or more on axial cuts of MRI ) and report long-term outcome .\\n',\n"," 'METHODS\\tOne hundred eighty-five patients with MED or standard open discectomy underwent follow-up for @ years .\\n',\n"," 'METHODS\\tPrimary ( clinical ) outcomes data included Numerical Rating Scale ( NRS ) for back and leg symptoms and Oswestry Disability Index ( ODI ) to quantify pain and disability , respectively .\\n',\n"," 'METHODS\\tSecondary ( objective ) outcomes data included operative time , blood loss , postoperative analgesics , length of hospital stay , time to return to work , reoperation and complication rate , patient satisfaction index ( PSI ) , and modified ( MacNab ) criteria .\\n',\n"," 'RESULTS\\tAt the end of the follow-up , the leg pain relief was statistically significant for both groups .\\n',\n"," 'RESULTS\\tNRS back pain , ODI , PSI and MacNab criteria showed significant deterioration for control group .\\n',\n"," 'RESULTS\\tSecondary outcomes data of MED group were significantly better than the control group .\\n',\n"," 'CONCLUSIONS\\tLarge , uncontained , lumbar disc herniations can be sufficiently removed using MED which is an effective alternative to open discectomy procedures with remarkable long-term outcome .\\n',\n"," 'CONCLUSIONS\\tAlthough the neurological outcome of the two procedures is the same , the morbidity of MED is significantly less than open discectomy .\\n',\n"," 'CONCLUSIONS\\tMaximum benefit can be gained if we adhere to strict selection criteria .\\n',\n"," 'CONCLUSIONS\\tThe optimum indication is single - or multi-level radiculopathy secondary to a single-level , large , uncontained , lumbar disc herniation .\\n',\n"," '\\n',\n"," '###25498992\\n',\n"," 'BACKGROUND\\tHeart failure ( HF ) patients suffer from frequent and repeated hospitalizations , causing a substantial economic burden on society .\\n',\n"," 'BACKGROUND\\tHospitalizations can be reduced considerably by better compliance with self-care .\\n',\n"," \"BACKGROUND\\tHome telemonitoring has the potential to boost patients ' compliance with self-care , although the results are still contradictory .\\n\",\n"," 'OBJECTIVE\\tA randomized controlled trial was conducted in order to study whether the multidisciplinary care of heart failure patients promoted with telemonitoring leads to decreased HF-related hospitalization .\\n',\n"," 'METHODS\\tHF patients were eligible whose left ventricular ejection fraction was lower than @ % , NYHA functional class @ , and who needed regular follow-up .\\n',\n"," 'METHODS\\tPatients in the telemonitoring group ( n = @ ) measured their body weight , blood pressure , and pulse and answered symptom-related questions on a weekly basis , reporting their values to the heart failure nurse using a mobile phone app .\\n',\n"," 'METHODS\\tThe heart failure nurse followed the status of patients weekly and if necessary contacted the patient .\\n',\n"," 'METHODS\\tThe primary outcome was the number of HF-related hospital days .\\n',\n"," 'METHODS\\tControl patients ( n = @ ) received multidisciplinary treatment according to standard practices .\\n',\n"," \"METHODS\\tPatients ' clinical status , use of health care resources , adherence , and user experience from the patients ' and the health care professionals ' perspective were studied .\\n\",\n"," 'RESULTS\\tAdherence , calculated as a proportion of weekly submitted self-measurements , was close to @ % .\\n',\n"," 'RESULTS\\tNo difference was found in the number of HF-related hospital days ( incidence rate ratio -LSB- IRR -RSB- = @ , P = @ ) , which was the primary outcome .\\n',\n"," 'RESULTS\\tThe intervention group used more health care resources : they paid an increased number of visits to the nurse ( IRR = @ , P < @ ) , spent more time at the nurse reception ( mean difference of @ minutes , P < @ ) , and there was a greater number of telephone contacts between the nurse and intervention patients ( IRR = @ , P < @ for nurse-induced contacts and IRR = @ , P = @ for patient-induced contacts ) .\\n',\n"," \"RESULTS\\tThere were no statistically significant differences in patients ' clinical health status or in their self-care behavior .\\n\",\n"," 'RESULTS\\tThe technology received excellent feedback from the patient and professional side with a high adherence rate throughout the study .\\n',\n"," \"CONCLUSIONS\\tHome telemonitoring did not reduce the number of patients ' HF-related hospital days and did not improve the patients ' clinical condition .\\n\",\n"," 'CONCLUSIONS\\tPatients in the telemonitoring group contacted the Cardiology Outpatient Clinic more frequently , and on this way increased the use of health care resources .\\n',\n"," 'BACKGROUND\\tClinicaltrials.gov NCT@ ; http://clinicaltrials.gov/show/NCT@ ( Archived by WebCite at http://www.webcitation.org/@UFxiCk@Z ) .\\n',\n"," '\\n',\n"," '###24411490\\n',\n"," 'OBJECTIVE\\tProbiotics help maintain balance in composition of the gut microbiota , and have been considered as a potential treatment for obesity .\\n',\n"," 'OBJECTIVE\\tThis study was conducted in order to assess the effects of probiotics when combined with herbal medicine in treatment of obesity .\\n',\n"," 'OBJECTIVE\\tProbiotics were tested for the ability to modulate gut microbiota , gut permeability , and endotoxin level , which may have correlation with factors involved in obesity .\\n',\n"," 'METHODS\\tA randomized , double-blind , placebo controlled study was conducted , in which patients with higher BMI ( > @kg/m ( @ ) ) and waist circumference ( > @cm ) were enrolled and randomly assigned to receive Bofutsushosan with either probiotics or placebo capsules for a period of eight weeks .\\n',\n"," 'METHODS\\tAssessment of body composition parameters , metabolic biomarkers , endotoxin level , gut permeability , and fecal bacteria in stool was performed at baseline and at week @ .\\n',\n"," 'METHODS\\tThe study was registered at the Clinical Research Information Service , approved by the Korea National Institute of Health ( KCT@ ) .\\n',\n"," 'RESULTS\\tAlthough both groups showed a significant reduction in weight and waist circumference ( p = @ ) , no significant differences in body composition and metabolic markers were observed .\\n',\n"," 'RESULTS\\tIn correlation analysis , change in body composition showed positive correlation with endotoxin level ( r = @ , p < @ for BW ; and r = @ , p < @ for fat mass ) and the population of gut Lactobacillus plantarum ( r = @ , p < @ for BW ; and r = @ , p < @ for BMI ) .\\n',\n"," 'RESULTS\\tThe Gram negative bacterial population in gut also exhibited positive correlation with changes in body composition ( WC ) and total cholesterol level ( r = @ , and @ , for the former and later parameters , respectively , p < @ for both ) .\\n',\n"," 'RESULTS\\tWhile , the profile of gut Bifidobacterium breve population showed negative correlation with endotoxin level ( r = -@ , p < @ ) .\\n',\n"," 'CONCLUSIONS\\tCorrelations between gut microbiota and change in body composition indicate that probiotics may influence energy metabolism in obesity .\\n',\n"," 'CONCLUSIONS\\tCorrelation between endotoxin level and weight reduction indicates that probiotics may play an important role in prevention of endotoxin production , which can lead to gut microbiota dysbiosis associated with obesity .\\n',\n"," '\\n',\n"," '###24471516\\n',\n"," 'OBJECTIVE\\tThe objective of this study is to analyze the effects of a @-week indoor intermittent training program on lung function , physical capacity , body composition and quality of life in children with asthma .\\n',\n"," 'METHODS\\tParticipants were randomized in an experimental group ( EG , @ children , age = @ years ) and in a control group ( CG , @ children , age = @ years ) .\\n',\n"," 'METHODS\\tThe training program was conducted indoors and consisted of alternating high - and low-intensity stimuli , for three sessions of @min/week , for @ weeks .\\n',\n"," \"METHODS\\tPhysical exercise and sports activities were organized to follow the criteria of the American College of Sports Medicine ( @ ) and previous interventions ' studies .\\n\",\n"," 'RESULTS\\tIn EG , there was a significant improvement ( p < @ ) in FEV@ , FEV@ , @MWT , handgrip strength , CMJ and flexibility .\\n',\n"," 'RESULTS\\tReductions in BMI and fat mass as well as an increase in quality of life were all shown .\\n',\n"," 'RESULTS\\tThe dyspnea index decreased significantly and there were no episodes of EIA .\\n',\n"," 'RESULTS\\tThere is a significant positive correlation ( p < @ ) between the FEV@ with handgrip strength and @MWT and a negative correlation with fat mass .\\n',\n"," 'CONCLUSIONS\\tAn indoor intermittent training program with these characteristics has improved lung function , physical capacity , body composition and quality of life in children with asthma .\\n',\n"," 'CONCLUSIONS\\tThese training adaptations are particularly relevant for those patients suffering from asthma as a regular physical exercise routine will greatly improve their quality of life .\\n',\n"," '\\n',\n"," '###26255514\\n',\n"," 'OBJECTIVE\\tTo observe the efficacy of catgut implantation at back-shu points in treatment of mild perimenopausal depression of kidney , deficiency and liver stagnation syndrome and analyze its essential function on target symptoms .\\n',\n"," 'METHODS\\tForty-five cases were randomized into a catgut implantation group ( @ cases ) and atid acupuncture group ( @ cases ) .\\n',\n"," 'METHODS\\tIn the catgut implantation group , catguts were implanted at Shenshu ( BL @ ) , Ganshu ( BL @ ) , Xinshu ( BL @ ) , Pishu ( BL @ ) , etc. , once every week .\\n',\n"," 'METHODS\\tIn the acupuncture group , the conventional acupuncture was applied to the same acupoints as the catgut implantation group , once every two days .\\n',\n"," 'METHODS\\tThe : treatment of @ weeks made one session , and continuous @ sessions were required .\\n',\n"," 'METHODS\\tThe efficacy was evaluated in , @ sessions .\\n',\n"," 'METHODS\\tThe follow-up started in the @th week .\\n',\n"," 'METHODS\\tBefore treatment , after treatment and in the follow-up period , Kupperman score and the total score in Hamilton depression scale ( HAMD ) , as well as the factor score were observed in the patients separately .\\n',\n"," 'RESULTS\\tKupperman score , the total HAMD score and the scores in the items of anxiety/somatization , retardation , sleep disorder and cognitive disorder after treatment were all reduced significantly as compared with those before treatment in the two groups ( P < @ , P < @ ) .\\n',\n"," 'RESULTS\\tIn the follow-up period , the difference in Kupperman was not significant in comparison with that after treatment in the catgut implantation : group ( P > @ ) .\\n',\n"," 'RESULTS\\tThe total HAMD score and sleep disorder were reduced significantly as compared with those after treatment in the catgut implantation group ( both P < @ ) ; in the acupuncture group , Kupperman score , the total HAMD score and sleep disorder were all increased as compared with those after treatment ( all P < @ ) .\\n',\n"," 'RESULTS\\tIn ; the catgut implantation group , the total HAMD score was lower than that in the acupuncture group ( P < @ ) , and the scores in the items of retardation and sleep disorder were reduced significantly as compared with those in the acupuncture group ( both P < @ ) .\\n',\n"," 'CONCLUSIONS\\tThe catgut implantation at back-shu points alleviates perimenopasual sympton is in patients of mild perimenopausal depression of kidney deficiency and liver stagnation syndrome .\\n',\n"," \"CONCLUSIONS\\tThis therapy effectively relieves depressive disorders by regulating the target symptoms such as anxiety / somatization , retardation , sleep disorder and cognitive ' disorder .\\n\",\n"," 'CONCLUSIONS\\tThe long-term efficacy of this therapy is better than the conventional acupuncture .\\n',\n"," '\\n',\n"," '###24952391\\n',\n"," 'OBJECTIVE\\tUp to @ % of patients who undergo a percutaneous coronary intervention show some limitation in the use of drug-eluting stents .\\n',\n"," 'OBJECTIVE\\tThe aim of this study was to evaluate if titanium-nitride-oxide-coated stents could be a good alternative to everolimus-eluting stents in diabetic patients .\\n',\n"," 'METHODS\\tA total of @ diabetic patients with lesions at moderate risk of restenosis ( exclusion criteria : diameter < @ mm or length > @ mm in vessels < @mm , chronic occlusion ) were randomized to a titanium group ( @ patients ) or an everolimus group ( @ patients ) .\\n',\n"," 'RESULTS\\tBaseline characteristics were well balanced ; @ % of patients were insulin dependent .\\n',\n"," 'RESULTS\\tAt @ year , the incidence of major adverse cardiac events ( death , nonfatal myocardial infarction , stroke , or repeat target vessel revascularization ) was significantly higher in the titanium group than in the everolimus group ( total , @ % vs @ % ; P = @ ; noninsulin-dependent subgroup , @ % vs @ % ; P = @ ; insulin-dependent subgroup , @ % vs @ % ; P = @ ) .\\n',\n"," 'RESULTS\\tThe incidence of death , nonfatal myocardial infarction , stroke , or any revascularization was @ % in the titanium group and @ % in the everolimus group ( P = @ ) .\\n',\n"," 'RESULTS\\tTarget lesion and vessel revascularizations occurred in @ % compared with @ % ( P = @ ) and in @ % compared with @ % ( P = @ ) in the titanium and everolimus groups , respectively .\\n',\n"," 'RESULTS\\tAngiographic follow-up at @ months showed significantly less late lumen loss in the everolimus group ( in-segment , @ -LSB- standard deviation , @ ) mm vs -@ -LSB- @ -RSB- mm ; in-stent , @ -LSB- @ -RSB- mm vs @ -LSB- @ -RSB- mm ; P < @ ) .\\n',\n"," 'CONCLUSIONS\\tThe everolimus-eluting stent is superior to the titanium stent for clinical and angiographic end points in diabetic patients with lesions at moderate risk of restenosis .\\n',\n"," '\\n',\n"," '###25516006\\n',\n"," 'OBJECTIVE\\tTo evaluate the safety of the fixed combination of ibuprofen and famotidine compared with ibuprofen alone from two @-week , multicenter , double-blind trials designed to evaluate the comparative incidence of endoscopically documented upper gastrointestinal ulcers and a @-week double-blind extension study .\\n',\n"," 'METHODS\\tSafety was analyzed by pooling data from the two double-blind trials and the follow-on study .\\n',\n"," 'METHODS\\tSafety was assessed by monitoring the incidence , causality , and severity of adverse events ( AEs ) .\\n',\n"," 'RESULTS\\tIn the pivotal efficacy and safety trials , discontinuation rates due to any cause and dyspepsia were significantly lower for the ibuprofen/famotidine combination versus ibuprofen alone .\\n',\n"," 'RESULTS\\tOther than dyspepsia , gastrointestinal and cardiovascular AEs of special interest were similar .\\n',\n"," 'RESULTS\\tEvents judged to be treatment related were significantly lower with the ibuprofen/famotidine combination ( @ % vs. @ % ) .\\n',\n"," 'RESULTS\\tIn the safety extension population , there were no differences in the discontinuation rates and the reporting of AEs or serious AEs ( SAEs ) between the two groups .\\n',\n"," 'RESULTS\\tGastrointestinal-related events were similar between the groups .\\n',\n"," 'RESULTS\\tIncidence of cardiovascular-related AEs of special interest were @ % ( ibuprofen/famotidine ) and @ % ( ibuprofen ) ( p = @ ) , possibly due to a higher number of rheumatoid arthritis patients in the combination group .\\n',\n"," 'RESULTS\\tOf these , @ % were reports of hypertension ( @ % ibuprofen/famotidine vs. @ % ibuprofen ) .\\n',\n"," 'RESULTS\\tThree cases of hypertension in the ibuprofen/famotidine group were considered treatment related .\\n',\n"," 'RESULTS\\tThe probability of a cardiovascular event decreased during days @-@ of treatment and remained low with continued treatment .\\n',\n"," 'CONCLUSIONS\\tOne-year safety data from two pivotal trials and a long-term extension study indicate that the ibuprofen/famotidine combination demonstrates a favorable gastrointestinal safety profile and more patients continued on therapy compared to ibuprofen alone .\\n',\n"," 'CONCLUSIONS\\tNo new safety signals have been identified .\\n',\n"," 'CONCLUSIONS\\tThese data offer additional evidence supporting a new therapeutic option to improve gastrointestinal safety and adherence for patients who require long-term ibuprofen .\\n',\n"," '\\n',\n"," '###24851689\\n',\n"," 'OBJECTIVE\\tTo compare the effects of volume-controlled ventilation ( VCV ) and pressure-controlled volume-guaranteed ( PCV-VG ) mode during one-lung ventilation ( OLV ) on circulation , pulmonary function and lung injury .\\n',\n"," 'METHODS\\t@ February to @ March in Ningbo No@ .\\n',\n"," 'METHODS\\tHospital cardiothoracic surgery , @ patients aged @ to @ years ( ASA grade II-III ) undergoing elective thoracoscopic lobectomy were randomly divided into VCV group and PCV-VG group , with @ cases in each group .\\n',\n"," 'METHODS\\tAfter anesthesia induction and endotracheal intubation , endobronchial blocker was inserted to start OLV .\\n',\n"," 'METHODS\\tHeart rate ( HR ) , mean arterial pressure ( MAP ) , measured tidal volume ( TV ) , peak airway pressure ( Ppeak ) , airway resistance ( Raw ) , chest compliance ( Cdyn ) and the end-tidal carbon dioxide pressure ( PetCO ( @ ) ) were recorded at the time point of @ minutes after turning to the lateral position , @ minutes and @ minutes after OLV , and @ minutes after the resumption of two lung ventilation .\\n',\n"," 'METHODS\\tIn the meanwhile , arterial blood gas analysis was conducted to measure indicators of pH , oxygen tension ( PaO ( @ ) ) and carbon dioxide partial pressure ( PaCO ( @ ) ) .\\n',\n"," 'METHODS\\tBlood was drawn before induction , @ hour after OLV and @ hour after the end of surgery , and the concentration of interleukin-@ ( IL-@ ) and tumor necrosis factor-alpha ( TNF - ) were detected by enzyme-linked immunosorbent assay ( ELISA ) .\\n',\n"," 'RESULTS\\tHR , MAP , TV , PetCO ( @ ) , pH and PaCO ( @ ) in two groups at the time point of @ minutes after turning to the lateral position , @ minutes and @ minutes after OLV , and @ minutes after the resumption of two lung ventilation showed no significant difference ( P > @ ) .\\n',\n"," 'RESULTS\\tAt the point of @ minutes after turning to the lateral position and @ minutes after two lung ventilation , Ppeak and Cdyn of two groups were significantly different ( P < @ ) ( Ppeak :@ @ cmH ( @ ) O , @ @ cmH ( @ ) O for VCV group and @ @ cmH ( @ ) O , @ @ cmH ( @ ) O for PCV-VG group ; Cdyn : @ @ ml/cmH ( @ ) O , @ @ ml/cmH@O for VCV group and @ @ ml/cmH ( @ ) O , @ @ ml/cmH ( @ ) O for PCV-VG group ) .\\n',\n"," 'RESULTS\\tCompared with VCV group , PCV-VG group showed a lower Ppeak @ minutes and @ minutes after OLV -LSB- ( @ @ cmH ( @ ) O ) vs ( @ @ cmH ( @ ) O ) and ( @ @ cmH ( @ ) O ) vs ( @ @ cmH ( @ ) O ) with a higher Cdyn at the same point ( @ @ ml/cmH ( @ ) O ) vs ( @ @ ml/cmH ( @ ) O ) and @ @ ml/cmH ( @ ) O ) vs ( @ @ ml/cmH ( @ ) O ) -RSB- ( P < @ ) .\\n',\n"," 'RESULTS\\tCompared with VCV group,IL-@ and TNF - of PCV-VG group @ hour after OLV and @ hour after the end of surgery were significantly lower ( P < @ ) ( IL-@ : @ @ vs @ @ pg/ml and @ @ vs @ @ pg/ml ; TNF - : @ @ vs @ @ pg/ml and @ @ vs. @ @ pg/ml ) .\\n',\n"," 'CONCLUSIONS\\tDuring one-lung ventilation in thoracoscopic lobectomy , PCV-VG mode has a competitive advantage over VCV mode in terms of pulmonary function and lung protection .\\n',\n"," '\\n',\n"," '###24748400\\n',\n"," 'OBJECTIVE\\tWe compared the recovery profile of propofol and sevoflurane when used for maintenance of anesthesia in elective day care operative procedures .\\n',\n"," 'METHODS\\tOne hundred ASA physical status I and II patients , aged between @ and @ years , were randomly assigned to receive either propofol-nitrous oxide or sevoflurane-nitrous oxide maintenance of anesthesia .\\n',\n"," 'METHODS\\tEarly and intermediate recovery in terms of cognitive and ambulatory functions was recorded .\\n',\n"," 'METHODS\\tPsychomotor testing , in the form of Trieger dot test and digit symbol substitution test , were performed before surgery and in the post-anesthesia care unit at @ min , @ min , @ h , @ h , and @ h following nitrous oxide switch-off to evaluate intermediate recovery .\\n',\n"," \"RESULTS\\tThere were no significant differences in recovery of early cognitive functions between the two groups , except that patients in the sevoflurane group were more responsive at around @ min following nitrous oxide switch-off and `` recalled address '' earlier than patients in the propofol group .\\n\",\n"," \"RESULTS\\tThere was no significant difference in between the two groups with regard to `` home-readiness . ''\\n\",\n"," \"CONCLUSIONS\\tRecovery from sevoflurane anesthesia , especially with regard to cognitive functions , may be slightly faster than from propofol , but the difference is not sufficiently significant to affect the time to `` home-readiness '' in patients undergoing day care surgery .\\n\",\n"," '\\n',\n"," '###24594499\\n',\n"," \"BACKGROUND\\tVertigo imposes considerable health restrictions with significant impact on the patient 's quality of life .\\n\",\n"," 'BACKGROUND\\tThe most effective antivertigo agent is undetermined thus far .\\n',\n"," 'OBJECTIVE\\tThis study was performed to assess whether promethazine has superior vertigo reduction compared with lorazepam in ED patients .\\n',\n"," 'METHODS\\tIn this randomized , double-blind , parallel group trial @ patients were assigned ( @:@ ratio ) to receive either promethazine , @ mg intravenously , or lorazepam , @ mg intravenously .\\n',\n"," 'METHODS\\tPrimary endpoint was mean change in vertigo intensity at @ hours measured using visual analog scale ( VAS ) .\\n',\n"," 'METHODS\\tSecondary endpoints were mean change in nausea score , need for second dose of study medications , and adverse events ( AEs ) .\\n',\n"," 'RESULTS\\tPromethazine was associated with significantly more reduction ( @ mm ) in vertigo than lorazepam ( @ mm , p < @ ) .\\n',\n"," 'RESULTS\\tMean change in nausea score @ hours after drug injection on the VAS was @ mm for promethazine and @ for lorazepam ( p = @ ) .\\n',\n"," 'RESULTS\\tThe most frequently reported AEs were lethargy ( @ % in lorazepam group , @ % in promethazine group , p = @ ) and drowsiness ( @ % for promethazine , @ % for lorazepam , p = @ ) .\\n',\n"," 'CONCLUSIONS\\tOur study demonstrated the evidence that promethazine is superior to lorazepam in management of peripheral vertigo and vertigo-related nausea in ED adults .\\n',\n"," '\\n',\n"," '###24604111\\n',\n"," 'BACKGROUND\\tDuring lower limb lengthening , distraction-induced muscle pain and surrounding joint contractures are frustrating complications for which few effective treatments are available .\\n',\n"," 'OBJECTIVE\\tWe evaluated Botulinum Toxin Type A ( BtX-A ) injection in the calf muscles during human tibial distraction osteogenesis .\\n',\n"," 'OBJECTIVE\\tWe hypothesized that it may decrease calf pain and increase ROM of the surrounding joints by reducing muscle stiffness .\\n',\n"," 'METHODS\\tBetween April @ and January @ , we evaluated @ patients undergoing bilateral tibia lengthening who met prespecified inclusion criteria .\\n',\n"," 'METHODS\\tAll patients underwent stature lengthening with lengthening over a nail or lengthening and then nailing .\\n',\n"," 'METHODS\\tBtX-A ( @IU ) was injected at the calf muscle only in one leg for each patient and the same amount of sterile normal saline was injected into the other leg as a control .\\n',\n"," 'METHODS\\tSelection of the leg receiving the toxin was randomized .\\n',\n"," 'METHODS\\tClinical evaluation included a VAS score for calf pain and measurement of ROM of the knees and ankles and calf circumference , with evaluations performed in a double-blinded manner .\\n',\n"," 'METHODS\\tSide-to-side differences were analyzed until the end of consolidation phase .\\n',\n"," 'METHODS\\tMinimum followup was @months ( mean , @months ; range , @-@months ) .\\n',\n"," 'METHODS\\tThe distraction rate and the final length gain were similar in the treated and control limbs .\\n',\n"," 'METHODS\\tA priori power analysis suggested that @ legs were required to achieve statistical significance of @ with @ % of power to detect a @ % difference in treatment effect between treatment and control groups .\\n',\n"," 'RESULTS\\tThere were no differences in calf pain , knee and ankle ROM , and maximal calf circumferences between the two legs at each time point .\\n',\n"," 'CONCLUSIONS\\tLocal injection of @IU BtX-A at the human calf muscle does not appear to reduce calf pain or help enhance ROM of the knee and ankle during tibial lengthening .\\n',\n"," 'CONCLUSIONS\\tHowever , the small sample size provided sufficient power to detect only relatively large clinical effects ; future , larger trials will be needed to determine whether smaller differences are present .\\n',\n"," 'METHODS\\tLevel II , therapeutic study .\\n',\n"," 'METHODS\\tSee Instructions for Authors for a complete description of levels of evidence .\\n',\n"," '\\n',\n"," '###25872390\\n',\n"," 'OBJECTIVE\\tTo assess potential of preoperative therapy with local steroid and non-steroid anti-inflammatory drugs ( SAIDs and NSAIDs ) for prolonging the hypotensive effect of trabeculectomy .\\n',\n"," 'METHODS\\tA total of @ patients with primary open-angle glaucoma planed for trabeculectomy were randomized into @ groups of @ each : @ groups that differed in the studied drug ( nepafenac , dexamethasone , or their non-fixed combination ) and a control group with no preoperative therapy .\\n',\n"," 'METHODS\\tThe patients instilled @ drop of either drug b.i.d. for @ weeks before the surgery and were examined each day of the first week and then at weeks @ , @ , @ and months @ , @ , and @ .\\n',\n"," 'METHODS\\tThe rate of postoperative surgical and medical interventions ( needling , needling revision , hypotensive therapy ) was used for outcome evaluation .\\n',\n"," 'RESULTS\\tPostoperative needling was required in @ % of the controls , @ % of the NSAIDs and @ % of the SAIDs patients as well as @ % the combination-therapy patients .\\n',\n"," 'RESULTS\\tNeedling revision had to be performed in @ % of patients from the control group and @ % of patients from the NSAIDs group .\\n',\n"," 'RESULTS\\tPatients from the steroid and combination-therapy groups had no need in needling procedure .\\n',\n"," 'RESULTS\\tFurther hypotensive therapy was required in @ % of the control group , @ % of the NSAIDs group , @ % of the SAIDs group and @ % of the combination-therapy group .\\n',\n"," 'RESULTS\\tDuring the first postoperative year complete success of the treatment was achieved in @ % of the controls , @ % of the NSAIDs patients , @ % of the SAIDs patients , and @ % of those under combination therapy .\\n',\n"," 'RESULTS\\tQualified success during the same period was achieved in @ % of cases .\\n',\n"," 'CONCLUSIONS\\tPreoperative local anti-inflammatory therapy helped to increase the one-year complete success rate after trabeculectomy as compared with the controls .\\n',\n"," 'CONCLUSIONS\\tThe most significant hypotensive effect was noted in the combination-therapy group ( @ % ) , less significant -- in the steroid and non-steroid monotherapy groups ( @ % and @ % correspondingly ) .\\n',\n"," 'CONCLUSIONS\\tA negative correlation was noted between the use of nepafenac and dexamethasone and other measures aimed at increasing the hypotensive effect of glaucoma surgery .\\n',\n"," '\\n',\n"," '###25899215\\n',\n"," 'METHODS\\tCase-control study ; ecological study .\\n',\n"," 'OBJECTIVE\\tTo examine the efficacy of wearing compression stockings to prevent muscle damage and to maintain running performance during a marathon competition .\\n',\n"," 'BACKGROUND\\tExercise-induced muscle damage has been identified as one of the main causes of the progressive decrease in running and muscular performance found during marathon races .\\n',\n"," 'METHODS\\tThirty-four experienced runners were pair-matched for age , anthropometric data , and best race time in the marathon , and randomly assigned to a control group ( n = @ ) of runners who wore conventional socks or to a group of runners who wore foot-to-knee graduated compression stockings ( n = @ ) .\\n',\n"," 'METHODS\\tBefore and after the race , a sample of venous blood was obtained , and jump height and leg muscle power were measured during a countermovement jump .\\n',\n"," 'METHODS\\tSerum myoglobin and creatine kinase concentrations were determined as blood markers of muscle fiber damage .\\n',\n"," 'RESULTS\\tTotal race time was not different between the control group and the compression stockings group ( @ @ and @ @ minutes , respectively ; P = @ ) .\\n',\n"," 'RESULTS\\tBetween the control group and the compression stockings group , postrace reductions in leg muscle power ( -@ % @ % versus -@ % @ % , respectively ; P = @ ) and jump height ( -@ % @ % versus -@ % .\\n',\n"," 'RESULTS\\t@ % , respectively ; P = @ ) were similar .\\n',\n"," 'RESULTS\\tAt the end of the race , there were no differences between the control group and the compression stockings group in serum myoglobin ( @ @ ngmL ( -@ ) versus @ @ ngmL ( -@ ) , respectively ; P = @ ) and creatine kinase concentration ( @ @ UL ( -@ ) versus @ @ UL ( -@ ) , respectively ; P = @ ) .\\n',\n"," 'CONCLUSIONS\\tThe use of compression stockings did not improve running pace and did not prevent exercise-induced muscle damage during the marathon .\\n',\n"," 'CONCLUSIONS\\tWearing compression stockings during long-distance running events is an ineffective strategy to avoid the deleterious effects of muscle damage on running performance .\\n',\n"," 'METHODS\\tTherapy , level @b .\\n',\n"," '\\n',\n"," '###24361853\\n',\n"," 'BACKGROUND\\tThe relationships of left ventricular ( LV ) longitudinal and circumferential systolic dysfunction with diastolic performance in hypertensive patients have never been compared .\\n',\n"," \"RESULTS\\tIn @ asymptomatic hypertensive patients , circumferential function was assessed with the use of midwall fractional shortening ( mFS ) and stress-corrected mFS ( SCmFS ) , whereas longitudinal function was assessed with the use of left atrioventricular plane displacement ( AVPD ) and systolic mitral annulus velocity ( s ' ) .\\n\",\n"," \"RESULTS\\tEarly diastolic annular velocity ( e ' ) and the E/e ' ratio were measured .\\n\",\n"," 'RESULTS\\tGlobal longitudinal and circumferential strain were determined in a subset of @ patients .\\n',\n"," \"RESULTS\\te ' was linearly related to all systolic indexes ( AVPD : R = @ ; s ' : R = @ ; mFS : R = @ ; SCmFS : R = @ ; all P < @ ) , but the correlations were stronger with longitudinal indexes than with circumferential ones ( P < @ ) .\\n\",\n"," \"RESULTS\\tE/e ' was nonlinearly related to AVPD ( R = -@ ; P < @ ) and s ' ( R = -@ ; P < @ ) and showed no relationship with mFS and SCmFS .\\n\",\n"," \"RESULTS\\tLongitudinal indexes were superior to circumferential ones in predicting e ' < @ cm/s , E/e ' < @ , and E/e ' @ .\\n\",\n"," 'RESULTS\\tThe effect of LV geometry on LV diastolic function was evident among patients with preserved systolic longitudinal function , but was blunted among patients with impaired longitudinal function .\\n',\n"," \"RESULTS\\tIn multivariable analyses , only longitudinal indexes remained associated with e ' and E/e ' .\\n\",\n"," 'RESULTS\\tAnalyses using strains provided similar results .\\n',\n"," 'CONCLUSIONS\\tIn asymptomatic hypertensive subjects , LV diastolic performance is independently associated with longitudinal systolic dysfunction , but not with circumferential systolic dysfunction .\\n',\n"," 'CONCLUSIONS\\tSubtle longitudinal systolic impairment plays a role in mediating the effect of LV geometry on diastolic performance .\\n',\n"," 'CONCLUSIONS\\tThese findings may support the need of critically revising the concept of isolated diastolic dysfunction in these patients .\\n',\n"," '\\n',\n"," '###25395709\\n',\n"," 'BACKGROUND\\tMultiple Sclerosis ( MS ) is a chronic and disabling disease resulting in disabilities in young and middle-aged persons .\\n',\n"," 'BACKGROUND\\tIn this study , researchers explored the effect of yoga techniques on physical activities and sexual function among some Iranian women with MS.\\n',\n"," 'METHODS\\tIn this study , @ Iranian women with multiple sclerosis ( MS ) were placed in two equally divided control and case groups through random selection to assess pre-and post-effects of yoga exercises on their physical activities and sexual satisfaction levels .\\n',\n"," 'METHODS\\tWomen in case group were offered a series of yoga training and exercises for @ months , which consisted of @ sessions per month for @ to @ minutes at each session .\\n',\n"," 'METHODS\\tYoga training program included the @ principles of slow motions ( Hatayoga ) , respiratory exercises ( Pranayama ) and centralization to control mind via meditation , expansion and stasis ( Rajayoga ) .\\n',\n"," 'METHODS\\tAfter @ months both groups were surveyed using the initial questionnaire to evaluate and compare findings with the base-line data .\\n',\n"," 'RESULTS\\tResearchers found significant statistical difference in physical activity and sexual satisfaction levels among the women in case group ( P = @ ) .\\n',\n"," 'RESULTS\\tWomen in case group showed improvement in physical ability while women in control group manifested exacerbated symptoms .\\n',\n"," 'CONCLUSIONS\\tYoga techniques may improve physical activities and sexual satisfaction function of women with MS.\\n',\n"," '\\n',\n"," '###26080882\\n',\n"," 'OBJECTIVE\\tTo evaluate the safety and efficacy of antiplatelet therapy of ticagrelor on patients suffering from acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention .\\n',\n"," 'METHODS\\tIn the study , @ patients suffering from acute ST segment elevation myocardial infarction onset within @ h undergoing primary percutaneous coronary intervention from May to October in @ were randomly divided into ticagrelor group ( n = @ ) and clopidogrel group ( n = @ ) by using the method of random number table .\\n',\n"," 'METHODS\\tTicagrelor and clopidogrel antiplatelet treatment were used before and after operation .\\n',\n"," 'METHODS\\tTheir baseline data , coronary artery disease characteristics , platelet count , adenosine diphosphate ( ADP ) - induced platelet inhibition rate by thrombelastograph after @ days of treatment , the major adverse cardiovascular events of the follow up for @ months and bleeding complications were observed and compared in the two groups .\\n',\n"," 'RESULTS\\tThe differences between the two groups of patients with their baseline data , the features of coronary artery lesions , platelet count before and after @ days of treatment had no statistical significance ( P > @ ) .\\n',\n"," 'RESULTS\\tADP induced platelet inhibition rate -LSB- ( @ ) % -RSB- after @ days of treatment in ticagrelor group was significantly higher than that in clopidogrel group -LSB- ( @ ) % , P < @ -RSB- .\\n',\n"," 'RESULTS\\tThe two groups of patients were followed up for @ months , @ cases of major adverse cardiovascular events occurred in clopidogrel group , @ cases of major adverse cardiovascular events occurred in ticagrelor group , and there was significant difference between the two groups ( P < @ ) .\\n',\n"," 'RESULTS\\tThe two groups ( @ cases of @ patients in ticagrelor group vs. @ cases of @ patients in clopidogrel group ) had no statistically significant difference in bleeding complications ( P > @ ) .\\n',\n"," 'CONCLUSIONS\\tAntiplatelet therapy of ticagrelor on patients suffering from acute ST segment elevation myocardial infarction undergoing emergency PCI has good efficacy and safety .\\n',\n"," '\\n',\n"," '###25100336\\n',\n"," 'OBJECTIVE\\tTo evaluate the image quality , radiation dose and diagnostic accuracy of @kVp , high-pitch CT pulmonary angiography ( CTPA ) with iterative reconstruction using @ ml of contrast agent .\\n',\n"," 'METHODS\\tOne hundred patients with suspected pulmonary embolism ( PE ) were randomly divided into two groups ( n = @ each ; group A , @ kVp , @ pitch , @ ml of contrast medium and filtered back projection algorithm ; group B , @ kVp , @ pitch , @ ml of contrast medium and sinogram affirmed iterative reconstruction ) .\\n',\n"," 'METHODS\\tImage quality , diagnostic accuracy and radiation dose were evaluated and compared .\\n',\n"," 'RESULTS\\tMean CT numbers of pulmonary arteries in group B were higher than those in group A ( all P < @ ) .\\n',\n"," 'RESULTS\\tContrast-to-noise ratio and signal-to-noise ratio of group B were higher than those of group A ( both P < @ ) .\\n',\n"," 'RESULTS\\tThere was no significant difference in subjective image quality scores between two groups ( P = @ ) .\\n',\n"," 'RESULTS\\tThe interobserver agreement was excellent ( k = @ ) .\\n',\n"," 'RESULTS\\tThere was no significant difference in diagnostic accuracy between the two groups ( P > @ ) .\\n',\n"," 'RESULTS\\tCompared with group A , radiation dose of group B was reduced by @ % ( P < @ ) .\\n',\n"," 'CONCLUSIONS\\tHigh-pitch CTPA at @ kVp can obtain sufficient image quality in normal-weight individuals with @ ml of contrast agent and half the radiation dose of a conventional CTPA protocol .\\n',\n"," 'CONCLUSIONS\\tCTPA is feasible at @ kVp using only @ ml of contrast agent .\\n',\n"," 'CONCLUSIONS\\tHigh-pitch CTPA at @ kVp has an effective dose under @ mSv .\\n',\n"," 'CONCLUSIONS\\tThis CTPA protocol can obtain sufficient image quality in normal-weight individuals .\\n',\n"," '\\n',\n"," '###25267532\\n',\n"," 'BACKGROUND\\tFamilies express a need for guidance in helping their loved ones with anorexia nervosa ( AN ) .\\n',\n"," 'BACKGROUND\\tGuided self-help interventions can offer support to caregivers .\\n',\n"," 'METHODS\\tOne hundred seventy-eight adult AN patients and their caregivers were recruited from @ UK treatment centres .\\n',\n"," \"METHODS\\tFamilies were randomized to carers ' assessment , skills and information sharing ( C ) intervention + treatment as usual ( TAU ) or TAU alone .\\n\",\n"," 'METHODS\\tFeedback forms were sent at @months post-discharge and , if not returned , at @months .\\n',\n"," 'METHODS\\tOne hundred two ( @ % ) patient forms ( n = @TAU ; n = @C ) and @ ( @ % ) caregiver forms ( n = @TAU ; n = @C ) were returned .\\n',\n"," 'METHODS\\tTwo researchers coded data blind , using thematic analysis .\\n',\n"," 'RESULTS\\t( i ) Caregivers and patients express a need for post-discharge support .\\n',\n"," 'RESULTS\\t( ii ) Patients identify helpful and unhelpful support strategies , useful for developing future interventions .\\n',\n"," 'RESULTS\\t( iii ) Patients could identify positive caregiver behaviour changes targeted in intervention .\\n',\n"," 'RESULTS\\t( iv ) Guided self-help may benefit caregiver and sufferer , post-discharge .\\n',\n"," 'CONCLUSIONS\\tCaregiver interventions can be a useful tool that will improve the cost effectiveness of inpatient treatment by enhancing the well-being of caregivers and patients .\\n',\n"," '\\n',\n"," '###24799513\\n',\n"," 'BACKGROUND\\tCardiac mortality and electrophysiological dysfunction both increase with age .\\n',\n"," 'BACKGROUND\\tHeart rate variability ( HRV ) provides indices of autonomic function and electrophysiology that are associated with cardiac risk .\\n',\n"," 'BACKGROUND\\tHow habitual physical activity among older adults prospectively relates to HRV , including nonlinear indices of erratic sinus patterns , is not established .\\n',\n"," 'BACKGROUND\\tWe hypothesized that increasing the levels of both total leisure-time activity and walking would be prospectively associated with more favorable time-domain , frequency-domain , and nonlinear HRV measures in older adults .\\n',\n"," 'RESULTS\\tWe evaluated serial longitudinal measures of both physical activity and @-hour Holter HRV over @ years among @ older US adults in the community-based Cardiovascular Health Study .\\n',\n"," 'RESULTS\\tAfter multivariable adjustment , greater total leisure-time activity , walking distance , and walking pace were each prospectively associated with specific , more favorable HRV indices , including higher @-hour standard deviation of all normal-to-normal intervals ( Ptrend = @ , @ , @ , respectively ) and ultralow-frequency power ( Ptrend = @ , @ , @ , respectively ) .\\n',\n"," 'RESULTS\\tGreater walking pace was also associated with a higher short-term fractal scaling exponent ( Ptrend = @ ) and lower Poincar ratio ( Ptrend = @ ) , markers of less erratic sinus patterns .\\n',\n"," 'CONCLUSIONS\\tGreater total leisure-time activity , and walking alone , as well , were prospectively associated with more favorable and specific indices of autonomic function in older adults , including several suggestive of more normal circadian fluctuations and less erratic sinoatrial firing .\\n',\n"," 'CONCLUSIONS\\tOur results suggest potential mechanisms that might contribute to lower cardiovascular mortality with habitual physical activity later in life .\\n',\n"," '\\n',\n"," '###24573358\\n',\n"," 'OBJECTIVE\\tOur aim was to compare anatomical and functional outcome between vaginal colposuspension and transvaginal mesh .\\n',\n"," 'METHODS\\tThis was a prospective randomized controlled trial in a teaching hospital .\\n',\n"," 'METHODS\\tSixty-eight women with stage @ anterior vaginal wall prolapse according to the Pelvic Organ Prolapse Quantification ( POP-Q ) system were assessed , randomized , and analyzed .\\n',\n"," 'METHODS\\tPatients were randomized to anterior colporrhaphy with vaginal colposuspension ( n = @ ) or transvaginal mesh ( n = @ ) .\\n',\n"," 'METHODS\\tPrimary outcome was objective cure rate of the anterior vaginal wall , defined as POP-Q @ at @years .\\n',\n"," 'METHODS\\tSecondary outcomes were functional results , quality-of-life ( QoL ) scores , mesh-related morbidity , and onset of urinary incontinence .\\n',\n"," 'RESULTS\\tThe anatomical result for point Ba was significantly better at @years in the mesh group ( -@ cm ) than in the colposuspension group ( -@ cm ) ( p = @ ) .\\n',\n"," 'RESULTS\\tConcerning POP-Q stages , the anatomical success rate at @years was @ % for colposuspension and @ % for mesh ( p = @ ) .\\n',\n"," 'RESULTS\\tThere were @ anatomic recurrences ( @ % ) in the colposuspension group .\\n',\n"," 'RESULTS\\tThe erosion rate was @ % ( n = @ ) .\\n',\n"," 'RESULTS\\tNo significant difference was noted regarding minor complications .\\n',\n"," 'RESULTS\\tAnalysis of QoL questionnaires showed overall improvement in both groups , with no significant difference between them .\\n',\n"," 'CONCLUSIONS\\tThe vaginal colposuspension technique of anterior vaginal wall prolapse repair gave good anatomical and functional results at @years .\\n',\n"," 'CONCLUSIONS\\tTransobturator vaginal mesh gave better @-year anatomical results than vaginal colposuspension , with overall improvement in QoL in both groups .\\n',\n"," '\\n',\n"," '###25249651\\n',\n"," 'OBJECTIVE\\tClinical studies evaluating the effects of medications on - cell function in type @ diabetes ( T@DM ) are compromised by an inability to determine the actual baseline degree of - cell dysfunction independent of the reversible dysfunction induced by hyperglycemia ( glucotoxicity ) .\\n',\n"," 'OBJECTIVE\\tShort-term intensive insulin therapy ( IIT ) is a strategy for eliminating glucotoxicity before randomization .\\n',\n"," 'OBJECTIVE\\tThis study determined whether liraglutide can preserve - cell function over @ weeks in early T@DM following initial elimination of glucotoxicity with IIT .\\n',\n"," \"METHODS\\tIn this double-blind , randomized , placebo-controlled trial , @ patients with T@DM of @ @ years ' duration and an A@C of @ @ % ( @ @ mmol/mol ) completed @ weeks of IIT before randomization to daily subcutaneous liraglutide or placebo injection , with serial assessment of - cell function by Insulin Secretion-Sensitivity Index-@ ( ISSI-@ ) on oral glucose tolerance test performed every @ weeks .\\n\",\n"," 'RESULTS\\tThe primary outcome of baseline-adjusted ISSI-@ at @ weeks was higher in the liraglutide group than in the placebo group ( @ @ vs. @ @ , P = @ ) .\\n',\n"," 'RESULTS\\tBaseline-adjusted HbA@c at @ weeks was lower in the liraglutide group ( @ @ % vs. @ @ % , P = @ ) ( @ @ vs. @ @ mmol/mol ) .\\n',\n"," 'RESULTS\\tAt each quarterly assessment , > @ % of participants on liraglutide had an HbA@c @ % ( @ mmol/mol ) and glucose tolerance in the nondiabetic range .\\n',\n"," 'RESULTS\\tDespite this level of glycemic control , no difference was found in the incidence of hypoglycemia between the liraglutide and placebo groups ( P = @ ) .\\n',\n"," 'RESULTS\\tTwo weeks after stopping treatment , however , the beneficial effect on ISSI-@ of liraglutide versus placebo was entirely lost ( @ @ vs. @ @ , P = @ ) .\\n',\n"," 'CONCLUSIONS\\tLiraglutide provides robust enhancement of - cell function that is sustained over @ weeks in early T@DM but lost upon cessation of therapy .\\n',\n"," '\\n',\n"," '###25110443\\n',\n"," 'OBJECTIVE\\tTo investigate the effectiveness of rectally administered indomethacin in the prophylaxis of post-endoscopic retrograde cholangiopancreatography ( ERCP ) pancreatitis and hyperamylasaemia in a multicentre study .\\n',\n"," 'METHODS\\tA prospective , randomised , placebo-controlled multicentre study in five endoscopic units was conducted on @ patients randomised to receive a suppository containing @ mg indomethacin , or an inert placebo , @-@ min before ERCP .\\n',\n"," 'METHODS\\tPost-ERCP pancreatitis and hyperamylasaemia were evaluated @ h following the procedure on the basis of clinical signs and laboratory parameters , and computed tomography/magnetic resonance imaging findings if required .\\n',\n"," 'RESULTS\\tTwenty-one patients were excluded because of incompleteness of their data or because of protocol violation .\\n',\n"," 'RESULTS\\tThe results of @ investigations were evaluated : @ in the indomethacin group and @ in the placebo group .\\n',\n"," 'RESULTS\\tThe distributions of the risk factors in the two groups did not differ significantly .\\n',\n"," 'RESULTS\\tPancreatitis developed in @ patients ( @ % ) : it was mild in @ ( @ % ) and severe in eight ( @ % ) cases .\\n',\n"," 'RESULTS\\tHyperamylaesemia occurred in @ patients ( @ % ) .\\n',\n"," 'RESULTS\\tThere was no significant difference between the indomethacin and placebo groups in the incidence of either post-ERCP pancreatitis ( @ % vs @ % ) or hyperamylasaemia ( @ % vs @ % ) .\\n',\n"," 'RESULTS\\tSimilarly , subgroup analysis did not reveal any significant differences between the two groups .\\n',\n"," 'CONCLUSIONS\\t@ mg rectal indomethacin administered before ERCP did not prove effective in preventing post-ERCP pancreatitis .\\n',\n"," '\\n',\n"," '###24249722\\n',\n"," 'BACKGROUND\\tWe sought to determine the incidence of newly diagnosed diabetes in treated elderly hypertensive patients and the prognostic impact of diabetes on long-term survival .\\n',\n"," 'METHODS\\tThe Second Australian National Blood Pressure ( ANBP@ ) study randomized @,@ hypertensive patients aged @-@ years to angiotensin-converting enzyme inhibitor ( ACEI ) or thiazide diuretic-based therapy and followed them for a median of @ years .\\n',\n"," 'METHODS\\tLong-term survival was determined in @,@ patients over an additional median of @ years after ANBP@ ( post-trial ) .\\n',\n"," 'RESULTS\\tAfter ANBP@ , the cohort was classified into preexisting ( @ % ) , newly diagnosed ( @ % ) , and no diabetes ( @ % ) groups .\\n',\n"," 'RESULTS\\tA @ % higher incidence of newly diagnosed diabetes was observed in patients randomized to thiazide diuretic compared with ACEI-based treatment .\\n',\n"," 'RESULTS\\tThe other predictors of newly diagnosed diabetes were having a higher body mass index , having a higher random blood glucose , and living in a regional location compared to major cities ( a geographical classification based on accessibility ) at study entry .\\n',\n"," 'RESULTS\\tAfter completion of ANBP@ , compared with those with no diabetes , the preexisting diabetes group experienced higher cardiovascular ( hazards ratio ( HR ) = @ ; @ % confidence interval ( CI ) = @-@ @ ) and all-cause mortality ( HR = @ ; @ % CI = @-@ @ ) when adjusted for age , sex , and treatment .\\n',\n"," 'RESULTS\\tA similar pattern was observed after including the post-trial period for cardiovascular ( HR = @ ; @ % CI = @-@ @ ) and all-cause mortality ( HR = @ ; @ % CI = @-@ @ ) .\\n',\n"," 'RESULTS\\tHowever , when the newly diagnosed group was compared with the no diabetes group , no significant difference was observed in cardiovascular ( HR = @ ; @ % CI = @-@ @ ) or all-cause mortality ( HR = @ ; @ % CI = @-@ @ ) either during the ANBP@ trial or including post-trial follow-up ( cardiovascular : HR = @ ; @ % CI = @-@ @ ; all-cause mortality : HR = @ ; @ % CI = @-@ @ ) .\\n',\n"," 'CONCLUSIONS\\tLong-term presence of diabetes reduces survival .\\n',\n"," 'CONCLUSIONS\\tCompared with thiazide diuretics , ACEI-based antihypertensives may delay the development of diabetes in those at risk and thus potentially improve cardiovascular outcome in the elderly .\\n',\n"," '\\n',\n"," '###25027286\\n',\n"," 'BACKGROUND\\tObesity is associated with a risk of gastroesophageal reflux disease .\\n',\n"," 'BACKGROUND\\tThe pharmacodynamic efficacy of proton pump inhibitors has not been specifically evaluated in obese subjects .\\n',\n"," 'BACKGROUND\\tThe aim of this study was to compare the antisecretory response to a single oral dose of @ mg rabeprazole , @ mg omeprazole and placebo in obese subjects .\\n',\n"," 'METHODS\\tGastric pH was monitored for @ hours on three separate occasions in eighteen H. pylori-negative , asymptomatic obese subjects .\\n',\n"," 'METHODS\\tSubjects were given omeprazole , rabeprazole or placebo in a randomized order and in a double-blind fashion .\\n',\n"," 'METHODS\\tThe main analysis criterion was @-h percent of time post dose with intragastric pH above @ ; secondary criteria were percentage of time above pH @ , median pH , -LSB- H + -RSB- concentrations and nocturnal acid breakthrough ( NAB ) .\\n',\n"," 'METHODS\\tResults were analyzed using linear mixed models and Wilks test comparing variances .\\n',\n"," 'RESULTS\\t@-h median -LSB- IQ -RSB- percentages of time with gastric pH above @ and @ were higher with rabeprazole than omeprazole ( @ -LSB- @-@ -RSB- vs. @ -LSB- @-@ -RSB- % , @ -LSB- @-@ -RSB- % for placebo ) but the differences did not reach statistical significance ( p = @ and @ , respectively ) .\\n',\n"," 'RESULTS\\tMedian acid concentrations were significantly lower with rabeprazole than with omeprazole and placebo ( @ -LSB- @-@ -RSB- vs. @ -LSB- @-@ -RSB- and @ -LSB- @-@ -RSB- mmoles/l , p < @ ) for all periods .\\n',\n"," 'RESULTS\\tThe number of NAB was significantly lower with rabeprazole than with omeprazole ( median @ -LSB- @,@ -RSB- vs. @ -LSB- @-@ -RSB- , p = @ ) .\\n',\n"," 'RESULTS\\tVariances of @-h data ( pH above @ and @ , median pH , -LSB- H + -RSB- concentrations ) were significantly lower with rabeprazole than with omeprazole ( p < @ ) .\\n',\n"," 'CONCLUSIONS\\tIn asymptomatic obese subjects the gastric antisecretory response to a single dose of rabeprazole and omeprazole was strong and not significantly different between drugs despite a significantly more homogeneous response with rabeprazole .\\n',\n"," 'BACKGROUND\\tClinicalTrial.gov : NCT@ .\\n',\n"," '\\n',\n"," '###25439809\\n',\n"," 'OBJECTIVE\\tTo study the effect of growth hormone ( GH ) treatment on ovarian and uterine morphology and function in short , prepubertal small-for-gestational-age ( SGA ) girls .\\n',\n"," 'METHODS\\tA multinational , randomized controlled trial on safety and efficacy of GH therapy in short , prepubertal children born SGA .\\n',\n"," 'METHODS\\tNot applicable .\\n',\n"," 'METHODS\\tA subgroup of @ Danish girls born SGA included in North European SGA Study ( NESGAS ) .\\n',\n"," 'METHODS\\tOne year of GH treatment ( @ g/kg/day ) followed by @ years of randomized GH treatment ( @ g/kg/day , @ g/kg/day , or IGF-I titrated ) .\\n',\n"," 'METHODS\\tData on anthropometrics , reproductive hormones , and ultrasonographic examination of the internal genitalia were collected during @ months of GH treatment .\\n',\n"," 'RESULTS\\tUterine and ovarian volume increased significantly during @ years of treatment ( @ % and @ % , respectively ) but remained low within normal reference ranges .\\n',\n"," 'RESULTS\\tOvarian follicles became visible in @ % after @ year compared with @ % before GH therapy .\\n',\n"," 'RESULTS\\tAnti-Mllerian hormone increased significantly during the @ years of GH therapy but remained within the normal range .\\n',\n"," 'RESULTS\\tPrecocious puberty was observed in one girl ; another girl developed multicystic ovaries .\\n',\n"," 'CONCLUSIONS\\tGH treatment was associated with statistically significant growth of the internal genitalia , but remained within the normal range .\\n',\n"," 'CONCLUSIONS\\tAs altered pubertal development and ovarian morphology were found in @ of @ girls , monitoring of puberty and ovarian function during GH therapy in SGA girls is prudent .\\n',\n"," 'CONCLUSIONS\\tAltogether , the findings are reassuring .\\n',\n"," 'CONCLUSIONS\\tHowever , long-term effects of GH treatment on adult reproductive function remain unknown .\\n',\n"," 'BACKGROUND\\tEudraCT @-@-@ .\\n',\n"," '\\n',\n"," '###24898858\\n',\n"," 'OBJECTIVE\\tTo test the hypothesis that a brief , clinic-based , single-session programme will reduce the rate of @ selected condom use errors in a clinical sample of young black men ( YBM ) ages @ through @ years .\\n',\n"," 'METHODS\\tData were collected in clinics treating patients with sexually transmitted infections ( STI ) in three southern US cities .\\n',\n"," 'METHODS\\tMales @-@years of age who identified as black/African-American , and reported recent ( past @months ) condom use were eligible .\\n',\n"," 'METHODS\\tOnly those also reporting condom use in the @months prior to a @-month follow-up assessment ( n = @ ) were included in this secondary analysis of data from a randomised , controlled trial .\\n',\n"," 'METHODS\\tDifference scores were used to capture a GroupTime effect .\\n',\n"," 'RESULTS\\tYBM reported @ condom use events in the @months preceding study enrolment and @ in the @months preceding the follow-up assessment .\\n',\n"," 'RESULTS\\tMean baseline error rates were @ and @ for young men randomised to the intervention and control conditions , respectively .\\n',\n"," 'RESULTS\\tFollow-up rates were @ and @ for young men randomised to the intervention and control conditions , respectively .\\n',\n"," 'RESULTS\\tControlled findings yielded a significant effect for the influence of group assignment on the difference score ( baseline to follow-up ) in the condom use error rate ( = @ ; p = @ ) .\\n',\n"," 'CONCLUSIONS\\tA brief , clinic-based counselling programme produced modest reductions in condom use errors among YBM attending STI clinics in the southern USA Intensified clinic-based intervention that helps YBM improve the quality of their condom use behaviours is warranted .\\n',\n"," 'BACKGROUND\\tNCT@ .\\n',\n"," '\\n',\n"," '###24672940\\n',\n"," 'OBJECTIVE\\tTo provide evidence for Chinese medical treatment of children with EB virus infection by exploring its clinical efficacy from multiple angles .\\n',\n"," 'METHODS\\tTotally @ children patients were randomly assigned to the treatment group ( @ cases ) and the control group ( @ cases ) .\\n',\n"," 'METHODS\\tPatients in the treatment group took Chinese medical decoction , while those in the control received intravenous dripping of Ganciclovir and oral administration of pidotimod .\\n',\n"," 'METHODS\\tThe treatment period for the two groups was @ weeks .\\n',\n"," 'METHODS\\tPatients were followed-up till the @th week .\\n',\n"," 'METHODS\\tClinical symptoms such as fever , lymphadenopathy and hepatosplenomegaly , as well as lab indices such as abnormal lymphocyte percentage , EB virus antibody , virus DNA load , T cell subsets , immunoglobulin , and so on were observed before and after treatment , at week @ and @ of follow-ups .\\n',\n"," 'RESULTS\\t( @ ) The total effective rate at week @ was @ % in the treatment group , higher than that of the control group ( @ % ) , but there was no statistical difference between the two groups .\\n',\n"," 'RESULTS\\t( @ ) The time for defervescence , duration of pharyngeal hyperemia , duration of swollen tonsils was shorter in the treatment group than in the control group ( P < @ ) .\\n',\n"," 'RESULTS\\tThe subsidence of lymphadenopathy , hepatomegaly , and abnormal lymphocytes was better in the treatment group than in the control group ( P < @ ) .\\n',\n"," 'RESULTS\\t( @ ) The positive cases of peripheral blood hetero-lymphocyte was significantly reduced after treatment , at week @ and @ of follow-ups both in the treatment group and the control group ( P < @ ) .\\n',\n"," 'RESULTS\\tThe expression of IgA and IgM decreased after treatment in the two groups when compared with before treatment in the same group ( P < @ , P < @ ) .\\n',\n"," 'RESULTS\\tIgG in the treatment group also obviously decreased after treatment , at week @ and @ of follow-ups ( P < @ , P < @ ) , while it decreased only after treatment in the control group ( P < @ ) .\\n',\n"," 'RESULTS\\tActivities of AST and ALT in the treatment group and the AST activity in the control group were markedly improved when compared with those before treatment ( P < @ ) .\\n',\n"," 'RESULTS\\tCompared with the control group , the abnormal lymphocyte positive case number obviously decreased in the treatment group after treatment , at week @ and @ of follow-ups ( P < @ ) .\\n',\n"," 'RESULTS\\t( @ ) After treatment , at week @ and @ of follow-ups , CD@ + and CD@ + significantly decreased ; CD@ + , CD@/CD@ , and B cells significantly increased in the two groups , when compared with before treatment ( P < @ ) .\\n',\n"," 'RESULTS\\tNK cells significantly increased more in the treatment group after treatment , at week @ and @ of follow-ups , higher than before treatment as well as the control group ( P < @ ) .\\n',\n"," 'RESULTS\\t( @ ) EB viral DNA and EB viral CA-IgM negative conversion case numbers significantly increased in the two groups after treatment , at week @ and @ of follow-ups ( P < @ ) .\\n',\n"," 'RESULTS\\tCompared with the control group , EB viral DNA and EB viral CA-IgM negative conversion case numbers significantly increased in the treatment group after treatment and at week @ of follow-ups ( P < @ ) .\\n',\n"," 'CONCLUSIONS\\tTreatment of EB virus infection by Chinese medical treatment was effective .\\n',\n"," 'CONCLUSIONS\\tIt could promote the recovery of EB viral infection , and reduce the risk of vicious disease after EB viral infection .\\n',\n"," '\\n',\n"," '###25039547\\n',\n"," 'OBJECTIVE\\tThe primary objective was to compare the cosmetic outcomes of traumatic trunk and extremity lacerations repaired using absorbable versus nonabsorbable sutures .\\n',\n"," 'OBJECTIVE\\tThe secondary objective was to compare complication rates between the two groups .\\n',\n"," 'METHODS\\tThis was a randomized controlled trial comparing wounds repaired with Vicryl Rapide and Prolene sutures .\\n',\n"," 'METHODS\\tPediatric and adult patients with lacerations were enrolled in the study .\\n',\n"," 'METHODS\\tAt a @-day follow-up , the wounds were evaluated for infection and dehiscence .\\n',\n"," 'METHODS\\tAfter @ months , patients returned to have the wounds photographed .\\n',\n"," 'METHODS\\tTwo plastic surgeons blinded to the method of closure rated the cosmetic outcome of each wound using a @-mm visual analog scale ( VAS ) .\\n',\n"," 'METHODS\\tUsing a noninferiority design , a VAS score of @ mm or greater was considered to be a clinically significant difference .\\n',\n"," \"METHODS\\tWe used a Student 's t-test to compare differences between mean VAS scores and odds ratios ( ORs ) to compare differences in complication rates between the two groups .\\n\",\n"," 'RESULTS\\tOf the @ patients enrolled , @ completed the study including @ in the Vicryl Rapide group and @ in the Prolene group .\\n',\n"," 'RESULTS\\tThe mean ( SD ) age of patients who completed the study was @ ( @ ) years , and @ were male .\\n',\n"," 'RESULTS\\tWe found no significant differences in the age , race , sex , length of wound , number of sutures , or layers of repair in the two groups .\\n',\n"," \"RESULTS\\tThe observer 's mean VAS for the Vicryl Rapide group was @ mm ( @ % confidence interval -LSB- CI -RSB- = @ to @ mm ) and for the Prolene group was @ mm ( @ % CI = @ to @ mm ) .\\n\",\n"," 'RESULTS\\tThe resulting mean difference was @ mm ( @ % CI = -@ to @ mm ; p = @ ) ; thus noninferiority was established .\\n',\n"," 'RESULTS\\tStatistical testing showed no differences in the rates of complications between the two groups , but a higher percentage of the Vicryl Rapide wounds developed complications .\\n',\n"," 'CONCLUSIONS\\tThe use of absorbable sutures for the repair of simple lacerations on the trunk and extremities should be considered as an alternative to nonabsorbable suture repair .\\n',\n"," '\\n',\n"," '###25139873\\n',\n"," 'OBJECTIVE\\tAspirin early after intravenous thrombolysis in acute ischemic stroke increases the risk of symptomatic intracranial hemorrhage ( SICH ) , without influencing functional outcome at @ months .\\n',\n"," 'OBJECTIVE\\tThe effect of aspirin on early neurological deterioration ( END ) was explored as a post hoc analysis of the randomized Antiplatelet Therapy in Combination With Recombinant t-PA Thrombolysis in Ischemic Stroke ( ARTIS ) trial .\\n',\n"," 'METHODS\\tEND , defined as a @ points National Institutes of Health Stroke Scale worsening @ hours after intravenous thrombolysis , was categorized into SICH ( ENDSICH ) and cerebral ischemia ( ENDCI ) .\\n',\n"," 'METHODS\\tMultinomial logistic regression was used to assess the effect of aspirin on END .\\n',\n"," 'RESULTS\\tOf the @ patients , @ patients ( @ % ) experienced END ( @ ENDSICH , @ ENDCI ) .\\n',\n"," 'RESULTS\\tAspirin increased the risk of ENDSICH ( odds ratio , @ ; @ % confidence interval , @-@ @ ) but not of ENDCI ( odds ratio , @ ; @ % confidence interval , @-@ @ ) .\\n',\n"," 'RESULTS\\tAfter adjustment for other explanatory variables , the association between aspirin and ENDSICH remained significant .\\n',\n"," 'CONCLUSIONS\\tIn this trial , there is no evidence of an early antithrombotic effect from the addition of aspirin to intravenous thrombolysis in acute ischemic stroke .\\n',\n"," '\\n',\n"," '###24917273\\n',\n"," 'OBJECTIVE\\tTo compare the relative effectiveness of methotrexate and mycophenolate mofetil for noninfectious intermediate uveitis , posterior uveitis , or panuveitis .\\n',\n"," 'METHODS\\tMulticenter , block-randomized , observer-masked clinical trial .\\n',\n"," ...]"]},"metadata":{},"execution_count":5}],"source":["train=get_lines(data_dir+\"train.txt\")\n","train"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"98SfZL6cLqcy"},"outputs":[],"source":["def preprocess_text_with_line_numbers(filename):\n","  \"\"\"Returns a list of dictionaries of abstract line data.\n","\n","  Takes in filename, reads its contents and sorts through each line,\n","  extracting things like the target label, the text of the sentence,\n","  how many sentences are in the current abstract and what sentence number\n","  the target line is.\n","\n","  Args:\n","      filename: a string of the target text file to read and extract line data\n","      from.\n","\n","  Returns:\n","      A list of dictionaries each containing a line from an abstract,\n","      the lines label, the lines position in the abstract and the total number\n","      of lines in the abstract where the line is from. For example:\n","\n","      [{\"target\": 'CONCLUSION',\n","        \"text\": The study couldn't have gone better, turns out people are kinder than you think\",\n","        \"line_number\": 8,\n","        \"total_lines\": 8}]\n","  \"\"\"\n","  input_lines = get_lines(filename) # get all lines from filename\n","  abstract_lines = \"\" # create an empty abstract\n","  abstract_samples = [] # create an empty list of abstracts\n","\n","  # Loop through each line in target file\n","  for line in input_lines:\n","    if line.startswith(\"###\"): # check to see if line is an ID line\n","      abstract_id = line\n","      abstract_lines = \"\" # reset abstract string\n","    elif line.isspace(): # check to see if line is a new line\n","      abstract_line_split = abstract_lines.splitlines() # split abstract into separate lines\n","\n","      # Iterate through each line in abstract and count them at the same time\n","      for abstract_line_number, abstract_line in enumerate(abstract_line_split):\n","        line_data = {} # create empty dict to store data from line\n","        target_text_split = abstract_line.split(\"\\t\") # split target label from text\n","        line_data[\"target\"] = target_text_split[0] # get target label\n","        line_data[\"text\"] = target_text_split[1].lower() # get target text and lower it\n","        line_data[\"line_number\"] = abstract_line_number # what number line does the line appear in the abstract?\n","        line_data[\"total_lines\"] = len(abstract_line_split) - 1 # how many total lines are in the abstract? (start from 0)\n","        abstract_samples.append(line_data) # add line data to abstract samples list\n","\n","    else: # if the above conditions aren't fulfilled, the line contains a labelled sentence\n","      abstract_lines += line\n","\n","  return abstract_samples"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":680,"status":"ok","timestamp":1702836981574,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"sDF8URMLNkHb","outputId":"7f05431f-fbb8-448e-8365-40f55166df8e"},"outputs":[{"output_type":"stream","name":"stdout","text":["CPU times: user 429 ms, sys: 86.9 ms, total: 516 ms\n","Wall time: 521 ms\n"]},{"output_type":"execute_result","data":{"text/plain":["(180040, 30212, 30135)"]},"metadata":{},"execution_count":7}],"source":["%%time\n","train_samples = preprocess_text_with_line_numbers(data_dir + \"train.txt\")\n","val_samples = preprocess_text_with_line_numbers(data_dir + \"dev.txt\") # dev is another name for validation set\n","test_samples = preprocess_text_with_line_numbers(data_dir + \"test.txt\")\n","len(train_samples), len(val_samples), len(test_samples)\n"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":27,"status":"ok","timestamp":1702836981575,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"3H7nah5JQZvi","outputId":"d2f4f410-2e28-47b7-a97b-fb8a49d677b7"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["[{'target': 'OBJECTIVE',\n","  'text': 'to investigate the efficacy of @ weeks of daily low-dose oral prednisolone in improving pain , mobility , and systemic low-grade inflammation in the short term and whether the effect would be sustained at @ weeks in older adults with moderate to severe knee osteoarthritis ( oa ) .',\n","  'line_number': 0,\n","  'total_lines': 11},\n"," {'target': 'METHODS',\n","  'text': 'a total of @ patients with primary knee oa were randomized @:@ ; @ received @ mg/day of prednisolone and @ received placebo for @ weeks .',\n","  'line_number': 1,\n","  'total_lines': 11},\n"," {'target': 'METHODS',\n","  'text': 'outcome measures included pain reduction and improvement in function scores and systemic inflammation markers .',\n","  'line_number': 2,\n","  'total_lines': 11},\n"," {'target': 'METHODS',\n","  'text': 'pain was assessed using the visual analog pain scale ( @-@ mm ) .',\n","  'line_number': 3,\n","  'total_lines': 11},\n"," {'target': 'METHODS',\n","  'text': 'secondary outcome measures included the western ontario and mcmaster universities osteoarthritis index scores , patient global assessment ( pga ) of the severity of knee oa , and @-min walk distance ( @mwd ) .',\n","  'line_number': 4,\n","  'total_lines': 11},\n"," {'target': 'METHODS',\n","  'text': 'serum levels of interleukin @ ( il-@ ) , il-@ , tumor necrosis factor ( tnf ) - , and high-sensitivity c-reactive protein ( hscrp ) were measured .',\n","  'line_number': 5,\n","  'total_lines': 11},\n"," {'target': 'RESULTS',\n","  'text': 'there was a clinically relevant reduction in the intervention group compared to the placebo group for knee pain , physical function , pga , and @mwd at @ weeks .',\n","  'line_number': 6,\n","  'total_lines': 11},\n"," {'target': 'RESULTS',\n","  'text': 'the mean difference between treatment arms ( @ % ci ) was @ ( @-@ @ ) , p < @ ; @ ( @-@ @ ) , p < @ ; @ ( @-@ @ ) , p < @ ; and @ ( @-@ @ ) , p < @ , respectively .',\n","  'line_number': 7,\n","  'total_lines': 11},\n"," {'target': 'RESULTS',\n","  'text': 'further , there was a clinically relevant reduction in the serum levels of il-@ , il-@ , tnf - , and hscrp at @ weeks in the intervention group when compared to the placebo group .',\n","  'line_number': 8,\n","  'total_lines': 11},\n"," {'target': 'RESULTS',\n","  'text': 'these differences remained significant at @ weeks .',\n","  'line_number': 9,\n","  'total_lines': 11},\n"," {'target': 'RESULTS',\n","  'text': 'the outcome measures in rheumatology clinical trials-osteoarthritis research society international responder rate was @ % in the intervention group and @ % in the placebo group ( p < @ ) .',\n","  'line_number': 10,\n","  'total_lines': 11},\n"," {'target': 'CONCLUSIONS',\n","  'text': 'low-dose oral prednisolone had both a short-term and a longer sustained effect resulting in less knee pain , better physical function , and attenuation of systemic inflammation in older patients with knee oa ( clinicaltrials.gov identifier nct@ ) .',\n","  'line_number': 11,\n","  'total_lines': 11},\n"," {'target': 'BACKGROUND',\n","  'text': 'emotional eating is associated with overeating and the development of obesity .',\n","  'line_number': 0,\n","  'total_lines': 10},\n"," {'target': 'BACKGROUND',\n","  'text': 'yet , empirical evidence for individual ( trait ) differences in emotional eating and cognitive mechanisms that contribute to eating during sad mood remain equivocal .',\n","  'line_number': 1,\n","  'total_lines': 10}]"]},"metadata":{},"execution_count":8}],"source":["\n","train_samples[:14]"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":731},"executionInfo":{"elapsed":23,"status":"ok","timestamp":1702836981575,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"um5Y597oQak6","outputId":"155314b5-e17c-4fd0-b3da-4d48a234f56a"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["         target                                               text  \\\n","0     OBJECTIVE  to investigate the efficacy of @ weeks of dail...   \n","1       METHODS  a total of @ patients with primary knee oa wer...   \n","2       METHODS  outcome measures included pain reduction and i...   \n","3       METHODS  pain was assessed using the visual analog pain...   \n","4       METHODS  secondary outcome measures included the wester...   \n","5       METHODS  serum levels of interleukin @ ( il-@ ) , il-@ ...   \n","6       RESULTS  there was a clinically relevant reduction in t...   \n","7       RESULTS  the mean difference between treatment arms ( @...   \n","8       RESULTS  further , there was a clinically relevant redu...   \n","9       RESULTS  these differences remained significant at @ we...   \n","10      RESULTS  the outcome measures in rheumatology clinical ...   \n","11  CONCLUSIONS  low-dose oral prednisolone had both a short-te...   \n","12   BACKGROUND  emotional eating is associated with overeating...   \n","13   BACKGROUND  yet , empirical evidence for individual ( trai...   \n","\n","    line_number  total_lines  \n","0             0           11  \n","1             1           11  \n","2             2           11  \n","3             3           11  \n","4             4           11  \n","5             5           11  \n","6             6           11  \n","7             7           11  \n","8             8           11  \n","9             9           11  \n","10           10           11  \n","11           11           11  \n","12            0           10  \n","13            1           10  "],"text/html":["\n","  <div id=\"df-97c9dcee-6b45-4027-9448-e4b401c5fbc0\" class=\"colab-df-container\">\n","    <div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>target</th>\n","      <th>text</th>\n","      <th>line_number</th>\n","      <th>total_lines</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>0</th>\n","      <td>OBJECTIVE</td>\n","      <td>to investigate the efficacy of @ weeks of dail...</td>\n","      <td>0</td>\n","      <td>11</td>\n","    </tr>\n","    <tr>\n","      <th>1</th>\n","      <td>METHODS</td>\n","      <td>a total of @ patients with primary knee oa wer...</td>\n","      <td>1</td>\n","      <td>11</td>\n","    </tr>\n","    <tr>\n","      <th>2</th>\n","      <td>METHODS</td>\n","      <td>outcome measures included pain reduction and i...</td>\n","      <td>2</td>\n","      <td>11</td>\n","    </tr>\n","    <tr>\n","      <th>3</th>\n","      <td>METHODS</td>\n","      <td>pain was assessed using the visual analog pain...</td>\n","      <td>3</td>\n","      <td>11</td>\n","    </tr>\n","    <tr>\n","      <th>4</th>\n","      <td>METHODS</td>\n","      <td>secondary outcome measures included the wester...</td>\n","      <td>4</td>\n","      <td>11</td>\n","    </tr>\n","    <tr>\n","      <th>5</th>\n","      <td>METHODS</td>\n","      <td>serum levels of interleukin @ ( il-@ ) , il-@ ...</td>\n","      <td>5</td>\n","      <td>11</td>\n","    </tr>\n","    <tr>\n","      <th>6</th>\n","      <td>RESULTS</td>\n","      <td>there was a clinically relevant reduction in t...</td>\n","      <td>6</td>\n","      <td>11</td>\n","    </tr>\n","    <tr>\n","      <th>7</th>\n","      <td>RESULTS</td>\n","      <td>the mean difference between treatment arms ( @...</td>\n","      <td>7</td>\n","      <td>11</td>\n","    </tr>\n","    <tr>\n","      <th>8</th>\n","      <td>RESULTS</td>\n","      <td>further , there was a clinically relevant redu...</td>\n","      <td>8</td>\n","      <td>11</td>\n","    </tr>\n","    <tr>\n","      <th>9</th>\n","      <td>RESULTS</td>\n","      <td>these differences remained significant at @ we...</td>\n","      <td>9</td>\n","      <td>11</td>\n","    </tr>\n","    <tr>\n","      <th>10</th>\n","      <td>RESULTS</td>\n","      <td>the outcome measures in rheumatology clinical ...</td>\n","      <td>10</td>\n","      <td>11</td>\n","    </tr>\n","    <tr>\n","      <th>11</th>\n","      <td>CONCLUSIONS</td>\n","      <td>low-dose oral prednisolone had both a short-te...</td>\n","      <td>11</td>\n","      <td>11</td>\n","    </tr>\n","    <tr>\n","      <th>12</th>\n","      <td>BACKGROUND</td>\n","      <td>emotional eating is associated with overeating...</td>\n","      <td>0</td>\n","      <td>10</td>\n","    </tr>\n","    <tr>\n","      <th>13</th>\n","      <td>BACKGROUND</td>\n","      <td>yet , empirical evidence for individual ( trai...</td>\n","      <td>1</td>\n","      <td>10</td>\n","    </tr>\n","  </tbody>\n","</table>\n","</div>\n","    <div class=\"colab-df-buttons\">\n","\n","  <div class=\"colab-df-container\">\n","    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-97c9dcee-6b45-4027-9448-e4b401c5fbc0')\"\n","            title=\"Convert this dataframe to an interactive table.\"\n","            style=\"display:none;\">\n","\n","  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n","    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n","  </svg>\n","    </button>\n","\n","  <style>\n","    .colab-df-container {\n","      display:flex;\n","      gap: 12px;\n","    }\n","\n","    .colab-df-convert {\n","      background-color: #E8F0FE;\n","      border: none;\n","      border-radius: 50%;\n","      cursor: pointer;\n","      display: none;\n","      fill: #1967D2;\n","      height: 32px;\n","      padding: 0 0 0 0;\n","      width: 32px;\n","    }\n","\n","    .colab-df-convert:hover {\n","      background-color: #E2EBFA;\n","      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","      fill: #174EA6;\n","    }\n","\n","    .colab-df-buttons div {\n","      margin-bottom: 4px;\n","    }\n","\n","    [theme=dark] .colab-df-convert {\n","      background-color: #3B4455;\n","      fill: #D2E3FC;\n","    }\n","\n","    [theme=dark] .colab-df-convert:hover {\n","      background-color: #434B5C;\n","      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","      fill: #FFFFFF;\n","    }\n","  </style>\n","\n","    <script>\n","      const buttonEl =\n","        document.querySelector('#df-97c9dcee-6b45-4027-9448-e4b401c5fbc0 button.colab-df-convert');\n","      buttonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","\n","      async function convertToInteractive(key) {\n","        const element = document.querySelector('#df-97c9dcee-6b45-4027-9448-e4b401c5fbc0');\n","        const dataTable =\n","          await google.colab.kernel.invokeFunction('convertToInteractive',\n","                                                    [key], {});\n","        if (!dataTable) return;\n","\n","        const docLinkHtml = 'Like what you see? Visit the ' +\n","          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n","          + ' to learn more about interactive tables.';\n","        element.innerHTML = '';\n","        dataTable['output_type'] = 'display_data';\n","        await google.colab.output.renderOutput(dataTable, element);\n","        const docLink = document.createElement('div');\n","        docLink.innerHTML = docLinkHtml;\n","        element.appendChild(docLink);\n","      }\n","    </script>\n","  </div>\n","\n","\n","<div id=\"df-f1e007b5-ca64-4a19-974e-9801bf5a4501\">\n","  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-f1e007b5-ca64-4a19-974e-9801bf5a4501')\"\n","            title=\"Suggest charts\"\n","            style=\"display:none;\">\n","\n","<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","     width=\"24px\">\n","    <g>\n","        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n","    </g>\n","</svg>\n","  </button>\n","\n","<style>\n","  .colab-df-quickchart {\n","      --bg-color: #E8F0FE;\n","      --fill-color: #1967D2;\n","      --hover-bg-color: #E2EBFA;\n","      --hover-fill-color: #174EA6;\n","      --disabled-fill-color: #AAA;\n","      --disabled-bg-color: #DDD;\n","  }\n","\n","  [theme=dark] .colab-df-quickchart {\n","      --bg-color: #3B4455;\n","      --fill-color: #D2E3FC;\n","      --hover-bg-color: #434B5C;\n","      --hover-fill-color: #FFFFFF;\n","      --disabled-bg-color: #3B4455;\n","      --disabled-fill-color: #666;\n","  }\n","\n","  .colab-df-quickchart {\n","    background-color: var(--bg-color);\n","    border: none;\n","    border-radius: 50%;\n","    cursor: pointer;\n","    display: none;\n","    fill: var(--fill-color);\n","    height: 32px;\n","    padding: 0;\n","    width: 32px;\n","  }\n","\n","  .colab-df-quickchart:hover {\n","    background-color: var(--hover-bg-color);\n","    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n","    fill: var(--button-hover-fill-color);\n","  }\n","\n","  .colab-df-quickchart-complete:disabled,\n","  .colab-df-quickchart-complete:disabled:hover {\n","    background-color: var(--disabled-bg-color);\n","    fill: var(--disabled-fill-color);\n","    box-shadow: none;\n","  }\n","\n","  .colab-df-spinner {\n","    border: 2px solid var(--fill-color);\n","    border-color: transparent;\n","    border-bottom-color: var(--fill-color);\n","    animation:\n","      spin 1s steps(1) infinite;\n","  }\n","\n","  @keyframes spin {\n","    0% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","      border-left-color: var(--fill-color);\n","    }\n","    20% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    30% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","      border-right-color: var(--fill-color);\n","    }\n","    40% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    60% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","    }\n","    80% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-bottom-color: var(--fill-color);\n","    }\n","    90% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","    }\n","  }\n","</style>\n","\n","  <script>\n","    async function quickchart(key) {\n","      const quickchartButtonEl =\n","        document.querySelector('#' + key + ' button');\n","      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n","      quickchartButtonEl.classList.add('colab-df-spinner');\n","      try {\n","        const charts = await google.colab.kernel.invokeFunction(\n","            'suggestCharts', [key], {});\n","      } catch (error) {\n","        console.error('Error during call to suggestCharts:', error);\n","      }\n","      quickchartButtonEl.classList.remove('colab-df-spinner');\n","      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n","    }\n","    (() => {\n","      let quickchartButtonEl =\n","        document.querySelector('#df-f1e007b5-ca64-4a19-974e-9801bf5a4501 button');\n","      quickchartButtonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","    })();\n","  </script>\n","</div>\n","\n","    </div>\n","  </div>\n"]},"metadata":{},"execution_count":9}],"source":["import pandas as pd\n","train_df = pd.DataFrame(train_samples)\n","val_df = pd.DataFrame(val_samples)\n","test_df = pd.DataFrame(test_samples)\n","train_df.head(14)"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":20,"status":"ok","timestamp":1702836981575,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"Jq52-TAoQm1T","outputId":"ca68f37e-deca-47ba-f746-780c62d42844"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["METHODS        59353\n","RESULTS        57953\n","CONCLUSIONS    27168\n","BACKGROUND     21727\n","OBJECTIVE      13839\n","Name: target, dtype: int64"]},"metadata":{},"execution_count":10}],"source":["train_df.target.value_counts()"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":983,"status":"ok","timestamp":1702836982545,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"x3t4uG5hRtk9","outputId":"9c08c94b-d9d9-4100-85af-dc4f1454306f"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["(180040, 30212, 30135)"]},"metadata":{},"execution_count":11}],"source":["train_sentences = train_df[\"text\"].tolist()\n","val_sentences = val_df[\"text\"].tolist()\n","test_sentences = test_df[\"text\"].tolist()\n","len(train_sentences),len(val_sentences),len(test_sentences)"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":16,"status":"ok","timestamp":1702836982545,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"dS9V-FC8TUTM","outputId":"078239c4-e947-42c7-815c-f4374eb84ca8"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["['to investigate the efficacy of @ weeks of daily low-dose oral prednisolone in improving pain , mobility , and systemic low-grade inflammation in the short term and whether the effect would be sustained at @ weeks in older adults with moderate to severe knee osteoarthritis ( oa ) .',\n"," 'a total of @ patients with primary knee oa were randomized @:@ ; @ received @ mg/day of prednisolone and @ received placebo for @ weeks .',\n"," 'outcome measures included pain reduction and improvement in function scores and systemic inflammation markers .',\n"," 'pain was assessed using the visual analog pain scale ( @-@ mm ) .',\n"," 'secondary outcome measures included the western ontario and mcmaster universities osteoarthritis index scores , patient global assessment ( pga ) of the severity of knee oa , and @-min walk distance ( @mwd ) .',\n"," 'serum levels of interleukin @ ( il-@ ) , il-@ , tumor necrosis factor ( tnf ) - , and high-sensitivity c-reactive protein ( hscrp ) were measured .',\n"," 'there was a clinically relevant reduction in the intervention group compared to the placebo group for knee pain , physical function , pga , and @mwd at @ weeks .',\n"," 'the mean difference between treatment arms ( @ % ci ) was @ ( @-@ @ ) , p < @ ; @ ( @-@ @ ) , p < @ ; @ ( @-@ @ ) , p < @ ; and @ ( @-@ @ ) , p < @ , respectively .',\n"," 'further , there was a clinically relevant reduction in the serum levels of il-@ , il-@ , tnf - , and hscrp at @ weeks in the intervention group when compared to the placebo group .',\n"," 'these differences remained significant at @ weeks .',\n"," 'the outcome measures in rheumatology clinical trials-osteoarthritis research society international responder rate was @ % in the intervention group and @ % in the placebo group ( p < @ ) .',\n"," 'low-dose oral prednisolone had both a short-term and a longer sustained effect resulting in less knee pain , better physical function , and attenuation of systemic inflammation in older patients with knee oa ( clinicaltrials.gov identifier nct@ ) .',\n"," 'emotional eating is associated with overeating and the development of obesity .',\n"," 'yet , empirical evidence for individual ( trait ) differences in emotional eating and cognitive mechanisms that contribute to eating during sad mood remain equivocal .',\n"," 'the aim of this study was to test if attention bias for food moderates the effect of self-reported emotional eating during sad mood ( vs neutral mood ) on actual food intake .',\n"," 'it was expected that emotional eating is predictive of elevated attention for food and higher food intake after an experimentally induced sad mood and that attentional maintenance on food predicts food intake during a sad versus a neutral mood .',\n"," 'participants ( n = @ ) were randomly assigned to one of the two experimental mood induction conditions ( sad/neutral ) .',\n"," 'attentional biases for high caloric foods were measured by eye tracking during a visual probe task with pictorial food and neutral stimuli .',\n"," 'self-reported emotional eating was assessed with the dutch eating behavior questionnaire ( debq ) and ad libitum food intake was tested by a disguised food offer .',\n"," 'hierarchical multivariate regression modeling showed that self-reported emotional eating did not account for changes in attention allocation for food or food intake in either condition .',\n"," 'yet , attention maintenance on food cues was significantly related to increased intake specifically in the neutral condition , but not in the sad mood condition .',\n"," 'the current findings show that self-reported emotional eating ( based on the debq ) might not validly predict who overeats when sad , at least not in a laboratory setting with healthy women .',\n"," 'results further suggest that attention maintenance on food relates to eating motivation when in a neutral affective state , and might therefore be a cognitive mechanism contributing to increased food intake in general , but maybe not during sad mood .',\n"," 'although working smoke alarms halve deaths in residential fires , many households do not keep alarms operational .',\n"," 'we tested whether theory-based education increases alarm operability .',\n"," 'randomised multiarm trial , with a single arm randomly selected for use each day , in low-income neighbourhoods in maryland , usa .',\n"," \"intervention arms : ( @ ) full education combining a health belief module with a social-cognitive theory module that provided hands-on practice installing alarm batteries and using the alarm 's hush button ; ( @ ) hands-on practice social-cognitive module supplemented by typical fire department education ; ( @ ) current norm receiving typical fire department education only .\",\n"," 'four hundred and thirty-six homes recruited through churches or by knocking on doors in @-@ .',\n"," 'follow-up visits checked alarm operability in @ homes ( @ % ) @-@ @ years after installation .',\n"," 'number of homes with working alarms defined as alarms with working batteries or hard-wired and number of working alarms per home .',\n"," 'regressions controlled for alarm status preintervention ; demographics and beliefs about fire risks and alarm effectiveness .',\n"," 'homes in the full education and practice arms were more likely to have a functioning smoke alarm at follow-up ( or = @ , @ % ci @ to @ ) and had an average of @ more working alarms per home ( @ % ci @ to @ ) .',\n"," 'working alarms per home rose @ % .',\n"," 'full education and practice had similar effectiveness ( p = @ on both outcome measures ) .',\n"," 'without exceeding typical fire department installation time , installers can achieve greater smoke alarm operability .',\n"," 'hands-on practice is key .',\n"," 'two years after installation , for every three homes that received hands-on practice , one had an additional working alarm .',\n"," 'http://www.clinicaltrials.gov number nct@ .',\n"," 'to evaluate the performance ( efficacy , safety and acceptability ) of a new micro-adherent absorbent dressing ( urgoclean ) compared with a hydrofiber dressing ( aquacel ) in the local management of venous leg ulcers , in the debridement stage .',\n"," 'a non-inferiority european randomised controlled clinical trial ( rct ) was conducted in @ centres , on patients presenting with venous or predominantly venous , mixed aetiology leg ulcers at their sloughy stage ( with more than @ % of the wound bed covered with slough at baseline ) .',\n"," 'patients were followed over a @-week period and assessed weekly .',\n"," 'the primary judgement criteria was the relative regression of the wound surface area after the @-week treatment period .',\n"," 'secondary endpoints were the relative reduction of sloughy tissue and the percentage of patients presenting with a debrided wound .',\n"," 'altogether , @ patients were randomised to either urgoclean ( test group ; n = @ ) or aquacel ( control group ; n = @ ) dressings .',\n"," 'regarding the wound healing process predictive factors ( wound area , duration , abpi value , recurrence ) , at baseline , the two groups were well balanced , for both wound and patient characteristics .',\n"," 'compression therapy was administered to both groups and after a median @-day treatment period , the percentage of relative reduction of the wound surface area was very similar ( -@ % vs -@ % in the urgoclean and control groups , respectively ) .',\n"," 'when considering the secondary criteria at week @ , the relative reduction of sloughy tissue was significantly higher in the urgoclean group than in the control group ( -@ % vs -@,@ % ; p = @ ) .',\n"," 'the percentage of debrided wounds was also significantly higher in the test group ( @ % vs @ % ; p = @ ) .',\n"," \"this ` earth ' rct confirmed that the urgoclean dressing has similar efficacy and safety compared to aquacel .\",\n"," 'however , urgoclean also showed better autolytic properties than the control group in the management of venous leg ulcers at the sloughy stage .',\n"," 'the new urgoclean dressing therefore represents a promising therapeutic option within the current range of autolytic dressings available .',\n"," 'this study was sponsored by a grant from the pharmaceutical company laboratoires urgo .',\n"," 's. bohbot and o. tacca are employees of laboratoires urgo .',\n"," 's. meaume , j. dissemond and g. perceau have received monetary compensation as presenters for laboratoires urgo .',\n"," 'data management and statistical analyses were conducted independently by vertical ( paris , france ) .',\n"," 'eye movements ( em ) during recall of an aversive memory is a treatment element unique to eye movement desensitization and reprocessing ( emdr ) .',\n"," 'experimental studies have shown that em reduce memory vividness and/or emotionality shortly after the intervention .',\n"," 'however , it is unclear whether the immediate effects of the intervention reflect actual changes in memory .',\n"," 'the aim of this study was to test whether immediate reductions in memory vividness and emotionality persist at a @h follow up and whether the magnitude of these effects is related to the duration of the intervention .',\n"," \"seventy-three undergraduates recalled two negative autobiographical memories , one with em ( `` recall with em '' ) and one without ( `` recall only '' ) .\",\n"," 'half of participants recalled each memory for four periods of @s , the other half for eight periods of @s .',\n"," 'memory vividness/emotionality were self-rated at a pre-test , an immediate post-test , and a @h follow-up test .',\n"," 'in both duration groups , recall with em , but not recall only , caused an immediate decrease in memory vividness .',\n"," 'there were no immediate reductions in memory emotionality .',\n"," \"furthermore , only the ` eight periods ' group showed that recall with em , but not recall only , caused a decrease in both memory emotionality and memory vividness from the pre-test to the follow-up .\",\n"," 'only self-report measures were used .',\n"," 'the findings suggest that recall with em causes @-hchanges in memory vividness/emotionality , which may explain part of the emdr treatment effect , and these effects are related to intervention duration .',\n"," 'few studies have tested the impact of motivational interviewing ( mi ) delivered by primary care providers on pediatric obesity .',\n"," 'this study tested the efficacy of mi delivered by providers and registered dietitians ( rds ) to parents of overweight children aged @ through @ .',\n"," 'forty-two practices from the pediatric research in office settings network of the american academy of pediatrics were randomly assigned to @ of @ groups .',\n"," 'group @ ( usual care ) measured bmi percentile at baseline and @ - and @-year follow-up .',\n"," 'group @ ( provider only ) delivered @ mi counseling sessions to parents of the index child over @ years .',\n"," 'group @ ( provider + rd ) delivered @ provider mi sessions plus @ mi sessions from a rd. .',\n"," 'the primary outcome was child bmi percentile at @-year follow up .',\n"," 'at @-year follow-up , the adjusted bmi percentile was @ , @ , and @ for groups @ , @ , and @ , respectively .',\n"," 'the group @ mean was significantly ( p = @ ) lower than group @ .',\n"," 'mean changes from baseline in bmi percentile were @ , @ , and @ across groups @ , @ , and @ .',\n"," 'mi delivered by providers and rds ( group @ ) resulted in statistically significant reductions in bmi percentile .',\n"," 'research is needed to determine the clinical significance and persistence of the bmi effects observed .',\n"," 'how the intervention can be brought to scale ( in particular , how to train physicians to use mi effectively and how best to train rds and integrate them into primary care settings ) also merits future research .',\n"," 'antithrombin ( at ) concentrations are reduced after cardiac surgery with cardiopulmonary bypass compared with the preoperative levels .',\n"," 'low postoperative at is associated with worse short - and mid-term clinical outcomes .',\n"," 'the aim of the study is to evaluate the effects of at administration on activation of the coagulation and fibrinolytic systems , platelet function , and the inflammatory response in patients with low postoperative at levels .',\n"," 'sixty patients with postoperative at levels of less than @ % were randomly assigned to receive purified at ( @ iu in three administrations ) or placebo in the postoperative intensive care unit .',\n"," 'thirty patients with postoperative at levels greater than @ % were observed as controls .',\n"," 'interleukin @ ( a marker of inflammation ) , prothrombin fragment @-@ ( a marker of thrombin generation ) , plasmin-antiplasmin complex ( a marker of fibrinolysis ) , and platelet factor @ ( a marker of platelet activation ) were measured at six different times .',\n"," 'compared with the no at group and control patients , patients receiving at showed significantly higher at values until @ hours after the last administration .',\n"," 'analysis of variance for repeated measures showed a significant effect of study treatment in reducing prothrombin fragment @-@ ( p = @ ; interaction with time sample , p = @ ) and plasmin-antiplasmin complex ( p < @ ; interaction with time sample , p < @ ) values but not interleukin @ ( p = @ ; interaction with time sample , p = @ ) and platelet factor @ ( p = @ ; interaction with time sample , p = @ ) .',\n"," 'no difference in chest tube drainage , reopening for bleeding , and blood transfusion was observed .',\n"," 'antithrombin administration in patients with low at activity after surgery with cardiopulmonary bypass reduces postoperative thrombin generation and fibrinolysis with no effects on platelet activation and inflammatory response .',\n"," 'we evaluated patients at tertiary -lsb- both percutaneous coronary intervention ( pci ) and coronary artery bypass grafting ( cabg ) capable -rsb- and primary hospitals in the early-acs trial .',\n"," 'early invasive management is recommended for high-risk non-st-segment elevation acute coronary syndromes .',\n"," \"we evaluated outcomes in @,@ patients presenting to : tertiary sites , primary sites with transfer to tertiary sites ( `` transferred '' ) and those who remained at primary sites ( `` non-transfer '' ) .\",\n"," 'there were @ tertiary ( n = @,@ patients ) and @ primary hospitals -lsb- n = @,@ patients ( @ transferred ; @,@ non-transfer ) -rsb- .',\n"," 'significant delays occurred in time from symptom onset to angiography ( @ hr ) , pci ( @h ) , and cabg ( @ hr ) for transferred patients ( p < @ ) .',\n"," 'non-transfer patients had less @-day death/myocardial infarction -lsb- @ % vs. @ % ( tertiary ) ; adjusted odds ratio ( or ) : @ ( @-@ @ ) , p = @ -rsb- ; transferred ( @ % ) and tertiary patients were similar -lsb- adjusted or : @ ( @-@ @ ) , p = @ -rsb- .',\n"," 'non-transfer patients had lower @-year mortality -lsb- @ % vs. @ % ( tertiary ) ; adjusted hazard ratio ( hr ) : @ ( @-@ @ ) , p = @ -rsb- : there was no difference between transferred and tertiary patients -lsb- @ % vs. @ % ; adjusted hr : @ ( @-@ @ ) , p = @ -rsb- .',\n"," 'despite similar rates of catheterization , gusto severe/moderate bleeding within @ hr was less in non-transfer -lsb- @ % vs. @ % ( tertiary ) ; adjusted or : @ ( @-@ @ ) , p < @ -rsb- , whereas transferred ( @ % ) and tertiary patients were similar -lsb- adjusted or : @ ( @-@ @ ) , p = @ -rsb- .',\n"," 'there was no difference in non-cabg bleeding .',\n"," 'timely angiography and revascularization were often not achieved in transferred patients .',\n"," 'non-transferred patients presenting to primary sites had the lowest event rates and the best long-term survival .',\n"," 'we hypothesized that a targeted temperature of @ c as compared to that of @ c would increase survival and reduce the severity of circulatory shock in patients with shock on admission after out-of-hospital cardiac arrest ( ohca ) .',\n"," 'the recently published target temperature management trial ( ttm-trial ) randomized @ ohca patients with no difference in outcome between groups and no difference in mortality at the end of the trial in a predefined subgroup of patients with shock at admission .',\n"," 'shock was defined as a systolic blood pressure of < @ mm hg for > @ min or the need of supportive measures to maintain a blood pressure @ mmhg and/or clinical signs of end-organ hypoperfusion .',\n"," 'in this post hoc analysis reported here , we further analyzed the @ patients with shock at admission ; all had been randomized to receive intervention at @ c ( ttm@ ; n = @ ) or @ c ( ttm@ ; n = @ ) .',\n"," 'primary outcome was @-day mortality .',\n"," 'secondary outcomes were intensive care unit ( icu ) and @-day mortality , severity of circulatory shock assessed by mean arterial pressure , serum lactate , fluid balance and the extended sequential organ failure assessment ( sofa ) score .',\n"," 'there was no significance difference between targeted temperature management at @ c or @ c on @-day mortality -lsb- log-rank test , p = @ , hazard ratio @ , @ % confidence interval ( ci ) @-@ @ -rsb- or icu mortality ( @ vs. @ % , p = @ ; relative risk @ , @ % ci @-@ @ ) .',\n"," 'serum lactate and the extended cardiovascular sofa score were higher in the ttm@ group ( p < @ ) .',\n"," 'we found no benefit in survival or severity of circulatory shock with targeted temperature management at @ c as compared to @ c in patients with shock on admission after ohca .',\n"," 'youths with a family history of alcohol and other drug use disorders ( fh + ) are at a greater risk of developing substance use disorders than their peers with no such family histories ( fh - ) , and this increased risk may be related to impaired maturation of forebrain circuitry .',\n"," 'fh + individuals have shown altered forebrain activity at rest and while performing cognitive tasks .',\n"," 'however , it is not fully understood how forebrain activity is altered in fh + individuals , and ultimately how these alterations may contribute to substance use disorder risk .',\n"," 'in this study , we tested @ fh + and @ fh - youths performing a go/no-go task and examined activations in blocks with only go trials ( go only ) , blocks with @ % go and @ % no-go trials ( go/nogo ) , and a contrast of those @ blocks .',\n"," 'fh + youths had significantly greater cerebral activations in both the go and go/nogo blocks than fh - youths in regions including the posterior cingulate/precuneus , bilateral middle/superior temporal gyrus , and medial superior frontal gyrus with no significant group differences in the subtraction between go only and go/nogo blocks .',\n"," 'additionally , fh + youths had moderately slower reaction times on go trials in the go only blocks .',\n"," 'our findings suggest that global activation increase in fh + youths are modulated by fh density and are not specific to the inhibitory components of the task .',\n"," 'this pattern of increased activations in fh + youths may be at least partially due to impaired forebrain white matter development leading to greater activations/less efficient neural communication during task performance .',\n"," 'risk factors have been proposed for running injuries including ( a ) reduced muscular strength , ( b ) excessive joint movements and ( c ) excessive joint moments in the frontal and transverse planes .',\n"," \"to date , many running injury prevention programs have focused on a `` top down '' approach to strengthen the hip musculature in the attempt to reduce movements and moments at the hip , knee , and/or ankle joints .\",\n"," 'however , running mechanics did not change when hip muscle strength increased .',\n"," \"it could be speculated that emphasis should be placed on increasing the strength of the ankle joint for a `` ground up '' approach .\",\n"," 'strengthening of the large and small muscles crossing the ankle joint is assumed to change the force distribution for these muscles and to increase the use of smaller muscles .',\n"," 'this would be associated with a reduction of joint and insertion forces , which could have a beneficial effect on injury prevention .',\n"," 'however , training of the ankle joint as an injury prevention strategy has not been studied .',\n"," 'ankle strengthening techniques include isolated strengthening or movement-related strengthening such as functional balance training .',\n"," 'there is little knowledge about the efficacy of such training programs on strength alteration , gait or injury reduction .',\n"," 'novice runners will be randomly assigned to one of three groups : an isolated ankle strengthening group ( strength , n = @ ) , a functional balance training group ( balance , n = @ ) or an activity-matched control group ( control , n = @ ) .',\n"," 'isokinetic strength will be measured using a biodex system @ dynamometer .',\n"," 'running kinematics and kinetics will be assessed using @d motion analysis and a force platform .',\n"," 'postural control will be assessed by quantifying the magnitude and temporal structure of the center of pressure trace during single leg stance on a force platform .',\n"," 'the change pre - and post-training in isokinetic strength , running mechanics , and postural control variables will be compared following the interventions .',\n"," 'injuries rates will be compared between groups over @months .',\n"," 'avoiding injury will allow individuals to enjoy the benefits of participating in aerobic activities and reduce the healthcare costs associated with running injuries .',\n"," 'current controlled trial nct@ .',\n"," 'vitamin b@ deficiency causes neurologic and psychiatric disease , especially in older adults .',\n"," 'subacute combined degeneration is characterized by damage to the posterior and lateral spinal cord affecting the corticospinal tract .',\n"," 'to test corticospinal tract projections using motor evoked potentials ( meps ) by transcranial magnetic stimulation ( tms ) in asymptomatic older adults with low vitamin b@ ( b@ ) levels .',\n"," 'cross-sectional study of @ healthy older adults ( > @ years ) .',\n"," 'meps were recorded in the abductor pollicis brevis and tibialis anterior muscles , at rest and during slight tonic contraction .',\n"," 'central motor conduction time ( cmct ) was derived from the latency of meps and peripheral motor conduction time ( pmct ) .',\n"," 'neurophysiological variables were analyzed statistically according to b@ status .',\n"," 'median age was @ years ( @ % women ) .',\n"," 'twenty-six out of the @ subjects had low vitamin b@ levels ( b@ < @pmol/l ) .',\n"," 'meps were recorded for all subjects in upper and lower extremities .',\n"," 'there were no significant differences in either latency or amplitude of meps and cmct between low and normal b@ groups .',\n"," 'there was a significant pmct delay in the lower extremities in the low b@ group ( p = @ ) .',\n"," 'no subclinical abnormality of the corticospinal tract is detected in asymptomatic b@-deficient older adults .',\n"," 'the peripheral nervous system appears to be more vulnerable to damage attributable to this vitamin deficit .',\n"," 'the neurophysiological evaluation of asymptomatic older adults with lower b@ levels should be focused mainly in peripheral nervous system evaluation .',\n"," 'uncontrolled hypertension ( htn ) is a significant public health problem among blacks in the united states .',\n"," 'despite the proven efficacy of therapeutic lifestyle change ( tlc ) on blood pressure ( bp ) reduction in clinical trials , few studies have examined their effectiveness in church-based settings-an influential institution for health promotion in black communities .',\n"," 'using a cluster-randomized , @-arm trial design , this study evaluates the effectiveness of a faith-based tlc intervention vs health education ( he ) control on bp reduction among hypertensive black adults .',\n"," 'the intervention is delivered by trained lay health advisors through group tlc sessions plus motivational interviewing in @ black churches .',\n"," 'participants in the intervention group receive @ weekly tlc sessions targeting weight loss , increasing physical activity , fruit , vegetable and low-fat dairy intake , and decreasing fat and sodium intake , plus @ monthly individual motivational interviewing sessions .',\n"," 'participants in the control group attend @ weekly classes on htn and other health topics delivered by health care experts .',\n"," 'the primary outcome is change in bp from baseline to @ months .',\n"," 'secondary outcomes include level of physical activity , percent change in weight , and fruit and vegetable consumption at @ months , and bp control at @ months .',\n"," 'if successful , this trial will provide an alternative and culturally appropriate model for htn control through evidence-based lifestyle modification delivered in churches by lay health advisors .',\n"," 'the classification of clinical severity of ebstein anomaly still remains a challenge .',\n"," 'the aim of this study was to focus on the interaction of the pathologically altered right heart with the anatomically-supposedly-normal left heart and to derive from cardiac magnetic resonance ( cmr ) a simple imaging measure for the clinical severity of ebstein anomaly .',\n"," 'twenty-five patients at a mean age of @ years with unrepaired ebstein anomaly were examined in a prospective study .',\n"," 'disease severity was classified using cmr volumes and functional measurements in comparison with heart failure markers from clinical data , ecg , laboratory and cardiopulmonary exercise testing , and echocardiography .',\n"," 'all examinations were completed within @ hours .',\n"," 'a total right/left-volume index was defined from end-diastolic volume measurements in cmr : total right/left-volume index = ( ra + arv + frv ) / ( la+lv ) .',\n"," 'mean total right/left-volume index was @ ( normal values : @ ) .',\n"," 'this new total right/left-volume index correlated with almost all clinically used biomarkers of heart failure : brain natriuretic peptide ( r = @ ; p = @ ) , qrs ( r = @ ; p = @ ) , peak oxygen consumption/kg ( r = -@ ; p = @ ) , ventilatory response to carbon dioxide production at anaerobic threshold ( r = @ ; p = @ ) , the severity of tricuspid regurgitation ( r = @ ; p = @ ) , tricuspid valve offset ( r = @ ; p = @ ) , and tricuspid annular plane systolic excursion ( r = @ ; p = @ ) .',\n"," 'previously described severity indices ( -lsb- ra + arv -rsb- / -lsb- frv + la+lv -rsb- ) and frv/lv end-diastolic volume corresponded only to some parameters .',\n"," 'in patients with ebstein anomaly , the easily acquired index of right-sided to left-sided heart volumes from cmr correlated well with established heart failure markers .',\n"," 'our data suggest that the total right/left-volume index should be used as a new and simplified cmr measure , allowing more accurate assessment of disease severity than previously described scoring systems .',\n"," 'this study sought to investigate the association of beta-blocker therapy at discharge with clinical outcomes in patients with st-segment elevation myocardial infarction ( stemi ) after primary percutaneous coronary intervention ( pci ) .',\n"," 'limited data are available on the efficacy of beta-blocker therapy for secondary prevention in stemi patients .',\n"," 'between november @ , @ and september @ , @ , @,@ patients were enrolled in nationwide , prospective , multicenter registries .',\n"," 'among these , we studied stemi patients undergoing primary pci who were discharged alive ( n = @,@ ) .',\n"," 'we classified patients into the beta-blocker group ( n = @,@ ) and no-beta-blocker group ( n = @,@ ) according to the use of beta-blockers at discharge .',\n"," 'propensity-score matching analysis was also performed in @,@ patient triplets .',\n"," 'the primary outcome was all-cause death .',\n"," 'the median follow-up duration was @ days ( interquartile range : @ to @ days ) .',\n"," 'all-cause death occurred in @ patients ( @ % ) of the beta-blocker group versus @ patients ( @ % ) of the no-beta-blocker group ( p < @ ) .',\n"," 'after @:@ propensity-score matching , beta-blocker therapy was associated with a lower incidence of all-cause death ( @ % vs. @ % , adjusted hazard ratio : @ , @ % confidence interval : @ to @ , p = @ ) .',\n"," 'the association with better outcome of beta-blocker therapy in terms of all-cause death was consistent across various subgroups , including patients with relatively low-risk profiles such as ejection fraction > @ % or single-vessel disease .',\n"," 'beta-blocker therapy at discharge was associated with improved survival in stemi patients treated with primary pci .',\n"," 'our results support the current american college of cardiology/american heart association guidelines , which recommend long-term beta-blocker therapy in all patients with stemi regardless of reperfusion therapy or risk profile .',\n"," 'local anesthetic wound infiltration is widely used as an effective adjunct during multimodal postoperative pain management .',\n"," 'the aim of this study was to evaluate the effectiveness of continuous wound infusion of ropivacaine in postoperative pain relief , opioid sparing , incidence of nausea and vomiting , and bowel and liver function improvement in patients undergoing open hepatectomy .',\n"," 'forty patients undergoing open hepatectomy were enrolled in this prospective , randomized , double-blinded , placebo-controlled trial .',\n"," 'patients were divided into @ groups : the @ % saline continuous infusion group ( the control group ; n = @ ) and the ropivacaine continuous infusion group ( the ropi group ; n = @ ) .',\n"," 'outcomes measured postoperatively were pain score at rest and on movement , sufentanil consumption , incidence of nausea and vomiting , and sedation score across @ postoperative hours .',\n"," 'time to bowel recovery , liver function change , mean length of hospitalization , patient satisfaction , and other data after @ postoperative hours were collected until hospital discharge .',\n"," 'pain scores at rest were lower for the ropivacaine group and reached significance after @ and @ hours ( p < @ ) .',\n"," 'sufentanil consumption ( @ vs. @ g ; p < @ ) after @ hours , time to bowel recovery ( @ vs. @ d ; p < @ ) , incidence of nausea and vomiting ( @ vs. @ ; p < @ ) , and mean length of hospitalization ( @ vs. @ d ; p < @ ) were significantly reduced , and the sedation score and liver function change were also comparable between the @ groups .',\n"," 'there was no difference with respect to pain scores on movement , nor with respect to patient satisfaction .',\n"," 'surgical wound infusion with ropivacaine after hepatectomy can improve pain relief at rest and accelerate recovery and discharge .',\n"," 'tuberculosis ( tb ) is highly prevalent among hiv-infected people , including those receiving combination antiretroviral therapy ( cart ) , necessitating a well tolerated and efficacious tb vaccine for these populations .',\n"," 'we evaluated the safety and immunogenicity of the candidate tb vaccine m@/as@ in adults with well controlled hiv infection on cart .',\n"," 'a randomized , observer-blind , controlled trial ( nct@ ) .',\n"," 'hiv-infected adults on cart in switzerland were randomized @:@:@ to receive two doses , @ month apart , of m@/as@ , as@ or @ % physiological saline ( n = @ , n = @ and n = @ , respectively ) and were followed up to @ months postdose @ ( d@ ) .',\n"," 'individuals with cd@ cell counts below @ cells/l were excluded .',\n"," 'adverse events ( aes ) including hiv-specific and laboratory safety parameters were recorded .',\n"," 'cell-mediated ( ics ) and humoral ( elisa ) responses were evaluated before vaccination , @ month after each dose ( d@ , d@ ) and d@ .',\n"," 'thirty-seven individuals -lsb- interquartile range ( iqr ) cd@ cell counts at screening : @-@ cells/l ; undetectable hiv-@ viremia -rsb- were enrolled ; @ % of individuals reported previous bcg vaccination , @ % tested negative for the quantiferon-tb assay .',\n"," 'for m@/as@ recipients , no vaccine-related serious aes or cart-regimen adjustments were recorded , and there were no clinically relevant effects on laboratory safety parameters , hiv-@ viral loads or cd@ cell counts .',\n"," 'm@/as@ was immunogenic , inducing persistent and polyfunctional m@-specific cd@ t-cell responses -lsb- medians @ % ( iqr @-@ @ ) at d@ -rsb- and @ % ( @-@ @ ) at d@ , predominantly cd@lil-@tnf - , cd@lil-@ and cd@lil-@tnf-ifn - -rsb- .',\n"," 'all m@/as@ vaccines were seropositive for anti-m@ igg after second vaccination until study end .',\n"," 'm@/as@ was clinically well tolerated and immunogenic in this population , supporting further clinical evaluation in hiv-infected individuals in tb-endemic settings .',\n"," 'the aim of this study was to investigate whether remedial hydration ( rh ) reduces the incidence of contrast-induced nephropathy ( cin ) and short-term adverse events in st-elevation myocardial infarction ( stemi ) patients undergoing primary percutaneous coronary intervention ( pci ) .',\n"," 'a total of @ consecutive stemi patients were prospectively and randomly assigned into two groups : @ patients in the rh group and @ patients in the no rh ( control ) group .',\n"," 'the serum creatinine ( scr ) and creatinine clearance ( ccr ) levels were measured on admission and at @ , @ and @ hours after primary pci .',\n"," 'the rates of cin and short-term adverse events were analyzed for each group .',\n"," 'after surgery , the patients were categorized into four groups according to the mehran risk score : low ( @ , n = @ ) , moderate ( @-@ , n = @ ) , high ( @-@ , n = @ ) or very high ( @ , n = @ ) .',\n"," 'the incidence of cin in the rh group was lower than that observed in the control group ( @/@ ; @ % vs. @/@ ; @ % , p < @ ) .',\n"," 'the subgroup analysis showed that the rate of cin was lower in the moderate ( @/@ ; @ % vs. @/@ ; @ % , p < @ ) and significantly lower in both the high ( @/@ ; @ % vs. @/@ ; @ % , p < @ ) and very high score groups ( @/@ ; @ % vs. @/@ ; @ % , p < @ ) among the rh patients compared to the controls .',\n"," 'at @ , @ and @ hours after pci , the patients in the rh group exhibited lower scr levels and higher ccr levels than the patients in the control group ( both p < @ ) .',\n"," 'a lower incidence of in-hospital clinical events was also observed in the rh group .',\n"," 'remedial hydration decreases the occurrence of cin and improves the short-term prognosis of stemi patients undergoing primary pci .',\n"," 'an increased production of oxidizing species related to reactive oral diseases , such as chronic apical periodontitis , could have systemic implications such as an increase in cardiovascular morbidity .',\n"," 'based on this consideration , we conducted a prospective study to assess whether subjects affected by chronic periodontitis presented with higher values of oxidative stress than reference values before endodontic treatment , and whether endodontic treatment can reduce the oxidative imbalance and bring it back to normal in these subjects .',\n"," 'the authors recruited @ groups of patients from private studies and dental clinics : these patients were recruited randomly .',\n"," 'the oxidative balance in both patients with chronic apical periodontitis ( cap ) and healthy control patients was determined by measuring the oxidant status , using an identification of the reactive oxygen metabolites ( d-roms ) test , while the antioxidant status in these patients was determined using a biological antioxidant potential ( bap ) test .',\n"," 'both these tests were carried on plasma samples taken from enrolled patients .',\n"," 'values were measured both before the endodontic treatment of the patients with chronic apical periodontitis , and @ and @ days after treatment , and compared to those obtained from healthy control patients .',\n"," 'it was found that , on recruitment , the patients with chronic apical periodontitis exhibited significantly higher levels of oxidative stress than control patients , as determined by the d-roms and bap tests .',\n"," 'furthermore , the d-roms test values were shown to decrease and the bap test values to increase over time in patients with chronic apical periodontitis following endodontic therapy .',\n"," 'as the levels of oxidative stress in these patients tended to reduce and return to normal by @ days following treatment .',\n"," 'this study has demonstrated a positive association between chronic apical periodontitis and oxidative stress .',\n"," 'subjects affected by chronic apical periodontitis are exposed to a condition of oxidative stress , which is extremely dangerous to general health .',\n"," 'moreover , one can infer from these findings that through proper endodontic therapy , a good oxidative balance can be restored , thereby avoiding the risk of contracting the abovementioned diseases .',\n"," 'placebo effect has been largely studied and debated in medicine .',\n"," 'research focused mainly on children and adults but not on newborns .',\n"," 'in osteopathy , few studies documented this effect and no research has been conducted in newborns .',\n"," 'to assess the presence of placebo effect in newborns using sham osteopathic manipulative treatment .',\n"," 'randomized control trial .',\n"," 'neonatal intensive care unit in italy .',\n"," 'two groups ( @ patients each ) of preterm infants aged @-@ weeks without medical complications received routine pediatric care and osteopathic sham therapy was administrated to the study group only for the entire period of hospitalization .',\n"," 'primary end point was the mean reduction of length of stay at discharge .',\n"," 'secondary objective was the change in daily weight gain .',\n"," '@ newborns entered the study .',\n"," 'no difference between sham and control group was found for the primary outcome length of stay ( @ ; @ ; p = @ ) .',\n"," 'multivariate analysis showed no difference between study and control group on length of stay .',\n"," 'a negative association was found for gestational age ( -@ ; @ % ci -@ to -@ ; p = @ ) , birth weight ( -@ ; @ % ci -@ to -@ ; p < @ ) and milk volume at study enrollment ( -@ ; @ % ci -@ to -@ ; p = @ ) .',\n"," 'to the best of our knowledge , this study is the first in the field showing no placebo effect on newborns .',\n"," 'further discussions are opened concerning the age when placebo effect starts .',\n"," 'clostridium difficile infection ( cdi ) is a leading cause of diarrhoea in health care settings with symptoms ranging from mild and self-limiting to life threatening .',\n"," 'smt@ is a novel , non-absorbable antibiotic currently under development for the treatment of cdi .',\n"," 'here we report the results from a phase i study .',\n"," 'a double-blind , randomized , placebo-controlled study assessing safety and tolerability of single and multiple oral doses of smt@ in healthy volunteers .',\n"," 'pharmacokinetic assessments included blood and faecal sampling .',\n"," 'the effect of food on systemic exposure and analysis of the gut microbiota were also included .',\n"," 'fifty-six healthy male subjects were enrolled .',\n"," 'following single oral doses of up to @,@ mg in the fasted state , plasma concentrations of smt@ were generally below the lower limit of quantification .',\n"," 'in the fed state levels ranged from @ to @ ng/ml after single dosing and after repeat dosing at day @ from @ to @ ng/ml .',\n"," 'following single and multiple oral doses of smt@ , mean daily faecal concentrations increased with increasing dose level and were significantly above the typical mic range for c. difficile ( @-@ @ g/ml ) .',\n"," 'at @ mg bid , mean ( sd ) faecal concentrations of @,@ ( @ ) g/g and @,@ ( @ ) g/g were determined on days @ and @ of dosing respectively .',\n"," 'no notable metabolites were detected in faeces .',\n"," 'overall , all doses of smt@ were well tolerated both as single oral doses or bid oral doses for @ days .',\n"," 'the majority ( @ % ) of adverse events ( aes ) were classified as gastrointestinal disorders and were mild in severity , resolving without treatment .',\n"," 'the gut microbiota was analysed in the multiple dose groups with minimal changes observed in the bacterial groups analysed except for total clostridia which were reduced to below the limit of detection by day @ of dosing .',\n"," 'oral administration of smt@ was considered safe and well tolerated and was associated with negligible plasma concentrations after single and multiple doses .',\n"," 'in addition , minimal disruption of normal gut microbiota was noted , confirming the highly selective spectrum of the compound .',\n"," 'these results support the further clinical development of smt@ as an oral therapy for cdi .',\n"," 'current controlled trials .',\n"," 'isrctn@ .',\n"," 'while overall survival for most common cancers in australia is improving , the rural-urban differential has been widening , with significant excess deaths due to lung , colorectal , breast and prostate cancer in regional australia .',\n"," 'internationally a major focus on understanding variations in cancer outcomes has been later presentation to healthcare and later diagnosis .',\n"," 'approaches to reducing time to diagnosis of symptomatic cancer include public symptom awareness campaigns and interventions in primary care to improve early cancer detection .',\n"," 'this paper reports the protocol of a factorial cluster-randomised trial of community and general practice ( gp ) level interventions to reduce the time to diagnosis of cancer in rural western australia ( wa ) .',\n"," 'the community intervention is a symptom awareness campaign tailored for rural australians delivered through a community engagement model .',\n"," 'the gp intervention includes a resource card with symptom risk assessment charts and local referral pathways implemented through multiple academic detailing visits and case studies .',\n"," 'participants are eligible if recently diagnosed with breast , colorectal , lung or prostate cancer who reside in specific regions of rural wa with a planned sample size of @ .',\n"," 'the primary outcome is the total diagnostic interval , defined as the duration from first symptom ( or date of cancer screening test ) to cancer diagnosis .',\n"," 'secondary outcomes include cancer stage , healthcare utilisation , disease-free status , survival at @ and @years and cost-effectiveness .',\n"," 'ethics approval has been granted by the university of western australia and from all relevant hospital recruitment sites in wa .',\n"," 'results of this trial will be reported in peer-reviewed publications and in conference presentations .',\n"," 'australian new zealand clinical trials registry ( anzctr ) .',\n"," 'actrn@ .',\n"," 'this study aimed to evaluate whether incidental ct findings of emphysema , airway thickening and bronchiectasis , as seen on ct scans performed for other non-pulmonary clinical indications , are associated with future acute exacerbations of copd resulting in hospitalisation or death .',\n"," 'this multicentre prospective case-cohort study comprised @ subjects who underwent routine diagnostic chest ct for non-pulmonary indications .',\n"," 'using a case-cohort approach , we visually graded ct scans from cases and a random sample of @ % of the baseline cohort ( n = @ ) for emphysema severity ( range @-@ ) , airway thickening ( range @-@ ) and bronchiectasis ( range @-@ ) .',\n"," 'we used weighted cox proportional hazards analysis to assess the independent association between ct findings and hospitalisation or death due to copd exacerbation .',\n"," 'during a median follow-up of @ years ( maximum @ years ) , @ copd events were identified .',\n"," 'the risk of experiencing a future acute exacerbation of copd resulting in hospitalisation or death was significantly increased in subjects with severe emphysema ( score @ ) and severe airway thickening ( score @ ) .',\n"," 'the respective hrs were @ ( @ % ci @ to @ ) and @ ( @ % ci @ to @ ) .',\n"," 'severe bronchiectasis ( score @ ) was not significantly associated with increased risk of adverse events ( hr @ ; @ % ci @ to @ ) .',\n"," 'morphological correlates of copd such as emphysema and airway thickening detected on ct scans obtained for other non-pulmonary indications are strong independent predictors of subsequent development of acute exacerbations of copd resulting in hospitalisation or death .',\n"," 'to explore the feasibility of making a preoperative diagnosis of lung adenocarcinoma shown as ground-glass nodule ( ggn ) on computed tomography ( ct ) .',\n"," 'a total of @ ggn lesions proved pathologically were divided randomly into a and b groups .',\n"," 'then each group was further divided pathologically into preinvasive lesion , minimal invasive adenocarcinoma ( mia ) and invasive adenocarcinoma ( iac ) subgroups .',\n"," 'group a ( n = @ ) , size of lesion , proportion of ground glass opacity ( ggo ) composition of lesion , long diameter , longest diameter and size of solid component in lesion were measured on ct so as to establish the ct diagnostic standard of lung adenocarcinoma shown as ggn on ct. .',\n"," 'group b ( n = @ ) was employed to evaluate the accuracy of the above ct diagnostic standard .',\n"," 'spss @ software was used for statistical analysis .',\n"," 'significant statistic significance existed in all parameters among all groups ( p < @ ) .',\n"," 'all parameters were correlated the pathologic type of lesion .',\n"," 'the differences were statistically significant ( p = @ ) .',\n"," 'through the receiver operating characteristic ( roc ) curve , between groups of preinvasive lesion and mia , each parameter had a medium diagnostic value of @-@ @ ; between groups of mia and iac , size of lesion and long diameter of solid component in lesion had a medium diagnostic value of @-@ @ , longest diameter of solid component , size of solid component in lesion and proportion of ggo composition of lesion had a high diagnostic value with an auc of > @ .',\n"," 'the ct diagnostic standard , derived from group a , was used to analyze the pathologic type of group b. and t no significant statistic significance existed between ct preoperative diagnosis and operative pathologic diagnosis ( p > @ ) .',\n"," 'the correct diagnosis rates of size of lesion , proportion of ggo composition of lesion , long diameter , longest diameter and size of solid component in lesion were @ % , @ % , @ % , @ % and @ % respectively .',\n"," 'based upon size of lesion , proportion of ggo composition of lesion , long diameter , longest diameter and size of solid component in lesion , preoperative ct examination may be used to determine the pathological types of lung adenocarcinoma shown as ggn .',\n"," 'tonsillectomy surgery is associated with severe postoperative pain that usually requires analgesics including opioids .',\n"," 'pain control is still a big problem after tonsillectomy surgery .',\n"," 'we aimed to evaluate the efficacy of preemptive analgesia using montelukast for pediatric post-tonsillectomy pain management .',\n"," 'this is the first-time use of montelukast in post-tonsillectomy pain .',\n"," 'double-blind , controlled-randomized study .',\n"," 'university teaching and research hospital .',\n"," 'a total of @ children , aged @ to @ years , american society of anesthesiologist class i-ii , scheduled for elective tonsillectomy were enrolled in this clinical trial study .',\n"," 'the patients were randomized into @ groups : the montelukast group ( group m , n = @ ) and control group ( group c , n = @ ) .',\n"," 'group m recieved an oral montelukast tablet and group c recieved placebo at @pm on the morning before surgery .',\n"," 'post-tonsillectomy pain was evaluated with the wong-baker faces scale during the @ hours after surgery .',\n"," \"patients ' intraoperative hemodynamic parameters and intraoperative and postoperative complications were recorded .\",\n"," 'there were statistically significant differences between group c and group m for wong-baker faces pain rating scale scores ( p < @ ) .',\n"," 'in the @ hours after surgery , the total number of patients using rescue analgesics was higher in group c than in group m , and the difference was statistically significant ( p < @ ) .',\n"," 'there was no significant difference in demographic parameters ( p > @ ) .',\n"," 'there were no significant differences in postoperative nausea and vomiting , otalgia , trismus , fever , or halitosis between the groups ( p > @ ) .',\n"," 'preemptive montelukast can be used safely to reduce the serious pain caused by tonsillectomy in children .',\n"," 'metastatic colon cancer patients are treated with the chemotherapy regimens , folfox and folfiri , in either order .',\n"," 'so far , we can not predict the response of chemotherapeutic agent , so it is necessary to find which regimen is adequate before starting chemotherapy .',\n"," 'enrolled patients are randomized into either conventional treatment or planned treatment preceded by pretreatment genetic analysis .',\n"," 'blood samples of patients in planned treatment group ( n = @ ) were analyzed for the genetic polymorphism before selection of chemotherapeutic agents .',\n"," 'target genes were xpd-@ , gstp-@-@ , xrcc@-@ for oxaliplatin , ugt@a@ for irinotecan .',\n"," 'the response was measured by computed tomographic scan after completion of three cycles of chemotherapy .',\n"," 'overall response rate was significantly higher in planned group ( @ % vs. @ % , p = @ ) .',\n"," 'in folfox group , response rate was significantly improved in the planned patients ( @ % vs. @ % , p = @ ) .',\n"," \"in folfiri group , the difference did n't reach statistical significance ( @ % vs. @ % , p = @ ) .\",\n"," 'we found significantly improved response rates in the chemotherapy of metastatic colon cancer by pretreatment genetic analysis , especially in folfox group .',\n"," 'cardiac arrest causes ischaemic brain injury .',\n"," 'arterial carbon dioxide tension ( paco@ ) is a major determinant of cerebral blood flow .',\n"," 'thus , mild hypercapnia in the @ h following cardiac arrest may increase cerebral blood flow and attenuate such injury .',\n"," 'we describe the carbon control and cardiac arrest ( ccc ) trial .',\n"," 'the ccc trial is a pilot multicentre feasibility , safety and biological efficacy randomized controlled trial recruiting adult cardiac arrest patients admitted to the intensive care unit after return of spontaneous circulation .',\n"," 'at admission , using concealed allocation , participants are randomized to @ h of either normocapnia ( paco@ @ to @ mmhg ) or mild hypercapnia ( paco@ @ to @ mmhg ) .',\n"," 'key feasibility outcomes are recruitment rate and protocol compliance rate .',\n"," 'the primary biological efficacy and biological safety measures are the between-groups difference in serum neuron-specific enolase and s@b protein levels at @ h , @ h and @ h. secondary outcome measure include adverse events , in-hospital mortality , and neurological assessment at @ months .',\n"," 'the trial commenced in december @ and , when completed , will provide clinical evidence as to whether targeting mild hypercapnia for @ h following intensive care unit admission for cardiac arrest patients is feasible and safe and whether it results in decreased concentrations of neurological injury biomarkers compared with normocapnia .',\n"," 'trial results will also be used to determine whether a phase iib study powered for survival at @ days is feasible and justified .',\n"," 'australian new zealand clinical trials registry actrn@ .',\n"," 'for decades thiopental has been considered as the hypnotic drug of choice for intracranial surgery .',\n"," 'however , total intravenous anesthesia performed with thiopental is associated with delayed recovery , whereas early post-operative neurological evaluation is critical .',\n"," 'for this reason , target controlled infusion ( tci ) of propofol is increasingly used for maintenance of anesthesia .',\n"," 'however , a thiopental tci has never been assessed for this purpose .',\n"," 'we tested the hypothesis that a thiopental tci provides an acceptable way to achieve early recovery compared to a propofol tci during supratentorial surgery .',\n"," 'eighty patients undergoing elective craniotomy for a supratentorial tumor were randomized to receive either a propofol tci ( group p ) or a thiopental tci ( group t ) .',\n"," 'both groups received a sufentanil tci and the bispectral index was monitored .',\n"," 'the primary end-point was time to tracheal extubation .',\n"," 'secondary end-points were per - and post-operative hemodynamics as well as respiratory and recovery parameters .',\n"," 'assessment of study end-points was performed by an intensive care specialist blinded ( like the patient ) to the received hypnotic .',\n"," 'time to extubation was significantly ( p < @ ) shorter in group p ( median @ minutes ; interquartile range @-@ minutes ) than in group t ( median @ minutes ; interquartile range @-@ minutes ) .',\n"," 'similarly , the recovery parameters were significantly better in group p than in group t.',\n"," 'there was no difference between groups in terms of patient characteristics and hemodynamic parameters .',\n"," 'even with tci and bispectral index monitoring , thiopental is associated with an inappropriate delayed recovery from supratentorial surgery compared to propofol tci .',\n"," 'to investigate the effects of conservative therapy applied before arthroscopic subacromial decompression on the clinical outcome in patients with stage @ shoulder impingement syndrome .',\n"," 'sixty-eight patients having stage @ shoulder impingement syndrome and treated with arthroscopic subacromial decompression were included in the study .',\n"," 'we divided these patients into @ groups , whereby @ ( @ % ) patients received conservative therapy before arthroscopic subacromial decompression and @ ( @ % ) patients did not receive conservative therapy .',\n"," 'we compared both groups in terms of the the constant , ucla , and vas scores for shoulder pain before and after arthroscopic subacromial decompression .',\n"," 'constant , ucla , and vas scores were statistically significantly improved in both groups after arthroscopic subacromial decompression ( p < @ ) .',\n"," 'constant , ucla , and vas scores before arthroscopic subacromial decompression were statistically better in group @ than in group @ ( p < @ ) .',\n"," 'no statistically significant difference was found between the groups in terms of constant , ucla , and vas scores after arthroscopic subacromial decompression ( p > @ ) .',\n"," 'conservative therapy applied in patients with stage @ shoulder impingement syndrome before arthroscopic subacromial decompression does not have a positive contribution on the clinical outcome after arthroscopic subacromial decompression .',\n"," 'obstructive sleep apnea is associated with considerable health risks .',\n"," 'although continuous positive airway pressure ( cpap ) can mitigate these risks , effectiveness can be reduced by inadequate adherence to treatment .',\n"," 'we evaluated the clinical safety and effectiveness of upper-airway stimulation at @ months for the treatment of moderate-to-severe obstructive sleep apnea .',\n"," 'using a multicenter , prospective , single-group , cohort design , we surgically implanted an upper-airway stimulation device in patients with obstructive sleep apnea who had difficulty either accepting or adhering to cpap therapy .',\n"," 'the primary outcome measures were the apnea-hypopnea index ( ahi ; the number of apnea or hypopnea events per hour , with a score of @ indicating moderate-to-severe apnea ) and the oxygen desaturation index ( odi ; the number of times per hour of sleep that the blood oxygen level drops by @ percentage points from baseline ) .',\n"," 'secondary outcome measures were the epworth sleepiness scale , the functional outcomes of sleep questionnaire ( fosq ) , and the percentage of sleep time with the oxygen saturation less than @ % .',\n"," 'consecutive participants with a response were included in a randomized , controlled therapy-withdrawal trial .',\n"," 'the study included @ participants ; @ % were men .',\n"," 'the mean age was @ years , and the mean body-mass index ( the weight in kilograms divided by the square of the height in meters ) was @ .',\n"," 'the median ahi score at @ months decreased @ % , from @ events per hour to @ events per hour ( p < @ ) ; the odi score decreased @ % , from @ events per hour to @ events per hour ( p < @ ) .',\n"," 'secondary outcome measures showed a reduction in the effects of sleep apnea and improved quality of life .',\n"," 'in the randomized phase , the mean ahi score did not differ significantly from the @-month score in the nonrandomized phase among the @ participants in the therapy-maintenance group ( @ and @ events per hour , respectively ) ; the ahi score was significantly higher ( indicating more severe apnea ) among the @ participants in the therapy-withdrawal group ( @ vs. @ events per hour , p < @ ) .',\n"," 'the odi results followed a similar pattern .',\n"," 'the rate of procedure-related serious adverse events was less than @ % .',\n"," 'in this uncontrolled cohort study , upper-airway stimulation led to significant improvements in objective and subjective measurements of the severity of obstructive sleep apnea .',\n"," '( funded by inspire medical systems ; star clinicaltrials.gov number , nct@ . )',\n"," 'to identify facilitators and barriers to clinical trial implementation in aboriginal health services .',\n"," 'indepth interview study with thematic analysis .',\n"," 'six aboriginal community-controlled health services and one government-run service involved in the kanyini guidelines adherence with the polypill ( kgap ) study , a pragmatic randomised controlled trial that aimed to improve adherence to indicated drug treatments for people at high risk of cardiovascular disease .',\n"," '@ health care providers and @ aboriginal and torres strait islander patients .',\n"," 'a fundamental enabler was that participants considered the research to be governed and endorsed by the local health service .',\n"," 'that the research was perceived to address a health priority for communities was also highly motivating for both providers and patients .',\n"," 'enlisting the support of aboriginal and torres strait islander staff champions who were visible to the community as the main source of information about the trial was particularly important .',\n"," 'the major implementation barrier for staff was balancing their service delivery roles with adherence to often highly demanding trial-related procedures .',\n"," \"this was partially alleviated by the research team 's provision of onsite support and attempts to make trial processes more streamlined .\",\n"," 'although more intensive support was highly desired , there were usually insufficient resources to provide this .',\n"," 'despite strong community and health service support , major investments in time and resources are needed to ensure successful implementation and minimal disruption to already overstretched , routine services .',\n"," 'trial budgets will necessarily be inflated as a result .',\n"," 'funding agencies need to consider these additional resource demands when supporting trials of a similar nature .',\n"," 'to compare the effect of incomplete caries removal ( icr ) and indirect pulp capping ( ipc ) with calcium hydroxide ( ch ) or an inert material ( wax ) on color , consistency and contamination of the remaining dentin of primary molars .',\n"," 'this double-blind , parallel-design , randomized controlled trial included @ children presenting one primary molar with deep caries lesion .',\n"," 'children were randomly assigned after icr to receive ipc with ch or wax .',\n"," 'all teeth were then restored with resin composite .',\n"," 'baseline dentin color and consistency were evaluated after icr , and dentin samples were collected for contamination analyses using scanning electron microscopy .',\n"," 'after @ months , restorations were removed and the three parameters were re-evaluated .',\n"," 'in both groups , dentin became significantly darker after @ months .',\n"," 'no cases of yellow dentin were observed after @ months with ch compared to @ % of the wax cases ( p < @ ) .',\n"," 'a statistically significant difference over time was observed only for ch regarding consistency .',\n"," 'ch stimulated a dentin hardening process in a statistically higher number of cases than wax ( @ % vs. @ % ; p = @ ) .',\n"," 'contamination changed significantly over time in ch and wax without significant difference between groups .',\n"," 'it was concluded that ch and wax arrested the carious process of the remaining carious dentin after indirect pulp capping , but ch showed superior dentin color and consistency after @ months .',\n"," 'in literature there is a general consensus that the use of the mirror improves proprioception .',\n"," 'during rehabilitation the mirror is an important instrument to improve stability .',\n"," 'in some sports , such as dancing , mirrors are widely used during training .',\n"," 'the purpose of this study is to evaluate the effectiveness of the use of a mirror on balance in young dancers .',\n"," 'sixty-four young dancers ( ranging from @-@ years ) were included in this study .',\n"," 'thirty-two attending lessons with a mirror ( mirror - group ) were compared to @ young dancers that attended the same lessons without a mirror ( non-mirror group ) .',\n"," 'balance was evaluated by bess ( balance error scoring system ) , which consists of three stances ( double limb , single limb , and tandem ) on two surfaces ( firm and foam ) .',\n"," 'the errors were assessed at each stance and summed to create the two subtotal scores ( firm and foam surface ) and the final total score ( bess ) .',\n"," 'the bess was performed at recruitment ( t@ ) and after @months of dance lessons ( t@ ) .',\n"," 'the repeated measures anova analysis showed that for the bess total score there is a difference due to the time ( f = @ ; p < @ ) .',\n"," 'no other differences due to the group or to the time of measurement were found ( p > @ ) .',\n"," 'the analysis of the multiple regression model showed the influence of the values at t@ for every bess items and the dominance of limb for stability on an unstable surface standing on one or two legs .',\n"," 'these preliminary results suggest that the use of a mirror in a ballet classroom does not improve balance acquisition of the dancer .',\n"," 'on the other hand , improvement found after @months confirms that at the age of the dancers studied motor skills and balance can easily be trained and improved .',\n"," 'long-term follow-up studies documenting maintenance of treatment effects are fewin adolescent anorexia nervosa ( an ) .',\n"," 'this exploratory study reports relapse from full remission and attainment of remission during a @-year open follow-up period using a convenience sample of a subgroup of @ % ( n = @ ) from an original cohort of @ participants who completed a randomized clinical trial comparing family-based therapy ( fbt ) and adolescent-focused individual therapy ( aft ) .',\n"," 'follow-up assessments were completed up to @years posttreatment ( average , @ years ) .',\n"," 'available participants completed the eating disorder examination as well as self-report measures of self-esteem and depression at @ to @ years posttreatment .',\n"," 'two participants ( @ % ) relapsed ( fbt : n = @ , @ % ; aft : n = @ , @ % ) , on average @ years ( sd = @ years ) after remission was achieved at @-year follow-up .',\n"," 'ten new participants ( @ % ) achieved remission ( fbt : n = @ , @ % ; aft : n = @ , @ % ) .',\n"," 'mean time to remission for this group was @ years ( sd = @ years ) from @-year follow-up .',\n"," 'there were no differences based on treatment group assignment in either relapse from full remission or new remission during long-term follow-up .',\n"," 'other psychopathology was stable over time .',\n"," 'there were few changes in the clinical presentation of participants who were assessed at long-term follow-up .',\n"," 'these data suggest that outcomes are generally stable posttreatment regardless of treatment type once remission is achieved .',\n"," 'clinical trial registration information-effectiveness of family-based versus individual psychotherapy in treating adolescents with anorexia nervosa ; http://www.clinicaltrials.gov/; nct@ .',\n"," 'coronary artery bypass grafting using the radial artery has , since the @s , gone through a revival .',\n"," 'observational studies have indicated better long-term patency when using radial arteries .',\n"," 'therefore , radial artery might be preferred especially in younger patients where long time patency is important .',\n"," 'during the last @years different endoscopic techniques to harvest the radial artery have evolved .',\n"," 'endoscopic radial artery harvest only requires a small incision near the wrist in contrast to open harvest , which requires an incision from the elbow to the wrist .',\n"," 'however , it is unknown whether the endoscopic technique results in fewer complications or a graft patency comparable to open harvest .',\n"," 'when the radial artery has been harvested , there are two ways to use the radial artery as a graft .',\n"," 'one way is sewing it onto the aorta and another is sewing it onto the mammary artery .',\n"," 'it is unknown which technique is the superior revascularisation technique .',\n"," 'the neo trial is a randomised clinical trial with a @ factorial design .',\n"," 'we plan to randomise @ participants into four intervention groups : ( @ ) mammario-radial endoscopic group ; ( @ ) aorto-radial endoscopic group ; ( @ ) mammario-radial open surgery group ; and ( @ ) aorto-radial open surgery group.the hand function will be assessed by a questionnaire , a clinical examination , the change in cutaneous sensibility , and the measurement of both sensory and motor nerve conduction velocity at @months postoperatively .',\n"," 'all the postoperative complications will be registered , and we will evaluate muscular function , scar appearance , vascular supply to the hand , and the graft patency including the patency of the central radial artery anastomosis .',\n"," 'a patency evaluation by multi-slice computer tomography will be done at one year postoperatively.we expect the nerve conduction studies and the standardised neurological examinations to be able to discriminate differences in hand function comparing endoscopic to open harvest of the radial artery .',\n"," 'the trial also aims to show if there is any patency difference between mammario-radial compared to aorto-radial revascularisation techniques but this objective is exploratory .',\n"," 'clinicaltrials.gov identifier : nct@.danish ethics committee number : h-@-@-@ .',\n"," 'danish data protection agency : @-@-@ / jr. n :@ -@ .',\n"," 'knowledge of essential amino acid requirements in infants is important because excessive intake of protein can lead to increased long-term morbidity such as obesity .',\n"," 'a deficient intake may lead to suboptimal growth and impaired neurodevelopment .',\n"," 'the current recommended branched-chain amino acid requirements in infants aged @-@ mo are based on the amino acid content of human milk .',\n"," 'we quantified the requirements for isoleucine , leucine , and valine for term neonates by using the indicator amino acid oxidation method with -lsb- @ - ( @ ) c -rsb- phenylalanine as the indicator .',\n"," 'fully enterally fed term infants received randomly graded amounts of isoleucine ( @-@ mg kg ( -@ ) d ( -@ ) ) , leucine ( @-@ mg kg ( -@ ) d ( -@ ) ) , or valine ( @-@ mg kg ( -@ ) d ( -@ ) ) as part of an elemental formula .',\n"," 'data are expressed as means sds .',\n"," 'eighty-three asian , term neonates ( mean sd birth weight : @ @ kg ; gestational age : @ @ wk ) were studied at a postnatal age of @ @ d. mean requirements for isoleucine , leucine , and valine ( measured in boys only ) were @ mg kg ( -@ ) d ( -@ ) ( r ( @ ) = @ , p < @ ) , @ mg kg ( -@ ) d ( -@ ) ( r ( @ ) = @ , p < @ ) , and @ mg kg ( -@ ) d ( -@ ) ( r ( @ ) = @ , p = @ ) , respectively .',\n"," 'current human milk-based recommendations for isoleucine and valine in term infants aged @-@ mo are correct .',\n"," 'however , the current recommendation for leucine ( @ mg kg ( -@ ) d ( -@ ) ) is higher than the mean requirement of @ mg kg ( -@ ) d ( -@ ) that we determined in this study .',\n"," 'this trial was registered at www.trialregister.nl as ntr@ .',\n"," 'we wanted to confirm the benefit of mometasone furoate ( mf ) in preventing acute radiation reactions , as shown in a previous study ( bostrm et al , radiother oncol @ ; @:@ -@ ) .',\n"," 'the study was a double-blind comparison of mf with d ( diprobase ) , administered daily from the start of radiation therapy for @ weeks in patients receiving breast radiation therapy , @ gy in @-gy fractions daily over @ weeks .',\n"," 'the primary endpoint was mean modified radiation therapy oncology group ( rtog ) score .',\n"," 'mean rtog scores were significantly less for mf than for d ( p = @ ) .',\n"," 'maximum rtog and mean erythema scores were significantly less for mf than for d ( p = @ and p = @ , respectively ) .',\n"," 'the dermatology life quality index ( dlqi ) score was significantly less for mf than for d at weeks @ and @ when corrected for hospital anxiety and depression ( had ) questionnaire scores .',\n"," 'mf cream significantly reduces radiation dermatitis when applied to the breast during and after radiation therapy .',\n"," 'for the first time , we have shown a significantly beneficial effect on quality of life using a validated instrument ( dlqi ) , for a topical steroid cream .',\n"," 'we believe that application of this cream should be the standard of care where radiation dermatitis is expected .',\n"," 'to compare the interstage cardiac catheterization hemodynamic and angiographic findings between shunt types for the pediatric heart network single ventricle reconstruction trial .',\n"," 'the trial , which randomized subjects to a modified blalock-taussig shunt ( mbts ) or right ventricle-to-pulmonary artery shunt ( rvpas ) for the norwood procedure , demonstrated the rvpas was associated with a smaller pulmonary artery diameter but superior @-month transplant-free survival .',\n"," 'we analyzed the pre-stage ii catheterization data for the trial subjects .',\n"," 'the hemodynamic variables and shunt and pulmonary angiographic data were compared between shunt types ; their association with @-month transplant-free survival was also evaluated .',\n"," 'of @ randomized subjects , @ underwent pre-stage ii catheterization .',\n"," 'a smaller size , lower aortic and superior vena cava saturation , and higher ventricular end-diastolic pressure were associated with worse @-month transplant-free survival .',\n"," 'the mbts group had a lower coronary perfusion pressure ( @ vs @ mm hg ; p < @ ) and greater pulmonary blood flow/systemic blood flow ratio ( @ vs @ , p = @ ) .',\n"," 'a greater pulmonary blood flow/systemic blood flow ratio increased the risk of death or transplantation only in the rvpas group ( p = @ ) .',\n"," 'the mbts group had fewer shunt ( @ % vs @ % , p = @ ) and severe left pulmonary artery ( @ % vs @ % , p = @ ) stenoses , larger mid-main branch pulmonary artery diameters , and greater nakata indexes ( @ vs @ , p < @ ) .',\n"," 'compared with the rvpas subjects , the mbts subjects had more hemodynamic abnormalities related to shunt physiology , and the rvpas subjects had more shunt or pulmonary obstruction of a severe degree and inferior pulmonary artery growth at pre-stage ii catheterization .',\n"," 'a lower body surface area , greater ventricular end-diastolic pressure , and lower superior vena cava saturation were associated with worse @-month transplant-free survival .',\n"," 'it has been hypothesized that the development of diabetic polyneuropathy ( dpn ) is due to swelling of the nerve , as well as thickening and stiffening of the surrounding ligaments , causing chronic compression of nerves .',\n"," 'we aimed to examine the effect of surgical decompression of the tibial nerve on the mean cross-sectional area ( csa ) .',\n"," 'we performed a randomized controlled trial of @ subjects with painful dpn diagnosed using the diabetic neuropathy score .',\n"," 'a computer randomized for the surgery arm of the study .',\n"," 'a control group consisting of @ healthy subjects was included .',\n"," 'an experienced sonographer measured the csa and thickness-to-width ( t/w ) ratio of the tibial nerve , as well as the thickness of the flexor retinaculum .',\n"," 'csa is significantly larger in patients with painful dpn ( @ @ mm ( @ ) ) than in control subjects ( @ @ mm ( @ ) ) , p = @ .',\n"," 'the t/w ratio in patients with painful dpn is @ and in control subjects @ , p = @ .',\n"," 'patients with dpn have a significantly thicker retinaculum ( @ mm ) than control subjects ( @ mm ) , p < @ .',\n"," 'mean follow-up was @ weeks ( range @-@ ) .',\n"," 'difference between baseline and follow-up in the operated leg was @ mm ( @ ) and in the control leg @ mm ( @ ) , p = @ .',\n"," 'decompression of the tibial nerve does not result in a significant difference between baseline and follow-up in csa using ultrasound between the operated and control leg .',\n"," 'ultrasound measurements show a significantly increased csa , a significantly thicker retinaculum , and a significantly increased t/w ratio in patients with painful dpn compared with healthy control subjects .',\n"," 'clinical trial reg .',\n"," 'no .',\n"," 'ntr@ , www.trialregister.nl .',\n"," 'a community-based randomized trial was conducted in costa rica to evaluate the hpv-@ / @ as@-adjuvanted vaccine ( nct@ ) .',\n"," 'the primary objective was to evaluate efficacy of the vaccine to prevent cervical intraepithelial neoplasia @ or more severe disease ( cin@ + ) associated with incident hpv-@ / @ cervical infections .',\n"," 'secondary objectives were to evaluate efficacy against cin@ + associated with incident cervical infection by any oncogenic hpvs and to evaluate duration of protection against incident cervical infection with hpv-@ / @ .',\n"," 'vaccine safety and immunogenicity over the @-year follow-up were also evaluated .',\n"," 'we randomized ( @ hpv arm ; @ control arm ) , vaccinated ( hpv-@ / @ or hepatitis a ) and followed ( median @ months ) @ healthy women aged @-@ years .',\n"," '@ women ( @ hpv arm ; @ control arm ) were included in the according to protocol analysis for efficacy .',\n"," 'the full cohort was evaluated for safety .',\n"," 'immunogenicity was considered on a subset of @ ( hpv-@ ) and @ ( hpv-@ ) women .',\n"," 'hpv type was assessed by pcr on cervical specimens .',\n"," 'immunogenicity was assessed using elisa and inhibition enzyme immunoassays .',\n"," 'disease outcomes were histologically confirmed .',\n"," 'vaccine efficacy and @ % confidence intervals ( @ % ci ) were computed .',\n"," 'vaccine efficacy was @ % ( @ % ci : @-@ @ ; n = @ events total ) against hpv-@ / @ associated cin@ + , @ % ( @ % ci : @-@ @ ; n = @ events total ) against cin@ + associated with non-hpv-@ / @ oncogenic hpvs and @ % ( @ % ci : @-@ @ ; n = @ events total ) against cin@ + irrespective of hpv type .',\n"," 'the vaccine had an acceptable safety profile and induced robust and long-lasting antibody responses .',\n"," 'our findings confirm the high efficacy and immunogenicity of the hpv-@ / @ vaccine against incident hpv infections and cervical disease associated with hpv-@ / @ and other oncogenic hpv types .',\n"," 'these results will serve as a benchmark to which we can compare future findings from the ongoing extended follow-up of participants in the costa rica trial .',\n"," 'registered with clinicaltrials.gov : nct@ .',\n"," 'there is a long-held concept among spine surgeons that endoscopic lumbar discectomy procedures are reserved for small-contained disc herniation ; @-year follow-up has not been reported .',\n"," 'the purpose of this study is to assess microendoscopic discectomy ( med ) in patients with large uncontained lumbar disc herniation ( the antero-posterior diameter of the extruded fragment is @-@ mm or more on axial cuts of mri ) and report long-term outcome .',\n"," 'one hundred eighty-five patients with med or standard open discectomy underwent follow-up for @ years .',\n"," 'primary ( clinical ) outcomes data included numerical rating scale ( nrs ) for back and leg symptoms and oswestry disability index ( odi ) to quantify pain and disability , respectively .',\n"," 'secondary ( objective ) outcomes data included operative time , blood loss , postoperative analgesics , length of hospital stay , time to return to work , reoperation and complication rate , patient satisfaction index ( psi ) , and modified ( macnab ) criteria .',\n"," 'at the end of the follow-up , the leg pain relief was statistically significant for both groups .',\n"," 'nrs back pain , odi , psi and macnab criteria showed significant deterioration for control group .',\n"," 'secondary outcomes data of med group were significantly better than the control group .',\n"," 'large , uncontained , lumbar disc herniations can be sufficiently removed using med which is an effective alternative to open discectomy procedures with remarkable long-term outcome .',\n"," 'although the neurological outcome of the two procedures is the same , the morbidity of med is significantly less than open discectomy .',\n"," 'maximum benefit can be gained if we adhere to strict selection criteria .',\n"," 'the optimum indication is single - or multi-level radiculopathy secondary to a single-level , large , uncontained , lumbar disc herniation .',\n"," 'heart failure ( hf ) patients suffer from frequent and repeated hospitalizations , causing a substantial economic burden on society .',\n"," 'hospitalizations can be reduced considerably by better compliance with self-care .',\n"," \"home telemonitoring has the potential to boost patients ' compliance with self-care , although the results are still contradictory .\",\n"," 'a randomized controlled trial was conducted in order to study whether the multidisciplinary care of heart failure patients promoted with telemonitoring leads to decreased hf-related hospitalization .',\n"," 'hf patients were eligible whose left ventricular ejection fraction was lower than @ % , nyha functional class @ , and who needed regular follow-up .',\n"," 'patients in the telemonitoring group ( n = @ ) measured their body weight , blood pressure , and pulse and answered symptom-related questions on a weekly basis , reporting their values to the heart failure nurse using a mobile phone app .',\n"," 'the heart failure nurse followed the status of patients weekly and if necessary contacted the patient .',\n"," 'the primary outcome was the number of hf-related hospital days .',\n"," 'control patients ( n = @ ) received multidisciplinary treatment according to standard practices .',\n"," \"patients ' clinical status , use of health care resources , adherence , and user experience from the patients ' and the health care professionals ' perspective were studied .\",\n"," 'adherence , calculated as a proportion of weekly submitted self-measurements , was close to @ % .',\n"," 'no difference was found in the number of hf-related hospital days ( incidence rate ratio -lsb- irr -rsb- = @ , p = @ ) , which was the primary outcome .',\n"," 'the intervention group used more health care resources : they paid an increased number of visits to the nurse ( irr = @ , p < @ ) , spent more time at the nurse reception ( mean difference of @ minutes , p < @ ) , and there was a greater number of telephone contacts between the nurse and intervention patients ( irr = @ , p < @ for nurse-induced contacts and irr = @ , p = @ for patient-induced contacts ) .',\n"," \"there were no statistically significant differences in patients ' clinical health status or in their self-care behavior .\",\n"," 'the technology received excellent feedback from the patient and professional side with a high adherence rate throughout the study .',\n"," \"home telemonitoring did not reduce the number of patients ' hf-related hospital days and did not improve the patients ' clinical condition .\",\n"," 'patients in the telemonitoring group contacted the cardiology outpatient clinic more frequently , and on this way increased the use of health care resources .',\n"," 'clinicaltrials.gov nct@ ; http://clinicaltrials.gov/show/nct@ ( archived by webcite at http://www.webcitation.org/@ufxick@z ) .',\n"," 'probiotics help maintain balance in composition of the gut microbiota , and have been considered as a potential treatment for obesity .',\n"," 'this study was conducted in order to assess the effects of probiotics when combined with herbal medicine in treatment of obesity .',\n"," 'probiotics were tested for the ability to modulate gut microbiota , gut permeability , and endotoxin level , which may have correlation with factors involved in obesity .',\n"," 'a randomized , double-blind , placebo controlled study was conducted , in which patients with higher bmi ( > @kg/m ( @ ) ) and waist circumference ( > @cm ) were enrolled and randomly assigned to receive bofutsushosan with either probiotics or placebo capsules for a period of eight weeks .',\n"," 'assessment of body composition parameters , metabolic biomarkers , endotoxin level , gut permeability , and fecal bacteria in stool was performed at baseline and at week @ .',\n"," 'the study was registered at the clinical research information service , approved by the korea national institute of health ( kct@ ) .',\n"," 'although both groups showed a significant reduction in weight and waist circumference ( p = @ ) , no significant differences in body composition and metabolic markers were observed .',\n"," 'in correlation analysis , change in body composition showed positive correlation with endotoxin level ( r = @ , p < @ for bw ; and r = @ , p < @ for fat mass ) and the population of gut lactobacillus plantarum ( r = @ , p < @ for bw ; and r = @ , p < @ for bmi ) .',\n"," 'the gram negative bacterial population in gut also exhibited positive correlation with changes in body composition ( wc ) and total cholesterol level ( r = @ , and @ , for the former and later parameters , respectively , p < @ for both ) .',\n"," 'while , the profile of gut bifidobacterium breve population showed negative correlation with endotoxin level ( r = -@ , p < @ ) .',\n"," 'correlations between gut microbiota and change in body composition indicate that probiotics may influence energy metabolism in obesity .',\n"," 'correlation between endotoxin level and weight reduction indicates that probiotics may play an important role in prevention of endotoxin production , which can lead to gut microbiota dysbiosis associated with obesity .',\n"," 'the objective of this study is to analyze the effects of a @-week indoor intermittent training program on lung function , physical capacity , body composition and quality of life in children with asthma .',\n"," 'participants were randomized in an experimental group ( eg , @ children , age = @ years ) and in a control group ( cg , @ children , age = @ years ) .',\n"," 'the training program was conducted indoors and consisted of alternating high - and low-intensity stimuli , for three sessions of @min/week , for @ weeks .',\n"," \"physical exercise and sports activities were organized to follow the criteria of the american college of sports medicine ( @ ) and previous interventions ' studies .\",\n"," 'in eg , there was a significant improvement ( p < @ ) in fev@ , fev@ , @mwt , handgrip strength , cmj and flexibility .',\n"," 'reductions in bmi and fat mass as well as an increase in quality of life were all shown .',\n"," 'the dyspnea index decreased significantly and there were no episodes of eia .',\n"," 'there is a significant positive correlation ( p < @ ) between the fev@ with handgrip strength and @mwt and a negative correlation with fat mass .',\n"," 'an indoor intermittent training program with these characteristics has improved lung function , physical capacity , body composition and quality of life in children with asthma .',\n"," 'these training adaptations are particularly relevant for those patients suffering from asthma as a regular physical exercise routine will greatly improve their quality of life .',\n"," 'to observe the efficacy of catgut implantation at back-shu points in treatment of mild perimenopausal depression of kidney , deficiency and liver stagnation syndrome and analyze its essential function on target symptoms .',\n"," 'forty-five cases were randomized into a catgut implantation group ( @ cases ) and atid acupuncture group ( @ cases ) .',\n"," 'in the catgut implantation group , catguts were implanted at shenshu ( bl @ ) , ganshu ( bl @ ) , xinshu ( bl @ ) , pishu ( bl @ ) , etc. , once every week .',\n"," 'in the acupuncture group , the conventional acupuncture was applied to the same acupoints as the catgut implantation group , once every two days .',\n"," 'the : treatment of @ weeks made one session , and continuous @ sessions were required .',\n"," 'the efficacy was evaluated in , @ sessions .',\n"," 'the follow-up started in the @th week .',\n"," 'before treatment , after treatment and in the follow-up period , kupperman score and the total score in hamilton depression scale ( hamd ) , as well as the factor score were observed in the patients separately .',\n"," 'kupperman score , the total hamd score and the scores in the items of anxiety/somatization , retardation , sleep disorder and cognitive disorder after treatment were all reduced significantly as compared with those before treatment in the two groups ( p < @ , p < @ ) .',\n"," 'in the follow-up period , the difference in kupperman was not significant in comparison with that after treatment in the catgut implantation : group ( p > @ ) .',\n"," 'the total hamd score and sleep disorder were reduced significantly as compared with those after treatment in the catgut implantation group ( both p < @ ) ; in the acupuncture group , kupperman score , the total hamd score and sleep disorder were all increased as compared with those after treatment ( all p < @ ) .',\n"," 'in ; the catgut implantation group , the total hamd score was lower than that in the acupuncture group ( p < @ ) , and the scores in the items of retardation and sleep disorder were reduced significantly as compared with those in the acupuncture group ( both p < @ ) .',\n"," 'the catgut implantation at back-shu points alleviates perimenopasual sympton is in patients of mild perimenopausal depression of kidney deficiency and liver stagnation syndrome .',\n"," \"this therapy effectively relieves depressive disorders by regulating the target symptoms such as anxiety / somatization , retardation , sleep disorder and cognitive ' disorder .\",\n"," 'the long-term efficacy of this therapy is better than the conventional acupuncture .',\n"," 'up to @ % of patients who undergo a percutaneous coronary intervention show some limitation in the use of drug-eluting stents .',\n"," 'the aim of this study was to evaluate if titanium-nitride-oxide-coated stents could be a good alternative to everolimus-eluting stents in diabetic patients .',\n"," 'a total of @ diabetic patients with lesions at moderate risk of restenosis ( exclusion criteria : diameter < @ mm or length > @ mm in vessels < @mm , chronic occlusion ) were randomized to a titanium group ( @ patients ) or an everolimus group ( @ patients ) .',\n"," 'baseline characteristics were well balanced ; @ % of patients were insulin dependent .',\n"," 'at @ year , the incidence of major adverse cardiac events ( death , nonfatal myocardial infarction , stroke , or repeat target vessel revascularization ) was significantly higher in the titanium group than in the everolimus group ( total , @ % vs @ % ; p = @ ; noninsulin-dependent subgroup , @ % vs @ % ; p = @ ; insulin-dependent subgroup , @ % vs @ % ; p = @ ) .',\n"," 'the incidence of death , nonfatal myocardial infarction , stroke , or any revascularization was @ % in the titanium group and @ % in the everolimus group ( p = @ ) .',\n"," 'target lesion and vessel revascularizations occurred in @ % compared with @ % ( p = @ ) and in @ % compared with @ % ( p = @ ) in the titanium and everolimus groups , respectively .',\n"," 'angiographic follow-up at @ months showed significantly less late lumen loss in the everolimus group ( in-segment , @ -lsb- standard deviation , @ ) mm vs -@ -lsb- @ -rsb- mm ; in-stent , @ -lsb- @ -rsb- mm vs @ -lsb- @ -rsb- mm ; p < @ ) .',\n"," 'the everolimus-eluting stent is superior to the titanium stent for clinical and angiographic end points in diabetic patients with lesions at moderate risk of restenosis .',\n"," 'to evaluate the safety of the fixed combination of ibuprofen and famotidine compared with ibuprofen alone from two @-week , multicenter , double-blind trials designed to evaluate the comparative incidence of endoscopically documented upper gastrointestinal ulcers and a @-week double-blind extension study .',\n"," 'safety was analyzed by pooling data from the two double-blind trials and the follow-on study .',\n"," 'safety was assessed by monitoring the incidence , causality , and severity of adverse events ( aes ) .',\n"," 'in the pivotal efficacy and safety trials , discontinuation rates due to any cause and dyspepsia were significantly lower for the ibuprofen/famotidine combination versus ibuprofen alone .',\n"," 'other than dyspepsia , gastrointestinal and cardiovascular aes of special interest were similar .',\n"," 'events judged to be treatment related were significantly lower with the ibuprofen/famotidine combination ( @ % vs. @ % ) .',\n"," 'in the safety extension population , there were no differences in the discontinuation rates and the reporting of aes or serious aes ( saes ) between the two groups .',\n"," 'gastrointestinal-related events were similar between the groups .',\n"," 'incidence of cardiovascular-related aes of special interest were @ % ( ibuprofen/famotidine ) and @ % ( ibuprofen ) ( p = @ ) , possibly due to a higher number of rheumatoid arthritis patients in the combination group .',\n"," 'of these , @ % were reports of hypertension ( @ % ibuprofen/famotidine vs. @ % ibuprofen ) .',\n"," 'three cases of hypertension in the ibuprofen/famotidine group were considered treatment related .',\n"," 'the probability of a cardiovascular event decreased during days @-@ of treatment and remained low with continued treatment .',\n"," 'one-year safety data from two pivotal trials and a long-term extension study indicate that the ibuprofen/famotidine combination demonstrates a favorable gastrointestinal safety profile and more patients continued on therapy compared to ibuprofen alone .',\n"," 'no new safety signals have been identified .',\n"," 'these data offer additional evidence supporting a new therapeutic option to improve gastrointestinal safety and adherence for patients who require long-term ibuprofen .',\n"," 'to compare the effects of volume-controlled ventilation ( vcv ) and pressure-controlled volume-guaranteed ( pcv-vg ) mode during one-lung ventilation ( olv ) on circulation , pulmonary function and lung injury .',\n"," '@ february to @ march in ningbo no@ .',\n"," 'hospital cardiothoracic surgery , @ patients aged @ to @ years ( asa grade ii-iii ) undergoing elective thoracoscopic lobectomy were randomly divided into vcv group and pcv-vg group , with @ cases in each group .',\n"," 'after anesthesia induction and endotracheal intubation , endobronchial blocker was inserted to start olv .',\n"," 'heart rate ( hr ) , mean arterial pressure ( map ) , measured tidal volume ( tv ) , peak airway pressure ( ppeak ) , airway resistance ( raw ) , chest compliance ( cdyn ) and the end-tidal carbon dioxide pressure ( petco ( @ ) ) were recorded at the time point of @ minutes after turning to the lateral position , @ minutes and @ minutes after olv , and @ minutes after the resumption of two lung ventilation .',\n"," 'in the meanwhile , arterial blood gas analysis was conducted to measure indicators of ph , oxygen tension ( pao ( @ ) ) and carbon dioxide partial pressure ( paco ( @ ) ) .',\n"," 'blood was drawn before induction , @ hour after olv and @ hour after the end of surgery , and the concentration of interleukin-@ ( il-@ ) and tumor necrosis factor-alpha ( tnf - ) were detected by enzyme-linked immunosorbent assay ( elisa ) .',\n"," 'hr , map , tv , petco ( @ ) , ph and paco ( @ ) in two groups at the time point of @ minutes after turning to the lateral position , @ minutes and @ minutes after olv , and @ minutes after the resumption of two lung ventilation showed no significant difference ( p > @ ) .',\n"," 'at the point of @ minutes after turning to the lateral position and @ minutes after two lung ventilation , ppeak and cdyn of two groups were significantly different ( p < @ ) ( ppeak :@ @ cmh ( @ ) o , @ @ cmh ( @ ) o for vcv group and @ @ cmh ( @ ) o , @ @ cmh ( @ ) o for pcv-vg group ; cdyn : @ @ ml/cmh ( @ ) o , @ @ ml/cmh@o for vcv group and @ @ ml/cmh ( @ ) o , @ @ ml/cmh ( @ ) o for pcv-vg group ) .',\n"," 'compared with vcv group , pcv-vg group showed a lower ppeak @ minutes and @ minutes after olv -lsb- ( @ @ cmh ( @ ) o ) vs ( @ @ cmh ( @ ) o ) and ( @ @ cmh ( @ ) o ) vs ( @ @ cmh ( @ ) o ) with a higher cdyn at the same point ( @ @ ml/cmh ( @ ) o ) vs ( @ @ ml/cmh ( @ ) o ) and @ @ ml/cmh ( @ ) o ) vs ( @ @ ml/cmh ( @ ) o ) -rsb- ( p < @ ) .',\n"," 'compared with vcv group,il-@ and tnf - of pcv-vg group @ hour after olv and @ hour after the end of surgery were significantly lower ( p < @ ) ( il-@ : @ @ vs @ @ pg/ml and @ @ vs @ @ pg/ml ; tnf - : @ @ vs @ @ pg/ml and @ @ vs. @ @ pg/ml ) .',\n"," 'during one-lung ventilation in thoracoscopic lobectomy , pcv-vg mode has a competitive advantage over vcv mode in terms of pulmonary function and lung protection .',\n"," 'we compared the recovery profile of propofol and sevoflurane when used for maintenance of anesthesia in elective day care operative procedures .',\n"," 'one hundred asa physical status i and ii patients , aged between @ and @ years , were randomly assigned to receive either propofol-nitrous oxide or sevoflurane-nitrous oxide maintenance of anesthesia .',\n"," 'early and intermediate recovery in terms of cognitive and ambulatory functions was recorded .',\n"," 'psychomotor testing , in the form of trieger dot test and digit symbol substitution test , were performed before surgery and in the post-anesthesia care unit at @ min , @ min , @ h , @ h , and @ h following nitrous oxide switch-off to evaluate intermediate recovery .',\n"," \"there were no significant differences in recovery of early cognitive functions between the two groups , except that patients in the sevoflurane group were more responsive at around @ min following nitrous oxide switch-off and `` recalled address '' earlier than patients in the propofol group .\",\n"," \"there was no significant difference in between the two groups with regard to `` home-readiness . ''\",\n"," \"recovery from sevoflurane anesthesia , especially with regard to cognitive functions , may be slightly faster than from propofol , but the difference is not sufficiently significant to affect the time to `` home-readiness '' in patients undergoing day care surgery .\",\n"," \"vertigo imposes considerable health restrictions with significant impact on the patient 's quality of life .\",\n"," 'the most effective antivertigo agent is undetermined thus far .',\n"," 'this study was performed to assess whether promethazine has superior vertigo reduction compared with lorazepam in ed patients .',\n"," 'in this randomized , double-blind , parallel group trial @ patients were assigned ( @:@ ratio ) to receive either promethazine , @ mg intravenously , or lorazepam , @ mg intravenously .',\n"," 'primary endpoint was mean change in vertigo intensity at @ hours measured using visual analog scale ( vas ) .',\n"," 'secondary endpoints were mean change in nausea score , need for second dose of study medications , and adverse events ( aes ) .',\n"," 'promethazine was associated with significantly more reduction ( @ mm ) in vertigo than lorazepam ( @ mm , p < @ ) .',\n"," 'mean change in nausea score @ hours after drug injection on the vas was @ mm for promethazine and @ for lorazepam ( p = @ ) .',\n"," 'the most frequently reported aes were lethargy ( @ % in lorazepam group , @ % in promethazine group , p = @ ) and drowsiness ( @ % for promethazine , @ % for lorazepam , p = @ ) .',\n"," 'our study demonstrated the evidence that promethazine is superior to lorazepam in management of peripheral vertigo and vertigo-related nausea in ed adults .',\n"," 'during lower limb lengthening , distraction-induced muscle pain and surrounding joint contractures are frustrating complications for which few effective treatments are available .',\n"," 'we evaluated botulinum toxin type a ( btx-a ) injection in the calf muscles during human tibial distraction osteogenesis .',\n"," 'we hypothesized that it may decrease calf pain and increase rom of the surrounding joints by reducing muscle stiffness .',\n"," 'between april @ and january @ , we evaluated @ patients undergoing bilateral tibia lengthening who met prespecified inclusion criteria .',\n"," 'all patients underwent stature lengthening with lengthening over a nail or lengthening and then nailing .',\n"," 'btx-a ( @iu ) was injected at the calf muscle only in one leg for each patient and the same amount of sterile normal saline was injected into the other leg as a control .',\n"," 'selection of the leg receiving the toxin was randomized .',\n"," 'clinical evaluation included a vas score for calf pain and measurement of rom of the knees and ankles and calf circumference , with evaluations performed in a double-blinded manner .',\n"," 'side-to-side differences were analyzed until the end of consolidation phase .',\n"," 'minimum followup was @months ( mean , @months ; range , @-@months ) .',\n"," 'the distraction rate and the final length gain were similar in the treated and control limbs .',\n"," 'a priori power analysis suggested that @ legs were required to achieve statistical significance of @ with @ % of power to detect a @ % difference in treatment effect between treatment and control groups .',\n"," 'there were no differences in calf pain , knee and ankle rom , and maximal calf circumferences between the two legs at each time point .',\n"," 'local injection of @iu btx-a at the human calf muscle does not appear to reduce calf pain or help enhance rom of the knee and ankle during tibial lengthening .',\n"," 'however , the small sample size provided sufficient power to detect only relatively large clinical effects ; future , larger trials will be needed to determine whether smaller differences are present .',\n"," 'level ii , therapeutic study .',\n"," 'see instructions for authors for a complete description of levels of evidence .',\n"," 'to assess potential of preoperative therapy with local steroid and non-steroid anti-inflammatory drugs ( saids and nsaids ) for prolonging the hypotensive effect of trabeculectomy .',\n"," 'a total of @ patients with primary open-angle glaucoma planed for trabeculectomy were randomized into @ groups of @ each : @ groups that differed in the studied drug ( nepafenac , dexamethasone , or their non-fixed combination ) and a control group with no preoperative therapy .',\n"," 'the patients instilled @ drop of either drug b.i.d. for @ weeks before the surgery and were examined each day of the first week and then at weeks @ , @ , @ and months @ , @ , and @ .',\n"," 'the rate of postoperative surgical and medical interventions ( needling , needling revision , hypotensive therapy ) was used for outcome evaluation .',\n"," 'postoperative needling was required in @ % of the controls , @ % of the nsaids and @ % of the saids patients as well as @ % the combination-therapy patients .',\n"," 'needling revision had to be performed in @ % of patients from the control group and @ % of patients from the nsaids group .',\n"," 'patients from the steroid and combination-therapy groups had no need in needling procedure .',\n"," 'further hypotensive therapy was required in @ % of the control group , @ % of the nsaids group , @ % of the saids group and @ % of the combination-therapy group .',\n"," 'during the first postoperative year complete success of the treatment was achieved in @ % of the controls , @ % of the nsaids patients , @ % of the saids patients , and @ % of those under combination therapy .',\n"," 'qualified success during the same period was achieved in @ % of cases .',\n"," 'preoperative local anti-inflammatory therapy helped to increase the one-year complete success rate after trabeculectomy as compared with the controls .',\n"," 'the most significant hypotensive effect was noted in the combination-therapy group ( @ % ) , less significant -- in the steroid and non-steroid monotherapy groups ( @ % and @ % correspondingly ) .',\n"," 'a negative correlation was noted between the use of nepafenac and dexamethasone and other measures aimed at increasing the hypotensive effect of glaucoma surgery .',\n"," 'case-control study ; ecological study .',\n"," 'to examine the efficacy of wearing compression stockings to prevent muscle damage and to maintain running performance during a marathon competition .',\n"," 'exercise-induced muscle damage has been identified as one of the main causes of the progressive decrease in running and muscular performance found during marathon races .',\n"," 'thirty-four experienced runners were pair-matched for age , anthropometric data , and best race time in the marathon , and randomly assigned to a control group ( n = @ ) of runners who wore conventional socks or to a group of runners who wore foot-to-knee graduated compression stockings ( n = @ ) .',\n"," 'before and after the race , a sample of venous blood was obtained , and jump height and leg muscle power were measured during a countermovement jump .',\n"," 'serum myoglobin and creatine kinase concentrations were determined as blood markers of muscle fiber damage .',\n"," 'total race time was not different between the control group and the compression stockings group ( @ @ and @ @ minutes , respectively ; p = @ ) .',\n"," 'between the control group and the compression stockings group , postrace reductions in leg muscle power ( -@ % @ % versus -@ % @ % , respectively ; p = @ ) and jump height ( -@ % @ % versus -@ % .',\n"," '@ % , respectively ; p = @ ) were similar .',\n"," 'at the end of the race , there were no differences between the control group and the compression stockings group in serum myoglobin ( @ @ ngml ( -@ ) versus @ @ ngml ( -@ ) , respectively ; p = @ ) and creatine kinase concentration ( @ @ ul ( -@ ) versus @ @ ul ( -@ ) , respectively ; p = @ ) .',\n"," 'the use of compression stockings did not improve running pace and did not prevent exercise-induced muscle damage during the marathon .',\n"," 'wearing compression stockings during long-distance running events is an ineffective strategy to avoid the deleterious effects of muscle damage on running performance .',\n"," 'therapy , level @b .',\n"," 'the relationships of left ventricular ( lv ) longitudinal and circumferential systolic dysfunction with diastolic performance in hypertensive patients have never been compared .',\n"," \"in @ asymptomatic hypertensive patients , circumferential function was assessed with the use of midwall fractional shortening ( mfs ) and stress-corrected mfs ( scmfs ) , whereas longitudinal function was assessed with the use of left atrioventricular plane displacement ( avpd ) and systolic mitral annulus velocity ( s ' ) .\",\n"," \"early diastolic annular velocity ( e ' ) and the e/e ' ratio were measured .\",\n"," 'global longitudinal and circumferential strain were determined in a subset of @ patients .',\n"," \"e ' was linearly related to all systolic indexes ( avpd : r = @ ; s ' : r = @ ; mfs : r = @ ; scmfs : r = @ ; all p < @ ) , but the correlations were stronger with longitudinal indexes than with circumferential ones ( p < @ ) .\",\n"," \"e/e ' was nonlinearly related to avpd ( r = -@ ; p < @ ) and s ' ( r = -@ ; p < @ ) and showed no relationship with mfs and scmfs .\",\n"," \"longitudinal indexes were superior to circumferential ones in predicting e ' < @ cm/s , e/e ' < @ , and e/e ' @ .\",\n"," 'the effect of lv geometry on lv diastolic function was evident among patients with preserved systolic longitudinal function , but was blunted among patients with impaired longitudinal function .',\n"," \"in multivariable analyses , only longitudinal indexes remained associated with e ' and e/e ' .\",\n"," 'analyses using strains provided similar results .',\n"," 'in asymptomatic hypertensive subjects , lv diastolic performance is independently associated with longitudinal systolic dysfunction , but not with circumferential systolic dysfunction .',\n"," 'subtle longitudinal systolic impairment plays a role in mediating the effect of lv geometry on diastolic performance .',\n"," 'these findings may support the need of critically revising the concept of isolated diastolic dysfunction in these patients .',\n"," 'multiple sclerosis ( ms ) is a chronic and disabling disease resulting in disabilities in young and middle-aged persons .',\n"," 'in this study , researchers explored the effect of yoga techniques on physical activities and sexual function among some iranian women with ms.',\n"," 'in this study , @ iranian women with multiple sclerosis ( ms ) were placed in two equally divided control and case groups through random selection to assess pre-and post-effects of yoga exercises on their physical activities and sexual satisfaction levels .',\n"," 'women in case group were offered a series of yoga training and exercises for @ months , which consisted of @ sessions per month for @ to @ minutes at each session .',\n"," 'yoga training program included the @ principles of slow motions ( hatayoga ) , respiratory exercises ( pranayama ) and centralization to control mind via meditation , expansion and stasis ( rajayoga ) .',\n"," 'after @ months both groups were surveyed using the initial questionnaire to evaluate and compare findings with the base-line data .',\n"," 'researchers found significant statistical difference in physical activity and sexual satisfaction levels among the women in case group ( p = @ ) .',\n"," 'women in case group showed improvement in physical ability while women in control group manifested exacerbated symptoms .',\n"," 'yoga techniques may improve physical activities and sexual satisfaction function of women with ms.',\n"," 'to evaluate the safety and efficacy of antiplatelet therapy of ticagrelor on patients suffering from acute st segment elevation myocardial infarction undergoing primary percutaneous coronary intervention .',\n"," 'in the study , @ patients suffering from acute st segment elevation myocardial infarction onset within @ h undergoing primary percutaneous coronary intervention from may to october in @ were randomly divided into ticagrelor group ( n = @ ) and clopidogrel group ( n = @ ) by using the method of random number table .',\n"," 'ticagrelor and clopidogrel antiplatelet treatment were used before and after operation .',\n"," 'their baseline data , coronary artery disease characteristics , platelet count , adenosine diphosphate ( adp ) - induced platelet inhibition rate by thrombelastograph after @ days of treatment , the major adverse cardiovascular events of the follow up for @ months and bleeding complications were observed and compared in the two groups .',\n"," 'the differences between the two groups of patients with their baseline data , the features of coronary artery lesions , platelet count before and after @ days of treatment had no statistical significance ( p > @ ) .',\n"," 'adp induced platelet inhibition rate -lsb- ( @ ) % -rsb- after @ days of treatment in ticagrelor group was significantly higher than that in clopidogrel group -lsb- ( @ ) % , p < @ -rsb- .',\n"," 'the two groups of patients were followed up for @ months , @ cases of major adverse cardiovascular events occurred in clopidogrel group , @ cases of major adverse cardiovascular events occurred in ticagrelor group , and there was significant difference between the two groups ( p < @ ) .',\n"," 'the two groups ( @ cases of @ patients in ticagrelor group vs. @ cases of @ patients in clopidogrel group ) had no statistically significant difference in bleeding complications ( p > @ ) .',\n"," 'antiplatelet therapy of ticagrelor on patients suffering from acute st segment elevation myocardial infarction undergoing emergency pci has good efficacy and safety .',\n"," 'to evaluate the image quality , radiation dose and diagnostic accuracy of @kvp , high-pitch ct pulmonary angiography ( ctpa ) with iterative reconstruction using @ ml of contrast agent .',\n"," 'one hundred patients with suspected pulmonary embolism ( pe ) were randomly divided into two groups ( n = @ each ; group a , @ kvp , @ pitch , @ ml of contrast medium and filtered back projection algorithm ; group b , @ kvp , @ pitch , @ ml of contrast medium and sinogram affirmed iterative reconstruction ) .',\n"," 'image quality , diagnostic accuracy and radiation dose were evaluated and compared .',\n"," 'mean ct numbers of pulmonary arteries in group b were higher than those in group a ( all p < @ ) .',\n"," 'contrast-to-noise ratio and signal-to-noise ratio of group b were higher than those of group a ( both p < @ ) .',\n"," 'there was no significant difference in subjective image quality scores between two groups ( p = @ ) .',\n"," 'the interobserver agreement was excellent ( k = @ ) .',\n"," 'there was no significant difference in diagnostic accuracy between the two groups ( p > @ ) .',\n"," 'compared with group a , radiation dose of group b was reduced by @ % ( p < @ ) .',\n"," 'high-pitch ctpa at @ kvp can obtain sufficient image quality in normal-weight individuals with @ ml of contrast agent and half the radiation dose of a conventional ctpa protocol .',\n"," 'ctpa is feasible at @ kvp using only @ ml of contrast agent .',\n"," 'high-pitch ctpa at @ kvp has an effective dose under @ msv .',\n"," 'this ctpa protocol can obtain sufficient image quality in normal-weight individuals .',\n"," 'families express a need for guidance in helping their loved ones with anorexia nervosa ( an ) .',\n"," 'guided self-help interventions can offer support to caregivers .',\n"," 'one hundred seventy-eight adult an patients and their caregivers were recruited from @ uk treatment centres .',\n"," \"families were randomized to carers ' assessment , skills and information sharing ( c ) intervention + treatment as usual ( tau ) or tau alone .\",\n"," 'feedback forms were sent at @months post-discharge and , if not returned , at @months .',\n"," 'one hundred two ( @ % ) patient forms ( n = @tau ; n = @c ) and @ ( @ % ) caregiver forms ( n = @tau ; n = @c ) were returned .',\n"," 'two researchers coded data blind , using thematic analysis .',\n"," '( i ) caregivers and patients express a need for post-discharge support .',\n"," '( ii ) patients identify helpful and unhelpful support strategies , useful for developing future interventions .',\n"," '( iii ) patients could identify positive caregiver behaviour changes targeted in intervention .',\n"," '( iv ) guided self-help may benefit caregiver and sufferer , post-discharge .',\n"," 'caregiver interventions can be a useful tool that will improve the cost effectiveness of inpatient treatment by enhancing the well-being of caregivers and patients .',\n"," 'cardiac mortality and electrophysiological dysfunction both increase with age .',\n"," 'heart rate variability ( hrv ) provides indices of autonomic function and electrophysiology that are associated with cardiac risk .',\n"," 'how habitual physical activity among older adults prospectively relates to hrv , including nonlinear indices of erratic sinus patterns , is not established .',\n"," 'we hypothesized that increasing the levels of both total leisure-time activity and walking would be prospectively associated with more favorable time-domain , frequency-domain , and nonlinear hrv measures in older adults .',\n"," 'we evaluated serial longitudinal measures of both physical activity and @-hour holter hrv over @ years among @ older us adults in the community-based cardiovascular health study .',\n"," 'after multivariable adjustment , greater total leisure-time activity , walking distance , and walking pace were each prospectively associated with specific , more favorable hrv indices , including higher @-hour standard deviation of all normal-to-normal intervals ( ptrend = @ , @ , @ , respectively ) and ultralow-frequency power ( ptrend = @ , @ , @ , respectively ) .',\n"," 'greater walking pace was also associated with a higher short-term fractal scaling exponent ( ptrend = @ ) and lower poincar ratio ( ptrend = @ ) , markers of less erratic sinus patterns .',\n"," 'greater total leisure-time activity , and walking alone , as well , were prospectively associated with more favorable and specific indices of autonomic function in older adults , including several suggestive of more normal circadian fluctuations and less erratic sinoatrial firing .',\n"," 'our results suggest potential mechanisms that might contribute to lower cardiovascular mortality with habitual physical activity later in life .',\n"," 'our aim was to compare anatomical and functional outcome between vaginal colposuspension and transvaginal mesh .',\n"," 'this was a prospective randomized controlled trial in a teaching hospital .',\n"," 'sixty-eight women with stage @ anterior vaginal wall prolapse according to the pelvic organ prolapse quantification ( pop-q ) system were assessed , randomized , and analyzed .',\n"," 'patients were randomized to anterior colporrhaphy with vaginal colposuspension ( n = @ ) or transvaginal mesh ( n = @ ) .',\n"," 'primary outcome was objective cure rate of the anterior vaginal wall , defined as pop-q @ at @years .',\n"," 'secondary outcomes were functional results , quality-of-life ( qol ) scores , mesh-related morbidity , and onset of urinary incontinence .',\n"," 'the anatomical result for point ba was significantly better at @years in the mesh group ( -@ cm ) than in the colposuspension group ( -@ cm ) ( p = @ ) .',\n"," 'concerning pop-q stages , the anatomical success rate at @years was @ % for colposuspension and @ % for mesh ( p = @ ) .',\n"," 'there were @ anatomic recurrences ( @ % ) in the colposuspension group .',\n"," 'the erosion rate was @ % ( n = @ ) .',\n"," 'no significant difference was noted regarding minor complications .',\n"," 'analysis of qol questionnaires showed overall improvement in both groups , with no significant difference between them .',\n"," 'the vaginal colposuspension technique of anterior vaginal wall prolapse repair gave good anatomical and functional results at @years .',\n"," 'transobturator vaginal mesh gave better @-year anatomical results than vaginal colposuspension , with overall improvement in qol in both groups .',\n"," 'clinical studies evaluating the effects of medications on - cell function in type @ diabetes ( t@dm ) are compromised by an inability to determine the actual baseline degree of - cell dysfunction independent of the reversible dysfunction induced by hyperglycemia ( glucotoxicity ) .',\n"," 'short-term intensive insulin therapy ( iit ) is a strategy for eliminating glucotoxicity before randomization .',\n"," 'this study determined whether liraglutide can preserve - cell function over @ weeks in early t@dm following initial elimination of glucotoxicity with iit .',\n"," \"in this double-blind , randomized , placebo-controlled trial , @ patients with t@dm of @ @ years ' duration and an a@c of @ @ % ( @ @ mmol/mol ) completed @ weeks of iit before randomization to daily subcutaneous liraglutide or placebo injection , with serial assessment of - cell function by insulin secretion-sensitivity index-@ ( issi-@ ) on oral glucose tolerance test performed every @ weeks .\",\n"," 'the primary outcome of baseline-adjusted issi-@ at @ weeks was higher in the liraglutide group than in the placebo group ( @ @ vs. @ @ , p = @ ) .',\n"," 'baseline-adjusted hba@c at @ weeks was lower in the liraglutide group ( @ @ % vs. @ @ % , p = @ ) ( @ @ vs. @ @ mmol/mol ) .',\n"," 'at each quarterly assessment , > @ % of participants on liraglutide had an hba@c @ % ( @ mmol/mol ) and glucose tolerance in the nondiabetic range .',\n"," 'despite this level of glycemic control , no difference was found in the incidence of hypoglycemia between the liraglutide and placebo groups ( p = @ ) .',\n"," 'two weeks after stopping treatment , however , the beneficial effect on issi-@ of liraglutide versus placebo was entirely lost ( @ @ vs. @ @ , p = @ ) .',\n"," 'liraglutide provides robust enhancement of - cell function that is sustained over @ weeks in early t@dm but lost upon cessation of therapy .',\n"," 'to investigate the effectiveness of rectally administered indomethacin in the prophylaxis of post-endoscopic retrograde cholangiopancreatography ( ercp ) pancreatitis and hyperamylasaemia in a multicentre study .',\n"," 'a prospective , randomised , placebo-controlled multicentre study in five endoscopic units was conducted on @ patients randomised to receive a suppository containing @ mg indomethacin , or an inert placebo , @-@ min before ercp .',\n"," 'post-ercp pancreatitis and hyperamylasaemia were evaluated @ h following the procedure on the basis of clinical signs and laboratory parameters , and computed tomography/magnetic resonance imaging findings if required .',\n"," 'twenty-one patients were excluded because of incompleteness of their data or because of protocol violation .',\n"," 'the results of @ investigations were evaluated : @ in the indomethacin group and @ in the placebo group .',\n"," 'the distributions of the risk factors in the two groups did not differ significantly .',\n"," 'pancreatitis developed in @ patients ( @ % ) : it was mild in @ ( @ % ) and severe in eight ( @ % ) cases .',\n"," 'hyperamylaesemia occurred in @ patients ( @ % ) .',\n"," 'there was no significant difference between the indomethacin and placebo groups in the incidence of either post-ercp pancreatitis ( @ % vs @ % ) or hyperamylasaemia ( @ % vs @ % ) .',\n"," 'similarly , subgroup analysis did not reveal any significant differences between the two groups .',\n"," '@ mg rectal indomethacin administered before ercp did not prove effective in preventing post-ercp pancreatitis .',\n"," 'we sought to determine the incidence of newly diagnosed diabetes in treated elderly hypertensive patients and the prognostic impact of diabetes on long-term survival .',\n"," 'the second australian national blood pressure ( anbp@ ) study randomized @,@ hypertensive patients aged @-@ years to angiotensin-converting enzyme inhibitor ( acei ) or thiazide diuretic-based therapy and followed them for a median of @ years .',\n"," 'long-term survival was determined in @,@ patients over an additional median of @ years after anbp@ ( post-trial ) .',\n"," 'after anbp@ , the cohort was classified into preexisting ( @ % ) , newly diagnosed ( @ % ) , and no diabetes ( @ % ) groups .',\n"," 'a @ % higher incidence of newly diagnosed diabetes was observed in patients randomized to thiazide diuretic compared with acei-based treatment .',\n"," 'the other predictors of newly diagnosed diabetes were having a higher body mass index , having a higher random blood glucose , and living in a regional location compared to major cities ( a geographical classification based on accessibility ) at study entry .',\n"," 'after completion of anbp@ , compared with those with no diabetes , the preexisting diabetes group experienced higher cardiovascular ( hazards ratio ( hr ) = @ ; @ % confidence interval ( ci ) = @-@ @ ) and all-cause mortality ( hr = @ ; @ % ci = @-@ @ ) when adjusted for age , sex , and treatment .',\n"," 'a similar pattern was observed after including the post-trial period for cardiovascular ( hr = @ ; @ % ci = @-@ @ ) and all-cause mortality ( hr = @ ; @ % ci = @-@ @ ) .',\n"," 'however , when the newly diagnosed group was compared with the no diabetes group , no significant difference was observed in cardiovascular ( hr = @ ; @ % ci = @-@ @ ) or all-cause mortality ( hr = @ ; @ % ci = @-@ @ ) either during the anbp@ trial or including post-trial follow-up ( cardiovascular : hr = @ ; @ % ci = @-@ @ ; all-cause mortality : hr = @ ; @ % ci = @-@ @ ) .',\n"," 'long-term presence of diabetes reduces survival .',\n"," 'compared with thiazide diuretics , acei-based antihypertensives may delay the development of diabetes in those at risk and thus potentially improve cardiovascular outcome in the elderly .',\n"," 'obesity is associated with a risk of gastroesophageal reflux disease .',\n"," 'the pharmacodynamic efficacy of proton pump inhibitors has not been specifically evaluated in obese subjects .',\n"," 'the aim of this study was to compare the antisecretory response to a single oral dose of @ mg rabeprazole , @ mg omeprazole and placebo in obese subjects .',\n"," 'gastric ph was monitored for @ hours on three separate occasions in eighteen h. pylori-negative , asymptomatic obese subjects .',\n"," 'subjects were given omeprazole , rabeprazole or placebo in a randomized order and in a double-blind fashion .',\n"," 'the main analysis criterion was @-h percent of time post dose with intragastric ph above @ ; secondary criteria were percentage of time above ph @ , median ph , -lsb- h + -rsb- concentrations and nocturnal acid breakthrough ( nab ) .',\n"," 'results were analyzed using linear mixed models and wilks test comparing variances .',\n"," '@-h median -lsb- iq -rsb- percentages of time with gastric ph above @ and @ were higher with rabeprazole than omeprazole ( @ -lsb- @-@ -rsb- vs. @ -lsb- @-@ -rsb- % , @ -lsb- @-@ -rsb- % for placebo ) but the differences did not reach statistical significance ( p = @ and @ , respectively ) .',\n"," 'median acid concentrations were significantly lower with rabeprazole than with omeprazole and placebo ( @ -lsb- @-@ -rsb- vs. @ -lsb- @-@ -rsb- and @ -lsb- @-@ -rsb- mmoles/l , p < @ ) for all periods .',\n"," 'the number of nab was significantly lower with rabeprazole than with omeprazole ( median @ -lsb- @,@ -rsb- vs. @ -lsb- @-@ -rsb- , p = @ ) .',\n"," 'variances of @-h data ( ph above @ and @ , median ph , -lsb- h + -rsb- concentrations ) were significantly lower with rabeprazole than with omeprazole ( p < @ ) .',\n"," 'in asymptomatic obese subjects the gastric antisecretory response to a single dose of rabeprazole and omeprazole was strong and not significantly different between drugs despite a significantly more homogeneous response with rabeprazole .',\n"," 'clinicaltrial.gov : nct@ .',\n"," 'to study the effect of growth hormone ( gh ) treatment on ovarian and uterine morphology and function in short , prepubertal small-for-gestational-age ( sga ) girls .',\n"," 'a multinational , randomized controlled trial on safety and efficacy of gh therapy in short , prepubertal children born sga .',\n"," 'not applicable .',\n"," 'a subgroup of @ danish girls born sga included in north european sga study ( nesgas ) .',\n"," 'one year of gh treatment ( @ g/kg/day ) followed by @ years of randomized gh treatment ( @ g/kg/day , @ g/kg/day , or igf-i titrated ) .',\n"," 'data on anthropometrics , reproductive hormones , and ultrasonographic examination of the internal genitalia were collected during @ months of gh treatment .',\n"," 'uterine and ovarian volume increased significantly during @ years of treatment ( @ % and @ % , respectively ) but remained low within normal reference ranges .',\n"," 'ovarian follicles became visible in @ % after @ year compared with @ % before gh therapy .',\n"," 'anti-mllerian hormone increased significantly during the @ years of gh therapy but remained within the normal range .',\n"," 'precocious puberty was observed in one girl ; another girl developed multicystic ovaries .',\n"," 'gh treatment was associated with statistically significant growth of the internal genitalia , but remained within the normal range .',\n"," 'as altered pubertal development and ovarian morphology were found in @ of @ girls , monitoring of puberty and ovarian function during gh therapy in sga girls is prudent .',\n"," 'altogether , the findings are reassuring .',\n"," 'however , long-term effects of gh treatment on adult reproductive function remain unknown .',\n"," 'eudract @-@-@ .',\n"," 'to test the hypothesis that a brief , clinic-based , single-session programme will reduce the rate of @ selected condom use errors in a clinical sample of young black men ( ybm ) ages @ through @ years .',\n"," 'data were collected in clinics treating patients with sexually transmitted infections ( sti ) in three southern us cities .',\n"," 'males @-@years of age who identified as black/african-american , and reported recent ( past @months ) condom use were eligible .',\n"," 'only those also reporting condom use in the @months prior to a @-month follow-up assessment ( n = @ ) were included in this secondary analysis of data from a randomised , controlled trial .',\n"," 'difference scores were used to capture a grouptime effect .',\n"," 'ybm reported @ condom use events in the @months preceding study enrolment and @ in the @months preceding the follow-up assessment .',\n"," 'mean baseline error rates were @ and @ for young men randomised to the intervention and control conditions , respectively .',\n"," 'follow-up rates were @ and @ for young men randomised to the intervention and control conditions , respectively .',\n"," 'controlled findings yielded a significant effect for the influence of group assignment on the difference score ( baseline to follow-up ) in the condom use error rate ( = @ ; p = @ ) .',\n"," 'a brief , clinic-based counselling programme produced modest reductions in condom use errors among ybm attending sti clinics in the southern usa intensified clinic-based intervention that helps ybm improve the quality of their condom use behaviours is warranted .',\n"," 'nct@ .',\n"," 'to provide evidence for chinese medical treatment of children with eb virus infection by exploring its clinical efficacy from multiple angles .',\n"," 'totally @ children patients were randomly assigned to the treatment group ( @ cases ) and the control group ( @ cases ) .',\n"," 'patients in the treatment group took chinese medical decoction , while those in the control received intravenous dripping of ganciclovir and oral administration of pidotimod .',\n"," 'the treatment period for the two groups was @ weeks .',\n"," 'patients were followed-up till the @th week .',\n"," 'clinical symptoms such as fever , lymphadenopathy and hepatosplenomegaly , as well as lab indices such as abnormal lymphocyte percentage , eb virus antibody , virus dna load , t cell subsets , immunoglobulin , and so on were observed before and after treatment , at week @ and @ of follow-ups .',\n"," '( @ ) the total effective rate at week @ was @ % in the treatment group , higher than that of the control group ( @ % ) , but there was no statistical difference between the two groups .',\n"," '( @ ) the time for defervescence , duration of pharyngeal hyperemia , duration of swollen tonsils was shorter in the treatment group than in the control group ( p < @ ) .',\n"," 'the subsidence of lymphadenopathy , hepatomegaly , and abnormal lymphocytes was better in the treatment group than in the control group ( p < @ ) .',\n"," '( @ ) the positive cases of peripheral blood hetero-lymphocyte was significantly reduced after treatment , at week @ and @ of follow-ups both in the treatment group and the control group ( p < @ ) .',\n"," 'the expression of iga and igm decreased after treatment in the two groups when compared with before treatment in the same group ( p < @ , p < @ ) .',\n"," 'igg in the treatment group also obviously decreased after treatment , at week @ and @ of follow-ups ( p < @ , p < @ ) , while it decreased only after treatment in the control group ( p < @ ) .',\n"," 'activities of ast and alt in the treatment group and the ast activity in the control group were markedly improved when compared with those before treatment ( p < @ ) .',\n"," 'compared with the control group , the abnormal lymphocyte positive case number obviously decreased in the treatment group after treatment , at week @ and @ of follow-ups ( p < @ ) .',\n"," '( @ ) after treatment , at week @ and @ of follow-ups , cd@ + and cd@ + significantly decreased ; cd@ + , cd@/cd@ , and b cells significantly increased in the two groups , when compared with before treatment ( p < @ ) .',\n"," 'nk cells significantly increased more in the treatment group after treatment , at week @ and @ of follow-ups , higher than before treatment as well as the control group ( p < @ ) .',\n"," '( @ ) eb viral dna and eb viral ca-igm negative conversion case numbers significantly increased in the two groups after treatment , at week @ and @ of follow-ups ( p < @ ) .',\n"," 'compared with the control group , eb viral dna and eb viral ca-igm negative conversion case numbers significantly increased in the treatment group after treatment and at week @ of follow-ups ( p < @ ) .',\n"," 'treatment of eb virus infection by chinese medical treatment was effective .',\n"," 'it could promote the recovery of eb viral infection , and reduce the risk of vicious disease after eb viral infection .',\n"," 'the primary objective was to compare the cosmetic outcomes of traumatic trunk and extremity lacerations repaired using absorbable versus nonabsorbable sutures .',\n"," 'the secondary objective was to compare complication rates between the two groups .',\n"," 'this was a randomized controlled trial comparing wounds repaired with vicryl rapide and prolene sutures .',\n"," 'pediatric and adult patients with lacerations were enrolled in the study .',\n"," 'at a @-day follow-up , the wounds were evaluated for infection and dehiscence .',\n"," 'after @ months , patients returned to have the wounds photographed .',\n"," 'two plastic surgeons blinded to the method of closure rated the cosmetic outcome of each wound using a @-mm visual analog scale ( vas ) .',\n"," 'using a noninferiority design , a vas score of @ mm or greater was considered to be a clinically significant difference .',\n"," \"we used a student 's t-test to compare differences between mean vas scores and odds ratios ( ors ) to compare differences in complication rates between the two groups .\",\n"," 'of the @ patients enrolled , @ completed the study including @ in the vicryl rapide group and @ in the prolene group .',\n"," 'the mean ( sd ) age of patients who completed the study was @ ( @ ) years , and @ were male .',\n"," 'we found no significant differences in the age , race , sex , length of wound , number of sutures , or layers of repair in the two groups .',\n"," \"the observer 's mean vas for the vicryl rapide group was @ mm ( @ % confidence interval -lsb- ci -rsb- = @ to @ mm ) and for the prolene group was @ mm ( @ % ci = @ to @ mm ) .\",\n"," 'the resulting mean difference was @ mm ( @ % ci = -@ to @ mm ; p = @ ) ; thus noninferiority was established .',\n"," 'statistical testing showed no differences in the rates of complications between the two groups , but a higher percentage of the vicryl rapide wounds developed complications .',\n"," 'the use of absorbable sutures for the repair of simple lacerations on the trunk and extremities should be considered as an alternative to nonabsorbable suture repair .',\n"," 'aspirin early after intravenous thrombolysis in acute ischemic stroke increases the risk of symptomatic intracranial hemorrhage ( sich ) , without influencing functional outcome at @ months .',\n"," 'the effect of aspirin on early neurological deterioration ( end ) was explored as a post hoc analysis of the randomized antiplatelet therapy in combination with recombinant t-pa thrombolysis in ischemic stroke ( artis ) trial .',\n"," 'end , defined as a @ points national institutes of health stroke scale worsening @ hours after intravenous thrombolysis , was categorized into sich ( endsich ) and cerebral ischemia ( endci ) .',\n"," 'multinomial logistic regression was used to assess the effect of aspirin on end .',\n"," 'of the @ patients , @ patients ( @ % ) experienced end ( @ endsich , @ endci ) .',\n"," 'aspirin increased the risk of endsich ( odds ratio , @ ; @ % confidence interval , @-@ @ ) but not of endci ( odds ratio , @ ; @ % confidence interval , @-@ @ ) .',\n"," 'after adjustment for other explanatory variables , the association between aspirin and endsich remained significant .',\n"," 'in this trial , there is no evidence of an early antithrombotic effect from the addition of aspirin to intravenous thrombolysis in acute ischemic stroke .',\n"," 'to compare the relative effectiveness of methotrexate and mycophenolate mofetil for noninfectious intermediate uveitis , posterior uveitis , or panuveitis .',\n"," 'multicenter , block-randomized , observer-masked clinical trial .',\n"," 'eighty patients with noninfectious intermediate , posterior , or panuveitis requiring corticosteroid-sparing therapy at aravind eye hospitals in madurai and coimbatore , india .',\n"," 'patients were randomized to receive @ mg weekly oral methotrexate or @ g twice daily oral mycophenolate mofetil and were monitored monthly for @ months .',\n"," 'oral prednisone and topical corticosteroids were tapered .',\n"," 'masked examiners assessed the primary outcome of treatment success , defined by achieving the following at @ and @ months : ( @ ) @ + anterior chamber cells , @ + vitreous cells , @ + vitreous haze and no active retinal/choroidal lesions in both eyes , ( @ ) @ mg of prednisone and @ drops of prednisolone acetate @ % a day , and ( @ ) no declaration of treatment failure because of intolerability or safety .',\n"," 'additional outcomes included time to sustained corticosteroid-sparing control of inflammation , change in best spectacle-corrected visual acuity , resolution of macular edema , adverse events , subgroup analysis by anatomic location , and medication adherence .',\n"," 'forty-one patients were randomized to methotrexate and @ to mycophenolate mofetil .',\n"," 'a total of @ patients ( @ methotrexate , @ mycophenolate mofetil ) contributed to the primary outcome .',\n"," 'sixty-nine percent of patients achieved treatment success with methotrexate and @ % with mycophenolate mofetil ( p = @ ) .',\n"," 'treatment failure from adverse events or tolerability was not different by treatment arm ( p = @ ) .',\n"," 'there were no differences between treatment groups in time to corticosteroid-sparing control of inflammation ( p = @ ) , change in best spectacle-corrected visual acuity ( p = @ ) , or resolution of macular edema ( p = @ ) .',\n"," 'there was no statistically significant difference in corticosteroid-sparing control of inflammation between patients receiving methotrexate or mycophenolate mofetil .',\n"," 'however , there was a @ % difference in treatment success favoring methotrexate .',\n"," 'the prevalence of methicillin-resistant staphylococcus aureus ( mrsa ) respiratory infection in cystic fibrosis ( cf ) has increased dramatically over the last decade , and is now affecting approximately @ % of patients .',\n"," 'epidemiologic evidence suggests that persistent infection with mrsa results in an increased rate of decline in fev@ and shortened survival .',\n"," 'currently , there are no conclusive studies demonstrating an effective and safe treatment protocol for persistent mrsa respiratory infection in cf.',\n"," 'the primary objective of this study is to evaluate the safety and efficacy of a @-day course of vancomycin for inhalation in combination with oral antibiotics in eliminating mrsa from the respiratory tract of individuals with cf and persistent mrsa infection .',\n"," 'this is a two-center , randomized , double-blind , comparator-controlled , parallel-group study with @:@ assignment to either vancomycin for inhalation ( @mg twice a day ) or taste-matched placebo for @days in individuals with cystic fibrosis .',\n"," 'in addition , both groups will receive oral rifampin , a second oral antibiotic - trimethoprim/sulfamethoxazole ( tmp/smx ) or doxycycline , protocol determined - mupirocin intranasal cream , and chlorhexidine body washes .',\n"," 'forty patients with persistent respiratory tract mrsa infection will be enrolled : @ will be randomized to vancomycin for inhalation and @ to a taste-matched placebo .',\n"," 'the primary outcome will be the presence of mrsa in sputum respiratory tract cultures @month after the conclusion of treatment .',\n"," 'secondary outcomes include the efficacy of the intervention on : fev@ % predicted , patient reported outcomes , pulmonary exacerbations , and mrsa colony-forming units found in respiratory tract sample culture .',\n"," 'results of this study will provide guidance to clinicians regarding the safety and effectiveness of a targeted eradication strategy for persistent mrsa infection in cf.',\n"," 'this trial is registered at clinicaltrials.gov ( nct@ , received @/@/@ ) and is funded by the cystic fibrosis foundation ( grants : pmep@k@ and pmep@k@ ) .',\n"," 'there is a strong association between weight gain and metabolic events in patients with schizophrenia receiving many of the second-generation antipsychotic agents .',\n"," 'we explored the relationship between body mass index ( bmi ) and metabolic events in patients with schizophrenia receiving long-acting injectable paliperidone palmitate ( pp ) in a long-term trial .',\n"," 'we conducted a post hoc analysis of data from a pp study that included a @-week open-label transition ( tr ) and maintenance phase ; a variable duration , randomized , double-blind ( db ) , placebo-controlled phase and a @-week open-label extension ( ole ) phase .',\n"," 'overall , @ patients received pp continuously from study entry through discontinuation or study completion and were grouped by baseline bmi ( kg/m@ ) : underweight ( bmi < @ ; n = @ , @ % ) , normal-weight ( bmi @ - < @ ; n = @ , @ % ) , overweight ( bmi @ - < @ ; n = @ , @ % ) and obese ( bmi @ ; n = @ , @ % ) .',\n"," 'metabolic treatment-emergent adverse events ( teaes ) and changes in related laboratory results from tr baseline were analyzed .',\n"," 'pp exposure was similar across bmi groups ; overall mean ( sd ) dose/month was @ ( @ ) mg eq .',\n"," '-lsb- @ ( @ ) mg -rsb- ; median duration of exposure was @ days ( @ to @ days ) .',\n"," 'occurrences of metabolic teaes overall by group were @ % ( underweight ) , @ % ( normal-weight ) , @ % ( overweight ) , and @ % ( obese ) .',\n"," 'the most common ( @ % ) metabolic teae were weight gain and elevated blood levels of glucose , lipids , and insulin .',\n"," 'mean bmi and weight increased in normal-weight and overweight groups at db endpoint , and in underweight , normal-weight and overweight groups at ole endpoint ( p @ ) .',\n"," 'no consistent trend for increased metabolic-related laboratory values by baseline bmi group was observed .',\n"," 'homeostatic model assessments for insulin resistance indicated preexisting insulin resistance at baseline , with minimal changes at ole endpoint across baseline bmi groups .',\n"," 'occurrences of metabolic-related teaes trended with greater bmi status in patients with schizophrenia treated with pp ; consistent trends in metabolic-related laboratory values were not observed .',\n"," 'this study is registered at clinicaltrials.gov ( nct @ ) .',\n"," 'fecal immunochemical tests ( fits ) are recommended to screen average-risk adults for colorectal cancer ( crc ) .',\n"," 'little research has examined whether a two-sample fit affects participant uptake , compared with a one-sample fit .',\n"," 'examining participant uptake is important , as evidence suggests that a two-sample fit may increase the sensitivity to detect crc .',\n"," 'this study had two objectives : ( i ) to evaluate fit completion in a population that received either a one-sample fit kit ( @-fit ) or a two-sample fit kit ( @-fit ) and ( ii ) to understand whether uptake varies by age , sex , or receipt of prior crc screening .',\n"," 'we conducted a randomized controlled trial in which @ participants who were aged between @ and @ years and were at an average risk for crc , and who had requested fits , randomly received @-fit ( n = @ ) or @-fit ( n = @ ) kits .',\n"," 'fit completion was defined as the completion and return of a one-sample test by the patients in the @-fit group or of both sample tests by those in the @-fit group .',\n"," 'cox proportional hazard regression models were used to determine the independent effect of group type ( @-fit vs. @-fit ) on the completion of the fit , adjusting for age , sex , and receipt of prior crc screening .',\n"," 'the @-fit group had lower test completion rates ( hazard ratio = @ ; @ % confidence interval = @-@ @ ; p = @ ) after adjusting for age , sex , and receipt of prior crc screening .',\n"," 'participant uptake did not vary by age , sex , or receipt of prior crc screening .',\n"," 'this unique , rigorous randomized controlled trial found that the @-fit regimen decreases completion of fit .',\n"," 'further research is needed to understand whether decreases in participant uptake are offset by increased gains in test sensitivity .',\n"," 'evaluation of the safety and efficacy of pazopanib , a multikinase angiogenesis inhibitor , in a single-arm , open-label , extension study ( veg@/nct@ ) for placebo-treated patients with advanced renal cell carcinoma ( rcc ) from a randomized , double-blind , placebo-controlled phase iii study ( veg@/nct@ ) .',\n"," 'patients received pazopanib @ mg/day .',\n"," 'the primary endpoint was the safety and tolerability of pazopanib treatment .',\n"," 'secondary endpoints included response rate per response evaluation criteria in solid tumors , progression-free survival ( pfs ) , and overall survival ( os ) .',\n"," 'seventy-nine placebo-treated patients from veg@/nct@ who experienced disease progression and one pazopanib-treated patient ( an exemption ) were enrolled .',\n"," 'forty-one patients ( @ % ) were treatment-naive ; @ ( @ % ) were cytokine-pretreated .',\n"," 'median exposure to pazopanib was @ months .',\n"," 'all patients had discontinued pazopanib at the time of analysis .',\n"," 'the most common reason for discontinuation was disease progression ( @ % ) .',\n"," 'the most common adverse events were hypertension ( @ % ) , diarrhea ( @ % ) , hair color changes ( @ % ) , anorexia ( @ % ) , and nausea ( @ % ) .',\n"," 'the response rate was @ % -lsb- @ % confidence interval ( ci ) : @-@ @ -rsb- ; median pfs was @ months ( @ % ci : @-@ @ ) ; median os was @ months ( @ % ci : @-@ @ ) .',\n"," 'efficacy and safety profiles for pazopanib in this extension study of patients with rcc previously treated with placebo were very similar to those observed for pazopanib-treated patients in the pivotal phase iii study .',\n"," 'an established multivariate serum protein test can be used to classify patients according to whether they are likely to have a good or poor outcome after treatment with egfr tyrosine-kinase inhibitors .',\n"," 'we assessed the predictive power of this test in the comparison of erlotinib and chemotherapy in patients with non-small-cell lung cancer .',\n"," 'from feb @ , @ , to april @ , @ , patients ( aged @ years ) with histologically or cytologically confirmed , second-line , stage iiib or iv non-small-cell lung cancer were enrolled in @ centres in italy .',\n"," 'patients were stratified according to a minimisation algorithm by eastern cooperative oncology group performance status , smoking history , centre , and masked pretreatment serum protein test classification , and randomly assigned centrally in a @:@ ratio to receive erlotinib ( @ mg/day , orally ) or chemotherapy ( pemetrexed @ mg/m ( @ ) , intravenously , every @ days , or docetaxel @ mg/m ( @ ) , intravenously , every @ days ) .',\n"," 'the proteomic test classification was masked for patients and investigators who gave treatments , and treatment allocation was masked for investigators who generated the proteomic classification .',\n"," 'the primary endpoint was overall survival and the primary hypothesis was the existence of a significant interaction between the serum protein test classification and treatment .',\n"," 'analyses were done on the per-protocol population .',\n"," 'this trial is registered with clinicaltrials.gov , number nct@ .',\n"," '@ patients were randomly assigned to chemotherapy and @ to erlotinib , and @ ( @ % ) and @ ( @ % ) , respectively , were included in the per-protocol analysis .',\n"," '@ ( @ % ) patients in the chemotherapy group and @ ( @ % ) in the erlotinib group had a proteomic test classification of good .',\n"," 'median overall survival was @ months ( @ % ci @-@ ) in the chemotherapy group and @ months ( @-@ ) in the erlotinib group .',\n"," 'we noted a significant interaction between treatment and proteomic classification ( pinteraction = @ when adjusted for stratification factors ; pinteraction = @ when unadjusted for stratification factors ) .',\n"," 'patients with a proteomic test classification of poor had worse survival on erlotinib than on chemotherapy ( hazard ratio @ -lsb- @ % ci @-@ -rsb- , p = @ ) .',\n"," 'there was no significant difference in overall survival between treatments for patients with a proteomic test classification of good ( adjusted hr @ -lsb- @-@ -rsb- , p = @ ) .',\n"," 'in the group of patients who received chemotherapy , the most common grade @ or @ toxic effect was neutropenia ( @ -lsb- @ % -rsb- vs one -lsb- < @ % -rsb- in the erlotinib group ) , whereas skin toxicity ( one -lsb- < @ % -rsb- vs @ -lsb- @ % -rsb- ) was the most frequent in the erlotinib group .',\n"," 'our findings indicate that serum protein test status is predictive of differential benefit in overall survival for erlotinib versus chemotherapy in the second-line setting .',\n"," 'patients classified as likely to have a poor outcome have better outcomes on chemotherapy than on erlotinib .',\n"," 'italian ministry of health , italian association of cancer research , and biodesix .',\n"," 'this study was to evaluate the effect of intraoperative continuous infusion of dexmedetomidine on intraocular pressure ( iop ) in patients undergoing robot-assisted laparoscopic radical prostatectomy ( ralrp ) in the steep trendelenburg ( st ) .',\n"," 'sixty-eight patients were randomly divided into two groups .',\n"," 'the dexmedetomidine group ( group d , n = @ ) received a continuous infusion of dexmedetomidine at a rate of @ g kg ( -@ ) hour ( -@ ) from the induction of anesthesia until the end of the st position , while the control group ( group c , n = @ ) received an equal volume of physiologic saline at the same rate under conventional general anesthesia with sevoflurane and remifentanil .',\n"," 'iop was measured at @ predefined time points for all patients .',\n"," 'significant differences in iop were detected between the two groups by a linear mixed model analysis ( p < @ ) .',\n"," 'the highest mean iop was @ mm hg in group d and @ mm hg in group c ; both were measured @ minutes after the patients had been placed in the st position .',\n"," 'no significant between-group differences in ocular perfusion pressure , mean blood pressure , or heart rate were observed between the two groups .',\n"," 'no ocular or other complications were noted .',\n"," 'intraoperative continuous infusion of dexmedetomidine may help alleviate iop increase in patients undergoing ralrp in the st position .',\n"," 'disruptive or challenging behavior problems pose a threat to children and adolescents with intellectual disabilities and their caregivers .',\n"," 'psychopharmacological treatment is mostly studied with new-generation antipsychotics and has been criticized for adverse side effects .',\n"," 'this study examined the effect of the classic antipsychotic zuclopenthixol .',\n"," 'a total of @ boys ( ages @-@ @ years ) with learning disabilities were included and examined for a response to zuclopenthixol during a @ week period of open label treatment .',\n"," 'doses started low and were adapted individually .',\n"," 'from responders , zuclopenthixol was randomly withdrawn for @ weeks .',\n"," 'responses to withdrawal were observed by external raters using the modified overt aggression scale .',\n"," 'of all patients included into the study , @ were not randomized because of insufficient therapeutic effect , adverse event , or noncompliance .',\n"," 'kaplan-meier estimations showed less aggressive behavior problems for the continuing subgroup ( n = @ ) than in the placebo group ( n = @ ) .',\n"," 'individual doses stayed < @mg/day .',\n"," 'zuclopenthixol proved to be effective in reducing challenging behavior in boys even at low doses .',\n"," 'the purpose of this multicenter , open label , randomized phase iii study was to determine whether ixabepilone resulted in improved overall survival ( os ) compared with commonly used single-agent chemotherapy ( doxorubicin or paclitaxel ) in women with locally advanced , recurrent , or metastatic endometrial cancer with at least one failed prior platinum-based chemotherapeutic regimen .',\n"," 'patients were randomized @:@ to ixabepilone ( @mg/m ( @ ) ) , or either paclitaxel ( @mg/m ( @ ) ) or doxorubicin ( @mg/m ( @ ) ) , every @days .',\n"," 'patients that had previously received an anthracycline were randomized to ixabepilone or paclitaxel ; all other patients were randomized to ixabepilone or doxorubicin .',\n"," 'an interim analysis of futility for os was planned .',\n"," 'at the time of database lock , @ patients were randomized to receive ixabepilone ( n = @ ) or control ( n = @ ) ; nine patients in the control arm were not treated .',\n"," 'the interim analysis of futility for os ( @ events ) favored the control chemotherapy arm ( hazard ratio = @ -lsb- @ % confidence interval : @-@ @ -rsb- , stratified log rank test p = @ ) , indicating that the study would not meet its primary objective .',\n"," 'the study was discontinued based on the interim os results .',\n"," 'the frequency of adverse events was comparable between the treatment arms .',\n"," 'the study did not meet its primary objective of improving os in the ixabepilone arm compared to the control chemotherapy arm .',\n"," 'a favorable risk/benefit ratio was not observed for ixabepilone versus control at the time of the interim analysis .',\n"," 'the safety results were consistent with the known safety profiles of ixabepilone and control .',\n"," 'to determine the impact of calcium and phosphorus on radiological and biochemical characteristics of osteopenia in premature infants .',\n"," 'the randomised clinical trial study was conducted at valie-e-asr hospital of zanjan city , iran , from december @ to june @ .',\n"," 'it involved monitoring @ premature neonates over a period of six months .',\n"," 'the babies , who were fed with breast milk and @ units of vitamin d daily , were randomly divided into two equal groups .',\n"," 'one group received supplement of calcium and phosphorus .',\n"," 'serum calcium , phosphorus and alkaline phosphatase levels as well as growth parameters ( including weight , height , and head circumference ) were measured every two weeks .',\n"," 'at the end of the study , wrist x-ray was done for evaluation of osteopenia .',\n"," 'data was analysed using spss @ .',\n"," 'radiological changes , characteristic of osteopenia , were found in @ ( @ % ) cases and @ ( @ % ) controls ( p < @ ) .',\n"," 'the mean of weight , length and head circumference increased significantly from second to sixth week during follow-up ( p < @ ) .',\n"," 'phosphorus and alkaline phosphatase activity decreased significantly from second to sixth week of follow-up ( p < @ , p < @ respectively ) .',\n"," 'however , repeated measurement analyses did not show significant effect of intervention in biochemical and growth parameters in the trial group .',\n"," \"the study did n't show significant effect of calcium and phosphorus on prevention of osteopenia and improvement of growth .\",\n"," 'further studies of longer duration and with different doses of supplement are recommended .',\n"," 'the purpose of this study was to test the efficacy of a @-month course of anti-inflammatory treatment with colchicinein improving functional status of patients with stable chronic heart failure ( chf ) .',\n"," 'chf has been shown to be associated with inflammatory activation .',\n"," 'inflammation has been designated as a therapeutic target in chf .',\n"," 'patients with stable chf were randomly assigned to colchicine ( @ mg twice daily ) or placebo for @ months .',\n"," 'theprimary endpoint was the proportion of patients achieving at least one-grade improvement in new york heartassociation class .',\n"," 'two hundred sixty-seven patients were available for final evaluation of the primary endpoint : its rate was @ % in the control group and @ % in the colchicine group ( odds ratio : @ ; @ % confidence interval : @ to @ ; p = @ ) .',\n"," 'the rate of the composite of death or hospital stay for heart failure was @ % in the control group , compared with @ % in the colchicine group ( p = @ ) .',\n"," 'the changes in treadmill exercise time with treatment were insignificant and similar in the @ groups ( p = @ ) .',\n"," 'c-reactive protein and interleukin-@ were both significantly reduced in the colchicine group ( -@ mg/l and -@ pg/ml , respectively ; p < @ for both , compared with the control group ) .',\n"," 'according to this prospective , randomized study , anti-inflammatory treatment with colchicine in patients with stable chf , although effective in reducing inflammation biomarker levels , did not affect in any significant way patient functional status ( in terms of new york heart association class and objective treadmill exercise tolerance ) or the likelihood of death or hospital stay for heart failure .',\n"," 'to examine the comparative antidepressant efficacy of s-adenosyl-l-methionine ( same ) and escitalopram in a placebo-controlled , randomized , double-blind clinical trial .',\n"," 'one hundred eighty-nine outpatients ( @ % female , mean -lsb- sd -rsb- age = @ -lsb- @ -rsb- years ) with dsm-iv-diagnosed major depressive disorder ( mdd ) were recruited from april @ , @ , to december @ , @ , at the massachusetts general hospital and at butler hospital .',\n"," 'patients were randomized for @ weeks to same @,@-@ ,@ mg/d , escitalopram @-@ mg/d , or placebo .',\n"," 'doses were escalated at @ weeks in the event of nonresponse .',\n"," 'the main outcome measure was the @-item hamilton depression rating scale ( hdrs-@ ) .',\n"," 'tolerability was assessed by the systematic assessment for treatment of emergent events-specific inquiry ( saftee-si ) .',\n"," ...]"]},"metadata":{},"execution_count":12}],"source":["train_sentences"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":736,"status":"ok","timestamp":1702836983277,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"Fjwovai7Tbgt","outputId":"afe0c1ee-aaf7-4ee2-ae4a-801d7a2029b1"},"outputs":[{"output_type":"stream","name":"stderr","text":["/usr/local/lib/python3.10/dist-packages/sklearn/preprocessing/_encoders.py:868: FutureWarning: `sparse` was renamed to `sparse_output` in version 1.2 and will be removed in 1.4. `sparse_output` is ignored unless you leave `sparse` to its default value.\n","  warnings.warn(\n"]},{"output_type":"execute_result","data":{"text/plain":["array([[0., 0., 0., 1., 0.],\n","       [0., 0., 1., 0., 0.],\n","       [0., 0., 1., 0., 0.],\n","       ...,\n","       [0., 0., 0., 0., 1.],\n","       [0., 1., 0., 0., 0.],\n","       [0., 1., 0., 0., 0.]])"]},"metadata":{},"execution_count":13}],"source":["\n","from sklearn.preprocessing import OneHotEncoder\n","one_hot_encoder = OneHotEncoder(sparse=False)\n","train_labels_one_hot = one_hot_encoder.fit_transform(train_df[\"target\"].to_numpy().reshape(-1, 1))\n","val_labels_one_hot = one_hot_encoder.transform(val_df[\"target\"].to_numpy().reshape(-1, 1))\n","test_labels_one_hot = one_hot_encoder.transform(test_df[\"target\"].to_numpy().reshape(-1, 1))\n","\n","\n","train_labels_one_hot"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":25,"status":"ok","timestamp":1702836983278,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"t7AJdQrRsCYx","outputId":"9503e707-2ee2-41f8-f778-62b5674ef54a"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["array([3, 2, 2, ..., 4, 1, 1])"]},"metadata":{},"execution_count":14}],"source":["from sklearn.preprocessing import LabelEncoder\n","label_encoder = LabelEncoder()\n","train_labels_encoded = label_encoder.fit_transform(train_df[\"target\"].to_numpy())\n","val_labels_encoded = label_encoder.transform(val_df[\"target\"].to_numpy())\n","test_labels_encoded = label_encoder.transform(test_df[\"target\"].to_numpy())\n","\n","train_labels_encoded"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":17,"status":"ok","timestamp":1702836983278,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"0H5sQwMCsKPt","outputId":"9a38bcf9-4791-4f2a-fd26-ea950a9a1dda"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["(5,\n"," array(['BACKGROUND', 'CONCLUSIONS', 'METHODS', 'OBJECTIVE', 'RESULTS'],\n","       dtype=object))"]},"metadata":{},"execution_count":15}],"source":["num_classes = len(label_encoder.classes_)\n","class_names = label_encoder.classes_\n","num_classes, class_names"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"ZGLknSyasKkM"},"outputs":[],"source":["from sklearn.feature_extraction.text import TfidfVectorizer\n","from sklearn.naive_bayes import MultinomialNB\n","from sklearn.pipeline import Pipeline\n","\n","model_0 = Pipeline([\n","  (\"tf-idf\", TfidfVectorizer()),\n","  (\"clf\", MultinomialNB())\n","])\n","\n","model_0.fit(X=train_sentences,\n","            y=train_labels_encoded);"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":518,"status":"ok","timestamp":1702836991162,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"nTEMfFVpsPuq","outputId":"1b62bc13-22ba-4664-bb1b-cccfb489aa07"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["0.7218323844829869"]},"metadata":{},"execution_count":17}],"source":["\n","model_0.score(X=val_sentences,\n","              y=val_labels_encoded)"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":1185,"status":"ok","timestamp":1702822682164,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"mnGdyho-sSNC","outputId":"eecd73f8-d7ed-4357-a007-77caecd31686"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["array([4, 1, 3, ..., 4, 4, 1])"]},"metadata":{},"execution_count":55}],"source":["\n","baseline_preds = model_0.predict(val_sentences)\n","baseline_preds"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":553,"status":"ok","timestamp":1702836991711,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"aNrZVn6LsV_R","outputId":"963a1bd5-c692-4ff5-c962-f88efc685753"},"outputs":[{"output_type":"stream","name":"stdout","text":["--2023-12-17 18:15:54--  https://raw.githubusercontent.com/mrdbourke/tensorflow-deep-learning/main/extras/helper_functions.py\n","Resolving raw.githubusercontent.com (raw.githubusercontent.com)... 185.199.111.133, 185.199.109.133, 185.199.108.133, ...\n","Connecting to raw.githubusercontent.com (raw.githubusercontent.com)|185.199.111.133|:443... connected.\n","HTTP request sent, awaiting response... 200 OK\n","Length: 10246 (10K) [text/plain]\n","Saving to: helper_functions.py\n","\n","helper_functions.py 100%[===================>]  10.01K  --.-KB/s    in 0s      \n","\n","2023-12-17 18:15:54 (82.0 MB/s) - helper_functions.py saved [10246/10246]\n","\n"]}],"source":["\n","!wget https://raw.githubusercontent.com/mrdbourke/tensorflow-deep-learning/main/extras/helper_functions.py"]},{"cell_type":"code","source":["from helper_functions import calculate_results"],"metadata":{"id":"cvkwBmRZsCxE"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":[],"metadata":{"id":"c5OrRwYg_liw"},"execution_count":null,"outputs":[]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":210},"executionInfo":{"elapsed":21574,"status":"error","timestamp":1702822659322,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"xU2tqLRZsXlC","outputId":"a3af6995-9918-4918-ab78-c21674b77588"},"outputs":[{"output_type":"error","ename":"NameError","evalue":"ignored","traceback":["\u001b[0;31m---------------------------------------------------------------------------\u001b[0m","\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)","\u001b[0;32m<ipython-input-51-2e6121bab15f>\u001b[0m in \u001b[0;36m<cell line: 1>\u001b[0;34m()\u001b[0m\n\u001b[1;32m      1\u001b[0m baseline_results = calculate_results(y_true=val_labels_encoded,\n\u001b[0;32m----> 2\u001b[0;31m                                      y_pred=baseline_preds)\n\u001b[0m\u001b[1;32m      3\u001b[0m \u001b[0mbaseline_results\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n","\u001b[0;31mNameError\u001b[0m: name 'baseline_preds' is not defined"]}],"source":["\n","baseline_results = calculate_results(y_true=val_labels_encoded,\n","                                     y_pred=baseline_preds)\n","baseline_results"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"wSBg9voAsX4l"},"outputs":[],"source":["import numpy as np\n","import tensorflow as tf\n","from tensorflow.keras import layers"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":8,"status":"ok","timestamp":1702836994949,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"XA6MXH9KsmF8","outputId":"15a44a1c-339a-4d47-d8d9-5579d14f51a6"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["26.338269273494777"]},"metadata":{},"execution_count":21}],"source":["\n","sent_lens = [len(sentence.split()) for sentence in train_sentences]\n","avg_sent_len = np.mean(sent_lens)\n","avg_sent_len"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":430},"executionInfo":{"elapsed":721,"status":"ok","timestamp":1702836995666,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"bAM8AhxRsnTn","outputId":"22548e9d-df5a-45d9-b605-e720faad23b5"},"outputs":[{"output_type":"display_data","data":{"text/plain":["<Figure size 640x480 with 1 Axes>"],"image/png":"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\n"},"metadata":{}}],"source":["\n","import matplotlib.pyplot as plt\n","plt.hist(sent_lens, bins=7);"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":11,"status":"ok","timestamp":1702836995667,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"Qrl0igAVsooY","outputId":"5560699e-1e39-49be-d3b2-97bbbb617b1f"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["55"]},"metadata":{},"execution_count":23}],"source":["\n","output_seq_len = int(np.percentile(sent_lens, 95))\n","output_seq_len"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":8,"status":"ok","timestamp":1702836995667,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"A7Zd-raksq8M","outputId":"888d2b87-c317-413a-9ea9-b0d3f2aee396"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["296"]},"metadata":{},"execution_count":24}],"source":["\n","max(sent_lens)"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"lJj1K_FUss68"},"outputs":[],"source":["max_tokens = 68000"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"zMgm-6P7svTO"},"outputs":[],"source":["\n","from tensorflow.keras.layers import TextVectorization\n","\n","\n","text_vectorizer = TextVectorization(max_tokens=max_tokens,\n","                                    output_sequence_length=55)"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"UyU6y15yszDj"},"outputs":[],"source":["text_vectorizer.adapt(train_sentences)"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":823,"status":"ok","timestamp":1702837013534,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"aUXU-S89s2lD","outputId":"85bccd3f-a0e0-4595-ca37-ca38afb38001"},"outputs":[{"output_type":"stream","name":"stdout","text":["Text:\n","restenosis was found in @ % ( ds ) , @ % ( cs ) , and @ % ( ps ) , p = @ .\n","\n","Length of text: 27\n","\n","Vectorized text:\n","[[3498   10  208    5 3511 2237    3 1882   14    0    0    0    0    0\n","     0    0    0    0    0    0    0    0    0    0    0    0    0    0\n","     0    0    0    0    0    0    0    0    0    0    0    0    0    0\n","     0    0    0    0    0    0    0    0    0    0    0    0    0]]\n"]}],"source":["\n","import random\n","target_sentence = random.choice(train_sentences)\n","print(f\"Text:\\n{target_sentence}\")\n","print(f\"\\nLength of text: {len(target_sentence.split())}\")\n","print(f\"\\nVectorized text:\\n{text_vectorizer([target_sentence])}\")"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":10,"status":"ok","timestamp":1702837013535,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"0IpOqUWUs3uq","outputId":"e3d60fca-7d7c-41ed-e26e-546bd1985126"},"outputs":[{"output_type":"stream","name":"stdout","text":["Number of words in vocabulary: 64841\n","Most common words in the vocabulary: ['', '[UNK]', 'the', 'and', 'of']\n","Least common words in the vocabulary: ['aainduced', 'aaigroup', 'aachener', 'aachen', 'aaacp']\n"]}],"source":["\n","rct_20k_text_vocab = text_vectorizer.get_vocabulary()\n","print(f\"Number of words in vocabulary: {len(rct_20k_text_vocab)}\"),\n","print(f\"Most common words in the vocabulary: {rct_20k_text_vocab[:5]}\")\n","print(f\"Least common words in the vocabulary: {rct_20k_text_vocab[-5:]}\")"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":8,"status":"ok","timestamp":1702837013535,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"3guVCgSdtkPW","outputId":"4b6befcf-5e63-41df-de13-e62723ea809f"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["{'name': 'text_vectorization',\n"," 'trainable': True,\n"," 'dtype': 'string',\n"," 'batch_input_shape': (None,),\n"," 'max_tokens': 68000,\n"," 'standardize': 'lower_and_strip_punctuation',\n"," 'split': 'whitespace',\n"," 'ngrams': None,\n"," 'output_mode': 'int',\n"," 'output_sequence_length': 55,\n"," 'pad_to_max_tokens': False,\n"," 'sparse': False,\n"," 'ragged': False,\n"," 'vocabulary': None,\n"," 'idf_weights': None,\n"," 'encoding': 'utf-8',\n"," 'vocabulary_size': 64841}"]},"metadata":{},"execution_count":30}],"source":["\n","text_vectorizer.get_config()"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":6,"status":"ok","timestamp":1702837013535,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"EDeeNkrCtkhJ","outputId":"43b294ad-3846-43d1-f976-45a9142ce5c7"},"outputs":[{"output_type":"stream","name":"stdout","text":["Sentence before vectorization:\n","restenosis was found in @ % ( ds ) , @ % ( cs ) , and @ % ( ps ) , p = @ .\n","\n","Sentence after vectorization (before embedding):\n","[[3498   10  208    5 3511 2237    3 1882   14    0    0    0    0    0\n","     0    0    0    0    0    0    0    0    0    0    0    0    0    0\n","     0    0    0    0    0    0    0    0    0    0    0    0    0    0\n","     0    0    0    0    0    0    0    0    0    0    0    0    0]]\n","\n","Sentence after embedding:\n","[[[-0.01605193  0.03333762 -0.04046053 ...  0.04988942 -0.0290791\n","   -0.01775221]\n","  [-0.00478635  0.02883193 -0.03720425 ... -0.03481445  0.00318336\n","    0.04857192]\n","  [-0.01801144 -0.0425665   0.01626723 ... -0.03824117  0.00433068\n","    0.0258874 ]\n","  ...\n","  [ 0.04146823  0.00667425  0.02900393 ... -0.02207282 -0.00337302\n","    0.00079755]\n","  [ 0.04146823  0.00667425  0.02900393 ... -0.02207282 -0.00337302\n","    0.00079755]\n","  [ 0.04146823  0.00667425  0.02900393 ... -0.02207282 -0.00337302\n","    0.00079755]]]\n","\n","Embedded sentence shape: (1, 55, 128)\n"]}],"source":["\n","token_embed = layers.Embedding(input_dim=len(rct_20k_text_vocab), # length of vocabulary\n","                               output_dim=128,\n","                               mask_zero=True,\n","                               name=\"token_embedding\")\n","\n","print(f\"Sentence before vectorization:\\n{target_sentence}\\n\")\n","vectorized_sentence = text_vectorizer([target_sentence])\n","print(f\"Sentence after vectorization (before embedding):\\n{vectorized_sentence}\\n\")\n","embedded_sentence = token_embed(vectorized_sentence)\n","print(f\"Sentence after embedding:\\n{embedded_sentence}\\n\")\n","print(f\"Embedded sentence shape: {embedded_sentence.shape}\")"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":724,"status":"ok","timestamp":1702822734778,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"SfdLy0c6tkvG","outputId":"ffd0f179-97a2-4c66-989a-366d269dda27"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["<_TensorSliceDataset element_spec=(TensorSpec(shape=(), dtype=tf.string, name=None), TensorSpec(shape=(5,), dtype=tf.float64, name=None))>"]},"metadata":{},"execution_count":66}],"source":["\n","train_dataset = tf.data.Dataset.from_tensor_slices((train_sentences, train_labels_one_hot))\n","valid_dataset = tf.data.Dataset.from_tensor_slices((val_sentences, val_labels_one_hot))\n","test_dataset = tf.data.Dataset.from_tensor_slices((test_sentences, test_labels_one_hot))\n","\n","train_dataset"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":11,"status":"ok","timestamp":1702535162675,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"HKRLYNEjtk8a","outputId":"a701153a-154d-4203-d99e-a215b2c37359"},"outputs":[{"data":{"text/plain":["<_PrefetchDataset element_spec=(TensorSpec(shape=(None,), dtype=tf.string, name=None), TensorSpec(shape=(None, 5), dtype=tf.float64, name=None))>"]},"execution_count":35,"metadata":{},"output_type":"execute_result"}],"source":["\n","train_dataset = train_dataset.batch(32).prefetch(tf.data.AUTOTUNE)\n","valid_dataset = valid_dataset.batch(32).prefetch(tf.data.AUTOTUNE)\n","test_dataset = test_dataset.batch(32).prefetch(tf.data.AUTOTUNE)\n","\n","train_dataset"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"e9UUDITbtlaj"},"outputs":[],"source":["\n","inputs = layers.Input(shape=(1,), dtype=tf.string)\n","text_vectors = text_vectorizer(inputs)\n","token_embeddings = token_embed(text_vectors)\n","x = layers.Conv1D(64, kernel_size=5, padding=\"same\", activation=\"relu\")(token_embeddings)\n","x = layers.GlobalAveragePooling1D()(x)\n","outputs = layers.Dense(num_classes, activation=\"softmax\")(x)\n","model_1 = tf.keras.Model(inputs, outputs)\n","\n","\n","model_1.compile(loss=\"categorical_crossentropy\",\n","                optimizer=tf.keras.optimizers.Adam(),\n","                metrics=[\"accuracy\"])"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":678,"status":"ok","timestamp":1702535163345,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"H4qiXd7stlv7","outputId":"abb3a8bc-48c6-42fc-cce4-f05505b01a0f"},"outputs":[{"name":"stdout","output_type":"stream","text":["Model: \"model\"\n","_________________________________________________________________\n"," Layer (type)                Output Shape              Param #   \n","=================================================================\n"," input_1 (InputLayer)        [(None, 1)]               0         \n","                                                                 \n"," text_vectorization (TextVe  (None, 55)                0         \n"," ctorization)                                                    \n","                                                                 \n"," token_embedding (Embedding  (None, 55, 128)           8299648   \n"," )                                                               \n","                                                                 \n"," conv1d (Conv1D)             (None, 55, 64)            41024     \n","                                                                 \n"," global_average_pooling1d (  (None, 64)                0         \n"," GlobalAveragePooling1D)                                         \n","                                                                 \n"," dense (Dense)               (None, 5)                 325       \n","                                                                 \n","=================================================================\n","Total params: 8340997 (31.82 MB)\n","Trainable params: 8340997 (31.82 MB)\n","Non-trainable params: 0 (0.00 Byte)\n","_________________________________________________________________\n"]}],"source":["\n","model_1.summary()"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":302746,"status":"ok","timestamp":1702535466085,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"Gc47lOv7tyd-","outputId":"c16829d2-2b08-4da4-c9b3-5e6d3788db61"},"outputs":[{"name":"stdout","output_type":"stream","text":["Epoch 1/3\n","562/562 [==============================] - 94s 165ms/step - loss: 0.9171 - accuracy: 0.6372 - val_loss: 0.6916 - val_accuracy: 0.7354\n","Epoch 2/3\n","562/562 [==============================] - 109s 195ms/step - loss: 0.6622 - accuracy: 0.7540 - val_loss: 0.6405 - val_accuracy: 0.7670\n","Epoch 3/3\n","562/562 [==============================] - 99s 177ms/step - loss: 0.6209 - accuracy: 0.7726 - val_loss: 0.6000 - val_accuracy: 0.7836\n"]}],"source":["\n","model_1_history = model_1.fit(train_dataset,\n","                              steps_per_epoch=int(0.1 * len(train_dataset)), # only fit on 10% of batches for faster training time\n","                              epochs=3,\n","                              validation_data=valid_dataset,\n","                              validation_steps=int(0.1 * len(valid_dataset))) # only validate on 10% of batches"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":10939,"status":"ok","timestamp":1702535477020,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"nn3eneogt_ZA","outputId":"3dad28ae-592f-49cf-b657-b2b5630cc857"},"outputs":[{"name":"stdout","output_type":"stream","text":["945/945 [==============================] - 11s 11ms/step - loss: 0.6007 - accuracy: 0.7865\n"]},{"data":{"text/plain":["[0.600668728351593, 0.7864755988121033]"]},"execution_count":39,"metadata":{},"output_type":"execute_result"}],"source":["model_1.evaluate(valid_dataset)"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":20940,"status":"ok","timestamp":1702535497955,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"ocaI4-jluA5E","outputId":"16573a69-0cb3-4e2d-9179-d959ee3e4ba9"},"outputs":[{"name":"stdout","output_type":"stream","text":["945/945 [==============================] - 11s 12ms/step\n"]},{"data":{"text/plain":["array([[4.1253862e-01, 1.7920849e-01, 7.8559302e-02, 2.9532060e-01,\n","        3.4372989e-02],\n","       [4.2657551e-01, 2.9865476e-01, 1.2719152e-02, 2.5441894e-01,\n","        7.6316111e-03],\n","       [1.7815009e-01, 1.1646187e-02, 2.5295790e-03, 8.0757922e-01,\n","        9.4861061e-05],\n","       ...,\n","       [6.1067744e-06, 6.8954157e-04, 8.5813523e-04, 4.1722656e-06,\n","        9.9844211e-01],\n","       [6.2577151e-02, 4.7851232e-01, 8.5751794e-02, 6.9911115e-02,\n","        3.0324763e-01],\n","       [1.8182409e-01, 6.5527499e-01, 4.7329005e-02, 5.8738567e-02,\n","        5.6833442e-02]], dtype=float32)"]},"execution_count":40,"metadata":{},"output_type":"execute_result"}],"source":["model_1_pred_probs = model_1.predict(valid_dataset)\n","model_1_pred_probs"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":29,"status":"ok","timestamp":1702535497956,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"rbNUNYPCuC4Z","outputId":"502f2cd3-4b10-4640-9c84-307355ba169c"},"outputs":[{"data":{"text/plain":["<tf.Tensor: shape=(30212,), dtype=int64, numpy=array([0, 0, 3, ..., 4, 1, 1])>"]},"execution_count":41,"metadata":{},"output_type":"execute_result"}],"source":["model_1_preds = tf.argmax(model_1_pred_probs, axis=1)\n","model_1_preds"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":27,"status":"ok","timestamp":1702535497956,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"lVe2J6ibuFnP","outputId":"598a3014-28c4-4d01-e79f-a348affad721"},"outputs":[{"data":{"text/plain":["{'accuracy': 78.64755726201508,\n"," 'precision': 0.7834330093293497,\n"," 'recall': 0.7864755726201509,\n"," 'f1': 0.7840969683885824}"]},"execution_count":42,"metadata":{},"output_type":"execute_result"}],"source":["\n","model_1_results = calculate_results(y_true=val_labels_encoded,\n","                                    y_pred=model_1_preds)\n","model_1_results"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"aqUKl9vYuMRV"},"outputs":[],"source":["\n","import tensorflow_hub as hub\n","tf_hub_embedding_layer = hub.KerasLayer(\"https://tfhub.dev/google/universal-sentence-encoder/4\",\n","                                        trainable=False,\n","                                        name=\"universal_sentence_encoder\")"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":3296,"status":"ok","timestamp":1702837048927,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"vRbtEC59uMgk","outputId":"04601c9b-3c09-4414-b7da-86698d5db316"},"outputs":[{"output_type":"stream","name":"stdout","text":["Random training sentence:\n","clinical pregnancy rates ( @ % vs @ % , p = @ ) and live birth rate ( @ % vs @ % , p = @ ) were higher for ivf than iui .\n","\n","Sentence after embedding:\n","[-0.00246401 -0.07831827  0.00150459  0.05065301  0.00516788 -0.01158448\n","  0.02316272 -0.03510187  0.01307143  0.00969314  0.0715576  -0.03718553\n"," -0.01783448  0.02689575  0.06980332 -0.04028868 -0.07949713 -0.02191518\n"," -0.04167633  0.05213691  0.07546124  0.009282    0.01156439  0.00232409\n","  0.06862163  0.04153307 -0.01117253  0.00983445 -0.04890132 -0.01393146] (truncated output)...\n","\n","Length of sentence embedding:\n","512\n"]}],"source":["\n","random_training_sentence = random.choice(train_sentences)\n","print(f\"Random training sentence:\\n{random_training_sentence}\\n\")\n","use_embedded_sentence = tf_hub_embedding_layer([random_training_sentence])\n","print(f\"Sentence after embedding:\\n{use_embedded_sentence[0][:30]} (truncated output)...\\n\")\n","print(f\"Length of sentence embedding:\\n{len(use_embedded_sentence[0])}\")"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"JaFvE3PzuMzi"},"outputs":[],"source":["\n","inputs = layers.Input(shape=[], dtype=tf.string)\n","pretrained_embedding = tf_hub_embedding_layer(inputs)\n","x = layers.Dense(128, activation=\"relu\")(pretrained_embedding)\n","\n","outputs = layers.Dense(5, activation=\"softmax\")(x)\n","model_2 = tf.keras.Model(inputs=inputs,\n","                        outputs=outputs)\n","\n","\n","model_2.compile(loss=\"categorical_crossentropy\",\n","                optimizer=tf.keras.optimizers.Adam(),\n","                metrics=[\"accuracy\"])"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":11,"status":"ok","timestamp":1702535521773,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"jBz38N3SucnR","outputId":"3c65bd2e-b8b4-41b4-ac54-ddbcbf1bc3fa"},"outputs":[{"name":"stdout","output_type":"stream","text":["Model: \"model_1\"\n","_________________________________________________________________\n"," Layer (type)                Output Shape              Param #   \n","=================================================================\n"," input_2 (InputLayer)        [(None,)]                 0         \n","                                                                 \n"," universal_sentence_encoder  (None, 512)               256797824 \n","  (KerasLayer)                                                   \n","                                                                 \n"," dense_1 (Dense)             (None, 128)               65664     \n","                                                                 \n"," dense_2 (Dense)             (None, 5)                 645       \n","                                                                 \n","=================================================================\n","Total params: 256864133 (979.86 MB)\n","Trainable params: 66309 (259.02 KB)\n","Non-trainable params: 256797824 (979.61 MB)\n","_________________________________________________________________\n"]}],"source":["# Get a summary of the model\n","model_2.summary()"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":49453,"status":"ok","timestamp":1702535571219,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"HrrsF8cr1zSx","outputId":"2195740a-9df1-44d3-e1e0-70eb63abdfa1"},"outputs":[{"name":"stdout","output_type":"stream","text":["Epoch 1/3\n","562/562 [==============================] - 19s 24ms/step - loss: 0.9164 - accuracy: 0.6475 - val_loss: 0.7986 - val_accuracy: 0.6872\n","Epoch 2/3\n","562/562 [==============================] - 15s 26ms/step - loss: 0.7701 - accuracy: 0.7001 - val_loss: 0.7580 - val_accuracy: 0.7028\n","Epoch 3/3\n","562/562 [==============================] - 15s 27ms/step - loss: 0.7548 - accuracy: 0.7111 - val_loss: 0.7435 - val_accuracy: 0.7098\n"]},{"data":{"text/plain":["<keras.src.callbacks.History at 0x7c1afb6f3760>"]},"execution_count":47,"metadata":{},"output_type":"execute_result"}],"source":["\n","model_2.fit(train_dataset,\n","            steps_per_epoch=int(0.1 * len(train_dataset)),\n","            epochs=3,\n","            validation_data=valid_dataset,\n","            validation_steps=int(0.1 * len(valid_dataset)))"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":19387,"status":"ok","timestamp":1702535590600,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"RrtwjcJv10qg","outputId":"3f8f2eb6-5874-4b48-cc7e-8fcb094e65cf"},"outputs":[{"name":"stdout","output_type":"stream","text":["945/945 [==============================] - 19s 20ms/step - loss: 0.7439 - accuracy: 0.7125\n"]},{"data":{"text/plain":["[0.7439358234405518, 0.7124983668327332]"]},"execution_count":48,"metadata":{},"output_type":"execute_result"}],"source":["\n","model_2.evaluate(valid_dataset)"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":22527,"status":"ok","timestamp":1702535613123,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"YW8bCROS139b","outputId":"6694cb5c-b96a-4e8a-d1b0-7a10229b2c35"},"outputs":[{"name":"stdout","output_type":"stream","text":["945/945 [==============================] - 22s 22ms/step\n"]},{"data":{"text/plain":["array([[4.4878930e-01, 3.6391559e-01, 2.4663175e-03, 1.7693824e-01,\n","        7.8906128e-03],\n","       [3.6923346e-01, 5.1012307e-01, 4.4196569e-03, 1.1274433e-01,\n","        3.4794703e-03],\n","       [2.3423009e-01, 1.4710833e-01, 2.2631804e-02, 5.5419934e-01,\n","        4.1830465e-02],\n","       ...,\n","       [1.8648378e-03, 7.2222776e-03, 5.5898897e-02, 8.1489788e-04,\n","        9.3419909e-01],\n","       [3.8543968e-03, 4.5893420e-02, 1.7230040e-01, 1.2615334e-03,\n","        7.7669024e-01],\n","       [1.8938529e-01, 2.1529926e-01, 5.3590930e-01, 6.4962446e-03,\n","        5.2909929e-02]], dtype=float32)"]},"execution_count":49,"metadata":{},"output_type":"execute_result"}],"source":["\n","model_2_pred_probs = model_2.predict(valid_dataset)\n","model_2_pred_probs"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":18,"status":"ok","timestamp":1702535613123,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"llQR1obf16S1","outputId":"ee2b4604-0ff0-46bb-d55a-401c27f19352"},"outputs":[{"data":{"text/plain":["<tf.Tensor: shape=(30212,), dtype=int64, numpy=array([0, 1, 3, ..., 4, 4, 2])>"]},"execution_count":50,"metadata":{},"output_type":"execute_result"}],"source":["\n","model_2_preds = tf.argmax(model_2_pred_probs, axis=1)\n","model_2_preds"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":17,"status":"ok","timestamp":1702535613125,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"pKejY4Jy19TY","outputId":"92d3af78-025a-47c2-86d6-be34eb400253"},"outputs":[{"data":{"text/plain":["{'accuracy': 71.24983450284655,\n"," 'precision': 0.7134725504084458,\n"," 'recall': 0.7124983450284655,\n"," 'f1': 0.7096901823032604}"]},"execution_count":51,"metadata":{},"output_type":"execute_result"}],"source":["model_2_results = calculate_results(y_true=val_labels_encoded,\n","                                    y_pred=model_2_preds)\n","model_2_results"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":140},"executionInfo":{"elapsed":12,"status":"ok","timestamp":1702837048928,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"s3JNbs7M1_ML","outputId":"2831aec3-340b-4d24-a3ce-a0228a7f5648"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["'t o   i n v e s t i g a t e   t h e   e f f i c a c y   o f   @   w e e k s   o f   d a i l y   l o w - d o s e   o r a l   p r e d n i s o l o n e   i n   i m p r o v i n g   p a i n   ,   m o b i l i t y   ,   a n d   s y s t e m i c   l o w - g r a d e   i n f l a m m a t i o n   i n   t h e   s h o r t   t e r m   a n d   w h e t h e r   t h e   e f f e c t   w o u l d   b e   s u s t a i n e d   a t   @   w e e k s   i n   o l d e r   a d u l t s   w i t h   m o d e r a t e   t o   s e v e r e   k n e e   o s t e o a r t h r i t i s   (   o a   )   .'"],"application/vnd.google.colaboratory.intrinsic+json":{"type":"string"}},"metadata":{},"execution_count":34}],"source":["\" \".join(list(train_sentences[0]))"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"DTD8ACqj1_im"},"outputs":[],"source":["def split_chars(text):\n","  return \" \".join(list(text))\n","#split_chars(random_training_sentence)"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":761,"status":"ok","timestamp":1702837049681,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"aZ-4SEvzO-ie","outputId":"787b3e37-f81a-4e72-d0d2-f325d5d79d6b"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["['t h i s   s t u d y   a n a l y z e d   l i v e r   f u n c t i o n   a b n o r m a l i t i e s   i n   h e a r t   f a i l u r e   p a t i e n t s   a d m i t t e d   w i t h   s e v e r e   a c u t e   d e c o m p e n s a t e d   h e a r t   f a i l u r e   (   a d h f   )   .',\n"," 'a   p o s t   h o c   a n a l y s i s   w a s   c o n d u c t e d   w i t h   t h e   u s e   o f   d a t a   f r o m   t h e   e v a l u a t i o n   s t u d y   o f   c o n g e s t i v e   h e a r t   f a i l u r e   a n d   p u l m o n a r y   a r t e r y   c a t h e t e r i z a t i o n   e f f e c t i v e n e s s   (   e s c a p e   )   .']"]},"metadata":{},"execution_count":36}],"source":["train_chars = [split_chars(sentence) for sentence in train_sentences]\n","val_chars = [split_chars(sentence) for sentence in val_sentences]\n","test_chars = [split_chars(sentence) for sentence in test_sentences]\n","test_chars[:2]"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":10,"status":"ok","timestamp":1702837049682,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"O-kDtOO2QxzS","outputId":"e469bf3e-b719-4b05-bd5d-06356dba5a30"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["290"]},"metadata":{},"execution_count":37}],"source":["chars_lens = [len(sentence) for sentence in train_sentences]\n","mean_char_len = np.mean(chars_lens)\n","per95 = int(np.percentile(chars_lens,95))\n","\n","per95"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":7,"status":"ok","timestamp":1702837049682,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"M4vxc31ASOE5","outputId":"15762d78-0ebd-4012-839c-a7e296e8a0e4"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["68"]},"metadata":{},"execution_count":38}],"source":["import string\n","alphabet = string.ascii_lowercase + string.digits + string.punctuation\n","len(alphabet)"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"Xa2gkObLS0IS"},"outputs":[],"source":["numchartok = len(alphabet) + 2 #add 2 for space and out of vocab\n","char_vectorizer = TextVectorization(\n","    max_tokens = numchartok,\n","    output_sequence_length = 290,\n","    #standardize = \"lower_and_strip_punctuation\",\n","    name = \"char_vectorizer\"\n",")"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"OgWO1-kOUMh-"},"outputs":[],"source":["char_vectorizer.adapt(train_chars)"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":30,"status":"ok","timestamp":1702837073493,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"WYtzVi6lURZZ","outputId":"491e4b99-da36-4fcb-81ba-393f26ac0793"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["(28, ['', '[UNK]', 'e', 't', 'i'], ['k', 'x', 'z', 'q', 'j'])"]},"metadata":{},"execution_count":41}],"source":["char_vocab = char_vectorizer.get_vocabulary()\n","len(char_vocab),char_vocab[:5],char_vocab[-5:]\n","\n"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":28,"status":"ok","timestamp":1702837073493,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"3ghayA7mUl7h","outputId":"15923963-d957-4a1e-9476-ba9b9f2f47e2"},"outputs":[{"output_type":"stream","name":"stdout","text":["the text is 455 and it is \n"," g e n e r a l i z e d   e s t i m a t i n g   e q u a t i o n s   w e r e   u s e d   t o   e v a l u a t e   i n d e p e n d e n t   c r o s s - s e c t i o n a l   a s s o c i a t i o n s   o f   c o m p o n e n t   v a r i a b l e s   (   f r o m   a l l   t i m e   p o i n t s   )   w i t h   c o n c u r r e n t   m r i   m e a s u r e s   o f   s y n o v i t i s   a n d   b o n e   e d e m a   i n   t h e   d e v e l o p m e n t   c o h o r t   .,\n"," and the vectorized is 290 and the text is \n"," [[18  2  6  2  8  5 12  4 25  2 10  2  9  3  4 15  5  3  4  6 18  2 26 16\n","   5  3  4  7  6  9 20  2  8  2 16  9  2 10  3  7  2 21  5 12 16  5  3  2\n","   4  6 10  2 14  2  6 10  2  6  3 11  8  7  9  9  9  2 11  3  4  7  6  5\n","  12  5  9  9  7 11  4  5  3  4  7  6  9  7 17 11  7 15 14  7  6  2  6  3\n","  21  5  8  4  5 22 12  2  9 17  8  7 15  5 12 12  3  4 15  2 14  7  4  6\n","   3  9 20  4  3 13 11  7  6 11 16  8  8  2  6  3 15  8  4 15  2  5  9 16\n","   8  2  9  7 17  9 19  6  7 21  4  3  4  9  5  6 10 22  7  6  2  2 10  2\n","  15  5  4  6  3 13  2 10  2 21  2 12  7 14 15  2  6  3 11  7 13  7  8  3\n","   0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0\n","   0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0\n","   0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0\n","   0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0\n","   0  0]]\n"]}],"source":["random_train_chars = random.choice(train_chars)\n","vectorized_chars = char_vectorizer([random_train_chars])\n","print(f\"the text is {len(random_train_chars)} and it is \\n {random_train_chars},\\n and the vectorized is {len(vectorized_chars[0])} and the text is \\n {vectorized_chars}\")"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"oxTx571Ee0C-"},"outputs":[],"source":["char_embed = layers.Embedding(input_dim = len(char_vocab),\n","                              output_dim = 25,\n","                              mask_zero = True,\n","                              name = \"char_embed\")"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":25,"status":"ok","timestamp":1702837073493,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"IcbPmb0igvDT","outputId":"7d5a4d42-c0af-48f7-8866-73beaa4a6f86"},"outputs":[{"output_type":"stream","name":"stdout","text":["text : g e n e r a l i z e d   e s t i m a t i n g   e q u a t i o n s   w e r e   u s e d   t o   e v a l u a t e   i n d e p e n d e n t   c r o s s - s e c t i o n a l   a s s o c i a t i o n s   o f   c o m p o n e n t   v a r i a b l e s   (   f r o m   a l l   t i m e   p o i n t s   )   w i t h   c o n c u r r e n t   m r i   m e a s u r e s   o f   s y n o v i t i s   a n d   b o n e   e d e m a   i n   t h e   d e v e l o p m e n t   c o h o r t   .\n","embed chars:\n"," [[[-0.00399848  0.02396255 -0.02571292 ... -0.04637727 -0.00765041\n","   -0.02732288]\n","  [ 0.00618453  0.02872049 -0.01179587 ... -0.02976826  0.02176608\n","    0.03713354]\n","  [ 0.01507879 -0.0276655  -0.04490795 ...  0.0008821  -0.01670107\n","   -0.04269934]\n","  ...\n","  [-0.02208297 -0.01990563 -0.04530763 ...  0.01482641  0.02505099\n","   -0.04581651]\n","  [-0.02208297 -0.01990563 -0.04530763 ...  0.01482641  0.02505099\n","   -0.04581651]\n","  [-0.02208297 -0.01990563 -0.04530763 ...  0.01482641  0.02505099\n","   -0.04581651]]]\n","(1, 290, 25)\n"]}],"source":["print(f\"text : {random_train_chars}\")\n","char_embed_example = char_embed(char_vectorizer([random_train_chars]))\n","print(f\"embed chars:\\n {char_embed_example}\")\n","print(char_embed_example.shape)"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"V2tWGIYOh26h"},"outputs":[],"source":["\n","inputs = layers.Input(shape=[1,], dtype=tf.string)\n","char_vectors=char_vectorizer(inputs)\n","char_embeddings = char_embed(char_vectors)\n","\n","x = layers.Conv1D(64,kernel_size=5,padding=\"same\", activation=\"relu\")(char_embeddings)\n","x = layers.GlobalMaxPooling1D()(x)\n","outputs = layers.Dense(5, activation=\"softmax\")(x)\n","model_3 = tf.keras.Model(inputs=inputs,\n","                        outputs=outputs,\n","                         name = \"model_3_conv_char\")\n","\n","model_3.compile(loss=\"categorical_crossentropy\",\n","                optimizer=tf.keras.optimizers.Adam(),\n","                metrics=[\"accuracy\"])"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":351,"status":"ok","timestamp":1702535666261,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"eyCGnMzznZPH","outputId":"460d87de-6ddf-4305-ce55-7178c8b1b19e"},"outputs":[{"name":"stdout","output_type":"stream","text":["Model: \"model_3_conv_char\"\n","_________________________________________________________________\n"," Layer (type)                Output Shape              Param #   \n","=================================================================\n"," input_3 (InputLayer)        [(None, 1)]               0         \n","                                                                 \n"," char_vectorizer (TextVecto  (None, 290)               0         \n"," rization)                                                       \n","                                                                 \n"," char_embed (Embedding)      (None, 290, 25)           700       \n","                                                                 \n"," conv1d_1 (Conv1D)           (None, 290, 64)           8064      \n","                                                                 \n"," global_max_pooling1d (Glob  (None, 64)                0         \n"," alMaxPooling1D)                                                 \n","                                                                 \n"," dense_3 (Dense)             (None, 5)                 325       \n","                                                                 \n","=================================================================\n","Total params: 9089 (35.50 KB)\n","Trainable params: 9089 (35.50 KB)\n","Non-trainable params: 0 (0.00 Byte)\n","_________________________________________________________________\n"]}],"source":["model_3.summary()"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":3325,"status":"ok","timestamp":1702535669583,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"Zl00GelgnqKu","outputId":"371bf115-f840-4ec5-e40c-9cb79fa7c4c7"},"outputs":[{"data":{"text/plain":["<_PrefetchDataset element_spec=(TensorSpec(shape=(None,), dtype=tf.string, name=None), TensorSpec(shape=(None, 5), dtype=tf.float64, name=None))>"]},"execution_count":65,"metadata":{},"output_type":"execute_result"}],"source":["train_char_dataset = tf.data.Dataset.from_tensor_slices((train_chars, train_labels_one_hot)).batch(32).prefetch(tf.data.AUTOTUNE)\n","val_char_dataset = tf.data.Dataset.from_tensor_slices((val_chars, val_labels_one_hot)).batch(32).prefetch(tf.data.AUTOTUNE)\n","test_char_dataset = tf.data.Dataset.from_tensor_slices((test_chars, test_labels_one_hot)).batch(32).prefetch(tf.data.AUTOTUNE)\n","\n","train_char_dataset"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":428195,"status":"ok","timestamp":1702536097768,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"ghd3UI8ooB_E","outputId":"3d3edd81-ccf4-4423-ac73-438f7cf9e412"},"outputs":[{"name":"stdout","output_type":"stream","text":["Epoch 1/3\n","5627/5627 [==============================] - 145s 25ms/step - loss: 0.8987 - accuracy: 0.6489 - val_loss: 0.7755 - val_accuracy: 0.6995\n","Epoch 2/3\n","5627/5627 [==============================] - 119s 21ms/step - loss: 0.7466 - accuracy: 0.7144 - val_loss: 0.7436 - val_accuracy: 0.7164\n","Epoch 3/3\n","5627/5627 [==============================] - 122s 22ms/step - loss: 0.7152 - accuracy: 0.7275 - val_loss: 0.7307 - val_accuracy: 0.7158\n"]}],"source":["model_3_history = model_3.fit(train_char_dataset,\n","                              steps_per_epoch = int(len(train_char_dataset)),\n","                              epochs = 3,\n","                              validation_data = val_char_dataset,\n","                              validation_steps = int(0.1*len(val_char_dataset)))"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":8073,"status":"ok","timestamp":1702536105818,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"tk0dwMowo2TU","outputId":"b55e0efb-f068-4517-eb40-7e176c67b80c"},"outputs":[{"name":"stdout","output_type":"stream","text":["945/945 [==============================] - 8s 8ms/step\n"]},{"data":{"text/plain":["array([[3.4862921e-01, 4.0264904e-01, 3.9928049e-02, 1.7883959e-01,\n","        2.9954020e-02],\n","       [2.2090669e-01, 6.5660423e-01, 9.9024887e-04, 1.1687723e-01,\n","        4.6214531e-03],\n","       [4.1404510e-01, 1.5209354e-01, 4.9345039e-02, 3.2113174e-01,\n","        6.3384451e-02],\n","       ...,\n","       [1.8382572e-03, 1.9145600e-03, 9.7255111e-03, 4.2650709e-04,\n","        9.8609519e-01],\n","       [6.7387052e-02, 1.8473858e-01, 2.6694208e-01, 2.8115686e-02,\n","        4.5281661e-01],\n","       [5.5763453e-02, 8.9969331e-01, 1.8934984e-02, 6.0750032e-03,\n","        1.9533344e-02]], dtype=float32)"]},"execution_count":67,"metadata":{},"output_type":"execute_result"}],"source":["model_3_pred_probs = model_3.predict(val_char_dataset)\n","model_3_pred_probs"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":30,"status":"ok","timestamp":1702536105819,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"xfYyxkjMpyDG","outputId":"7c1bd2c2-1710-4b29-d12e-e5790a89adc1"},"outputs":[{"data":{"text/plain":["30212"]},"execution_count":68,"metadata":{},"output_type":"execute_result"}],"source":["len(model_3_pred_probs)"]},{"cell_type":"markdown","metadata":{"id":"jQ54ZmXXABkb"},"source":["#combining pretained token embeddings + character embedding layer"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"ifEEfrZcABIR","colab":{"base_uri":"https://localhost:8080/","height":245},"executionInfo":{"status":"error","timestamp":1702613937252,"user_tz":-180,"elapsed":362,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"37ff3885-b848-4296-800b-1a473d5c6a3f"},"outputs":[{"output_type":"error","ename":"NameError","evalue":"ignored","traceback":["\u001b[0;31m---------------------------------------------------------------------------\u001b[0m","\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)","\u001b[0;32m<ipython-input-31-7885f1375e0c>\u001b[0m in \u001b[0;36m<cell line: 2>\u001b[0;34m()\u001b[0m\n\u001b[1;32m      1\u001b[0m \u001b[0mtoken_inputs\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mlayers\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mInput\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mshape\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mdtype\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mtf\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mstring\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mname\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;34m\"token_input\"\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m----> 2\u001b[0;31m \u001b[0mtoken_embeddings\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mtf_hub_embedding_layer\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mtoken_inputs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m      3\u001b[0m \u001b[0mtoken_output\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mlayers\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mDense\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;36m128\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mactivation\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;34m\"relu\"\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mtoken_embeddings\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      4\u001b[0m token_model = tf.keras.Model(inputs=token_inputs,\n\u001b[1;32m      5\u001b[0m                              outputs=token_output)\n","\u001b[0;31mNameError\u001b[0m: name 'tf_hub_embedding_layer' is not defined"]}],"source":["\n","token_inputs = layers.Input(shape=[], dtype=tf.string, name=\"token_input\")\n","token_embeddings = tf_hub_embedding_layer(token_inputs)\n","token_output = layers.Dense(128, activation=\"relu\")(token_embeddings)\n","token_model = tf.keras.Model(inputs=token_inputs,\n","                             outputs=token_output)\n","\n","char_inputs = layers.Input(shape=(1,), dtype=tf.string, name=\"char_input\")\n","char_vectors = char_vectorizer(char_inputs)\n","char_embeddings = char_embed(char_vectors)\n","char_bi_lstm = layers.Bidirectional(layers.LSTM(25))(char_embeddings)\n","char_model = tf.keras.Model(inputs=char_inputs,\n","                            outputs=char_bi_lstm)\n","\n","token_char_concat = layers.Concatenate(name=\"token_char_hybrid\")([token_model.output,\n","                                                                  char_model.output])\n","\n","combined_dropout = layers.Dropout(0.5)(token_char_concat)\n","combined_dense = layers.Dense(200, activation=\"relu\")(combined_dropout)\n","final_dropout = layers.Dropout(0.5)(combined_dense)\n","output_layer = layers.Dense(num_classes, activation=\"softmax\")(final_dropout)\n","\n","model_4 = tf.keras.Model(inputs=[token_model.input, char_model.input],\n","                         outputs=output_layer,\n","                         name=\"model_4_token_and_char_embeddings\")"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":590,"status":"ok","timestamp":1702536340234,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"2jeu37bWEmmu","outputId":"be97bbd3-1e60-4f4b-dd90-1775601dd0b9"},"outputs":[{"name":"stdout","output_type":"stream","text":["Model: \"model_4_token_and_char_embeddings\"\n","__________________________________________________________________________________________________\n"," Layer (type)                Output Shape                 Param #   Connected to                  \n","==================================================================================================\n"," char_input (InputLayer)     [(None, 1)]                  0         []                            \n","                                                                                                  \n"," token_input (InputLayer)    [(None,)]                    0         []                            \n","                                                                                                  \n"," char_vectorizer (TextVecto  (None, 290)                  0         ['char_input[0][0]']          \n"," rization)                                                                                        \n","                                                                                                  \n"," universal_sentence_encoder  (None, 512)                  2567978   ['token_input[0][0]']         \n","  (KerasLayer)                                            24                                      \n","                                                                                                  \n"," char_embed (Embedding)      (None, 290, 25)              700       ['char_vectorizer[1][0]']     \n","                                                                                                  \n"," dense_4 (Dense)             (None, 128)                  65664     ['universal_sentence_encoder[1\n","                                                                    ][0]']                        \n","                                                                                                  \n"," bidirectional (Bidirection  (None, 50)                   10200     ['char_embed[1][0]']          \n"," al)                                                                                              \n","                                                                                                  \n"," token_char_hybrid (Concate  (None, 178)                  0         ['dense_4[0][0]',             \n"," nate)                                                               'bidirectional[0][0]']       \n","                                                                                                  \n"," dropout (Dropout)           (None, 178)                  0         ['token_char_hybrid[0][0]']   \n","                                                                                                  \n"," dense_5 (Dense)             (None, 200)                  35800     ['dropout[0][0]']             \n","                                                                                                  \n"," dropout_1 (Dropout)         (None, 200)                  0         ['dense_5[0][0]']             \n","                                                                                                  \n"," dense_6 (Dense)             (None, 5)                    1005      ['dropout_1[0][0]']           \n","                                                                                                  \n","==================================================================================================\n","Total params: 256911193 (980.04 MB)\n","Trainable params: 113369 (442.85 KB)\n","Non-trainable params: 256797824 (979.61 MB)\n","__________________________________________________________________________________________________\n"]}],"source":["model_4.summary()"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":856},"executionInfo":{"elapsed":992,"status":"ok","timestamp":1702536405217,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"DTCh08YSEtxB","outputId":"edc27f6a-a660-4c06-f8ab-cff82b62f778"},"outputs":[{"data":{"image/png":"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\n","text/plain":["<IPython.core.display.Image object>"]},"execution_count":72,"metadata":{},"output_type":"execute_result"}],"source":["# Plot hybrid token and character model\n","from tensorflow.keras.utils import plot_model\n","plot_model(model_4)"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"a3siJKqcE9ko"},"outputs":[],"source":["model_4.compile(loss = \"categorical_crossentropy\",\n","                optimizer = tf.keras.optimizers.Adam(),\n","                metrics = [\"accuracy\"])"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"aYoOAnXrF3Uk","colab":{"base_uri":"https://localhost:8080/","height":245},"executionInfo":{"status":"error","timestamp":1702614214709,"user_tz":-180,"elapsed":558,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"00fb4010-f8b9-4580-98b8-93fb01e34e57"},"outputs":[{"output_type":"error","ename":"NameError","evalue":"ignored","traceback":["\u001b[0;31m---------------------------------------------------------------------------\u001b[0m","\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)","\u001b[0;32m<ipython-input-47-df0d8912afaf>\u001b[0m in \u001b[0;36m<cell line: 1>\u001b[0;34m()\u001b[0m\n\u001b[0;32m----> 1\u001b[0;31m \u001b[0mtrain_char_token_data\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mtf\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mdata\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mDataset\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mfrom_tensor_slices\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mtrain_sentences\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mtrain_chars\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m      2\u001b[0m \u001b[0mtrain_char_token_labels\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mtf\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mdata\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mDataset\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mfrom_tensor_slices\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mtrain_labels_one_hot\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      3\u001b[0m \u001b[0mtrain_char_token_dataset\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mtf\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mdata\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mDataset\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mzip\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mtrain_char_token_data\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mtrain_char_token_labels\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      4\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      5\u001b[0m \u001b[0mtrain_char_token_dataset\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mtrain_char_token_dataset\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mbatch\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;36m32\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mprefetch\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mtf\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mdata\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mAUTOTUNE\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n","\u001b[0;31mNameError\u001b[0m: name 'train_chars' is not defined"]}],"source":["\n","train_char_token_data = tf.data.Dataset.from_tensor_slices((train_sentences, train_chars))\n","train_char_token_labels = tf.data.Dataset.from_tensor_slices(train_labels_one_hot)\n","train_char_token_dataset = tf.data.Dataset.zip((train_char_token_data, train_char_token_labels))\n","\n","train_char_token_dataset = train_char_token_dataset.batch(32).prefetch(tf.data.AUTOTUNE)\n","\n","val_char_token_data = tf.data.Dataset.from_tensor_slices((val_sentences, val_chars))\n","val_char_token_labels = tf.data.Dataset.from_tensor_slices(val_labels_one_hot)\n","val_char_token_dataset = tf.data.Dataset.zip((val_char_token_data, val_char_token_labels))\n","val_char_token_dataset = val_char_token_dataset.batch(32).prefetch(tf.data.AUTOTUNE)"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":1888372,"status":"ok","timestamp":1702540108000,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"qBptp02nGbEz","outputId":"c9c668fe-5074-4156-f31d-c998bb17af5e"},"outputs":[{"name":"stdout","output_type":"stream","text":["Epoch 1/10\n","562/562 [==============================] - 188s 334ms/step - loss: 0.7374 - accuracy: 0.7206 - val_loss: 0.6675 - val_accuracy: 0.7457\n","Epoch 2/10\n","562/562 [==============================] - 189s 336ms/step - loss: 0.7071 - accuracy: 0.7286 - val_loss: 0.6462 - val_accuracy: 0.7566\n","Epoch 3/10\n","562/562 [==============================] - 183s 326ms/step - loss: 0.7072 - accuracy: 0.7296 - val_loss: 0.6422 - val_accuracy: 0.7573\n","Epoch 4/10\n","562/562 [==============================] - 185s 330ms/step - loss: 0.7046 - accuracy: 0.7359 - val_loss: 0.6362 - val_accuracy: 0.7570\n","Epoch 5/10\n","562/562 [==============================] - 185s 330ms/step - loss: 0.7113 - accuracy: 0.7262 - val_loss: 0.6221 - val_accuracy: 0.7646\n","Epoch 6/10\n","562/562 [==============================] - 190s 338ms/step - loss: 0.7194 - accuracy: 0.7237 - val_loss: 0.6242 - val_accuracy: 0.7696\n","Epoch 7/10\n","562/562 [==============================] - 195s 347ms/step - loss: 0.6908 - accuracy: 0.7378 - val_loss: 0.6120 - val_accuracy: 0.7749\n","Epoch 8/10\n","562/562 [==============================] - 186s 331ms/step - loss: 0.6802 - accuracy: 0.7441 - val_loss: 0.6056 - val_accuracy: 0.7716\n","Epoch 9/10\n","562/562 [==============================] - 191s 339ms/step - loss: 0.6806 - accuracy: 0.7414 - val_loss: 0.6089 - val_accuracy: 0.7719\n","Epoch 10/10\n","562/562 [==============================] - 196s 349ms/step - loss: 0.6824 - accuracy: 0.7423 - val_loss: 0.5992 - val_accuracy: 0.7743\n"]}],"source":["model_4_history = model_4.fit(train_char_token_dataset,\n","                              steps_per_epoch=int(0.1 * len(train_char_token_dataset)),\n","                              epochs=10,\n","                              validation_data=val_char_token_dataset,\n","                              validation_steps=int(0.1 * len(val_char_token_dataset)))"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"Ll8LKtquTO82"},"outputs":[],"source":["\n","train_line_numbers_one_hot = tf.one_hot(train_df[\"line_number\"].to_numpy(), depth=15)\n","val_line_numbers_one_hot = tf.one_hot(val_df[\"line_number\"].to_numpy(), depth=15)\n","test_line_numbers_one_hot = tf.one_hot(test_df[\"line_number\"].to_numpy(), depth=15)"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":14,"status":"ok","timestamp":1702837074077,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"IgXMAxJYQWy1","outputId":"b348981c-e017-4e94-abf9-660230363e51"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["(TensorShape([180040, 20]),\n"," <tf.Tensor: shape=(10, 20), dtype=float32, numpy=\n"," array([[0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0.,\n","         0., 0., 0., 0.],\n","        [0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0.,\n","         0., 0., 0., 0.],\n","        [0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0.,\n","         0., 0., 0., 0.],\n","        [0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0.,\n","         0., 0., 0., 0.],\n","        [0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0.,\n","         0., 0., 0., 0.],\n","        [0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0.,\n","         0., 0., 0., 0.],\n","        [0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0.,\n","         0., 0., 0., 0.],\n","        [0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0.,\n","         0., 0., 0., 0.],\n","        [0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0.,\n","         0., 0., 0., 0.],\n","        [0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0.,\n","         0., 0., 0., 0.]], dtype=float32)>)"]},"metadata":{},"execution_count":47}],"source":["train_total_lines_one_hot = tf.one_hot(train_df[\"total_lines\"].to_numpy(), depth=20)\n","val_total_lines_one_hot = tf.one_hot(val_df[\"total_lines\"].to_numpy(), depth=20)\n","test_total_lines_one_hot = tf.one_hot(test_df[\"total_lines\"].to_numpy(), depth=20)\n","\n","train_total_lines_one_hot.shape, train_total_lines_one_hot[:10]"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"jMZ9b5adQbkq"},"outputs":[],"source":["\n","token_inputs = layers.Input(shape=[], dtype=\"string\", name=\"token_inputs\")\n","token_embeddings = tf_hub_embedding_layer(token_inputs)\n","token_outputs = layers.Dense(128, activation=\"relu\")(token_embeddings)\n","token_model = tf.keras.Model(inputs=token_inputs,\n","                             outputs=token_outputs)\n","\n","char_inputs = layers.Input(shape=(1,), dtype=\"string\", name=\"char_inputs\")\n","char_vectors = char_vectorizer(char_inputs)\n","char_embeddings = char_embed(char_vectors)\n","char_bi_lstm = layers.Bidirectional(layers.LSTM(32))(char_embeddings)\n","char_model = tf.keras.Model(inputs=char_inputs,\n","                            outputs=char_bi_lstm)\n","\n","line_number_inputs = layers.Input(shape=(15,), dtype=tf.int32, name=\"line_number_input\")\n","x = layers.Dense(32, activation=\"relu\")(line_number_inputs)\n","line_number_model = tf.keras.Model(inputs=line_number_inputs,\n","                                   outputs=x)\n","\n","total_lines_inputs = layers.Input(shape=(20,), dtype=tf.int32, name=\"total_lines_input\")\n","y = layers.Dense(32, activation=\"relu\")(total_lines_inputs)\n","total_line_model = tf.keras.Model(inputs=total_lines_inputs,\n","                                  outputs=y)\n","\n","combined_embeddings = layers.Concatenate(name=\"token_char_hybrid_embedding\")([token_model.output,\n","                                                                              char_model.output])\n","z = layers.Dense(256, activation=\"relu\")(combined_embeddings)\n","z = layers.Dropout(0.5)(z)\n","\n","z = layers.Concatenate(name=\"token_char_positional_embedding\")([line_number_model.output,\n","                                                                total_line_model.output,\n","                                                                z])\n","\n","output_layer = layers.Dense(5, activation=\"softmax\", name=\"output_layer\")(z)\n","\n","model_5 = tf.keras.Model(inputs=[line_number_model.input,\n","                                 total_line_model.input,\n","                                 token_model.input,\n","                                 char_model.input],\n","                         outputs=output_layer)"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":776,"status":"ok","timestamp":1702837080018,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"XfdQnwq5Sts8","outputId":"f6e082e3-d74b-440d-a8c9-df88ca763d98"},"outputs":[{"output_type":"stream","name":"stdout","text":["Model: \"model_4\"\n","__________________________________________________________________________________________________\n"," Layer (type)                Output Shape                 Param #   Connected to                  \n","==================================================================================================\n"," char_inputs (InputLayer)    [(None, 1)]                  0         []                            \n","                                                                                                  \n"," token_inputs (InputLayer)   [(None,)]                    0         []                            \n","                                                                                                  \n"," char_vectorizer (TextVecto  (None, 290)                  0         ['char_inputs[0][0]']         \n"," rization)                                                                                        \n","                                                                                                  \n"," universal_sentence_encoder  (None, 512)                  2567978   ['token_inputs[0][0]']        \n","  (KerasLayer)                                            24                                      \n","                                                                                                  \n"," char_embed (Embedding)      (None, 290, 25)              700       ['char_vectorizer[1][0]']     \n","                                                                                                  \n"," dense_1 (Dense)             (None, 128)                  65664     ['universal_sentence_encoder[0\n","                                                                    ][0]']                        \n","                                                                                                  \n"," bidirectional (Bidirection  (None, 64)                   14848     ['char_embed[1][0]']          \n"," al)                                                                                              \n","                                                                                                  \n"," token_char_hybrid_embeddin  (None, 192)                  0         ['dense_1[0][0]',             \n"," g (Concatenate)                                                     'bidirectional[0][0]']       \n","                                                                                                  \n"," line_number_input (InputLa  [(None, 15)]                 0         []                            \n"," yer)                                                                                             \n","                                                                                                  \n"," total_lines_input (InputLa  [(None, 20)]                 0         []                            \n"," yer)                                                                                             \n","                                                                                                  \n"," dense_4 (Dense)             (None, 256)                  49408     ['token_char_hybrid_embedding[\n","                                                                    0][0]']                       \n","                                                                                                  \n"," dense_2 (Dense)             (None, 32)                   512       ['line_number_input[0][0]']   \n","                                                                                                  \n"," dense_3 (Dense)             (None, 32)                   672       ['total_lines_input[0][0]']   \n","                                                                                                  \n"," dropout (Dropout)           (None, 256)                  0         ['dense_4[0][0]']             \n","                                                                                                  \n"," token_char_positional_embe  (None, 320)                  0         ['dense_2[0][0]',             \n"," dding (Concatenate)                                                 'dense_3[0][0]',             \n","                                                                     'dropout[0][0]']             \n","                                                                                                  \n"," output_layer (Dense)        (None, 5)                    1605      ['token_char_positional_embedd\n","                                                                    ing[0][0]']                   \n","                                                                                                  \n","==================================================================================================\n","Total params: 256931233 (980.11 MB)\n","Trainable params: 133409 (521.13 KB)\n","Non-trainable params: 256797824 (979.61 MB)\n","__________________________________________________________________________________________________\n"]}],"source":["model_5.summary()"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":577},"executionInfo":{"elapsed":984,"status":"ok","timestamp":1702837080999,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"AsFn37EcSwa2","outputId":"2f314897-c700-4a94-9de0-05f982de617e"},"outputs":[{"output_type":"execute_result","data":{"image/png":"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\n","text/plain":["<IPython.core.display.Image object>"]},"metadata":{},"execution_count":50}],"source":["from tensorflow.keras.utils import plot_model\n","plot_model(model_5)\n"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"0vadiQS_XQ1Q"},"outputs":[],"source":["\n","model_5.compile(loss=tf.keras.losses.CategoricalCrossentropy(label_smoothing=0.2), # add label smoothing (examples which are really confident get smoothed a little)\n","                optimizer=tf.keras.optimizers.Adam(),\n","                metrics=[\"accuracy\"])"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":1990,"status":"ok","timestamp":1702837082983,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"u1J9-QKATQJY","outputId":"1fa8fcf1-3357-476d-de42-e8cc09bfe65d"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["(<_PrefetchDataset element_spec=((TensorSpec(shape=(None, 15), dtype=tf.float32, name=None), TensorSpec(shape=(None, 20), dtype=tf.float32, name=None), TensorSpec(shape=(None,), dtype=tf.string, name=None), TensorSpec(shape=(None,), dtype=tf.string, name=None)), TensorSpec(shape=(None, 5), dtype=tf.float64, name=None))>,\n"," <_PrefetchDataset element_spec=((TensorSpec(shape=(None, 15), dtype=tf.float32, name=None), TensorSpec(shape=(None, 20), dtype=tf.float32, name=None), TensorSpec(shape=(None,), dtype=tf.string, name=None), TensorSpec(shape=(None,), dtype=tf.string, name=None)), TensorSpec(shape=(None, 5), dtype=tf.float64, name=None))>)"]},"metadata":{},"execution_count":52}],"source":["train_pos_char_token_data = tf.data.Dataset.from_tensor_slices((train_line_numbers_one_hot,\n","                                                                train_total_lines_one_hot,\n","                                                                train_sentences,\n","                                                                train_chars))\n","train_pos_char_token_labels = tf.data.Dataset.from_tensor_slices(train_labels_one_hot)\n","train_pos_char_token_dataset = tf.data.Dataset.zip((train_pos_char_token_data, train_pos_char_token_labels))\n","train_pos_char_token_dataset = train_pos_char_token_dataset.batch(32).prefetch(tf.data.AUTOTUNE)\n","\n","val_pos_char_token_data = tf.data.Dataset.from_tensor_slices((val_line_numbers_one_hot,\n","                                                              val_total_lines_one_hot,\n","                                                              val_sentences,\n","                                                              val_chars))\n","val_pos_char_token_labels = tf.data.Dataset.from_tensor_slices(val_labels_one_hot)\n","val_pos_char_token_dataset = tf.data.Dataset.zip((val_pos_char_token_data, val_pos_char_token_labels))\n","val_pos_char_token_dataset = val_pos_char_token_dataset.batch(32).prefetch(tf.data.AUTOTUNE)\n","\n","train_pos_char_token_dataset, val_pos_char_token_dataset"]},{"cell_type":"code","source":["early_stopping = tf.keras.callbacks.EarlyStopping(monitor=\"val_loss\",\n","                                                  verbose = 1,\n","                                                  patience=3)\n","\n","\n","checkpoint_path = \"/content/drive/Othercomputers/My Laptop/code/MacDeepL/Skim-lit/basicbasiccheckpoints\"\n","model_checkpoint = tf.keras.callbacks.ModelCheckpoint(checkpoint_path,\n","                                                      verbose = 1,\n","                                                      save_best_only=True,\n","                                                      monitor=\"val_loss\")"],"metadata":{"id":"xfg0-z_evOCi"},"execution_count":null,"outputs":[]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"0_frL5s2Xc2u","outputId":"0d19bd53-d7d7-4110-d5e0-e1b63861d7e0","executionInfo":{"status":"ok","timestamp":1702839887704,"user_tz":-180,"elapsed":2450684,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}}},"outputs":[{"output_type":"stream","name":"stdout","text":["Epoch 1/20\n","5626/5627 [============================>.] - ETA: 0s - loss: 0.9092 - accuracy: 0.8538\n","Epoch 1: val_loss improved from inf to 0.90259, saving model to /content/drive/Othercomputers/My Laptop/code/MacDeepL/Skim-lit/basicbasiccheckpoints\n","5627/5627 [==============================] - 286s 51ms/step - loss: 0.9092 - accuracy: 0.8538 - val_loss: 0.9026 - val_accuracy: 0.8534\n","Epoch 2/20\n","5627/5627 [==============================] - ETA: 0s - loss: 0.8968 - accuracy: 0.8626\n","Epoch 2: val_loss did not improve from 0.90259\n","5627/5627 [==============================] - 266s 47ms/step - loss: 0.8968 - accuracy: 0.8626 - val_loss: 0.9032 - val_accuracy: 0.8521\n","Epoch 3/20\n","5627/5627 [==============================] - ETA: 0s - loss: 0.8882 - accuracy: 0.8692\n","Epoch 3: val_loss improved from 0.90259 to 0.90066, saving model to /content/drive/Othercomputers/My Laptop/code/MacDeepL/Skim-lit/basicbasiccheckpoints\n","5627/5627 [==============================] - 321s 57ms/step - loss: 0.8882 - accuracy: 0.8692 - val_loss: 0.9007 - val_accuracy: 0.8570\n","Epoch 4/20\n","5627/5627 [==============================] - ETA: 0s - loss: 0.8816 - accuracy: 0.8740\n","Epoch 4: val_loss improved from 0.90066 to 0.90042, saving model to /content/drive/Othercomputers/My Laptop/code/MacDeepL/Skim-lit/basicbasiccheckpoints\n","5627/5627 [==============================] - 292s 52ms/step - loss: 0.8816 - accuracy: 0.8740 - val_loss: 0.9004 - val_accuracy: 0.8544\n","Epoch 5/20\n","5627/5627 [==============================] - ETA: 0s - loss: 0.8763 - accuracy: 0.8788\n","Epoch 5: val_loss improved from 0.90042 to 0.90031, saving model to /content/drive/Othercomputers/My Laptop/code/MacDeepL/Skim-lit/basicbasiccheckpoints\n","5627/5627 [==============================] - 297s 53ms/step - loss: 0.8763 - accuracy: 0.8788 - val_loss: 0.9003 - val_accuracy: 0.8580\n","Epoch 6/20\n","5627/5627 [==============================] - ETA: 0s - loss: 0.8715 - accuracy: 0.8823\n","Epoch 6: val_loss did not improve from 0.90031\n","5627/5627 [==============================] - 263s 47ms/step - loss: 0.8715 - accuracy: 0.8823 - val_loss: 0.9028 - val_accuracy: 0.8574\n","Epoch 7/20\n","5627/5627 [==============================] - ETA: 0s - loss: 0.8670 - accuracy: 0.8858\n","Epoch 7: val_loss did not improve from 0.90031\n","5627/5627 [==============================] - 258s 46ms/step - loss: 0.8670 - accuracy: 0.8858 - val_loss: 0.9012 - val_accuracy: 0.8551\n","Epoch 8/20\n","5627/5627 [==============================] - ETA: 0s - loss: 0.8631 - accuracy: 0.8887\n","Epoch 8: val_loss did not improve from 0.90031\n","5627/5627 [==============================] - 257s 46ms/step - loss: 0.8631 - accuracy: 0.8887 - val_loss: 0.9022 - val_accuracy: 0.8564\n","Epoch 8: early stopping\n"]}],"source":["\n","history_model_5 = model_5.fit(train_pos_char_token_dataset,\n","                              steps_per_epoch=int( len(train_pos_char_token_dataset)),\n","                              epochs=20,\n","                              validation_data=val_pos_char_token_dataset,\n","                              validation_steps=int(0.1 * len(val_pos_char_token_dataset)),\n","                              callbacks=[model_checkpoint,\n","                                         early_stopping])"]},{"cell_type":"code","source":["basemodel = tf.keras.Model(inputs=[line_number_model.input,\n","                                 total_line_model.input,\n","                                 token_model.input,\n","                                 char_model.input],\n","                         outputs=output_layer)"],"metadata":{"id":"RQerZzTZL2Ge"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["basemodel.load_weights(checkpoint_path)"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"lLwd-l1iLant","executionInfo":{"status":"ok","timestamp":1702839894914,"user_tz":-180,"elapsed":7213,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"234b8955-4bfb-4257-966b-72b90088885a"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["<tensorflow.python.checkpoint.checkpoint.CheckpointLoadStatus at 0x798346af4f40>"]},"metadata":{},"execution_count":58}]},{"cell_type":"code","source":["dire  = \"/content/drive/Othercomputers/My Laptop/code/MacDeepL/Skim-lit\"\n","#from tensorflow.keras.Model import save\n","model_5.save('/content/drive/Othercomputers/My Laptop/code/MacDeepL/Skim-lit/perkeras.keras')"],"metadata":{"id":"_S11gXK4Ei40"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["model_5.save('/content/drive/Othercomputers/My Laptop/code/MacDeepL/Skim-lit/nmodelmain')"],"metadata":{"id":"VT4V5JYKEihJ"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["model_5.save('/content/drive/Othercomputers/My Laptop/code/MacDeepL/Skim-lit/modelhdf5.hdf5')"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":514},"id":"gPwYapD2NEUr","executionInfo":{"status":"error","timestamp":1702840313670,"user_tz":-180,"elapsed":8,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"b86866ca-9ec8-4d3e-bf51-9e41a99e49a7"},"execution_count":null,"outputs":[{"output_type":"stream","name":"stderr","text":["/usr/local/lib/python3.10/dist-packages/keras/src/engine/training.py:3103: UserWarning: You are saving your model as an HDF5 file via `model.save()`. This file format is considered legacy. We recommend using instead the native Keras format, e.g. `model.save('my_model.keras')`.\n","  saving_api.save_model(\n"]},{"output_type":"error","ename":"NotImplementedError","evalue":"ignored","traceback":["\u001b[0;31m---------------------------------------------------------------------------\u001b[0m","\u001b[0;31mNotImplementedError\u001b[0m                       Traceback (most recent call last)","\u001b[0;32m<ipython-input-69-58670af87e7d>\u001b[0m in \u001b[0;36m<cell line: 1>\u001b[0;34m()\u001b[0m\n\u001b[0;32m----> 1\u001b[0;31m \u001b[0mmodel_5\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0msave\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m'/content/drive/Othercomputers/My Laptop/code/MacDeepL/Skim-lit/modelhdf5.hdf5'\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m","\u001b[0;32m/usr/local/lib/python3.10/dist-packages/keras/src/utils/traceback_utils.py\u001b[0m in \u001b[0;36merror_handler\u001b[0;34m(*args, **kwargs)\u001b[0m\n\u001b[1;32m     68\u001b[0m             \u001b[0;31m# To get the full stack trace, call:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     69\u001b[0m             \u001b[0;31m# `tf.debugging.disable_traceback_filtering()`\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 70\u001b[0;31m             \u001b[0;32mraise\u001b[0m \u001b[0me\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mwith_traceback\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mfiltered_tb\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;32mfrom\u001b[0m \u001b[0;32mNone\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     71\u001b[0m         \u001b[0;32mfinally\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     72\u001b[0m             \u001b[0;32mdel\u001b[0m \u001b[0mfiltered_tb\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n","\u001b[0;32m/usr/local/lib/python3.10/dist-packages/keras/src/saving/legacy/hdf5_format.py\u001b[0m in \u001b[0;36m_legacy_weights\u001b[0;34m(layer)\u001b[0m\n\u001b[1;32m   1111\u001b[0m     \u001b[0mweights\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mlayer\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mtrainable_weights\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0mlayer\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mnon_trainable_weights\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1112\u001b[0m     \u001b[0;32mif\u001b[0m \u001b[0many\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;32mnot\u001b[0m \u001b[0misinstance\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mw\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mtf\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mVariable\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;32mfor\u001b[0m \u001b[0mw\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mweights\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1113\u001b[0;31m         raise NotImplementedError(\n\u001b[0m\u001b[1;32m   1114\u001b[0m             \u001b[0;34m\"Save or restore weights that is not an instance of `tf.Variable` \"\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1115\u001b[0m             \u001b[0;34m\"is not supported in h5, use `save_format='tf'` instead. Received \"\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n","\u001b[0;31mNotImplementedError\u001b[0m: Save or restore weights that is not an instance of `tf.Variable` is not supported in h5, use `save_format='tf'` instead. Received a model or layer TextVectorization with weights [<keras.src.layers.preprocessing.index_lookup.VocabWeightHandler object at 0x7983366a4100>]"]}]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":27298,"status":"ok","timestamp":1702840379269,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"CL57YKBtX0pS","outputId":"96bc69f9-4dea-460a-80ea-d5ed38a919c1"},"outputs":[{"output_type":"stream","name":"stdout","text":["945/945 [==============================] - 26s 23ms/step\n"]},{"output_type":"execute_result","data":{"text/plain":["array([[0.63266337, 0.09848451, 0.01745777, 0.23058894, 0.02080541],\n","       [0.5785793 , 0.10692455, 0.0461501 , 0.24301212, 0.02533391],\n","       [0.38941556, 0.08705255, 0.02460165, 0.4564583 , 0.0424719 ],\n","       ...,\n","       [0.02881608, 0.1271994 , 0.04373207, 0.03885479, 0.7613977 ],\n","       [0.02809207, 0.3884828 , 0.09814287, 0.0291361 , 0.45614615],\n","       [0.05202125, 0.89313245, 0.01890244, 0.02265998, 0.01328382]],\n","      dtype=float32)"]},"metadata":{},"execution_count":70}],"source":["\n","model_5_pred_probs = basemodel.predict(val_pos_char_token_dataset, verbose=1)\n","model_5_pred_probs"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":427,"status":"ok","timestamp":1702840093416,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"MRJHAj_4YEPy","outputId":"8254d4f0-59e3-410f-dc5a-9defc6ee6fb1"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["<tf.Tensor: shape=(30212,), dtype=int64, numpy=array([0, 0, 3, ..., 4, 4, 1])>"]},"metadata":{},"execution_count":64}],"source":["\n","model_5_preds = tf.argmax(model_5_pred_probs, axis=1)\n","model_5_preds"]},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"elapsed":604,"status":"ok","timestamp":1702840096293,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"},"user_tz":-180},"id":"0hlX6l35YEqa","outputId":"cd036689-f267-4153-e84c-c83b2d5b9bdd"},"outputs":[{"output_type":"execute_result","data":{"text/plain":["{'accuracy': 85.58519793459553,\n"," 'precision': 0.8580397781523046,\n"," 'recall': 0.8558519793459552,\n"," 'f1': 0.8527785955714621}"]},"metadata":{},"execution_count":65}],"source":["\n","model_5_results = calculate_results(y_true=val_labels_encoded,\n","                                    y_pred=model_5_preds)\n","model_5_results"]},{"cell_type":"code","source":[],"metadata":{"id":"xYvuIhJsJ8So"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":[],"metadata":{"id":"_9zDDUOkJ_Df"},"execution_count":null,"outputs":[]},{"cell_type":"markdown","source":["#full data on model 5\n"],"metadata":{"id":"YlfChAzUwPmA"}},{"cell_type":"code","source":["data_dir = \"/content/pubmed-rct/PubMed_200k_RCT_numbers_replaced_with_at_sign/\""],"metadata":{"id":"wfiPH1C7wsNr"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["import os\n","filenames = [data_dir+filename for filename in os.listdir(data_dir)]\n","filenames"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"bcQneSx3wq7Z","executionInfo":{"status":"ok","timestamp":1702840887504,"user_tz":-180,"elapsed":3,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"e56c1c4a-3cad-4df4-d03a-431e90a5f3c2"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["['/content/pubmed-rct/PubMed_200k_RCT_numbers_replaced_with_at_sign/dev.txt',\n"," '/content/pubmed-rct/PubMed_200k_RCT_numbers_replaced_with_at_sign/test.txt',\n"," '/content/pubmed-rct/PubMed_200k_RCT_numbers_replaced_with_at_sign/train.zip']"]},"metadata":{},"execution_count":88}]},{"cell_type":"code","source":["def get_lines(filename):\n","  with open(filename,\"r\") as f:\n","    return f.readlines()"],"metadata":{"id":"XXkXltK1wpcf"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["!unzip /content/pubmed-rct/PubMed_200k_RCT_numbers_replaced_with_at_sign/train.zip -d /content/pubmed-rct/PubMed_200k_RCT_numbers_replaced_with_at_sign/train.txt"],"metadata":{"id":"YTNn6acd425s","colab":{"base_uri":"https://localhost:8080/"},"outputId":"8bb55618-3a0e-4f64-8806-d96b8ea8b7c0","executionInfo":{"status":"ok","timestamp":1702840896121,"user_tz":-180,"elapsed":6790,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}}},"execution_count":null,"outputs":[{"output_type":"stream","name":"stdout","text":["Archive:  /content/pubmed-rct/PubMed_200k_RCT_numbers_replaced_with_at_sign/train.zip\n","  inflating: /content/pubmed-rct/PubMed_200k_RCT_numbers_replaced_with_at_sign/train.txt/train.txt  \n"]}]},{"cell_type":"code","source":["train=get_lines(data_dir+\"train.txt/train.txt\")\n","train"],"metadata":{"id":"1bnVxGPfwUb3","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1702840897316,"user_tz":-180,"elapsed":1198,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"ddd9e3e8-cc00-486f-b7f7-66264f6c6002"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["['###24491034\\n',\n"," 'BACKGROUND\\tThe emergence of HIV as a chronic condition means that people living with HIV are required to take more responsibility for the self-management of their condition , including making physical , emotional and social adjustments .\\n',\n"," 'BACKGROUND\\tThis paper describes the design and evaluation of Positive Outlook , an online program aiming to enhance the self-management skills of gay men living with HIV .\\n',\n"," 'METHODS\\tThis study is designed as a randomised controlled trial in which men living with HIV in Australia will be assigned to either an intervention group or usual care control group .\\n',\n"," \"METHODS\\tThe intervention group will participate in the online group program ` Positive Outlook ' .\\n\",\n"," 'METHODS\\tThe program is based on self-efficacy theory and uses a self-management approach to enhance skills , confidence and abilities to manage the psychosocial issues associated with HIV in daily life .\\n',\n"," 'METHODS\\tParticipants will access the program for a minimum of @ minutes per week over seven weeks .\\n',\n"," 'METHODS\\tPrimary outcomes are domain specific self-efficacy , HIV related quality of life , and outcomes of health education .\\n',\n"," 'METHODS\\tSecondary outcomes include : depression , anxiety and stress ; general health and quality of life ; adjustment to HIV ; and social support .\\n',\n"," 'METHODS\\tData collection will take place at baseline , completion of the intervention ( or eight weeks post randomisation ) and at @ week follow-up .\\n',\n"," 'CONCLUSIONS\\tResults of the Positive Outlook study will provide information regarding the effectiveness of online group programs improving health related outcomes for men living with HIV .\\n',\n"," 'BACKGROUND\\tACTRN@ .\\n',\n"," '\\n',\n"," '###20497432\\n',\n"," 'BACKGROUND\\tThe aim of this study was to evaluate the efficacy , safety and complications of orbital steroid injection versus oral steroid therapy in the management of thyroid-related ophthalmopathy .\\n',\n"," 'METHODS\\tA total of @ patients suffering from thyroid ophthalmopathy were included in this study .\\n',\n"," 'METHODS\\tPatients were randomized into two groups : group I included @ patients treated with oral prednisolone and group II included @ patients treated with peribulbar triamcinolone orbital injection .\\n',\n"," 'METHODS\\tOnly @ patients in both groups ( @ female and @ male ) completed the study .\\n',\n"," 'RESULTS\\tBoth groups showed improvement in symptoms and in clinical evidence of inflammation with improvement of eye movement and proptosis in most cases .\\n',\n"," 'RESULTS\\tMean exophthalmometry value before treatment was @ @ mm that decreased to @ @ mm in group I , compared with @ @ mm that decreased to @ @ mm in group II .\\n',\n"," 'RESULTS\\tMean initial clinical activity score was @ @ and @ @ for group I and group II before treatment , respectively , which dropped to @ @ and @ @ , @ months after treatment , respectively .\\n',\n"," 'RESULTS\\tThere was no change in the best-corrected visual acuity in both groups .\\n',\n"," 'RESULTS\\tThere was an increase in body weight , blood sugar , blood pressure and gastritis in group I in @ % , @ % , @ % and @ % , respectively , compared with @ % , @ % , @ % and @ % in group II .\\n',\n"," 'RESULTS\\tNo adverse local side effects were observed in group II .\\n',\n"," 'CONCLUSIONS\\tOrbital steroid injection for thyroid-related ophthalmopathy is effective and safe .\\n',\n"," 'CONCLUSIONS\\tIt eliminates the adverse reactions associated with oral corticosteroid use .\\n',\n"," '\\n',\n"," '###19062107\\n',\n"," 'OBJECTIVE\\tThe aim of this prospective randomized study was to examine whether active counseling and more liberal oral fluid intake decrease postoperative pain , nausea and vomiting in pediatric ambulatory tonsillectomy .\\n',\n"," 'METHODS\\tFamilies , whose child was admitted for ambulatory tonsillectomy or adenotonsillectomy , were randomly assigned to the study groups ( n = @ ; @ families in each group ) .\\n',\n"," \"METHODS\\tThe intervention group received the fasting instructions with face-to-face counseling for the child 's active preoperative nutrition , and the control group the fasting instructions according to the hospital 's standard procedure .\\n\",\n"," 'METHODS\\tThe level of postoperative pain and nausea was scored in the postanesthesia care unit ( PACU ) during the first postoperative hour , as well as at @ , @ , @ and @h postoperatively .\\n',\n"," 'METHODS\\tThe first scoring in PACU was performed by the attending nurse with a @-@ scale .\\n',\n"," 'METHODS\\tThe rest of the estimations were made independently and simultaneously by the children using a VAS scale , and by the parents using a @-@ scale .\\n',\n"," 'RESULTS\\tThe children in the control group were in more pain in the PACU than the children in the intervention group , and the difference between the groups was statistically significant ( p = @ ) .\\n',\n"," 'RESULTS\\tAll pain scores , according to the children and the parents , increased after the surgery .\\n',\n"," 'RESULTS\\tIn both groups the highest score values were found at home @h after surgery , and no significant difference was found between the study groups .\\n',\n"," 'RESULTS\\tOn the first postoperative morning , the children in the control group were in pain ( p = @ ) .\\n',\n"," 'RESULTS\\tThe children did not have significant nausea in the PACU , but the nausea increased postoperatively .\\n',\n"," 'RESULTS\\tFour hours after surgery the children were most nauseous according to all estimations ( @ % , n = @ ) .\\n',\n"," 'RESULTS\\tMore than half of the children vomited and most vomited clotted blood .\\n',\n"," 'RESULTS\\tNausea and vomiting decreased during the evening of the surgery , but six children vomited the next morning , four of them vomited blood .\\n',\n"," 'RESULTS\\tThe incidence and intensity of postoperative nausea and vomiting between the intervention and control groups were not statistically significant .\\n',\n"," \"RESULTS\\tHowever , preoperative nutritional counseling and more liberal per oral fluid intake appeared to have a positive effect on the children 's well-being and helped them to better tolerate postoperative nausea and vomiting .\\n\",\n"," \"CONCLUSIONS\\tThe preoperative counseling about active preoperative nutrition significantly reduces the child 's pain during the first posttonsillectomy hours and might prepare the child to better tolerate the stress of potential postoperative nausea and vomiting .\\n\",\n"," '\\n',\n"," '###19769482\\n',\n"," 'OBJECTIVE\\tTo explore the effects of GengNianLe ( GNL , also called perimenopausal depression relieving formula ) , a defined formula of Chinese medicinal herbs in relieving perimenopausal depression in Chinese women .\\n',\n"," 'METHODS\\tBetween September @ and April @ , @ Chinese women were randomized into a GNL group ( n = @ ) and a control group which received tibolone ( n = @ ) using a randomization chart .\\n',\n"," 'METHODS\\tDepression was rated with the @-item Hamilton Depression Scale ( HAMD ) .\\n',\n"," 'METHODS\\tThe serum levels of follicle stimulating hormone ( FSH ) , luteinizing hormone ( LH ) , and estradiol ( E ( @ ) ) were detected before and after the treatment .\\n',\n"," 'RESULTS\\tAfter @ weeks of treatment , HAMD scores in both groups decreased significantly ( p < @ ) with no significant difference between the groups ( p > @ ) .\\n',\n"," 'RESULTS\\tThe levels of FSH decreased significantly and the level of E ( @ ) increased significantly in both groups , and they changed more in the control group .\\n',\n"," 'RESULTS\\tNo side-effect of treatment was reported in either group during treatment .\\n',\n"," 'CONCLUSIONS\\tThe Chinese medicinal formula GNL showed promise in relieving perimenopausal depression and merits further study .\\n',\n"," '\\n',\n"," '###26077436\\n',\n"," 'BACKGROUND\\tTopical formulations of nonsteroidal anti-inflammatory drugs ( NSAIDs ) are generally considered to be safer alternatives to oral NSAIDs due to lower systemic absorption .\\n',\n"," 'BACKGROUND\\tWe conducted randomized , crossover studies that compared the pharmacokinetics ( PK ) , bioequivalence and safety of topical diclofenac sodium @ % twice daily ( BID ) , diclofenac sodium @ % four times daily ( QID ) and oral diclofenac sodium in healthy subjects .\\n',\n"," 'METHODS\\tThe results of three bioequivalence studies are reviewed .\\n',\n"," 'METHODS\\tHealthy adult subjects ( n = @ ) applied topical diclofenac sodium @ % solution ( @ mg/@ mL ) BID ; or @ % solution ( @ mg/@ drops ) QID to each knee for @ consecutive days separated by a washout period .\\n',\n"," 'METHODS\\tSubjects ( n = @ ) in one study also received oral diclofenac sodium @ mg BID for @ days .\\n',\n"," 'METHODS\\tPlasma diclofenac concentrations were determined from serial blood samples collected on Days @ and @ ( steady state ) , and diclofenac PK parameters were estimated by noncompartmental methods .\\n',\n"," 'RESULTS\\tThe studies demonstrated comparable bioequivalence between the @ % and @ % topical solutions as well as lower systemic exposure compared to oral dosing ( approximately @ % less ) .\\n',\n"," 'RESULTS\\tDaily systemic exposure was comparable between the two formulations with only a @ % difference in the AUCss ( @-@ ) ( p = @ ) .\\n',\n"," 'RESULTS\\tFurthermore , both topical solutions demonstrated delayed elimination with a t ( @/@ ) of @ - to @-fold longer , as compared to oral diclofenac .\\n',\n"," 'RESULTS\\tThe @ % solution provided more consistent dosing relative to the @ % solution when comparing AUCss ( @-@ ) and Cmaxss across studies .\\n',\n"," 'RESULTS\\tMild application site reactions were the most common treatment-emergent adverse event reported with topical diclofenac .\\n',\n"," 'CONCLUSIONS\\tThe steady-state PK profile of topical diclofenac @ % solution administered BID is similar to that of the @ % solution administered QID .\\n',\n"," 'CONCLUSIONS\\tSystemic exposure to diclofenac is substantially lower after topical application as compared to oral administration .\\n',\n"," 'CONCLUSIONS\\t( Study @ was registered with ClinicalTrials.gov ; NCT@ ; https://clinicaltrials.gov/ct@/results?term=@&Search=Search ) .\\n',\n"," '\\n',\n"," '###20656965\\n',\n"," 'BACKGROUND\\tNo long-term studies have been reported on the effect of training programs on driving after stroke .\\n',\n"," \"OBJECTIVE\\tThe authors ' primary aim was to determine the effect of simulator versus cognitive rehabilitation therapy on fitness-to-drive at @ years poststroke .\\n\",\n"," 'OBJECTIVE\\tA second aim was to investigate differences in clinical characteristics between stroke survivors who resumed and stopped driving .\\n',\n"," 'METHODS\\tIn a previously reported randomized controlled trial , @ stroke survivors received @ hours of simulator training ( n = @ ) or cognitive therapy ( n = @ ) .\\n',\n"," 'METHODS\\tIn this @-year follow-up study , @ participants were reassessed .\\n',\n"," 'METHODS\\tFitness-to-drive decisions were obtained from medical , visual , neuropsychological , and on-road tests ; @ participants ( simulator group , n = @ ; cognitive group , n = @ ) completed all assessments .\\n',\n"," 'METHODS\\tThe primary outcome measures were fitness-to-drive decision and current driving status .\\n',\n"," 'RESULTS\\tThe authors found that @ years after stroke , @ of @ participants ( @ % ) in the simulator group were considered fit to drive , compared with @ of @ ( @ % ) in the cognitive group ( P = @ ) ; @ of @ ( @ % ) participants were driving .\\n',\n"," 'RESULTS\\tCurrent drivers were younger ( P = @ ) , had higher Barthel scores ( P = @ ) , had less comorbidity ( P = @ ) , and were less severely depressed ( P = @ ) than those who gave up driving .\\n',\n"," 'CONCLUSIONS\\tThe advantage of simulator-based driving training over cognitive rehabilitation therapy , evident at @ months poststroke , had faded @ years later .\\n',\n"," 'CONCLUSIONS\\tPoststroke drivers were younger and less severely affected and depressed than nondrivers .\\n',\n"," '\\n',\n"," '###17889242\\n',\n"," 'BACKGROUND\\tThe potential of insecticide-treated bednets ( ITNs ) to contribute to child survival has been well documented in randomised controlled trials .\\n',\n"," 'BACKGROUND\\tITN coverage has increased rapidly in Kenya from @ % in @ to @ % in @ .\\n',\n"," 'BACKGROUND\\tWe aimed to assess the extent to which this investment has led to improvements in child survival .\\n',\n"," 'METHODS\\tA dynamic cohort of about @ children aged @-@ months were enumerated three times at yearly intervals in @ rural clusters located in four districts of Kenya .\\n',\n"," 'METHODS\\tThe effect of ITN use on mortality was assessed with Poisson regression to take account of potential effect-modifying and confounding covariates .\\n',\n"," 'RESULTS\\t@ children died over @ years .\\n',\n"," 'RESULTS\\tOverall mortality rates were much the same in the first and second years of the study ( @ per @ person-years in the first year and @ per @ person-years in the second ) .\\n',\n"," 'RESULTS\\tAfter adjustment for age , time period , and a number of other possible confounding variables , ITN use was associated with a @ % reduction in mortality ( mortality rate ratio @ , @ % CI @-@ @ ; p = @ ) .\\n',\n"," 'RESULTS\\tThis level of protection corresponds to about seven deaths averted for every @ ITNs distributed .\\n',\n"," 'CONCLUSIONS\\tA combined approach of social marketing followed by mass free distribution of ITNs translated into child survival effects that are comparable with those seen in previous randomised controlled trials .\\n',\n"," '\\n',\n"," '###23615091\\n',\n"," 'BACKGROUND\\tCortical stimulation mapping ( CSM ) commonly uses visual naming to determine resection margins in the dominant hemisphere of patients with epilepsy .\\n',\n"," 'BACKGROUND\\tVisual naming alone may not identify all language sites in resection-prone areas , prompting additional tasks for comprehensive language mapping .\\n',\n"," 'OBJECTIVE\\tTo demonstrate word-finding distinctions between visual , auditory , and reading modalities during CSM and the percentage of modality-specific language sites within dominant hemisphere subregions .\\n',\n"," 'METHODS\\tTwenty-eight patients with epilepsy underwent CSM by the use of visual , auditory , and sentence-completion tasks .\\n',\n"," 'METHODS\\tHierarchical logistic regression analyzed errors to identify language sites and provide modality-specific percentages within subregions .\\n',\n"," 'RESULTS\\tThe percentage of sites classified as language sites based on auditory naming was twice as high in anterior temporal regions compared with visual naming , marginally higher in posterior temporal areas , and comparable in parietal regions .\\n',\n"," 'RESULTS\\tSentence completion was comparable to visual and auditory naming in parietal regions and lower in most temporal areas .\\n',\n"," 'RESULTS\\tOf @ sites tested with both visual and auditory naming , @ sites were distinctly auditory , whereas @ sites were distinctly visual .\\n',\n"," 'RESULTS\\tThe remaining sites overlapped .\\n',\n"," 'CONCLUSIONS\\tDistinct cortical areas were found for distinct input modalities , with language sites in anterior tip regions found most often by using auditory naming .\\n',\n"," 'CONCLUSIONS\\tThe vulnerability of anterior temporal tip regions to resection in this population and distinct sites for each modality suggest that a multimodality approach may be needed to spare crucial language sites , if sparing those sites can be shown to significantly reduce the rate of postoperative language deficits without sacrificing seizure control .\\n',\n"," '\\n',\n"," '###8532270\\n',\n"," 'OBJECTIVE\\tTo determine if suppressive acyclovir therapy given to term gravidas experiencing a first episode of genital herpes simplex virus ( HSV ) - infection during pregnancy decreases the need for cesarean delivery for that indication .\\n',\n"," \"METHODS\\tForty-six pregnant women with first episodes of genital herpes during pregnancy were randomly assigned to receive oral acyclovir @ mg or placebo , three times per day , from @ weeks ' gestation until delivery as part of a prospective , double-blind trial .\\n\",\n"," 'METHODS\\tHerpes simplex virus cultures were obtained when patients presented for delivery .\\n',\n"," 'METHODS\\tVaginal delivery was permitted if no clinical recurrence was present ; otherwise , a cesarean was performed .\\n',\n"," 'METHODS\\tNeonatal HSV cultures were obtained and infants were followed-up clinically .\\n',\n"," 'RESULTS\\tNone of the @ patients treated with acyclovir and nine of @ ( @ % ) treated with placebo had clinical evidence of recurrent genital herpes at delivery ( odds ratio [ OR ] @ , @ % confidence interval [ CI ] @-@ @ ; P = @ ) .\\n',\n"," 'RESULTS\\tNo woman treated with acyclovir had a cesarean for herpes , compared with nine of @ ( @ % ) of those treated with placebo ( OR @ , CI @-@ @ ; P = @ ) .\\n',\n"," 'RESULTS\\tNo patient in either treatment group experienced asymptomatic genital viral shedding at delivery .\\n',\n"," 'RESULTS\\tNo neonate had evidence of herpes infection or adverse effects from acyclovir .\\n',\n"," 'CONCLUSIONS\\tSuppressive acyclovir therapy reduced the need for cesarean for recurrent herpes in women whose first clinical episode of genital HSV occurred during pregnancy .\\n',\n"," 'CONCLUSIONS\\tSuppressive acyclovir treatment did not increase asymptomatic viral shedding and was not harmful to the term fetus .\\n',\n"," '\\n',\n"," '###1458072\\n',\n"," 'OBJECTIVE\\tTo compare the tolerance , efficacy , and pharmacokinetics of amphotericin deoxycholate ( Fungizone ) prepared in a parenteral fat emulsion ( Intralipid @ % ) or glucose in HIV patients with candidiasis .\\n',\n"," 'METHODS\\tNon-blind randomised controlled trial .\\n',\n"," 'METHODS\\tUniversity hospital ; tertiary clinical care .\\n',\n"," 'METHODS\\t@ HIV positive patients with oral candidiasis .\\n',\n"," 'METHODS\\tAmphotericin @ mg/kg/day given on four consecutive days as a one hour infusion dissolved in either @ % glucose ( amphotericin-glucose ) or parenteral fat emulsion at a final concentration of @ g/l fat emulsion ( amphotericin-fat emulsion ) .\\n',\n"," 'METHODS\\tClinical tolerance ( fever , chills , sweats , nausea , arterial pressure , and pulse rate ) ; biological tolerance ( serum creatinine , electrolyte , and magnesium values ) ; clinical score of candidiasis ; and serum concentrations of amphotericin .\\n',\n"," 'RESULTS\\t@ patients were enrolled in each group .\\n',\n"," 'RESULTS\\tAll the amphotericin-fat emulsion infusions were given without serious problem whereas four amphotericin-glucose infusions were stopped because of renal impairment ( n = @ ) or severe chills ( n = @ ) , or both .\\n',\n"," 'RESULTS\\tFor patients completing the amphotericin-glucose treatment creatine concentration increased by @ mumol/l ; four of seven patients had at least one creatinine value > or = @ mumol/l versus one of @ receiving amphotericin-fat emulsion .\\n',\n"," 'RESULTS\\tMagnesium concentration fell significantly with amphotericin-glucose but not with amphotericin-fat emulsion .\\n',\n"," 'RESULTS\\tClinical side effects were noted in @/@ infusions with amphotericin-glucose but @/@ with amphotericin-fat emulsion .\\n',\n"," 'RESULTS\\tOral candidiasis score was reduced similarly in both groups .\\n',\n"," 'RESULTS\\tSerum amphotericin concentrations were significantly lower and the volume of distribution of the drug higher after infusion of amphotericin-fat emulsion than after amphotericin-glucose .\\n',\n"," 'CONCLUSIONS\\tClinical and renal toxicity of amphotericin are reduced when the drug is prepared in fat emulsion .\\n',\n"," 'CONCLUSIONS\\tPreparation is simple and cost effective .\\n',\n"," 'CONCLUSIONS\\tIts efficacy is similar to that of conventional amphotericin .\\n',\n"," '\\n',\n"," '###24135831\\n',\n"," 'OBJECTIVE\\tRate control of atrial fibrillation ( AF ) has become a main treatment modality , but we need more knowledge regarding the different drugs used for this purpose .\\n',\n"," 'OBJECTIVE\\tIn this study , we aimed to compare the effect of four common rate-reducing drugs on exercise capacity and levels of N-terminal pro-B-type natriuretic peptide ( NT-proBNP ) in patients with permanent AF .\\n',\n"," 'RESULTS\\tWe included @ patients ( mean age @ @ years , @ women ) with permanent AF and normal left ventricular function in a randomized , cross-over , investigator-blind study .\\n',\n"," 'RESULTS\\tDiltiazem @ mg , verapamil @ mg , metoprolol @ mg , and carvedilol @ mg were administered o.d. for @ weeks .\\n',\n"," 'RESULTS\\tAt baseline and on the last day of each treatment period , the patients underwent a maximal cardiopulmonary exercise test and blood samples were obtained at rest and at peak exercise .\\n',\n"," 'RESULTS\\tThe exercise capacity ( peak VO@ ) was significantly lower during treatment with metoprolol and carvedilol compared with baseline ( no treatment ) or treatment with diltiazem and verapamil ( P < @ for all ) .\\n',\n"," 'RESULTS\\tCompared with baseline , treatment with diltiazem and verapamil significantly reduced the NT-proBNP levels both at rest and at peak exercise , whereas treatment with metoprolol and carvedilol increased the levels ( P < @ for all ) .\\n',\n"," 'CONCLUSIONS\\tRate-reducing treatment with diltiazem or verapamil preserved exercise capacity and reduced levels of NT-proBNP compared with baseline , whereas treatment with metoprolol or carvedilol reduced the exercise capacity and increased levels of NT-proBNP .\\n',\n"," '\\n',\n"," '###11467142\\n',\n"," 'BACKGROUND\\tPost-exposure prophylaxis for rabies with cell culture vaccines by the conventional intramuscular regimen is very expensive .\\n',\n"," 'BACKGROUND\\tThe World Health Organization has advocated two cost-effective intradermal regimens with cell culture vaccines for use in developing countries .\\n',\n"," 'BACKGROUND\\tWe evaluated these two regimens -- the @-site and the @-site regimens -- in terms of immunogenicity , safety and tolerance in people with category I exposure to rabies .\\n',\n"," 'METHODS\\tEighty-two subjects who had mild category I exposure to rabies were immunized using a purified chick embryo cell vaccine .\\n',\n"," 'METHODS\\tThe first regimen given to @ subjects , consisted of intradermal administration of @ ml of vaccine at @ sites on days @ , @ and @ and at one site on days @ and @ .\\n',\n"," 'METHODS\\tThe second regimen , given to @ subjects , consisted of intradermal administration of @ ml of vaccine at @ sites on day @ , at @ sites on day @ and at one site on days @ and @ .\\n',\n"," 'METHODS\\tThe mouse neutralization test was used to estimate titres of rabies neutralizing antibody in these subjects on different days after vaccination .\\n',\n"," 'METHODS\\tThe subjects were followed up for @ year .\\n',\n"," 'RESULTS\\tBoth regimens produced adequate neutralizing antibody titres from day @ onwards , though the second regimen produced a more rapid antibody response and significantly higher titres ( p < @ ) on all days tested .\\n',\n"," 'RESULTS\\tThere were minimal side-effects and both regimens were well tolerated .\\n',\n"," 'CONCLUSIONS\\tBoth the @-site and @-site intradermal regimens with purified chick embryo cell vaccine produce adequate levels of neutralizing antibodies but the @-site regimen appears to be more immunogenic .\\n',\n"," 'CONCLUSIONS\\tThe feasibility of using these cost-effective regimens in routine practice needs to be further evaluated under the field conditions prevalent in India .\\n',\n"," '\\n',\n"," '###21766893\\n',\n"," 'BACKGROUND\\tDiscrete-choice experiments are based on the premise that any good or service can be described by its characteristics ( or attributes ) , and the extent to which an individual values a good or service depends on the levels of these characteristics .\\n',\n"," 'BACKGROUND\\tLittle is known about patient preferences for treatment of chronic musculoskeletal pain such as Achilles tendinopathy .\\n',\n"," 'METHODS\\tA discrete-choice experiment was conducted in @ adults with a history of Achilles tendon pain at the conclusion of a three-arm randomized clinical trial .\\n',\n"," 'METHODS\\tParticipants were asked to complete a questionnaire consisting of ten hypothetical treatment scenarios and some sociodemographic questions .\\n',\n"," 'METHODS\\tFor each scenario , participants were asked to choose which option they would prefer if seeking treatment for their painful Achilles tendon .\\n',\n"," 'METHODS\\tA mixed logit model was estimated to quantify subject preferences and marginal willingness to pay for the treatment attributes .\\n',\n"," 'RESULTS\\tA response rate of @ % was achieved .\\n',\n"," 'RESULTS\\tA significant positive impact on utility was observed for chance of treatment success .\\n',\n"," 'RESULTS\\tA significant negative impact on utility was observed for cost , weeks before exercise can be completed free of pain , chance of side effects ( p = @ ) , and injections as a stand-alone treatment .\\n',\n"," 'RESULTS\\tRespondents were willing to pay Australian dollars ( $ A ) @ ( @ % CI -@ , @ ) for a @ % increase in the chance of treatment success .\\n',\n"," 'CONCLUSIONS\\tStudy participants with Achilles tendon pain who had either participated or expressed an interest in participating in a randomized trial prefer a treatment that costs less , has a greater chance of success , has a shorter duration before being able to exercise free of pain , and has less likelihood of side effects .\\n',\n"," 'CONCLUSIONS\\tOn average , participants preferred exercises over injections as a stand-alone treatment .\\n',\n"," 'CONCLUSIONS\\tFurther research is required to confirm the findings in patients outside of the trial setting .\\n',\n"," 'CONCLUSIONS\\tNevertheless , this study contributes to an area that is deficient in research by identifying priorities and marginal willingness to pay for attributes related to Achilles tendinopathy .\\n',\n"," '\\n',\n"," '###24816809\\n',\n"," 'OBJECTIVE\\tWhether prasugrel plus bivalirudin is a superior strategy to unfractionated heparin plus clopidogrel in patients with ST-segment elevation myocardial infarction ( STEMI ) undergoing primary percutaneous coronary intervention ( PCI ) has never been assessed in specifically designed randomized trials .\\n',\n"," 'RESULTS\\tThe Bavarian Reperfusion Alternatives Evaluation ( BRAVE ) @ study is an investigator-initiated , randomized , open-label , multicentre trial , designed to test the hypothesis that in STEMI patients with planned primary PCI a strategy based on prasugrel plus bivalirudin is superior to a strategy based on clopidogrel plus heparin in terms of net clinical outcome .\\n',\n"," 'RESULTS\\tOwing to slow recruitment , the trial was stopped prematurely after enrolment of @ of @ planned patients .\\n',\n"," 'RESULTS\\tAt @ days , the primary composite endpoint of death , myocardial infarction , unplanned revascularization of the infarct related artery , stent thrombosis , stroke , or bleeding was observed in @ patients ( @ % ) randomized to prasugrel plus bivalirudin and @ patients ( @ % ) randomized to clopidogrel plus heparin [ relative risk , @ ; one-sided @ % confidence interval ( CI ) @-@ @ , P = @ ] .\\n',\n"," 'RESULTS\\tThe composite ischaemic endpoint of death , myocardial infarction , unplanned revascularization of the infarct-related artery , stent thrombosis , or stroke occurred in @ patients ( @ % ) in the prasugrel plus bivalirudin group and @ patients ( @ % ) in the clopidogrel plus heparin group ( relative risk , @ ; @ % CI @-@ @ , P = @ ) .\\n',\n"," 'RESULTS\\tBleeding according to the HORIZONS-AMI definition was observed in @ patients ( @ % ) in the prasugrel plus bivalirudin group and @ patients ( @ % ) in the clopidogrel plus heparin group ( relative risk , @ ; @ % CI @-@ @ , P = @ ) .\\n',\n"," 'RESULTS\\tResults were consistent across various subgroups of patients .\\n',\n"," 'CONCLUSIONS\\tIn this randomized trial of STEMI patients , we were unable to demonstrate significant differences in net clinical outcome between prasugrel plus bivalirudin and clopidogrel plus heparin .\\n',\n"," 'CONCLUSIONS\\tNeither the composite of ischaemic complications nor bleeding were favourably affected by prasugrel plus bivalirudin compared with a regimen of clopidogrel plus unfractionated heparin .\\n',\n"," 'CONCLUSIONS\\tHowever , the results must be interpreted in view of the premature termination of the trial .\\n',\n"," 'BACKGROUND\\tUnique identifier NCT@ ( www.clinicaltrials.gov ) .\\n',\n"," '\\n',\n"," '###12551795\\n',\n"," 'OBJECTIVE\\tTo evaluate the long-term recurrence rates and complication of different techniques of cervical ablation .\\n',\n"," 'METHODS\\tA randomized trial of three techniques of conization ( cold knife , laser , and loop electrosurgical excisional procedure ( LEEP ) ) for cervical intraepithelial neoplasia ( CIN ) in which @ patients had been recruited .\\n',\n"," 'RESULTS\\tEighty-six patients were followed-up for more than @ years .\\n',\n"," 'RESULTS\\tOf these @ had been treated with the cold knife , @ with LEEP and @ by laser .\\n',\n"," 'RESULTS\\tFive recurrences were observed , one in the cold knife group , two in the LEEP group and two in the laser group ( P = NS ) .\\n',\n"," 'RESULTS\\tThe only observed complication was cervical stenosis : zero cases in the laser group , one case in the LEEP group and four cases in the cold knife group ( laser versus cold knife : P = @ ; LEEP versus cold knife : P = @ ) .\\n',\n"," 'RESULTS\\tFifty pregnancies were observed in @ patients .\\n',\n"," 'RESULTS\\tFirst and second trimester outcomes of pregnancy were without complications .\\n',\n"," 'RESULTS\\tOne patient treated with the LEEP presented with a premature rupture of membranes and premature labor at @ weeks .\\n',\n"," 'RESULTS\\tA total of nine cesarean sections were performed with two cases for cervical dystocia .\\n',\n"," 'CONCLUSIONS\\tThere is no major difference in obstetrical outcome between the three techniques .\\n',\n"," '\\n',\n"," '###15897479\\n',\n"," 'OBJECTIVE\\tTo determine whether macronutrient composition of a hypocaloric diet can enhance its effectiveness and whether insulin sensitivity ( Si ) affects the response to hypocaloric diets .\\n',\n"," 'METHODS\\tObese nondiabetic insulin-sensitive ( fasting insulin < @ microU/mL ; n = @ ) and obese nondiabetic insulin-resistant ( fasting insulin > @ microU/mL ; n = @ ) women ( @ to @ years old ) were randomized to either a high carbohydrate ( CHO ) ( HC ) / low fat ( LF ) ( @ % CHO , @ % fat ) or low CHO ( LC ) / high fat ( HF ) ( @ % CHO , @ % fat ) hypocaloric diet .\\n',\n"," 'METHODS\\tPrimary outcome measures after a @-week dietary intervention were : changes in body weight ( BW ) , Si , resting metabolic rate , and fasting lipids .\\n',\n"," 'RESULTS\\tInsulin-sensitive women on the HC/LF diet lost @ + / - @ % ( p < @ ) of their initial BW , whereas those on the LC/HF diet lost @ + / - @ % ( p < @ ; p < @ between the groups ) .\\n',\n"," 'RESULTS\\tIn contrast , among the insulin-resistant women , those on the LC/HF diet lost @ + / - @ % ( p < @ ) of their initial BW as compared with @ + / - @ % ( p < @ ) lost by those on the HC/LF diet ( p < @ between two groups ) .\\n',\n"," 'RESULTS\\tThese differences could not be explained by changes in resting metabolic rate , activity , or intake .\\n',\n"," 'RESULTS\\tOverall , changes in Si were associated with the degree of weight loss ( r = -@ , p < @ ) .\\n',\n"," 'CONCLUSIONS\\tThe state of Si determines the effectiveness of macronutrient composition of hypocaloric diets in obese women .\\n',\n"," 'CONCLUSIONS\\tFor maximal benefit , the macronutrient composition of a hypocaloric diet may need to be adjusted to correspond to the state of Si .\\n',\n"," '\\n',\n"," '###8182401\\n',\n"," 'OBJECTIVE\\tTo compare the effects of dry needling of myofascial trigger points in the neck region to metoprolol in migraine prophylaxis .\\n',\n"," 'METHODS\\tRandomized , group comparative study .\\n',\n"," 'METHODS\\tpatients , investigator and statistician were blinded as to treatment , the therapist was blinded as to results .\\n',\n"," 'METHODS\\tOutpatient pain clinic in the northern Copenhagen area .\\n',\n"," 'METHODS\\tPatients were referred by general practitioners or respondents to newspaper advertisements .\\n',\n"," 'METHODS\\tIncluded were patients with a history of migraine with or without aura for at least @ years .\\n',\n"," 'METHODS\\tExcluded were persons with contraindications against treatment with beta blockers , chronic pain syndromes , pregnancy or previous experience with acupuncture or beta-blocking agents .\\n',\n"," 'METHODS\\tA total of @ patients were included ; @ completed the study .\\n',\n"," 'METHODS\\tAfter a @-week run-in period , patients were allocated to a @-week regimen either with acupuncture and placebo tablets or to placebo stimulation and metoprolol @ mg daily .\\n',\n"," 'RESULTS\\tBoth groups exhibited significant reduction in attack frequency ( P < @ ) .\\n',\n"," 'RESULTS\\tNo difference was found between the groups regarding frequency ( P > @ ) or duration ( P > @ ) of attacks , whereas we found a significant difference in global rating of attacks in favour of metoprolol ( P < @ ) .\\n',\n"," 'CONCLUSIONS\\tTrigger point inactivation by dry needling is a valuable supplement to the list of migraine prophylactic tools , being equipotent to metoprolol in the influence on frequency and duration ( but not severity ) of attacks , and superior in terms of negative side-effects .\\n',\n"," '\\n',\n"," '###17217318\\n',\n"," 'OBJECTIVE\\tThis study aimed to evaluate the effects of monophasic estrogen-progestogen therapy on the sexuality and climacteric symptoms of postmenopausal women .\\n',\n"," 'METHODS\\tA prospective , randomised , double-blind , crossover , placebo-controlled , single-centre study was carried out over a total of @ consecutive months in @ postmenopausal women with an intact uterus who had no contraindications to hormone therapy .\\n',\n"," 'METHODS\\tPatients received @beta-estradiol @mg in combination with norethisterone acetate @mg ( Cliane ) daily for @ months or one placebo tablet daily for @ months .\\n',\n"," 'METHODS\\tThe tablets were identical in appearance .\\n',\n"," 'METHODS\\tAfter @ months , the groups were crossed over and the patients were followed up for another @ months .\\n',\n"," 'METHODS\\tThe groups were homogenous with respect to age , height , bodyweight , body mass index and race .\\n',\n"," 'METHODS\\tFor the statistical analysis , the group receiving hormone therapy was referred to as group A and the placebo group was designated group B , irrespective of the placebo/hormone therapy sequence .\\n',\n"," 'RESULTS\\tIn group A there were fewer hot flashes ( F = @ , p < @ ) and an improvement in sexual interest ( F = @ , p < @ ) .\\n',\n"," 'RESULTS\\tThe sequence in which the medication was received resulted in a statistically significant difference with respect to dyspareunia ( F = @ , p < @ ) and satisfaction with the duration of penetration ( F = @ , p < @ ) .\\n',\n"," \"RESULTS\\tIn the intrapatient analysis of variation with respect to orgasmic capability and the presence of dialogue with partner regarding the couple 's sexual life , whether the placebo was taken prior to or following hormone therapy was significant ( F = @ , p < @ and F = @ , p < @ , respectively ) .\\n\",\n"," 'CONCLUSIONS\\tMonophasic estrogen-progestogen therapy has a beneficial effect on sexuality and on hot flashes in postmenopausal women .\\n',\n"," '\\n',\n"," '###19852282\\n',\n"," 'OBJECTIVE\\tTo investigate the clinical effect of the Chinese medicinal preparation Shengling Capsule on patients with oligoasthenospermia .\\n',\n"," 'METHODS\\tA total of @ male patients with infertility induced by oligoasthenospermia were equally divided into a treatment and a control group , the former medicated with Shengling Capsule at the dose of @ g tid , and the latter given Vit E at @ mg tid , both for a course of @ weeks .\\n',\n"," 'METHODS\\tThen we analyzed the changes in the patients ` seminal parameters and the pregnancy of their wives .\\n',\n"," 'RESULTS\\tAfter @ weeks of medication , both the seminal parameters of the patients and pregnancy of their wives were remarkably improved , with extremely significant differences from pre-treatment and the control ( P < @ ) .\\n',\n"," 'CONCLUSIONS\\tShengjing Capsule can improve sperm motility and vitality as well as sperm count .\\n',\n"," 'CONCLUSIONS\\tWith few adverse effects , it can be used as a safe and effective therapeutic for male infertility induced by oligoasthenospermia .\\n',\n"," '\\n',\n"," '###9072052\\n',\n"," 'OBJECTIVE\\tTo assess the usefulness of HELISAL in the diagnosis of Helicobacter pylori infection by comparing it with ELISA , JATROX and histopathologic findings .\\n',\n"," 'METHODS\\tRandomized prospective study .\\n',\n"," 'METHODS\\tSixty-one patients , thirty-three males and twenty-eight females , @-@ years old , submitted to esophagogastroduodenoscopy .\\n',\n"," 'RESULTS\\tThe sensitivity of HELISAL when compared to ELISA test was @ % , the specificity @ % , the positive predictive value @ % , the negative predictive value @ % , and the kappa index @ .\\n',\n"," 'RESULTS\\tWhen compared to histopathologic test : sensitivity @ % , specificity @ % , positive predictive value @ % , negative predictive value @ % , kappa @ .\\n',\n"," 'RESULTS\\tWhen compared to JATROX , sensitivity @ % , specificity @ % , positive predictive value @ % , negative predictive value @ % , kappa @ .\\n',\n"," 'CONCLUSIONS\\tThe sensitivity of HELISAL test is lower than that of other compared tests , and the negative predictive value is very low .\\n',\n"," 'CONCLUSIONS\\tThe specificity and the positive predictive value are higher than the sensitivity .\\n',\n"," 'CONCLUSIONS\\tThe kappa index shows a very low concordance .\\n',\n"," '\\n',\n"," '###10510951\\n',\n"," 'OBJECTIVE\\tTo evaluate the effects of simvastatin on serum lipids and insulin sensitivity in Type @ diabetic patients with hypercholesterolaemia .\\n',\n"," 'METHODS\\tA double-blind , randomized , placebo-controlled and two-period crossover study .\\n',\n"," 'METHODS\\tAfter a @-month run-in , @ eligible Type @ diabetic patients with hypercholesterolaemia were randomized to receive either simvastatin or placebo for @ months , exchanging their treatment thereafter for another @ months .\\n',\n"," 'METHODS\\tBlood samples were taken in month @ and at monthly intervals to measure serum lipids and indices of glycaemic control .\\n',\n"," 'METHODS\\tAn euglycaemic insulin clamp was performed in months @ , @ and @ to assess change of insulin sensitivity .\\n',\n"," 'METHODS\\tThe amount of glucose infused during @-@ min of the clamp ( M ) , and the mean values of serum insulin during @-@ min ( I ) were measured .\\n',\n"," 'METHODS\\tThe M and M/I ratio were used to represent the in vivo insulin sensitivity of the subject .\\n',\n"," 'RESULTS\\tSimvastatin significantly reduced serum total cholesterol ( TC ) by @ + / -@ % and low density lipoprotein-cholesterol ( LDL-C ) by @ + / -@ % .\\n',\n"," 'RESULTS\\tIt did not alter glycaemic control .\\n',\n"," 'RESULTS\\tThe M-values and M/I ratios were similar in both groups in each period and no drug effect on insulin sensitivity could be identified .\\n',\n"," 'CONCLUSIONS\\tSimvastatin significantly reduced the serum TC and LDL-C levels without alteration of insulin sensitivity in Type @ diabetic patients with hypercholesterolaemia .\\n',\n"," '\\n',\n"," '###10871561\\n',\n"," 'BACKGROUND\\tPremenopausal African American women have a @-@ times greater incidence of coronary heart disease ( CHD ) than do white women .\\n',\n"," 'BACKGROUND\\tThe plasma lipid responsiveness to dietary fat , which may be associated with CHD , has not been adequately studied in premenopausal African American or white women .\\n',\n"," 'OBJECTIVE\\tThe objective of our study was to compare the effect of diet on fasting plasma lipids and lipoproteins and postprandial lipemia in premenopausal African American and white women .\\n',\n"," 'METHODS\\tThirteen African American and @ white healthy premenopausal women were fed a low-fat , high-fiber diet and a high-fat , low-fiber diet for @ wk each in a randomized crossover design .\\n',\n"," 'METHODS\\tFasting plasma lipid and lipoprotein concentrations and the @-h plasma triacylglycerol response to a standard fatty test meal were measured at the end of each dietary period .\\n',\n"," 'RESULTS\\tPlasma total and LDL-cholesterol concentrations were higher after the high-fat , low-fiber diet in both white and African American women ( P < @ ) .\\n',\n"," 'RESULTS\\tThe @-h area under the plasma triacylglycerol curve after the test meal was lower after the low-fat diet than after the high-fat diet ( P < @ ) .\\n',\n"," 'CONCLUSIONS\\tAfrican American and white women had lower fasting plasma total and LDL-cholesterol concentrations and less postprandial lipemia after the low-fat than the high-fat diet .\\n',\n"," 'CONCLUSIONS\\tDiets low in total and saturated fat and cholesterol and high in fiber may reduce the risk of CHD by lowering fasting plasma total and LDL-cholesterol concentrations and by reducing the lipemic response to fatty meals .\\n',\n"," '\\n',\n"," '###23497763\\n',\n"," 'BACKGROUND\\tMirabegron is a @-adrenoceptor agonist used for the treatment of overactive bladder .\\n',\n"," 'BACKGROUND\\tMirabegron is formulated as an extended-release tablet using oral controlled-absorption system ( OCAS ) technology .\\n',\n"," 'OBJECTIVE\\tThis study was designed to assess the effects of food on the pharmacokinetic properties of mirabegron OCAS in accordance with regulatory requirements to support dosing recommendations .\\n',\n"," 'METHODS\\tIn this single-dose , randomized , open-label , @-period , parallel-dose-group , crossover study , mirabegron OCAS @ or @ mg was administered orally to healthy adult subjects in the fasted state or after a high - or low-fat breakfast .\\n',\n"," 'METHODS\\tDose administrations were separated by a washout period of at least @ days .\\n',\n"," 'METHODS\\tBlood samples were drawn up to @ hours after dosing , and plasma concentrations of mirabegron were analyzed by LC/MS-MS .\\n',\n"," 'METHODS\\tPK properties were determined using noncompartmental methods .\\n',\n"," 'METHODS\\tPrimary end points for the assessment of food effects were Cmax and AUC@ - .\\n',\n"," \"METHODS\\tFor tolerability assessment , adverse events ( AEs ) were monitored using investigators ' questionnaires and subjects ' spontaneous reports , vital sign measurements , hematology , clinical chemistry , and ECG .\\n\",\n"," 'RESULTS\\tThirty-eight subjects ( male , @ % ; mean age , @ years ; mean weight , @ kg ; race , @ % white ) were enrolled in the @-mg dose group and @ subjects ( male , @ % ; mean age , @ years ; mean weight , @ kg ; race , @ % white ) in the @-mg dose group .\\n',\n"," 'RESULTS\\tWith either fed condition or dose , the @ % CIs for the fed/fasted ratios of both Cmax and AUC@ - of mirabegron fell below the predetermined range for bioequivalence ( @ % -@ % ) , suggesting that food had no effect on exposure to mirabegron OCAS .\\n',\n"," 'RESULTS\\tWith the @-mg dose , mirabegron Cmax was reduced by @ % with a high-fat breakfast compared with fasted conditions ( geometric mean ratio [ GMR ] , @ % [ @ % CI , @ % -@ % ] ) and AUC@ - , by @ % ( GMR , @ % [ @ % CI , @ % -@ % ] ) .\\n',\n"," 'RESULTS\\tWith the @-mg dose , mirabegron Cmax and AUC@ - were reduced by @ % ( GMR , @ % [ @ % CI , @ % -@ % ] ) and @ % ( @ % [ @ % -@ % ] ) , respectively , after a high-fat breakfast .\\n',\n"," 'RESULTS\\tWith the @-mg dose , mirabegron Cmax was decreased by @ % ( GMR , @ % [ @ % CI , @ % -@ % ] ) and AUC@ - by @ % ( @ % [ @ % -@ % ] ) after a low-fat breakfast .\\n',\n"," 'RESULTS\\tCorresponding reductions with the @-mg dose were @ % ( GMR , @ % [ @ % CI , @ % -@ % ] ) for Cmax and @ % ( GMR , @ % [ @ % CI , @ % -@ % ] ) for AUC@ - .\\n',\n"," 'RESULTS\\tThe fed/fasted ratios for mirabegron Cmax and AUC@ - were in general independent of dose or sex .\\n',\n"," 'RESULTS\\tFood delayed Tmax compared with the fasted state , with similar increases with the high - and low-fat meals ( @ hours with @ mg and @-@ @ hours with @ mg ) .\\n',\n"," 'RESULTS\\tMirabegron was generally well tolerated , with no apparent difference in AE frequency between the fasted and fed states .\\n',\n"," 'CONCLUSIONS\\tMirabegron OCAS tablets exhibited a decrease in mirabegron plasma exposure with food that was independent of dose ( @ or @ mg ) or gender but dependent on meal composition .\\n',\n"," 'CONCLUSIONS\\tA greater reduction in mirabegron exposure was observed after a low-fat breakfast compared with after a high-fat breakfast .\\n',\n"," 'CONCLUSIONS\\tBased on findings from previous studies , the effects of food observed in this study do not warrant dose adjustment in clinical practice .\\n',\n"," 'CONCLUSIONS\\tClinicalTrials.gov identifier : NCT@ .\\n',\n"," '\\n',\n"," '###16458629\\n',\n"," 'OBJECTIVE\\tThe purpose of this study was to determine predictors of worsening insulin sensitivity in postmenopausal women .\\n',\n"," 'METHODS\\tSeventy-one nonobese postmenopausal women were assigned randomly to receive hormone replacement therapy ( conjugated estrogens , @ mg , plus medroxyprogesterone acetate , @ mg ) or placebo daily for @ year ( @ women received hormone replacement therapy , and @ women received placebo ) .\\n',\n"," 'METHODS\\tAt baseline and @ months , the women received a computed tomography scan at the L@-L@ vertebral disk space , a dual x-ray absorptiometry scan , a euglycemic hyperinsulinemic clamp to measure insulin sensitivity , and a lipid profile .\\n',\n"," 'METHODS\\tDeclining insulin sensitivity was defined as the largest quartile change in insulin sensitivity in the women who received the placebo ( -@ mg/min/kg lean body mass ) .\\n',\n"," 'RESULTS\\tBy univariate analysis , we found that significant predictors of worsening insulin sensitivity were the use of hormone replacement therapy , baseline insulin sensitivity , a younger age , and < @ years since menopause .\\n',\n"," 'RESULTS\\tBy logistic regression , we determined that hormone replacement therapy use and higher baseline insulin sensitivity were independent predictors of worsening insulin sensitivity .\\n',\n"," 'CONCLUSIONS\\tThe use of hormone replacement therapy and baseline insulin sensitivity are significant independent predictors of the development of worsening insulin sensitivity in postmenopausal women .\\n',\n"," '\\n',\n"," '###24107907\\n',\n"," 'BACKGROUND\\tAblative surgery of oropharyngeal tumors frequently leads to defects in the speech organs , resulting in impairment of speech up to the point of unintelligibility .\\n',\n"," 'BACKGROUND\\tThe aim of the present study was the assessment of selected parameters of speech with and without resection prostheses .\\n',\n"," 'METHODS\\tThe speech sounds of @ patients suffering from maxillary and mandibular defects were recorded using a digital audio tape ( DAT ) recorder with and without resection prostheses .\\n',\n"," 'METHODS\\tEvaluation of the resonance and the production of the sounds / s / , / sch / , and / ch / was performed by @ experienced speech therapists .\\n',\n"," 'METHODS\\tAdditionally , the patients completed a non-standardized questionnaire containing a linguistic self-assessment .\\n',\n"," 'RESULTS\\tAfter prosthesis supply , the number of patients with rhinophonia aperta decreased from @ to @ while the number of patients with intelligible speech increased from @ to @ .\\n',\n"," 'RESULTS\\tCorrect production of the sounds / s / , / sch / , and / ch / increased from @ to @ patients .\\n',\n"," 'RESULTS\\tA significant improvement of the evaluated parameters could be observed only in patients with maxillary defects .\\n',\n"," 'RESULTS\\tThe linguistic self-assessment showed a higher satisfaction in patients with maxillary defects .\\n',\n"," 'CONCLUSIONS\\tIn patients with maxillary defects due to ablative tumor surgery , an increase in speech performance and intelligibility is possible by supplying resection prostheses .\\n',\n"," '\\n',\n"," '###18366490\\n',\n"," 'BACKGROUND\\tMisoprostol is the drug of choice for medical abortion worldwide but consensus is yet to be reached regarding its preferred route of administration .\\n',\n"," 'OBJECTIVE\\tTo compare the outcome of sublingual with vaginal administrations of misoprostol for induction of second trimester abortion .\\n',\n"," 'METHODS\\tA randomised comparative trial where @ women at @-@ weeks gestation , requiring medical abortion , were randomly assigned to sublingual or vaginal route for misoprostol administration with a dose schedule of @ microg three-hourly , up to a maximum five doses over @ h.\\n',\n"," 'METHODS\\tThe same doses were repeated for another @ h in non-responders .\\n',\n"," \"METHODS\\tPrimary outcome measure was complete abortion rate at @ and @ h , and the secondary outcome measures were induction-abortion interval , failure rate , side-effects and patients ' preference to the route .\\n\",\n"," 'RESULTS\\tNo statistically significant differences in the complete abortion rates were observed at @ h ( @ % vs @ % , P = @ ) and at @ h ( @ % vs @ % , P = @ ) when sublingual and vaginal groups were compared .\\n',\n"," 'RESULTS\\tMean induction-abortion intervals in sublingual and vaginal groups were @ and @ h , respectively ( P = @ ) .\\n',\n"," 'RESULTS\\tOther outcome measures were also more or less similar in both groups .\\n',\n"," 'RESULTS\\tDifferences in the incidence of side-effects were also statistically insignificant when both groups were compared .\\n',\n"," 'RESULTS\\tSublingual administration of the drug was preferred by most of the women as compared to vaginal administration ( P < @ ) .\\n',\n"," 'CONCLUSIONS\\tBoth sublingual and vaginal administrations of misoprostol are equally effective in inducing medical abortion during second trimester but sublingual route was preferred by the patients .\\n',\n"," '\\n',\n"," '###10676676\\n',\n"," 'OBJECTIVE\\tTo test the hypothesis that a garlic supplement alters plasma lipoproteins , postprandial lipemia , low-density lipoprotein ( LDL ) size and high-density lipoprotein ( HDL ) subclass distribution differently in @ moderately hypercholesterolemic subjects classified as LDL subclass pattern A or B.\\n',\n"," 'BACKGROUND\\tGarlic has been variably reported to reduce or not affect plasma cholesterol values .\\n',\n"," 'BACKGROUND\\tLow-density lipoprotein pattern B is a common inherited disorder of lipoprotein metabolism that has been shown to have a significantly greater response to several lipid lowering treatments including low fat diet when compared with LDL pattern A individuals .\\n',\n"," 'METHODS\\tA double blind , randomized , placebo controlled trial in an outpatient lipid research clinic was performed and included fifty moderately hypercholesterolemic subjects ( mean LDL cholesterol = @ + / - @ mg/dl ) classified as LDL subclass pattern A ( predominantly large LDL , n = @ ) or B ( predominantly small LDL , n = @ ) .\\n',\n"," 'METHODS\\tFollowing a two-month stabilization period , subjects were randomly assigned to a placebo or @ mg three times a day of a standardized garlic tablet for three months .\\n',\n"," 'RESULTS\\tFor all subjects , LDL pattern A and B subjects combined , garlic treatment for three months resulted in no significant change in total cholesterol , LDL cholesterol , HDL cholesterol , HDL subclass distribution , postprandial triglycerides , apolipoprotein B , lipoprotein ( a ) ( Lp [ a ] ) , LDL peak particle diameter or LDL subclass distribution .\\n',\n"," 'RESULTS\\tThere was no significant difference in response for the same parameters among subjects classified as LDL pattern A or B with the exception of significantly greater ( p = @ ) reduction in mean peak particle diameter in pattern A subjects treated with either garlic or placebo .\\n',\n"," 'RESULTS\\tThere was no significant change in LDL subclass distribution .\\n',\n"," 'CONCLUSIONS\\tThis investigation confirms that garlic therapy has no effect on major plasma lipoproteins and further , that it has no impact on HDL subclasses , Lp ( a ) , apolipoprotein B , postprandial triglycerides or LDL subclass distribution .\\n',\n"," 'CONCLUSIONS\\tGarlic may have a greater effect on LDL particle diameter in LDL pattern A compared with pattern B subjects .\\n',\n"," 'CONCLUSIONS\\tThis difference was not reflected in other plasma lipid measurements .\\n',\n"," '\\n',\n"," '###16427930\\n',\n"," 'BACKGROUND\\tIleoscopy is the criterion standard for mucosal lesions of terminal ileum but is performed in @ % of colonoscopy activity , and the need for training is undefined .\\n',\n"," 'OBJECTIVE\\tTo assess the learning curve and skill-keeping line of ileoscopy .\\n',\n"," 'METHODS\\tProspective randomized study .\\n',\n"," 'METHODS\\tSingle GI endoscopy unit .\\n',\n"," 'METHODS\\tAdult outpatients referred for colonoscopy .\\n',\n"," 'METHODS\\tPatient randomization to ileocolonoscopy by trainees and seniors .\\n',\n"," 'METHODS\\tIleoscopy skill was divided into the following : ileocecal valve ( ICV ) intubation ( success rate , time ) and ileal exploration ( length , time ) .\\n',\n"," 'METHODS\\tConsecutive blocks of @ procedures were used to calculate the learning curve and the skill-keeping line .\\n',\n"," 'METHODS\\tVariables considered to influence ICV intubation were the following : endoscopist experience , ICV morphology , patient age , gender , body mass index , diverticular disease , and preceding abdominal/pelvic surgery .\\n',\n"," 'RESULTS\\tLearning curve showed that competency in ICV intubation ( @ % success rate ) and ileal exploration ( @ cm ) was achieved after @ procedures .\\n',\n"," 'RESULTS\\tThe skill-keeping line showed that ileoscopy was easy ( @ % success rate ) , fast ( @ minute ) , and well accepted up to @ cm of the ileum .\\n',\n"," 'RESULTS\\tThin-lipped and volcanic ICV are the most difficult and easiest to intubate , respectively .\\n',\n"," \"RESULTS\\tCrohn 's disease and adenomas of the proximal edge of ICV were diagnosed in @ % .\\n\",\n"," 'CONCLUSIONS\\tTraining in ileoscopy is recommended to achieve competency , and endoscopists should consider practicing ICV intubation to maintain and increase their skill .\\n',\n"," 'CONCLUSIONS\\tIleoscopy can be difficult when the ICV is thin lipped or single bulged , and easy when it has a volcanic morphology .\\n',\n"," '\\n',\n"," '###16540546\\n',\n"," 'OBJECTIVE\\tTo estimate minimally important differences ( MIDs ) in scores for the modified Rodnan Skin Score ( mRSS ) and Health Assessment Questionnaire-Disability Index ( HAQ-DI ) in a clinical trial on diffuse systemic sclerosis ( SSc ) .\\n',\n"," 'METHODS\\t@ people participated in a @-year , double-blind , randomised clinical trial comparing efficacy of low-dose and high-dose D-penicillamine in diffuse SSc .\\n',\n"," \"METHODS\\tAt @ , @ , @ and @ months , the investigator was asked to rate the change in the patient 's health since entering the study : markedly worsened , moderately worsened , slightly worsened , unchanged , slightly improved , moderately improved or markedly improved .\\n\",\n"," 'METHODS\\tPatients who were rated as slightly improved were defined as the minimally changed subgroup and compared with patients rated as moderately or markedly improved .\\n',\n"," 'RESULTS\\tThe MID estimates for the mRSS improvement ranged from @ to @ ( @-@ @ effect size ) and for the HAQ-DI from @ to @ ( @-@ @ effect size ) .\\n',\n"," 'RESULTS\\tPatients who were rated to improve more than slightly were found to improve by @-@ @ ( @-@ @ effect size ) on the mRSS and @-@ @ ( @-@ @ effect size ) on the HAQ-DI score .\\n',\n"," 'CONCLUSIONS\\tMID estimates are provided for improvement in the mRSS and HAQ-DI scores , which can help in interpreting clinical trials on patients with SSc and be used for sample size calculation for future clinical trials on diffuse SSc .\\n',\n"," '\\n',\n"," '###23169695\\n',\n"," 'OBJECTIVE\\tLong-term pharmacological glucocorticoid ( GC ) therapy leads to skeletal muscle atrophy and weakness .\\n',\n"," 'OBJECTIVE\\tThe objective of this study was to investigate whether short-term treatment with GH and testosterone ( T ) can increase lean mass without major impairment of glucose homoeostasis in patients on GC therapy .\\n',\n"," 'METHODS\\tThis was a prospective , open-label , randomised , crossover study .\\n',\n"," 'METHODS\\tTwelve men ( age @ years ) on chronic GC treatment participated .\\n',\n"," \"METHODS\\tThe effects of @ weeks ' treatment with GH , testosterone and the combination of both on lean body mass ( LBM ) , appendicular skeletal muscle mass ( ASMM ) , extracellular water ( ECW ) , body cell mass ( BCM ) and plasma glucose concentrations were investigated .\\n\",\n"," 'RESULTS\\tLBM increased significantly after GH ( @ kg ; P = @ ) and GH + testosterone ( @ kg ; P = @ ) , but not testosterone alone .\\n',\n"," 'RESULTS\\tASMM increased after all three treatment periods ; by @ kg after GH ( P = @ ) , @ kg after GH + testosterone ( P = @ ) and @ kg after testosterone ( P = @ ) .\\n',\n"," 'RESULTS\\tThe increase in ASMM was larger with combined treatment than either GH or testosterone alone ( P < @ ) .\\n',\n"," 'RESULTS\\tECW increased significantly after GH + testosterone by @ l ( P = @ ) but not after GH or testosterone alone .\\n',\n"," 'RESULTS\\tBCM increased slightly after single and combined treatments , but the changes were not significant .\\n',\n"," 'RESULTS\\tFasting glucose increased significantly after GH ( @ mmol/l , P = @ ) while both fasting ( @ mmol/l , P = @ ) and post glucose-load ( @ mmol/l , P = @ ) plasma glucose concentrations increased after GH + testosterone .\\n',\n"," 'CONCLUSIONS\\tGH and testosterone induce favourable and additive body compositional changes in men on chronic , low-dose GC treatment .\\n',\n"," 'CONCLUSIONS\\tIn the doses used , combination therapy increases fasting and postprandial glucose concentration .\\n',\n"," '\\n',\n"," '###24566233\\n',\n"," 'BACKGROUND\\tUtilization rates ( URs ) for implantable cardioverter-defibrillators ( ICDs ) for primary prevention of sudden cardiac death ( PPSCD ) are lacking in the community .\\n',\n"," 'OBJECTIVE\\tThe purpose of this study was to establish the ICD UR in central Indiana .\\n',\n"," 'METHODS\\tA query run on @ hospitals in a health information exchange database in Indianapolis identified patients between @ and @ with left ventricular ejection fraction ( EF ) @ .\\n',\n"," 'METHODS\\tICD eligibility and utilization were determined from chart review .\\n',\n"," 'RESULTS\\tWe identified @ patients with at least @ low EF study .\\n',\n"," 'RESULTS\\tTwo cohorts were analyzed : @ patients without and @ patients with International Classification of Diseases , Ninth Revision , Clinical Modification procedure code @ for ICD placement .\\n',\n"," 'RESULTS\\tWe manually reviewed a stratified ( by hospital ) random sample of @ patients from the no-ICD procedure code cohort and found that @ ( @ % ) had no ICD but had class I indications for ICD .\\n',\n"," 'RESULTS\\tEight of @ ( @ % ) actually had ICD implantation for PPSCD .\\n',\n"," 'RESULTS\\tReview of all @ patients in the ICD procedure code cohort identified @ with ICD implantation for PPSCD .\\n',\n"," 'RESULTS\\tThe ICD UR ( ratio between patients with ICD for PPSCD and all with indication ) was @ % overall ( @ % confidence interval [ CI ] @ % -@ % ) .\\n',\n"," 'RESULTS\\tURs were @ % for males ( @ % CI @ % -@ % ) , @ % for females ( @ % CI @ % -@ % , P = @ vs males ) , @ % for whites ( @ % CI @ % -@ % ) , and @ % for blacks ( @ % CI @ % -@ % , P = @ vs whites ) .\\n',\n"," 'CONCLUSIONS\\tICD UR is @ % among patients meeting class I indications , suggesting further opportunities for improving guideline compliance .\\n',\n"," 'CONCLUSIONS\\tThis study also illustrates limitations in calculating ICD UR using large electronic repositories without hands-on chart review .\\n',\n"," '\\n',\n"," '###22005747\\n',\n"," \"OBJECTIVE\\tThe study 's purpose was to analyze the effects of exercise training on exercise tolerance and left ventricular systolic function and structure in heart failure patients with preserved , mild , and moderate to severe reduction of left ventricular ejection fraction ( LVEF ) .\\n\",\n"," 'METHODS\\tNinety-eight patients with moderate to severe ( n = @ ) , mild ( n = @ ) , and preserved ( n = @ ) LVEF were randomly assigned to exercise training plus usual care ( n = @ ) or usual care alone ( n = @ ) in a randomization ratio of @:@ .\\n',\n"," 'METHODS\\tLeft ventricular function , left ventricular dimensions , and exercise tolerance were assessed before and after each intervention .\\n',\n"," 'RESULTS\\tExercise tolerance and LVEF increased with exercise training in all patient groups , whereas they remained unchanged after usual care alone .\\n',\n"," 'RESULTS\\tExercise training increased the mean ratio of early to late mitral inflow velocities ( E/A ratio ) and decreased deceleration time ( DT ) of early filling in patients with mild and preserved LVEF .\\n',\n"," 'RESULTS\\tIn patients with moderate to severe systolic dysfunction and advanced diastolic dysfunction ( DT < @ ms ) , exercise training decreased E/A ratio and increased DT , both of which were unchanged after usual care alone .\\n',\n"," 'RESULTS\\tIn the remaining patients ( DT > @ ms ) , exercise training also improved mitral inflow patterns .\\n',\n"," 'RESULTS\\tExercise training decreased left ventricular dimensions in patients with mild and moderate to severe reduction of LVEF but not in patients with preserved LVEF .\\n',\n"," 'CONCLUSIONS\\tThese results indicate that exercise training can improve the course of heart failure independent of the degree of baseline left ventricular dysfunction .\\n',\n"," '\\n',\n"," '###22367233\\n',\n"," 'OBJECTIVE\\tTo investigate the feasibility of implementing a Sleep Education Program ( SEP ) for improving sleep in adult family home ( AFH ) residents with dementia , and the relative efficacy of SEP compared with usual care control in a pilot randomized controlled trial .\\n',\n"," 'METHODS\\tThirty-seven AFH staff-caregivers and @ residents with comorbid dementia and sleep disturbances .\\n',\n"," 'METHODS\\tSEP consisted of four training sessions with staff-caregivers to develop and implement individualized resident behavioral sleep plans .\\n',\n"," 'METHODS\\tTreatment fidelity to the SEP was assessed following the National Institutes of Health ( NIH ) Behavior Change Consortium model utilizing trainer observations and staff-caregiver reports .\\n',\n"," 'METHODS\\tResident sleep was assessed by wrist actigraphy at baseline , @-month posttreatment , and @-month follow-up .\\n',\n"," 'METHODS\\tCaregiver reports of resident daytime sleepiness , depression , and disruptive behaviors were also collected .\\n',\n"," 'RESULTS\\tEach key area of treatment fidelity ( SEP delivery , receipt , enactment ) was identified , measured , and yielded significant outcomes .\\n',\n"," 'RESULTS\\tStaff-caregivers learned how to identify sleep scheduling , daily activity , and environmental factors that could contribute to nocturnal disturbances and developed and implemented strategies for modifying these factors .\\n',\n"," 'RESULTS\\tSEP decreased the frequency and disturbance level of target resident nocturnal behaviors and improved actigraphically measured sleep percent and total sleep time over the @-month follow-up period compared with the control condition .\\n',\n"," 'CONCLUSIONS\\tResults suggest behavioral interventions to improve sleep are feasible to implement in adult family homes and merit further investigation as a promising intervention for use with AFH residents with dementia .\\n',\n"," '\\n',\n"," '###16632233\\n',\n"," 'OBJECTIVE\\tTo compare the effects of prandial insulin therapy focusing on postprandial glucose control vs. basal insulin therapy focusing on fasting glucose control in patients with type @ diabetes .\\n',\n"," 'METHODS\\tThis was an open-label , randomized , parallel , three-arm multicenter trial in patients with type @ diabetes starting insulin treatment .\\n',\n"," 'METHODS\\tPatients ( n = @ ) were randomly assigned to @-week treatment with @x daily insulin lispro , @x daily lispro mid mixture ( MidMix ; @ % lispro , @ % protaminated lispro ) , or @x daily insulin glargine ; oral antihyperglycemic agents were discontinued .\\n',\n"," 'METHODS\\tPrimary end point was the postprandial glucose excursion @ h after breakfast at the end of study .\\n',\n"," 'METHODS\\tSecondary outcomes included HbA@c , self-monitored blood glucose profiles , hypoglycemic episodes , body weight , and patient satisfaction .\\n',\n"," 'RESULTS\\tAt the end of study , glucose excursions @ h after breakfast were significantly lower with lispro and MidMix than with glargine ( P < @ for each vs. glargine ) : lispro , -@ + / -@ mmol/l ; MidMix , +@ + / -@ mmol/l ; glargine , +@ + / -@ mmol/l .\\n',\n"," 'RESULTS\\tFasting glucose decreases were significantly greater with glargine ( -@ + / -@ mmol/l ) than with lispro or MidMix ( -@ + / -@ mmol/l ; +@ + / -@ mmol/l ) .\\n',\n"," 'RESULTS\\tNevertheless , HbA@c decreased by @ % ( lispro ) and @ % ( MidMix ) , vs. @ % with glargine .\\n',\n"," 'RESULTS\\tHypoglycemic episodes were rare with @-@ @ self-reported episodes per @ patient-days .\\n',\n"," 'CONCLUSIONS\\tIn patients with type @ diabetes starting insulin , @x daily prandial treatment with a rapid-acting analog focusing on postprandial glucose values enabled better control of postprandial and circadian blood glucose profiles than once-daily glargine , in spite suboptimal fasting glucose levels , which targets fasting glucose values .\\n',\n"," 'CONCLUSIONS\\tThese results support studies suggesting that control of postprandial hyperglycemia plays a key role in achieving HbA@c targets .\\n',\n"," '\\n',\n"," '###22891807\\n',\n"," 'BACKGROUND\\tFemale sex workers who inject drugs ( FSW-IDUs ) are at risk of acquiring HIV , sexually transmitted infections ( STI ) and blood-borne infections through unprotected sex and sharing injection equipment .\\n',\n"," 'BACKGROUND\\tWe conducted a @ factorial randomized controlled trial to evaluate combination interventions to simultaneously reduce sexual and injection risks among FSW-IDUs in Tijuana and Ciudad Juarez , Mexico .\\n',\n"," 'METHODS\\tFSW-IDUs @ years reporting sharing injection equipment and unprotected sex with clients within the last month were randomized to one of four conditions based on an a priori randomization schedule , blinding interviewer/counselors to assignment .\\n',\n"," 'METHODS\\tDue to the extreme vulnerability of this population , we did not include a control group that would deny some women access to preventive information .\\n',\n"," 'METHODS\\tAll women received similar information regardless of group allocation ; the difference was in the way the information was delivered and the extent to which women had an interactive role .\\n',\n"," 'METHODS\\tEach condition was a single @-minute session , including either an interactive or didactic version of an injection risk intervention and sexual risk intervention .\\n',\n"," 'METHODS\\tWomen underwent interviewer-administered surveys and testing for HIV , syphilis , gonorrhea , Chlamydia , and Trichomonas at baseline and quarterly for @ months .\\n',\n"," 'METHODS\\tCombined HIV/STI incidence will be the primary outcome .\\n',\n"," 'METHODS\\tSecondary outcomes are proportionate reductions in sharing of injection equipment and unprotected sex with clients .\\n',\n"," 'CONCLUSIONS\\tOf @,@ women , @ ( @ % ) were excluded ( @ % were ineligible ; @ % refused to participate or did not return ) ; @ eligible women enrolled ( @ in Tijuana ; @ in Ciudad Juarez ) .\\n',\n"," 'CONCLUSIONS\\tAll @ participants completed the baseline interview , provided biological samples and were randomized to one of the four groups .\\n',\n"," 'CONCLUSIONS\\tDuring follow-up , @ participants ( @ % ) were lost to follow-up , of whom @ ( @ % ) had died , leaving @ participants for analysis .\\n',\n"," 'CONCLUSIONS\\tThis study appears to be the first intervention to attempt to simultaneously reduce injection and sexual risk behaviors among FSW-IDUs .\\n',\n"," 'CONCLUSIONS\\tThe factorial design will permit analysis to determine whether the combination of the two interactive interventions and/or its respective components are effective in reducing injection and/or sexual risks , which will have direct , tangible policy implications for Mexico and potentially other resource-poor countries .\\n',\n"," 'BACKGROUND\\tNCT@ .\\n',\n"," '\\n',\n"," '###16728906\\n',\n"," 'OBJECTIVE\\tTo compare oral risperidone and intramuscular ( IM ) haloperidol , both in combination with IM lorazepam , in the management of acute agitation and psychosis in the medical emergency department .\\n',\n"," 'METHODS\\tIn this prospective , randomized , placebo-controlled , double-blind study of @ patients presenting to the emergency department with acute agitation and/or psychosis , three groups of @ patients received oral and IM medications : @ ) @ mg oral risperidone and @ mg IM lorazepam ; @ ) @ mg oral haloperidol and @ mg IM lorazepam ; @ ) oral placebo and @ mg IM lorazepam .\\n',\n"," 'METHODS\\tEach treatment group received both an injection and a tablet to reduce treatment group variability .\\n',\n"," 'METHODS\\tPatients were evaluated using the Brief Psychiatric Rating Scale ( BPRS ) and the Positive and Negative Syndrome Scale ( PANSS ) before receiving medication and at @ and @ minutes after medication was administered .\\n',\n"," 'METHODS\\tThe intergroup mean percent reductions in rating scale scores were compared using ANOVA , chi-square , and Kruskal-Wallis tests .\\n',\n"," 'RESULTS\\tThere were no statistically significant differences among the groups at any point .\\n',\n"," 'RESULTS\\tThe two groups receiving an antipsychotic plus lorazepam showed a trend towards increased symptom reduction compared with the group receiving lorazepam alone , although this trend was not statistically significant .\\n',\n"," 'CONCLUSIONS\\tLorazepam alone was as effective as lorazepam plus haloperidol or lorazepam plus risperidone in this small trial .\\n',\n"," 'CONCLUSIONS\\tWhile not statistically significant , a trend toward better outcomes with combined treatment warrants further study .\\n',\n"," '\\n',\n"," '###19442372\\n',\n"," 'OBJECTIVE\\tTo prospectively evaluate the efficacy of routine ultrasound-guided fine-needle aspiration cytology ( FNAC ) of thyroid nodules in an endemic area and to analyze the factors influencing it .\\n',\n"," 'METHODS\\tPatients with thyroid nodules were randomly subjected to either conventional palpation-guided fine-needle aspiration cytology ( PFNAC ) or ultrasound-guided fine-needle aspiration cytology ( USFNAC ) .\\n',\n"," 'METHODS\\tThe results of cytology were compared with the final histopathologic diagnosis in @ patients who had undergone surgery .\\n',\n"," 'METHODS\\tThe performance of both methods was individually analyzed in solid nodules , cystic nodules , and solitary and multinodular goitres .\\n',\n"," 'RESULTS\\tOverall , USFNAC showed a significantly higher sensitivity ( @ % vs @ % , p < @ ) , positive predictive value ( @ % vs @ % , p < @ ) , and greater diagnostic accuracy ( @ % vs @ % , p = @ ) compared with PFNAC .\\n',\n"," 'RESULTS\\tThe sensitivity of USFNAC was significantly higher compared with that of PFNAC in cystic and complex nodules ( @ % vs @ % , p < @ ) but not in solid nodules ( @ % vs @ % , p > @ ) .\\n',\n"," 'RESULTS\\tUSFNAC was more sensitive and more accurate than PFNAC for detection of malignancy in multinodular goitres ( @ % vs @ % , p < @ ; @ % vs @ % , p < @ , respectively ) .\\n',\n"," \"CONCLUSIONS\\tThe superiority of `` routine '' USFNAC over PFNAC is mainly due to its better performance in cystic nodules and multinodular goitres .\\n\",\n"," 'CONCLUSIONS\\tHence , routine USFNAC can be recommended in areas where such lesions constitute the majority of thyroid nodules .\\n',\n"," '\\n',\n"," '###21908036\\n',\n"," 'BACKGROUND\\tDalcetrapib modulates cholesteryl ester transfer protein ( CETP ) activity to raise high-density lipoprotein cholesterol ( HDL-C ) .\\n',\n"," 'BACKGROUND\\tAfter the failure of torcetrapib it was unknown if HDL produced by interaction with CETP had pro-atherogenic or pro-inflammatory properties .\\n',\n"," 'BACKGROUND\\tdal-PLAQUE is the first multicentre study using novel non-invasive multimodality imaging to assess structural and inflammatory indices of atherosclerosis as primary endpoints .\\n',\n"," 'METHODS\\tIn this phase @b , double-blind , multicentre trial , patients ( aged @-@ years ) with , or with high risk of , coronary heart disease were randomly assigned ( @:@ ) to dalcetrapib @ mg/day or placebo for @ months .\\n',\n"," 'METHODS\\tRandomisation was done with a computer-generated randomisation code and was stratified by centre .\\n',\n"," 'METHODS\\tPatients and investigators were masked to treatment .\\n',\n"," 'METHODS\\tCoprimary endpoints were MRI-assessed indices ( total vessel area , wall area , wall thickness , and normalised wall index [ average carotid ] ) after @ months and ( @ ) F-fluorodeoxyglucose ( ( @ ) F-FDG ) PET/CT assessment of arterial inflammation within an index vessel ( right carotid , left carotid , or ascending thoracic aorta ) after @ months , with no-harm boundaries established before unblinding of the trial .\\n',\n"," 'METHODS\\tAnalysis was by intention to treat .\\n',\n"," 'METHODS\\tThis trial is registered at ClinicalTrials.gov , NCT@ .\\n',\n"," 'RESULTS\\t@ patients were screened and @ randomly assigned to placebo ( @ patients ) or dalcetrapib ( @ patients ) .\\n',\n"," 'RESULTS\\tFor the coprimary MRI and PET/CT endpoints , CIs were below the no-harm boundary or the adverse change was numerically lower in the dalcetrapib group than in the placebo group .\\n',\n"," 'RESULTS\\tMRI-derived change in total vessel area was reduced in patients given dalcetrapib compared with those given placebo after @ months ; absolute change from baseline relative to placebo was -@ mm ( @ ) ( @ % CI -@ to -@ ; nominal p = @ ) .\\n',\n"," 'RESULTS\\tThe PET/CT measure of index vessel most-diseased-segment target-to-background ratio ( TBR ) was not different between groups , but carotid artery analysis showed a @ % reduction in most-diseased-segment TBR in the dalcetrapib group compared with the placebo group ( -@ [ @ % CI -@ to -@ ] ; nominal p = @ ) .\\n',\n"," 'RESULTS\\tDalcetrapib did not increase office blood pressure and the frequency of adverse events was similar between groups .\\n',\n"," 'CONCLUSIONS\\tDalcetrapib showed no evidence of a pathological effect related to the arterial wall over @ months .\\n',\n"," 'CONCLUSIONS\\tMoreover , this trial suggests possible beneficial vascular effects of dalcetrapib , including the reduction in total vessel enlargement over @ months , but long-term safety and clinical outcomes efficacy of dalcetrapib need to be analysed .\\n',\n"," 'BACKGROUND\\tF Hoffmann-La Roche Ltd. .\\n',\n"," '\\n',\n"," '###24629703\\n',\n"," 'BACKGROUND\\tAlthough limitation of pronation/supination following both-bone forearm fractures in children is often attributed to an angular malunion , no clinical study has compared pronation/supination and angular malalignment of the same child by analysis of prospectively collected clinical data .\\n',\n"," 'OBJECTIVE\\tThe purpose of this trial is to explore whether limitation of pronation/supination can be predicted by the degree of angular malalignment in children who sustained a both-bone forearm fracture .\\n',\n"," 'METHODS\\tIn four Dutch hospitals , children aged @ years with a both-bone forearm fracture were prospectively followed up consecutive children for @-@ months .\\n',\n"," 'METHODS\\tAt the final follow-up , pronation/supination and angular malunion on radiographs were determined .\\n',\n"," 'RESULTS\\tBetween January @ and August @ , a total of @ children were prospectively followed up , of which @ children were included for analysis in this study .\\n',\n"," 'RESULTS\\tThe mean age of the children was @ ( @ ) years , of which @ % were male and @ % fractured their dominant arm .\\n',\n"," 'RESULTS\\tThe mean time to final examination was @ ( @ ) days .\\n',\n"," 'RESULTS\\tChildren with a metaphyseal both-bone fracture of the distal forearm with an angular malalignment of @ had a @-@ % chance of developing a clinically relevant limitation ( i.e. , < @ of pronation and/or supination ) , while children with an angular malalignment of @ had a @ % chance .\\n',\n"," 'RESULTS\\tChildren with diaphyseal both-bone forearm fractures with @ of angular malalignment had a @ % chance of developing a clinically relevant limitation , which showed no significant increase with a further increase of angular malalignment .\\n',\n"," 'CONCLUSIONS\\tChildren who sustained a both-bone forearm fracture localised in the distal metaphysis have a higher chance of developing a clinically relevant limitation of forearm rotation in case of a more severe angular malalignment , while children with a diaphyseal both-bone forearm fracture had a moderate chance of limitation , irrespective of the severity of the angular malalignment .\\n',\n"," '\\n',\n"," '###19960205\\n',\n"," 'BACKGROUND\\tLaparoscopic Nissen fundoplication ( LNF ) has become established as the procedure of choice in the surgical management of the majority of patients suffering from gastroesophageal reflux disease ( GERD ) .\\n',\n"," 'BACKGROUND\\tPostoperative paraesophageal herniation has an incidence range up to @ % in the immediate postoperative period .\\n',\n"," 'OBJECTIVE\\tA prospective randomized trial was scheduled to study the role of posterior gastropexy , in combination with LNF , in prevention of paraesophageal herniation and improvement of postoperative results in surgical treatment of GERD .\\n',\n"," 'METHODS\\tEighty-two patients with GERD were randomized to LNF combined with ( group A , n = @ ) or without ( group B , n = @ ) posterior gastropexy .\\n',\n"," 'METHODS\\tSubjective evaluation using disease-specific and generic questionnaires and structured interviews , and objective evaluation by endoscopy , esophageal manometry , and @-h pH monitoring , were performed before operation , at @ and @ months after surgery , and then every year .\\n',\n"," 'METHODS\\tCrura approximation was performed by stitches if the diameter was less than @ cm , or with a patch to reinforce the conventional crural closure or by tension-free technique to close the hiatus .\\n',\n"," 'METHODS\\tPosterior gastropexy ( group A ) was performed with one stitch between the posterior wall of the wrap and the crura near the arcuate ligament .\\n',\n"," 'RESULTS\\tSixteen patients of group A and @ patients of group B with concomitant abdominal diseases had simultaneous procedures [ cholecystectomy @ , vagotomy @ , ventral hernia repair @ , gastric polypectomy @ , gastric fundus diverticulectomy @ , gastrointestinal stromal tumor ( GIST ) wedge resection @ ] .\\n',\n"," \"RESULTS\\tIn mean follow-up of @ + / - @ months ( range @-@ months ) , one patient of group B presented with paraesophageal herniation in the first postoperative month ( reoperation ) , while recurrent gastroesophageal reflux ( Visick III or IV ) , successfully treated by medication , was noted in three patients of group B and in one patient of group A. Only mild dysphagia , during the first two postoperative months , was noted in nine patients of group A and eight patients of group B. Six patients of each group with Barrett 's esophagus had endoscopic improvement after the second postoperative month .\\n\",\n"," 'RESULTS\\tVisick score in groups A/B was I in @/@ ( P < @ ) , II in @/@ ( P = @ ) , III in @/@ ( not significant , NS ) , and IV in @/@ .\\n',\n"," 'RESULTS\\tGenerally , Visick score was I or II in @/@ in groups A/B ( @ % / @ % , NS ) and III or IV in @/@ ( @ % / @ % , P < @ ) .\\n',\n"," 'CONCLUSIONS\\tLNF combined with posterior gastropexy may prevent postoperative paraesophageal or sliding herniation in surgical treatment of GERD , providing better early and long-term postoperative results .\\n',\n"," 'CONCLUSIONS\\t( Registered Clinical Trial number : NCT@ .\\n',\n"," 'CONCLUSIONS\\twww.clinicaltrials.gov . )\\n',\n"," '\\n',\n"," '###23410885\\n',\n"," 'BACKGROUND\\tVitamin D deficiency is common in the general public and athletic populations and may impair skeletal muscle function .\\n',\n"," 'BACKGROUND\\tWe therefore assessed the effects of vitamin D@ supplementation on serum @ [ OH ] D concentrations and physical performance .\\n',\n"," 'METHODS\\t@ club-level athletes were block randomised ( using baseline @ [ OH ] D concentrations ) into one of three groups receiving either a placebo ( PLB ) , @ @ or @ @ IU/week oral vitamin D@ for @ weeks .\\n',\n"," 'METHODS\\tSerum @ [ OH ] D and muscle function ( @-RM bench press and leg press and vertical jump height ) were measured presupplementation , @ and @ weeks postsupplementation .\\n',\n"," 'METHODS\\tVitamin D deficiency was defined in accordance with the US Institute of Medicine guideline ( < @ nmol/l ) .\\n',\n"," 'RESULTS\\t@ % of the subject population were vitamin D deficient at baseline ( meanSD value @ nmol/l ) .\\n',\n"," 'RESULTS\\tFollowing @ and @ weeks supplementation with @ @ IU ( @ and @ nmol/l , respectively ) or @ @ IU vitamin D@ ( @ and @ nmol/l , respectively ) , serum vitamin D concentrations increased in all participants , with every individual achieving concentrations greater than @ nmol/l .\\n',\n"," 'RESULTS\\tIn contrast , vitamin D concentration in the PLB group decreased at @ and @ weeks ( @ and @ nmol/l , respectively ) .\\n',\n"," 'RESULTS\\tIncreasing serum @ [ OH ] D had no significant effect on any physical performance parameter ( p > @ ) .\\n',\n"," 'CONCLUSIONS\\tBoth @ @ and @ @ IU vitamin D@ supplementation over a @-week period elevates serum @ [ OH ] D concentrations above @ nmol/l , but neither dose given for @ weeks improved our chosen measures of physical performance .\\n',\n"," '\\n',\n"," '###18822974\\n',\n"," 'OBJECTIVE\\tTo probe into the clinical therapeutic effect of acupuncture on coronary heart disease complicated by type @ diabetes mellitus ( CDM ) and the mechanism .\\n',\n"," 'METHODS\\tUsing multi-central , randomized , controlled and blind methods , @ cases of CDM were divided into an observation group and a control group , @ cases in each group .\\n',\n"," 'METHODS\\tThey were treated by routine therapy for diabetes mellitus , and in the observation group , acupuncture at Quchi ( LI @ ) , Hegu ( LI @ ) , Xuehai ( SP @ ) , Zusanli ( ST @ ) , Yinlingquan ( SP @ ) , Fenglong ( ST @ ) .\\n',\n"," 'METHODS\\tDiji ( SP @ ) , Sanyinjiao ( SP @ ) , etc. were added with the needling method for regulating spleen-stomach ; while in the control group , acupuncture was given at Weiwanxiashu ( EX-B @ ) , Feishu ( BL @ ) , Pishu ( BL @ ) , Shenshu ( BL @ ) , Yanglingquan ( GB @ ) , etc. .\\n',\n"," 'METHODS\\tThe treatment was given twice a day in the two groups .\\n',\n"," 'METHODS\\tClinical therapeutic effects were assessed according to clinical symptoms and signs , frequency and lasting time of angina pectoris , quantity of taking Glycerol Trinitrate , blood sugar , blood lipids , urinary albumin excretion rate , urinary beta@-microglobulin , urinary monocyte chemotactic protein-@ ( MCP-@ ) , ECG , heart color Doppler , etc. .\\n',\n"," 'RESULTS\\tThe needling method for regulating spleen-stomach not only could improve the symptoms and signs of the patient , but also could improve the degree of ST segment moving down and the function of left artrium relaxation , and had benign regulative effect on glycometabolism , lipids metabolism and urinary albumin level , with significant differences as compared with the control group ( P < @ or P < @ ) .\\n',\n"," 'RESULTS\\tThe markedly effective rate for improvement of ECG was @ % in the observation group and @ % in the control group .\\n',\n"," 'CONCLUSIONS\\tThe needling method for regulating spleen-stomach can improve the damage of heart and blood vessels induced by abnormal sugar and lipids , decrease the level of urinary protein , inhibit MCP-@ excessive expression , relieve myocardial load and raise cardiac output in the patient of coronary heart disease complicated by type @ diabetes mellitus .\\n',\n"," '\\n',\n"," '###16308853\\n',\n"," 'BACKGROUND\\tUse of blue dye alone as a marker for sentinel lymph node ( SLN ) biopsy is effective , but combining it with isotope marking can improve the success rate .\\n',\n"," 'BACKGROUND\\tUse of the isotope adds extra cost and there are potential radiation hazards .\\n',\n"," 'BACKGROUND\\tThe two techniques were compared in a randomized trial .\\n',\n"," 'METHODS\\tWomen with early breast cancer ( less than @ cm ) and no palpable axillary nodes were recruited .\\n',\n"," 'METHODS\\tWomen older than @ years with multicentric cancers or previous surgery to the breast or axilla were excluded .\\n',\n"," 'METHODS\\tPatients were randomized to either blue dye alone or combined mapping for SLN biopsy .\\n',\n"," 'METHODS\\tAll women had a level I and II axillary dissection after the SLN biopsy .\\n',\n"," 'RESULTS\\tA total of @ patients were recruited , of whom five were excluded from analysis .\\n',\n"," 'RESULTS\\tBlue dye alone was used in @ women and @ had combined mapping .\\n',\n"," 'RESULTS\\tBaseline demographic data were similar in the two cohorts .\\n',\n"," 'RESULTS\\tThe success rate of SLN biopsy was higher with combined mapping than with blue dye alone ( @ versus @ per cent ; P = @ ) .\\n',\n"," 'RESULTS\\tThe accuracy and false-negative rate were similar ( accuracy @ per cent for combined mapping versus @ per cent for blue dye ; false-negative rate @ versus @ per cent ) .\\n',\n"," 'CONCLUSIONS\\tCombined mapping was superior to blue dye alone in identification of the SLN , but accuracy and false-negative rates were similar .\\n',\n"," '\\n',\n"," '###22624776\\n',\n"," 'BACKGROUND\\tKnowledge translation ( KT ) research in long-term care ( LTC ) is still in its early stages .\\n',\n"," 'BACKGROUND\\tThis protocol describes the evaluation of a multifaceted , interdisciplinary KT intervention aimed at integrating evidence-based osteoporosis and fracture prevention strategies into LTC care processes .\\n',\n"," 'METHODS\\tThe Vitamin D and Osteoporosis Study ( ViDOS ) is underway in @ LTC homes ( n = @ intervention , n = @ control ) across Ontario , Canada .\\n',\n"," 'METHODS\\tThe primary objectives of this study are to assess the feasibility of delivering the KT intervention , and clinically , to increase the percent of LTC residents prescribed @ IU of vitamin D daily .\\n',\n"," 'METHODS\\tEligibility criteria are LTC homes that are serviced by our partner pharmacy provider and have more than one prescribing physician .\\n',\n"," 'METHODS\\tThe target audience within each LTC home is the Professional Advisory Committee ( PAC ) , an interdisciplinary team who meets quarterly .\\n',\n"," 'METHODS\\tThe key elements of the intervention are three interactive educational sessions led by an expert opinion leader , action planning using a quality improvement cycle , audit and feedback reports , nominated internal champions , and reminders/point-of-care tools .\\n',\n"," 'METHODS\\tControl homes do not receive any intervention , however both intervention and control homes received educational materials as part of the Ontario Osteoporosis Strategy .\\n',\n"," 'METHODS\\tPrimary outcomes are feasibility measures ( recruitment , retention , attendance at educational sessions , action plan items identified and initiated , internal champions identified , performance reports provided and reviewed ) , and vitamin D ( @ IU/daily ) prescribing at @ and @ months .\\n',\n"," 'METHODS\\tSecondary outcomes include the proportion of residents prescribed calcium supplements and osteoporosis medications , and falls and fractures .\\n',\n"," 'METHODS\\tQualitative methods will examine the experience of the LTC team with the KT intervention .\\n',\n"," 'METHODS\\tHomes are centrally randomized to intervention and control groups in blocks of variable size using a computer generated allocation sequence .\\n',\n"," 'METHODS\\tRandomization is stratified by home size and profit/nonprofit status .\\n',\n"," 'METHODS\\tPrescribing data retrieval and analysis are performed by blinded personnel .\\n',\n"," 'CONCLUSIONS\\tOur study will contribute to an improved understanding of the feasibility and acceptability of a multifaceted intervention aimed at translating knowledge to LTC practitioners .\\n',\n"," 'CONCLUSIONS\\tLessons learned from this study will be valuable in guiding future research and understanding the complexities of translating knowledge in LTC .\\n',\n"," '\\n',\n"," '###24036634\\n',\n"," 'OBJECTIVE\\tTo describe the psychometric properties and identify the minimally important difference ( MID ) of the hepatitis C virus patient-reported outcomes ( HCV-PRO ) instrument .\\n',\n"," 'OBJECTIVE\\tChronic HCV infection and associated treatments negatively affect PROs of function and well-being .\\n',\n"," 'METHODS\\tIn a phase @ trial , HCV-infected patients received direct-acting antivirals ( DAAs ) for @weeks with peg-interferon/ribavirin ( peg-IFN/RBV ) for @weeks , or placebo plus peg-IFN/RBV .\\n',\n"," 'METHODS\\tThe HCV-PRO total score , SF-@ PCS and MCS scores , EQ-@D-@L , and EQ VAS were measured at baseline , week @ , end of DAA treatment ( EODT ) , end of peg-IFN/RBV treatment ( EOT ) , and posttreatment week @ ( SVR@ ) .\\n',\n"," \"METHODS\\tConvergent validity of the HCV-PRO was assessed by Pearson 's correlation coefficients .\\n\",\n"," 'METHODS\\tDiscriminant validity was assessed by analyzing mean HCV-PRO total scores by EQ-@D anxiety/depression and pain/discomfort domain scores ( none vs. some ) and presence/absence of depression or fatigue adverse events .\\n',\n"," 'METHODS\\tMID was identified through effect size ( ES ) and receiver-operating characteristic ( ROC ) curve analyses ( HCV-PRO response vs. SF-@ PCS/MCS and EQ VAS MID thresholds ) .\\n',\n"," 'RESULTS\\tIn @ patients ( @ % female ; @ % White ; @ % @years ) , correlations ( @-@ @ ) between HCV-PRO total scores , SF-@ PCS/MCS scores , and EQ VAS scores at all time points supported convergent validity .\\n',\n"," 'RESULTS\\tHCV-PRO total scores were reduced to @-@ points in patients impaired by depression , pain , or fatigue symptoms .\\n',\n"," 'RESULTS\\tImpact of peg-IFN/RBV regimen on HCV-PRO ES increased over time ( EODT -@ ; EOT -@ ) .\\n',\n"," 'RESULTS\\tES and ROC curve analyses indicated an MID of -@ points .\\n',\n"," 'CONCLUSIONS\\tThe HCV-PRO was valid and responsive in the population studied .\\n',\n"," 'CONCLUSIONS\\tAn MID of -@ points represented a threshold of clinical significance for the HCV-PRO .\\n',\n"," '\\n',\n"," '###15622577\\n',\n"," 'BACKGROUND\\tSevere fecal incontinence remains a disabling condition for the patient and a major therapeutic challenge for the physician .\\n',\n"," 'BACKGROUND\\tA series of observational studies have indicated that placement of an artificial bowel sphincter is associated with marked improvement of continence and quality of life .\\n',\n"," 'BACKGROUND\\tWe have performed a prospective , randomized , controlled trial to evaluate the effect of placement of an artificial bowel sphincter ( Acticon Neosphincter ) on continence and quality of life in a group of severely incontinent adults .\\n',\n"," 'METHODS\\tFourteen adults ( male : female , @:@ ; age range , @-@ years ) were randomized to placement of the artificial bowel sphincter or to a program of supportive care and were followed for six months from operation or entry into the study .\\n',\n"," 'METHODS\\tThe principal outcome measure was the level of continence , measured with the Cleveland Continence Score , which provides a scale from @ to @ , representing perfect control through to total incontinence .\\n',\n"," 'METHODS\\tSecondary outcome measures were perioperative and late complications in the artificial bowel sphincter group , and the changes in quality of life in both groups .\\n',\n"," 'RESULTS\\tIn the control group , the Cleveland Continence Score was not significantly altered , with an initial value of @ + / - @ and a final value of @ + / - @ at six months .\\n',\n"," 'RESULTS\\tThe artificial bowel sphincter group showed a highly significant improvement , changing from @ + / - @ before placement to @ + / - @ at six months after placement .\\n',\n"," 'RESULTS\\tOne patient in the artificial bowel sphincter group had failure of healing of the perineal wound and explantation of the device ( @ percent explantation rate ) .\\n',\n"," 'RESULTS\\tThere were two other significant perioperative events of recurring fecal impaction initially after placement in one patient and additional suturing of the perineal wound in another .\\n',\n"," 'RESULTS\\tThere were major improvements in the quality of life for all measures in the artificial bowel sphincter group .\\n',\n"," 'RESULTS\\tThere was significant improvement in all eight subscales of the Medical Outcome Study Short Form-@ measures .\\n',\n"," 'RESULTS\\tThe American Medical Systems Quality of Life score was raised from @ + / - @ to @ + / - @ and the Beck Depression Inventory showed reduction from a level of mild depression ( @ + / - @ ) to a normal value ( @ + / - @ ) .\\n',\n"," 'RESULTS\\tNo significant changes in any of the quality of life measures occurred for the control group .\\n',\n"," 'CONCLUSIONS\\tThrough a prospective , randomized trial format , we have shown that placement of an artificial bowel sphincter is safe and effective when compared with supportive care alone .\\n',\n"," 'CONCLUSIONS\\tPerioperative and late problems are likely to continue to occur and between @ percent and @ percent of patients may require permanent explantation .\\n',\n"," 'CONCLUSIONS\\tFor the remainder , the device is easy and discrete to use , highly effective in achieving continence , and able to generate a major improvement in the quality of life .\\n',\n"," '\\n',\n"," '###23218801\\n',\n"," 'OBJECTIVE\\tStatins are known to reduce plasma C-reactive protein ( CRP ) concentrations .\\n',\n"," 'OBJECTIVE\\tOur goal was to define the mechanisms by which CRP was reduced by maximal dose atorvastatin .\\n',\n"," 'METHODS\\tEight subjects with combined hyperlipidemia ( @ men and @ postmenopausal women ) were enrolled in a randomized , placebo-controlled double-blind , cross over study .\\n',\n"," 'METHODS\\tSubjects underwent a @-h primed-constant infusion with deuterated leucine after @ weeks of placebo and @mg/day of atorvastatin .\\n',\n"," 'METHODS\\tCRP was isolated from lipoprotein deficient plasma , ( density > @ g/ml ) by affinity chromatography .\\n',\n"," 'METHODS\\tIsotopic enrichment was determined by gas chromatography/mass spectrometry .\\n',\n"," 'METHODS\\tKinetic parameters were determined using compartmental modeling .\\n',\n"," 'METHODS\\tPaired t test and Wilcoxon signed ranks test were used to compare differences between placebo and atorvastatin .\\n',\n"," 'RESULTS\\tCompared with placebo , atorvastatin decreased median CRP pool size by @ % ( @ vs @ mg ; p = @ ) , associated with a median CRP fractional catabolic rate increase of @ % ( @ vs @ pools/day ; p = @ ) , with no significant effect on median CRP production rate ( @ vs @ mg/kg/day ; p = @ ) .\\n',\n"," 'CONCLUSIONS\\tOur data indicate that maximal doses of atorvastatin lower plasma CRP levels by substantially decreasing the median CRP plasma residence time from @ days to @ days , with no significant effect on the median CRP production rate .\\n',\n"," '\\n',\n"," '###8117360\\n',\n"," 'OBJECTIVE\\tTo compare the influence on blood pressure , glucose , and lipid levels of a diet rich in monounsaturated fatty acids with an isocaloric , high-carbohydrate diet in @ NIDDM subjects .\\n',\n"," 'METHODS\\tA crossover design with diet interventions and wash-out periods of @ wk was applied .\\n',\n"," 'METHODS\\tThe patients were randomly assigned to a @-wk treatment with a high-carbohydrate diet containing @ % of energy as carbohydrate and @ % of energy as fat ( @ % of energy as monounsaturated fatty acids ) or an isocaloric diet with @ % of energy as carbohydrate and @ % of energy as fat ( @ % of energy as monounsaturated fatty acids ) .\\n',\n"," 'METHODS\\tOn the last day of the two diets , @-h ambulatory blood pressure was measured and day profiles of glucose , hormones , and lipids were performed to a test menu rich in carbohydrates .\\n',\n"," 'RESULTS\\tThe diet rich in monounsaturated fat reduced daytime systolic ( @ + / - @ vs. @ + / - @ mmHg , P < @ ) and @-h systolic blood pressure ( @ + / - @ vs. @ + / - @ mmHg , P < @ ) as well as daytime diastolic ( @ + / - @ vs. @ + / - @ mmHg , P < @ ) and diurnal diastolic blood pressure ( @ + / - @ vs. @ + / - @ mmHg , P < @ ) as compared with the high-carbohydrate diet .\\n',\n"," 'RESULTS\\tEvidence of lowered blood glucose levels on the high-monounsaturated diet compared with the high-carbohydrate diet were found with lower fasting blood glucose ( @ + / - @ vs. @ + / - @ mM , P < @ ) , lower average blood glucose levels ( @ + / - @ vs. @ + / - @ mM , P < @ ) , and peak blood glucose responses ( @ + / - @ vs. @ + / - @ mM , P < @ ) .\\n',\n"," 'RESULTS\\tThe two diets had the same impact on lipid levels .\\n',\n"," 'CONCLUSIONS\\tA diet rich in monounsaturated fat has beneficial effects on blood pressure and glucose metabolism , whereas no adverse effects on lipid composition in NIDDM subjects is detected .\\n',\n"," '\\n',\n"," '###22193396\\n',\n"," 'BACKGROUND\\tThe injection of stem cells in the context of acute myocardial infarction ( AMI ) has been tested almost exclusively by anterograde intra-arterial coronary ( IAC ) delivery .\\n',\n"," 'BACKGROUND\\tThe retrograde intravenous coronary ( IVC ) delivery may be an additional route .\\n',\n"," 'OBJECTIVE\\tTo compare the cell distribution and retention pattern in the anterograde and retrograde routes .\\n',\n"," 'OBJECTIVE\\tTo investigate the role of microvascular obstruction by magnetic resonance imaging in cell retention by cardiac tissue after the injection of bone marrow mononuclear cells ( BMMC ) in AMI .\\n',\n"," 'METHODS\\tThis was a prospective , open label , randomized study .\\n',\n"," 'METHODS\\tPatients with AMI who presented : ( @ ) successful chemical or mechanical reperfusion within @ hours of symptom onset and ( @ ) infarction involving more than @ % of the left ventricle ( LV ) at the myocardial scintigraphy were included in the study .\\n',\n"," 'METHODS\\tOne hundred million BMMC were injected into the infarction-related artery through IAC route , or vein through the IVC route .\\n',\n"," 'METHODS\\tOne percent of the injected cells were labeled with @mTc-hexamethyl-propylene-amine-oxime ( @mTc-HMPAO ) .\\n',\n"," 'METHODS\\tCell distribution was evaluated at @ and @ hours after the myocardial scintigraphy injection .\\n',\n"," 'METHODS\\tCardiac magnetic resonance imaging was performed before cell injection .\\n',\n"," 'RESULTS\\tThirty patients were randomized into three groups .\\n',\n"," 'RESULTS\\tThere were no serious adverse events related to the procedure .\\n',\n"," 'RESULTS\\tThe early and late retention of labeled cells was higher in the IAC group than in IVC group , regardless of the presence of microcirculation obstruction .\\n',\n"," 'CONCLUSIONS\\tThe injection using the retrograde approach was feasible and safe .\\n',\n"," 'CONCLUSIONS\\tCell retention by cardiac tissue was higher using the anterograde approach .\\n',\n"," 'CONCLUSIONS\\tMore studies are needed to confirm these findings .\\n',\n"," '\\n',\n"," '###22249909\\n',\n"," 'BACKGROUND\\tMaximal consumption of oxygen ( VO ( @ ) max ) during exercise is used in patients with chronic obstructive pulmonary disease ( COPD ) to stratify perioperative risk .\\n',\n"," 'BACKGROUND\\tHowever , the impact of therapeutic hyperoxia ( i.e. , use of supplemental oxygen to prevent hypoxemia during exercise ) on ( VO ( @ ) max and other ventilatory parameters during maximal exercise in the resting normoxic COPD population is poorly defined .\\n',\n"," 'METHODS\\tA randomized , double-blind crossover study was performed in which resting normoxic subjects ( n = @ ) with COPD underwent two standard symptom-limited , ramped-protocol bicycle ergometry cardiopulmonary exercise tests > @ days apart with FiO ( @ ) of @ ( control ) and ~ @ ( therapeutic hyperoxia ) .\\n',\n"," 'METHODS\\tVO ( @ ) max and other ventilatory parameters were compared using a paired two-sample t-test .\\n',\n"," 'RESULTS\\tTherapeutic hyperoxia significantly increased VO ( @ ) max ( @ @ vs. @ @ ml/kg/min , P = @ ) , partial pressure of end-tidal carbon dioxide , and oxygen saturation and significantly decreased VE-VCO ( @ ) slope , but it did not affect exercise time , maximum watts achieved , maximum minute ventilation , or change in end-expiratory lung volume .\\n',\n"," 'RESULTS\\tThree of four subjects with VO ( @ ) max < @ ml/kg/min without supplemental oxygen increased VO ( @ ) max to @ ml/kg/min on therapeutic hyperoxia and potentially changed perioperative risk category .\\n',\n"," 'CONCLUSIONS\\tTherapeutic hyperoxia in a resting normoxic COPD population significantly improves VO ( @ ) max and may change perioperative risk stratification by conventional criteria .\\n',\n"," 'CONCLUSIONS\\tFurther studies are needed to determine if this change in stratification is appropriate .\\n',\n"," '\\n',\n"," '###1384949\\n',\n"," 'BACKGROUND\\tSurvivors of advanced Hodgkin disease , who were assigned randomly to treatment by mechlorethamine , vincristine , procarbazine , and prednisone ( MOPP ) ; doxorubicin , bleomycin , vinblastine , and dacarbazine ( ABVD ) ; or MOPP alternating with ABVD in a clinical trial of the Cancer and Leukemia Group B ( protocol @ ) , were compared in terms of their psychosocial adaptation and psychosexual function an average of @ years after completion of treatment ( range , @-@ years ) .\\n',\n"," 'BACKGROUND\\tThe study was undertaken to determine if there were differences among treatments in these functional areas as a consequence of differential long-term gonadal damage in the three regimens .\\n',\n"," 'METHODS\\tNinety-three disease-free survivors of advanced Hodgkin disease ( @ men and @ women ) were studied ( a minimum of @ year after completion of treatment ) by an interview conducted over the telephone .\\n',\n"," 'METHODS\\tStandardized measures were used to assess their psychologic , sexual , family , and vocational functioning , including the following tests : the Psychosocial Adjustment to Illness Scale -- Self Report , the Brief Symptom Inventory , the Profile of Mood States , and the Impact of Event Scale .\\n',\n"," \"RESULTS\\tContrary to expectation , no statistically significant differences in survivors ' psychosocial adaptation or psychosexual function were found by treatment arm .\\n\",\n"," \"RESULTS\\tInfertility ( based on survivors ' reports of medical test results and perceptions ) and lower income @ year before the diagnosis of cancer were significant predictors of poorer adjustment .\\n\",\n"," 'RESULTS\\tMost survivors reported a range of problems that they attributed to having had cancer : @ % , proven or perceived infertility ; @ % , sexual problems ; @ % , health and life insurance problems ; @ % , a negative socioeconomic effect ; and @ % , conditioned nausea , associated with visual or olfactory reminders of chemotherapy .\\n',\n"," 'CONCLUSIONS\\tNo significant long-term advantage in psychosocial adaptation or psychosexual function was found for survivors of Hodgkin disease treated by the less gonadally toxic ABVD regimen @ to @ years after completion of treatment .\\n',\n"," '\\n',\n"," '###7868872\\n',\n"," 'BACKGROUND\\tCalcitonin gene-related peptide is a pleiotropic neuropeptide with potent vasodilatory properties , which interferes with renin release and might participate in cardiovascular homeostasis .\\n',\n"," 'METHODS\\tWe studied the influence of salt intake on the plasma concentration of calcitonin gene-related peptide , parathyroid hormone and on the renin-aldosterone system in @ patients with mild hypertension .\\n',\n"," 'METHODS\\tEach participant was studied after @ week of high salt intake ( @ mmol/day ) and after @ week of low salt intake ( @ mmol/day ) .\\n',\n"," 'METHODS\\tThe order of the two diet periods was randomized and crossover .\\n',\n"," 'METHODS\\tPlasma calcitonin gene-related peptide concentration was measured by radioimmunoassay after pre-extraction by reverse chromatography .\\n',\n"," 'METHODS\\tSeven patients were classified as salt-sensitive and eight as salt-resistant .\\n',\n"," 'RESULTS\\tIn the whole group the low salt intake caused a significant decrease in arterial pressure and the expected increase in plasma renin activity and in plasma aldosterone concentration .\\n',\n"," 'RESULTS\\tSuch changes were accompanied by a significant increase in plasma calcitonin gene-related peptide .\\n',\n"," 'RESULTS\\tIn salt-resistant patients in the sodium-replete state calcitonin gene-related peptide levels tended to be reduced in comparison with salt-sensitive patients .\\n',\n"," 'RESULTS\\tSodium depletion , however , caused a more pronounced rise in plasma calcitonin gene-related peptide in salt-resistant hypertensives , who attained levels close to those in salt-sensitive hypertensives .\\n',\n"," 'RESULTS\\tInterestingly , in salt-resistant hypertensives changes in plasma calcitonin gene-related peptide were closely related to plasma renin activity ( r = @ , P = @ ) , whereas no such correlation was found in salt-sensitive patients .\\n',\n"," 'RESULTS\\tParathyroid hormone was not influenced by changes in salt intake .\\n',\n"," 'CONCLUSIONS\\tIn subjects with mild hypertension calcitonin gene-related peptide is sensitive to changes in salt intake in the physiological range .\\n',\n"," 'CONCLUSIONS\\tSuch a response seems to be linked to the individual arterial pressure response to salt , because salt-resistant patients showed reduced calcitonin gene-related peptide levels in the sodium-replete state and a more pronounced calcitonin gene-related peptide increase , closely related to plasma renin activity , during sodium deprivation .\\n',\n"," '\\n',\n"," '###19777852\\n',\n"," 'OBJECTIVE\\tTo make a study of the effect of Chaihu Shihuang soup on blood serum level TNF , IL-@ and IL-@ of severe acute pancratitis .\\n',\n"," 'METHODS\\tSixty SAP cases were divided at random into treatment group and control group ( @ cases each ) .\\n',\n"," 'METHODS\\tThe treatment group were given chai-hu-shi-huang-soup once a day ; the control group were given Dachaihu soup once daily , with both treatment period for @ days .\\n',\n"," 'METHODS\\tThe tumor necrosis factor-alpha ( TNF-alpha ) , interleukin level @ ( IL-@ ) and @ ( IL-@ ) of both groups were determined before and after the treatment .\\n',\n"," 'METHODS\\tWe also had @ healthy cases .\\n',\n"," 'RESULTS\\tIL-@ level in both groups was lower than healthy group while TNF-alpha and IL-@ were higher than healthy group ( P < @ ) .\\n',\n"," \"RESULTS\\tAfter treatment , the treatment group 's TNF-alpha , IL-@ level were comparatively lower than that in the control group ( P < @ ) , and IL-@ level were clearly higher than that of the control group ( P < @ ) , comparison of the treatment group before treatment ( P < @ ) .\\n\",\n"," 'CONCLUSIONS\\tChaihu Shihuang soup can significantly regulate cytokine and improve early recovery of SAP .\\n',\n"," '\\n',\n"," '###24361227\\n',\n"," 'BACKGROUND\\tPaclitaxel and gemcitabine ( PG ) combination chemotherapy is effective as a maintenance chemotherapeutic regimen in metastatic breast cancer ( MBC ) patients because it increases progression-free survival ( PFS ) , which increases overall survival ( OS ) .\\n',\n"," 'BACKGROUND\\tThe primary purpose of our study was to investigate the association between genetic polymorphisms in the genes involved in PG pathways and clinical outcomes in MBC patients treated with PG chemotherapy .\\n',\n"," 'METHODS\\tA total of @ MBC patients were enrolled in this prospective multicenter trial of PG as the first-line chemotherapy .\\n',\n"," 'METHODS\\tEighty-five of the @ patients from two institutes were available for analysis of single nucleotide polymorphisms ( SNPs ) .\\n',\n"," 'METHODS\\tGermline DNA was extracted from peripheral blood mononuclear cells .\\n',\n"," 'METHODS\\tThirty-eight SNPs in @ candidate genes selected from pathways that may influence the metabolism and transport of , or sensitivity , to PG were analysed .\\n',\n"," 'RESULTS\\tThe median PFS and OS of all @ patients were @ months ( @ % confidence interval [ CI ] : @-@ @ months ) and @ months ( @ % CI : @-@ @ months ) , respectively .\\n',\n"," 'RESULTS\\tAn SNP in SLC@A@ ( rs@ , C/T ) was associated with OS ( CC or CT versus TT : @ versus @ months , p = @ , hazard ratio [ HR ] @ , @ % CI : @-@ @ ) .\\n',\n"," 'RESULTS\\tSLC@A@ GA haplotype had a significantly shorter OS ( p = @ , HR @ , @ % CI : @-@ @ ) .\\n',\n"," 'RESULTS\\tRRM@ ( ribonucleotide reductase large subunit M@ ) SNP ( rs@ ) , and haplotypes ATAA and ATGA were significantly associated with neurotoxicity .\\n',\n"," 'CONCLUSIONS\\tGenetic polymorphisms in SLC@A@ , SLC@A@ and RRM@ can influence the clinical outcome of MBC patients treated with PG chemotherapy .\\n',\n"," 'CONCLUSIONS\\tFurther studies on the functional mechanisms relating to these germline polymorphisms in these genes are warranted .\\n',\n"," '\\n',\n"," '###23460711\\n',\n"," 'OBJECTIVE\\tElderly patients form a heterogeneous population .\\n',\n"," \"OBJECTIVE\\tEvaluation of geriatric factors may help evaluate a patient 's health status to better adapt treatment .\\n\",\n"," 'METHODS\\tElderly patients with previously untreated metastatic colorectal cancer ( mCRC ) were randomly assigned to receive fluorouracil ( FU ) - based chemotherapy either alone or in combination with irinotecan ( IRI ) in the Fdration Francophone de Cancrologie Digestive ( FFCD ) @-@ study .\\n',\n"," 'METHODS\\tSites participating in the geriatric substudy completed geriatric screening tools to perform prognostic factor analyses for treatment safety during the first @ months after treatment initiation .\\n',\n"," 'RESULTS\\tThe geriatric score was calculated in @ patients ( @ % ) .\\n',\n"," 'RESULTS\\tMedian age was @ years ( range , @ to @ years ) .\\n',\n"," 'RESULTS\\tThe Charlson comorbidity index was @ in @ % , Mini-Mental State Examination ( MMSE ) score was @/@ in @ % , and Instrumental Activities of Daily Living ( IADL ) showed impairment in @ % of the patients .\\n',\n"," 'RESULTS\\tSeventy-one patients ( @ % ) had grade @ to @ toxicity , @ ( @ % ) had a dose-intensity reduction of more than @ % , and @ ( @ % ) had at least one unexpected hospitalization during the first @ months after starting treatment .\\n',\n"," 'RESULTS\\tIn multivariate analysis , significant predictive factors for grade @-@ toxicity were IRI arm ( odds ratio [ OR ] , @ ) , MMSE @/@ ( OR , @ ) , and impaired IADL ( OR , @ ) ; for dose-intensity reduction of > @ % , the significant predictive factors were alkaline phosphates > @ upper limit of normal ( OR , @ ) and IRI arm ( OR , @ ) ; and for unexpected hospitalization , significant predictive factors were MMSE @/@ ( OR , @ ) and Geriatric Depression Scale @ ( OR , @ ) .\\n',\n"," 'CONCLUSIONS\\tGeriatric factors ( MMSE and IADL ) are predictive of severe toxicity or unexpected hospitalization ( MMSE ) in a randomized prospective phase III study in mCRC .\\n',\n"," 'CONCLUSIONS\\tThese results suggest that cognitive function and autonomy impairment should be taken into account when choosing a regimen for chemotherapy .\\n',\n"," '\\n',\n"," '###1905621\\n',\n"," 'OBJECTIVE\\tTo study the effect of aldose reductase inhibition with ponalrestat on resistance to ischemic conduction block ( RICB ) in diabetic subjects .\\n',\n"," 'METHODS\\tTwenty-one healthy diabetic subjects without neuropathy were studied .\\n',\n"," 'METHODS\\tSubjects were randomized to take either a double-blind trial of @ mg ponalrestat or placebo once daily for @ wk .\\n',\n"," 'METHODS\\tThe median nerve action potential ( MNAP ) and conduction velocity ( NCV ) , before and after @ min of forearm ischemia , were measured at the start and finish of the study .\\n',\n"," 'RESULTS\\tRICB ( MNAP remaining after ischemia ) decreased from @ to @ % in the ponalrestat-treated group ( P less than @ ) and increased from @ + / - @ to @ + / - @ % in the placebo-treated group .\\n',\n"," 'RESULTS\\tMNAP and NCV were unchanged in both groups .\\n',\n"," 'CONCLUSIONS\\tAldose reductase inhibition with ponalrestat partly reverses RICB in diabetes , perhaps by improving nerve hypoxia or reducing nerve energy substrates .\\n',\n"," '\\n',\n"," '###23967878\\n',\n"," 'BACKGROUND\\tPain is a common symptom of chronic fatigue syndrome ( CFS ) .\\n',\n"," 'BACKGROUND\\tWe investigated the effects of the treatments used in the PACE trial [ cognitive behavioural therapy ( CBT ) , graded exercise therapy ( GET ) , adaptive pacing therapy ( APT ) and specialist medical care ( SMC ) ] on pain in CFS .\\n',\n"," 'METHODS\\tWe compared pain outcomes including individual painful symptoms , taken from the CDC criteria for CFS and co-morbid fibromyalgia .\\n',\n"," 'METHODS\\tWe modelled outcomes adjusting for baseline variables with multiple linear regression .\\n',\n"," 'RESULTS\\tSignificantly less frequent muscle pain was reported by patients following treatment with CBT compared to SMC ( mean difference = @ unit change in frequency , p = @ ) , GET versus SMC ( @ , p = @ ) and GET versus APT ( @ , p = @ ) .\\n',\n"," 'RESULTS\\tSignificantly less joint pain was reported following CBT versus APT ( @ , p = @ ) and GET versus APT ( @ , p = @ ) .\\n',\n"," 'RESULTS\\tCo-morbid fibromyalgia was less frequent following GET versus SMC ( @ , p = @ ) .\\n',\n"," 'RESULTS\\tThe effect sizes of these differences varied between @ and @ for muscle pain and @ and @ for joint pain .\\n',\n"," \"RESULTS\\tTreatment effects on pain were independent of ` change in fatigue ' .\\n\",\n"," 'CONCLUSIONS\\tCBT and GET were more effective in reducing the frequency of both muscle and joint pain than APT and SMC .\\n',\n"," 'CONCLUSIONS\\tWhen compared to SMC , GET also reduced the frequency of co-morbid fibromyalgia ; the size of this effect on pain was small .\\n',\n"," '\\n',\n"," '###25833972\\n',\n"," 'BACKGROUND\\tPoor nutritional quality of complementary foods often limits growth .\\n',\n"," 'BACKGROUND\\tAnimal source foods , such as milk or meat , are often unaffordable .\\n',\n"," 'BACKGROUND\\tLocal affordable alternatives are needed .\\n',\n"," 'OBJECTIVE\\tWe evaluate the efficacy of @ newly developed , rice-based complementary food products : WinFood ( WF ) with small fish and edible spiders and WinFood-Lite ( WF-L ) fortified with small fish , against @ existing fortified corn-soy blend products , CSB + ( purely plant based ) and CSB + + ( @ % dried skimmed milk ) .\\n',\n"," 'METHODS\\tIn total , @ infants aged @ mo were enrolled in this randomized , single-blinded study for @ mo , designed primarily to assess increments in fat-free mass by a deuterium dilution technique and change in plasma ferritin and soluble transferrin receptor .\\n',\n"," 'METHODS\\tSecondary endpoints were changes in anthropometric variables , including knee-heel length .\\n',\n"," 'METHODS\\tData were analyzed by the intention-to-treat approach .\\n',\n"," 'RESULTS\\tThere was no difference in fat-free mass increment in WF or WF-L compared with CSB + [ WF : +@ kg ( @ % CI : -@ , @ kg ) ; WF-L : +@ kg ( @ % CI : -@ , @ kg ) ] or CSB + + [ WF : -@ kg ( @ % CI : -@ , @ kg ) ; WF-L : +@ kg ( @ % CI : -@ , @ kg ) ] and no effect on iron status .\\n',\n"," 'RESULTS\\tThe @-mm ( @ % CI : -@ , @ mm ) greater increase in knee-heel length in WF-L than in CSB + was not significant .\\n',\n"," 'CONCLUSIONS\\tNo difference was found between the locally produced products ( WF and WF-L ) and the CSBs .\\n',\n"," 'CONCLUSIONS\\tMicronutrient fortification may be necessary , and small fish may be an affordable alternative to milk to improve complementary foods .\\n',\n"," 'CONCLUSIONS\\tThe dietary role of edible spiders needs to be further explored .\\n',\n"," 'CONCLUSIONS\\tThis trial was registered at controlled-trials .\\n',\n"," 'CONCLUSIONS\\tcom as ISRCTN@ .\\n',\n"," '\\n',\n"," '###24184063\\n',\n"," 'OBJECTIVE\\tThis study investigated the effect of contingent electrical stimulation ( CES ) on present pain intensity ( PI ) , pressure pain threshold ( PPT ) , and electromyographic events per hour of sleep ( EMG/h ) on probable bruxers with masticatory myofascial pain .\\n',\n"," 'METHODS\\tThe study enrolled @ probable bruxers with masticatory myofascial pain in @ phases : ( @ ) baseline EMG/h recording , ( @ ) biofeedback treatment using a CES paradigm ( active group , n = @ ) or inactive device ( control group , n = @ ) , and ( @ ) posttreatment EMG/h recording .\\n',\n"," 'METHODS\\tPI and PPT were assessed after each phase .\\n',\n"," 'METHODS\\tAnalysis of variance models were used to compare results at a @ % significance level .\\n',\n"," 'RESULTS\\tPatients in the active group had @ % lower EMG/h in P@ and @ % lower EMG/h in P@ , when compared with baseline .\\n',\n"," 'RESULTS\\tThere were no differences in PI or PPT levels at any phase .\\n',\n"," 'CONCLUSIONS\\tCES could reduce EMG activity associated with sleep bruxism in patients with masticatory myofascial pain but did not influence perceived pain .\\n',\n"," '\\n',\n"," '###21742094\\n',\n"," 'BACKGROUND\\tMortality after ST-elevation myocardial infarction ( STEMI ) has reduced with reperfusion by primary percutaneous coronary intervention ( PCI ) , which may have impacted on the adverse outcomes of cardiogenic shock ( CS ) and congestive heart failure ( CHF ) .\\n',\n"," 'RESULTS\\tIn the APEX-AMI trial , @,@ patients with STEMI and planned primary PCI were randomly assigned pexelizumab or matching placebo .\\n',\n"," 'RESULTS\\tPost-randomization CS or CHF was adjudicated by a clinical endpoints committee .\\n',\n"," 'RESULTS\\tTreatment assignment to pexelizumab did not influence either endpoint or mortality rates .\\n',\n"," 'RESULTS\\tCardiogenic shock developed in @ patients ( @ % ) at a median of @ hours ( interquartile range @-@ @ ) post-randomization , and mortality at @ days was @ % .\\n',\n"," 'RESULTS\\tCongestive heart failure occurred in @ of patients ( @ % ) at a median of @ days ( IQR @-@ @ ) , and mortality through @ days was @ % ; mortality among those with neither endpoint was @ % .\\n',\n"," 'RESULTS\\tPatients with CS or CHF were older , were more often female , and had more hypertension and diabetes , but smoked less compared with non-CS/CHF patients ( all P < @ ) .\\n',\n"," 'RESULTS\\tIndependent mortality predictors among those with CS or CHF were hyperlipidemia and a history of angina ( interaction P = @ and @ , respectively ) ; procedural predictors among survivors to PCI were pre-PCI Thrombolysis In Myocardial Infarction ( TIMI ) flow @-@ and post-PCI TIMI flow < @ ( P = @ and < @ , respectively ) .\\n',\n"," 'CONCLUSIONS\\tSurvival after CS remains poor despite aggressive reperfusion .\\n',\n"," 'CONCLUSIONS\\tBoth CS and CHF remain the major causes of death among STEMI patients undergoing primary PCI .\\n',\n"," 'CONCLUSIONS\\tFuture studies should examine treatments that aim to reduce mortality in these highest risk patients .\\n',\n"," '\\n',\n"," '###23297810\\n',\n"," 'BACKGROUND\\tInappropriate use of antidepressants ( AD ) , defined as either continuation in the absence of a proper indication or continuation despite the lack of therapeutic efficacy , applies to approximately half of all long term AD users .\\n',\n"," 'METHODS\\tWe have designed a cluster randomized controlled clinical trial to assess the ( cost - ) effectiveness of an antidepressant cessation advice in the absence of a proper indication for maintenance treatment with antidepressants in primary care.We will select all patients using antidepressants for over @ months from @ general practices .\\n',\n"," 'METHODS\\tPatients will be diagnosed using the Composite International Diagnostic Interview ( CIDI ) version @ , extended with questions about the psychiatric history and previous treatment strategies .\\n',\n"," 'METHODS\\tGeneral practices will be randomized to either the intervention or the control group .\\n',\n"," 'METHODS\\tIn case of overtreatment , defined as the absence of a proper indication according to current guidelines , a cessation advice is given to the general practitioner .\\n',\n"," 'METHODS\\tIn the control groups no specific information is given .\\n',\n"," 'METHODS\\tThe primary outcome measure will be the proportion of patients that successfully discontinue their antidepressants at one-year follow-up .\\n',\n"," 'METHODS\\tSecondary outcomes are dimensional measures of psychopathology and costs .\\n',\n"," 'CONCLUSIONS\\tThis study protocol provides a detailed overview of the design of the trial .\\n',\n"," 'CONCLUSIONS\\tStudy results will be of importance for refining current guidelines .\\n',\n"," 'CONCLUSIONS\\tIf the intervention is effective it can be used in managed care programs .\\n',\n"," 'BACKGROUND\\tNTR@ .\\n',\n"," '\\n',\n"," '###24687165\\n',\n"," 'OBJECTIVE\\tRecent studies show that cerebral - amyloid ( A ) deposition is associated with blood pressure and measures of arterial stiffness in nondemented individuals .\\n',\n"," 'OBJECTIVE\\tTo examine the association between measures of arterial stiffness and change in A deposition over time .\\n',\n"," 'METHODS\\tDeposition of A was determined in a longitudinal observational study of aging by positron emission tomography using the Pittsburgh compound B twice @ years apart in @ nondemented individuals @ years and older .\\n',\n"," 'METHODS\\tArterial stiffness was measured with a noninvasive and automated waveform analyzer at the time closest to the second positron emission tomography scan .\\n',\n"," 'METHODS\\tAll measures were performed under standardized conditions .\\n',\n"," 'METHODS\\tPulse wave velocity ( PWV ) was measured in the central ( carotid-femoral and heart-femoral PWV ) , peripheral ( femoral-ankle PWV ) , and mixed ( brachial-ankle PWV ) vascular beds .\\n',\n"," 'METHODS\\tThe change in A deposition over @ years was calculated from the @ individuals with repeat A-positron emission tomography .\\n',\n"," 'RESULTS\\tThe proportion of A-positive individuals increased from @ % at baseline to @ % at follow-up .\\n',\n"," 'RESULTS\\tBrachial-ankle PWV was significantly higher among A-positive participants at baseline and follow-up .\\n',\n"," 'RESULTS\\tFemoral-ankle PWV was only higher among A-positive participants at follow-up .\\n',\n"," 'RESULTS\\tMeasures of central stiffness and blood pressure were not associated with A status at baseline or follow-up , but central stiffness was associated with a change in A deposition over time .\\n',\n"," 'RESULTS\\tEach standard deviation increase in central stiffness ( carotid-femoral PWV , P = @ ; heart-femoral PWV , P = @ ) was linked with increases in A deposition over @ years .\\n',\n"," 'CONCLUSIONS\\tThis study showed that A deposition increases with age in nondemented individuals and that arterial stiffness is strongly associated with the progressive deposition of A in the brain , especially in this age group .\\n',\n"," 'CONCLUSIONS\\tThe association between A deposition changes over time and generalized arterial stiffness indicated a relationship between the severity of subclinical vascular disease and progressive cerebral A deposition .\\n',\n"," '\\n',\n"," '###19078934\\n',\n"," 'BACKGROUND\\tIn a low socioeconomic-status population of Latina women , we evaluated the potential of storytelling ( ST ) as a culturally aligned narrative method to promote colorectal cancer ( CRC ) prevention and screening , compared to a risk tool ( RT ) - based intervention .\\n',\n"," 'METHODS\\tSeventy-eight women were randomized in this pilot study to one of two brief interventions to communicate CRC risk reduction options : ST or an RT. .\\n',\n"," 'METHODS\\tMeasures of behavioral intentions relative to CRC prevention and screening were obtained following the intervention .\\n',\n"," 'RESULTS\\tMean scores for intent to obtain and recommend endoscopy to others were significantly better for participants receiving ST than RT ( P = @ and P = @ , respectively ) .\\n',\n"," 'RESULTS\\tAll participants expressed intent to increase fruit and vegetable consumption and physical activity in response to interventions .\\n',\n"," 'RESULTS\\tPost-intervention perceptions of cancer risk and fear of CRC were not significantly different for participants receiving ST compared with RT. .\\n',\n"," 'RESULTS\\tPre - to post-intervention perceptions of risk increased in ST and decreased in RT , while decreases in fear were similar across both intervention groups .\\n',\n"," 'CONCLUSIONS\\tStorytelling may be an effective approach for changing CRC risk-related behavioral intentions among Latinas .\\n',\n"," 'CONCLUSIONS\\tMediating factors ( such as perceived risk or fear ) often used to predict behavior change may not adequately explain the potential persuasive mechanisms of storytelling .\\n',\n"," '\\n',\n"," '###17520382\\n',\n"," 'OBJECTIVE\\tTo evaluate enhanced recovery after surgery ( ERAS ) protocol in colorectal surgery .\\n',\n"," 'METHODS\\tFrom september @ to February @ , @ patients with colorectal cancer were randomly assigned to ERAS group and control group .\\n',\n"," 'METHODS\\tThe stress index , nutrition and metabolism index , intraoperative index and postoperative index were evaluated .\\n',\n"," 'RESULTS\\tSix patients were excluded , @ in ERAS group ( @ cases received hepatectomy concomitantly and @ case received partial ileum resection ) , and @ in control group ( @ case received hepatectomy and @ case received colorectomy concomitantly , another presented asthma paroxysm ) .\\n',\n"," 'RESULTS\\tSo there were @ cases in ERAS group and @ cases in control , with no statistical differences in sex , age , BMI index and operation types .\\n',\n"," 'RESULTS\\tDeviation of HOMA-IR index of ERAS was lower than the control ( P > @ ) , the same as plasma cortisol at the @st day after operation ( P < @ ) , but plasma glucagons in the operation of ERAS group was higher than that of control ( P < @ ) .\\n',\n"," 'RESULTS\\tPlasma glucose @st day after operation of ERAS group was lower than control ( P < @ ) , while plasma triglyceride intraoperation , at @st day , @nd day after operation of ERAS was higher than control ( P < @ ) .\\n',\n"," 'RESULTS\\tNitrogen negative balance of ERAS group was higher than control at @nd day after surgery , but is lower intraoperation and at @th day after operation ( P < @ ) .\\n',\n"," 'RESULTS\\tThe time of exhaust gas and stool , time to eat fluidity and semi-fluidity , out-of-bed time and exercise time per-day , residual time and complication rate in ERAS group were better than those of control ( P < @ ) .\\n',\n"," 'RESULTS\\tPost-operative expenses of ERAS was lower than that of control ( P < @ ) .\\n',\n"," 'CONCLUSIONS\\tERAS can decrease surgical stress , increase functional recovery and reduce complication rate .\\n',\n"," '\\n',\n"," '###11390121\\n',\n"," 'OBJECTIVE\\tTo demonstrate equivalent efficacy for menopausal symptoms between Aerodiol nasal spray and reference oral estradiol therapy , and to investigate the endometrial safety and tolerability of Aerodiol in the long term .\\n',\n"," 'METHODS\\tThe efficacy of Aerodiol @ microg , once daily , was compared with oral estradiol @ mg/day in a randomized , double-blind trial .\\n',\n"," 'METHODS\\tA statistical test of noninferiority was performed on the mean absolute Kupperman index ( KI ) obtained after @ and @ weeks of the two treatments .\\n',\n"," 'METHODS\\tLong-term safety was assessed in a @-year open-label study .\\n',\n"," 'METHODS\\tThe initial Aerodiol dose was @ microg/day , and was adjusted if required .\\n',\n"," 'METHODS\\tEndometrial biopsies were obtained at inclusion and at the end of the trial and examined independently by two pathologists .\\n',\n"," 'RESULTS\\tIn the equivalence trial , the KI improved similarly in the Aerodiol group ( n = @ ) and the oral estradiol group ( n = @ ) .\\n',\n"," 'RESULTS\\tAerodiol was shown statistically to be at least as effective as oral therapy ( P < @ ) , but the incidences of mastalgia and withdrawal bleeding were significantly lower in the Aerodiol group ( P < @ and P < @ , respectively ) .\\n',\n"," 'RESULTS\\tIn the long-term safety trial ( n = @ ) , the rate of Aerodiol treatment continuation at @ months was @ % , and there was no incidence of endometrial hyperplasia or cancer .\\n',\n"," 'RESULTS\\tAerodiol dose adaptation was performed by @ % of women .\\n',\n"," 'CONCLUSIONS\\tAerodiol was shown to have equivalent efficacy to reference oral estradiol therapy , but with better gynaecological acceptability .\\n',\n"," 'CONCLUSIONS\\tThe endometrial safety of Aerodiol was confirmed in the long term , and the ability to adjust the dosage easily was of benefit to a substantial proportion of women .\\n',\n"," '\\n',\n"," '###20369533\\n',\n"," 'OBJECTIVE\\tTo observe the operative technique and clinical effects of hidden tension suture after tibiofibular fracture fixation with absorbable thread .\\n',\n"," 'METHODS\\tFrom October @ to October @ , @ patients ( @ sides ) with tibiofibular fracture underwent hidden tension suture ( test group , @ cases of @ sides ) and the common interrupted suture ( control group , @ cases of @ sides ) , including @ males and @ females with an median age of @ years ( @-@ years ) .\\n',\n"," 'METHODS\\tFracture was caused by traffic accident in @ cases , by heavy bruise in @ cases , and by falling from height in @ cases .\\n',\n"," 'METHODS\\tThere were @ cases of single-side fracture , and @ cases of double-side fracture .\\n',\n"," 'METHODS\\tOf them , @ sides were closed fracture , and @ sides were open fracture ( including @ sides of type I , @ sides of type II , and @ sides of type IIIA according to Gustilo classification for the open fracture ) .\\n',\n"," 'METHODS\\tThe locations were upper tibia in @ sides , middle tibia in @ sides , and lower tibia in @ sides .\\n',\n"," 'METHODS\\tThe X-ray films showed that there were transverse fractures in @ sides , oblique fractures in @ sides , spiral fractures in @ sides , and comminuted fractures in @ sides .\\n',\n"," 'METHODS\\tNo blood vessel injury , osteofascial compartment syndrome and pressure syndrome were observed .\\n',\n"," 'METHODS\\tThe time from injury to operation was @ hours to @ days with an average of @ days .\\n',\n"," 'METHODS\\tOf @ sides , @ sides were fixed by interlocking nails , others by internal steel plate .\\n',\n"," 'RESULTS\\tIn control group , healing by first intention was achieved in @ cases ( @ % ) and healing by secondary intention in @ cases ( @ % ) ; in test group , healing by first intention was achieved in @ cases ( @ % ) and healing by secondary intention in @ cases ( @ % ) ; and showing significant difference ( P < @ ) .\\n',\n"," 'RESULTS\\tAll patients were followed up for @ months to @ years ( average @ months ) .\\n',\n"," 'RESULTS\\tNo complication occurred in test group , and scar was obvious in the control group .\\n',\n"," 'CONCLUSIONS\\tThe hidden tension suture with absorbable thread can be a good alternative for the incision healing after tibiofibular fracture fixation .\\n',\n"," 'CONCLUSIONS\\tIt deals with the problems of the incision tension and difficult-to-suture , and is good for the incision healing after operation .\\n',\n"," '\\n',\n"," '###21641516\\n',\n"," 'OBJECTIVE\\tTo observe the effect of regular yogic practices and self-discipline in reducing body fat and elevated lipids in CAD patients .\\n',\n"," 'METHODS\\tIn this study one hundred seventy ( @ ) subjects , of both sexes having coronary artery disease were randomly selected form Department of Cardiology .\\n',\n"," 'METHODS\\tSubjects were divided in to two groups randomly in yoga group and in non-yoga group , eighty five ( @ ) in each group .\\n',\n"," 'METHODS\\tOut of these ( @ subjects ) , one hundred fifty four ( @ ) completed the study protocol .\\n',\n"," 'METHODS\\tTIME LINE : The yogic intervention consisted of @-@ min/day , five days in a week till six months in the Department of Physiology CSMMU UP Lucknow .\\n',\n"," 'METHODS\\tBody fat testing and estimation of lipid profile were done of the both groups at zero time and after six months of yogic intervention in yoga group and without yogic intervention in non yoga group .\\n',\n"," 'RESULTS\\tIn present study , BMI ( p < @ ) , fat % ( p < @ ) , fat free mass ( p < @ ) , SBP ( p < @ ) , DBP ( p < @ ) , heart rate ( p < @ ) , total cholesterol ( p < @ ) , triglycerides ( p < @ ) , HDL ( p < @ ) and low density lipoprotein ( p < @ ) were changed significantly .\\n',\n"," 'CONCLUSIONS\\tReduction of SBP , DBP , heart rate , body fat % , total cholesterol , triglycerides and LDL after regular yogic practices is beneficial for cardiac and hypertensive patients .\\n',\n"," 'CONCLUSIONS\\tTherefore yogic practices included in this study are helpful for the patients of coronary artery disease .\\n',\n"," '\\n',\n"," '###20131031\\n',\n"," 'OBJECTIVE\\tTo observe the effect of Chinese medicine therapy for strengthening-Pi and nourishing-Shen ( SPNS ) in preventing lamivudine induced YMDD mutation and its immunological mechanism .\\n',\n"," 'METHODS\\tOne hundred and sixty chronic hepatitis B ( CHB ) patients with positive HBeAg were equally assigned to two groups at random : the observation group and the control group .\\n',\n"," 'METHODS\\tPatients in the observation group were treated with lamivudine combined with SPNS , and those in the control group were treated with lamivudine only , with the treatment lasting for @ weeks in total .\\n',\n"," 'METHODS\\tChanges in indexes , including liver function , HbeAg , HBV-DNA , YMDD variation , CD ( @ ) , CD ( @ ) / CD ( @ ) ratio , interferon-gamma ( IFN-gamma ) , interleukin-@ ( IL-@ ) , blood routine , renal function , as well as any adverse reactions that occurred in patients , were observed at different time points .\\n',\n"," 'RESULTS\\tThe ALT , AST recovery rate and HBV-DNA negatively inversing rate at the @th week , the @th week and the @nd week were all higher ( P < @ ) ; meanwhile , the YMDD mutation rate at the @th week and the @nd week was lower ( P < @ ) in the observation group than in the control group .\\n',\n"," 'RESULTS\\tThe posttreatment levels of CD ( @ ) , CD ( @ ) / CD ( @ ) ratio , IFN-gamma , and IL-@ as well as the pre-post treatment difference of these indexes in the observation group were significantly different from those in the control group ( P < @ ) .\\n',\n"," 'CONCLUSIONS\\tChinese medicine SPNS therapy can significantly reduce the YMDD variation of HBV , and the mechanism may be related to its regulation of the CD ( @ ) level , CD ( @ ) / CD ( @ ) ratio and Th@/Th@ balance .\\n',\n"," '\\n',\n"," '###7694528\\n',\n"," 'BACKGROUND\\tInhaled anesthetics can alter the arrhythmogenicity of exogenously administered epinephrine .\\n',\n"," 'BACKGROUND\\tAlthough swine anesthetized with desflurane or isoflurane do not differ in their arrhythmic response to exogenous epinephrine , the relative effect of epinephrine in the presence of these anesthetics in humans is untested .\\n',\n"," 'METHODS\\tThe authors compared the arrhythmogenicity of submucosally administered epinephrine in @ ASA physical status @ and @ patients undergoing transsphenoidal resection of pituitary tumors who were randomly assigned to receive @-@ @ MAC desflurane or isoflurane anesthesia .\\n',\n"," 'METHODS\\tA surgeon , blinded to the administered anesthetic and the concentration of epinephrine , injected @:@,@ , @:@,@ , or @:@,@ ( @ , @ , or @ micrograms/ml ) epinephrine in saline of volumes sufficient for surgical need .\\n',\n"," 'METHODS\\tThe authors defined a positive response as three or more premature ventricular contractions ( PVCs ) in the @ min after starting the injection .\\n',\n"," 'RESULTS\\tNo patient given either anesthetic developed any PVCs with epinephrine doses less than @ micrograms/kg .\\n',\n"," 'RESULTS\\tGreater doses of epinephrine ( @-@ @ micrograms/kg ) produced positive responses at equal frequencies in the two anesthetic groups .\\n',\n"," 'CONCLUSIONS\\tThe authors concluded that isoflurane and desflurane do not differ in their sensitization of human myocardium to the arrhythmogenic effects of exogenously administered epinephrine .\\n',\n"," '\\n',\n"," '###15769772\\n',\n"," 'BACKGROUND\\tBlack subjects with a family history of premature coronary heart disease ( CHD ) have a marked excess risk , yet barriers prevent effective risk reduction .\\n',\n"," \"BACKGROUND\\tWe tested a community-based multiple risk factor intervention ( community-based care [ CBC ] ) and compared it with `` enhanced '' primary care ( EPC ) to reduce CHD risk in high-risk black families .\\n\",\n"," 'RESULTS\\tBlack @ - to @-year-old siblings of a proband with CHD aged < @ years were randomized for care of BP > or = @/@ mm Hg , LDL cholesterol > or = @ mmol/L , or current smoking to EPC ( n = @ ) or CBC ( n = @ ) and monitored for @ year .\\n',\n"," 'RESULTS\\tEPC and CBC were designed to eliminate barriers to care .\\n',\n"," 'RESULTS\\tThe CBC group received care by a nurse practitioner and a community health worker in a community setting .\\n',\n"," 'RESULTS\\tThe CBC group was @ times more likely to achieve goal levels of LDL cholesterol and blood pressure compared with the EPC group ( @ % CI , @ to @ and @ to @ , respectively ) with adjustment for baseline levels of age , sex , education , and baseline use of medications .\\n',\n"," 'RESULTS\\tThe CBC group demonstrated a significant reduction in global CHD risk , whereas no reduction was seen in the EPC group ( P < @ ) .\\n',\n"," 'CONCLUSIONS\\tEliminating known barriers may not be sufficient to reduce CHD risk in primary care settings .\\n',\n"," 'CONCLUSIONS\\tAn alternative community care model that addresses barriers may be a more effective way to ameliorate CHD risk in high-risk black families .\\n',\n"," '\\n',\n"," '###22793957\\n',\n"," 'OBJECTIVE\\tThis study was undertaken to compare the healing outcome of a short period ( @ weeks ) of intermaxillary fixation ( IMF ) with conventional ( @-@ weeks ) IMF in the management of fractures of the mandibular tooth-bearing area .\\n',\n"," 'METHODS\\tThis was a randomized controlled study conducted at the Lagos University Teaching Hospital , Lagos , Nigeria , between November @ and January @ .\\n',\n"," 'METHODS\\tSubjects with minimally displaced mandibular fractures in the tooth-bearing area were randomly allocated into @ treatment groups : IMF for @ weeks ( study group ) or IMF for @ to @ weeks ( control group ) .\\n',\n"," 'METHODS\\tFor the purpose of study analysis , the primary predictor variable was the treatment ( IMF for @ weeks vs IMF for @-@ weeks ) .\\n',\n"," 'METHODS\\tOther predictor variables were the age and gender of subjects .\\n',\n"," 'METHODS\\tThe primary healing outcome was considered either satisfactory or unsatisfactory .\\n',\n"," 'METHODS\\tThe following outcome variables that described the healing process were also compared in the @ groups : healing time , postoperative infection , paresthesia , and maximal interincisal opening .\\n',\n"," 'METHODS\\tLoss of body weight and oral hygiene status at the end of treatment were compared in the @ groups .\\n',\n"," 'METHODS\\tA value of P < @ was considered significant .\\n',\n"," 'RESULTS\\tSatisfactory healing was observed in all cases in both groups .\\n',\n"," 'RESULTS\\tHowever , satisfactory healing was observed earlier ( @ @ weeks ) in the control group than in patients with the short IMF period ( @ @ weeks ) ( P < @ ) .\\n',\n"," 'RESULTS\\tMalocclusion that was amenable to selective grinding was the only complication seen in both groups ( n = @ in study group and n = @ in control group ) ( P = @ ) .\\n',\n"," 'RESULTS\\tSubjects in the control group lost more weight after treatment than those in the study group ( P < @ ) .\\n',\n"," 'RESULTS\\tThe recovery of interincisal mouth opening was also better in the study group than in the control group ( P < @ ) .\\n',\n"," 'RESULTS\\tThe study group had better oral hygiene than the control group at the end of treatment .\\n',\n"," 'CONCLUSIONS\\tThe healing outcome was comparable in both groups .\\n',\n"," 'CONCLUSIONS\\tHowever , the healing time was significantly longer in the group with the short IMF period .\\n',\n"," 'CONCLUSIONS\\tThe recovery of maximal mouth opening , oral hygiene status , and loss of weight body in the study group were significantly better than those in the control group .\\n',\n"," 'CONCLUSIONS\\tThis study suggests that a short period ( @ weeks ) of IMF in the management of minimally displaced mandibular fractures of the tooth-bearing area in young adults is a suitable alternative to the conventional method in terms of the healing outcome .\\n',\n"," '\\n',\n"," '###21294416\\n',\n"," 'OBJECTIVE\\tTo be a preliminary , prospective , randomized double blinded , placebo-controlled trial to evaluate the efficacy of Morinda citrifolia Linn or noni for the prevention of postoperative nausea and vomiting ( PONV ) in patients considered high risk for PONV after various types of surgery .\\n',\n"," 'METHODS\\tThe plant extract was prepared by boiling of dried noni fruit ( maturity stage @-@ ) then evaporated under standard procedure and processed into capsules .\\n',\n"," 'METHODS\\tThe doses were @ mg , @ mg and @ mg which are equivalent to @ , @ and @ g of dried noni fruit , respectively .\\n',\n"," 'METHODS\\tOne hundred patients of ASA physical status I or II , aged @-@ years , and considered at risk for PONV , were randomized to receive @ , @ , @ mg of noni extract or a placebo orally @ hours before surgery .\\n',\n"," 'METHODS\\tStandard general anesthetic technique and postoperative analgesia were employed .\\n',\n"," 'RESULTS\\tSignificantly fewer patients who had received the @ mg noni extract experienced nausea during the first @ hours compared to the placebo group ( @ % for the @ mg noni group and @ % for the placebo group , p-value = @ ) .\\n',\n"," 'RESULTS\\tThe incidence of PONV in other time periods was not statistically different for all three noni doses compared to the placebo group .\\n',\n"," 'RESULTS\\tNo side effects were reported in all groups .\\n',\n"," 'CONCLUSIONS\\tMorinda citrifolia Linn .\\n',\n"," 'CONCLUSIONS\\thas an antiemetic property and prophylactic noni extract at @ mg ( equivalent to @g of dried noni fruit or scopoletin @ microg ) effectively reduces the incidence of early postoperative nausea ( @-@ hours ) .\\n',\n"," '\\n',\n"," '###19262561\\n',\n"," 'OBJECTIVE\\tTo observe the efficacy and safety of Rocaltrol ( calcitriol ) and/or Caltrate D ( calicum carbonate plus vitamin D ) in elderly Chinese women with osteopenia or osteoporosis .\\n',\n"," 'METHODS\\tOne hundred fifty Chinese women aged over @ years with osteopenia or osteoporosis from three centers were randomly divided into two groups .\\n',\n"," 'METHODS\\tSeventy-six participants received Caltrate D as one pill daily ; the other @ participants received @ mug Caltrate D plus Rocaltrol daily .\\n',\n"," 'METHODS\\tThe changes in bone mineral density ( BMD ) served as primary end-points .\\n',\n"," 'METHODS\\tHeight changes , the presence of new vertebral fractures , muscle strength and balance were evaluated .\\n',\n"," 'RESULTS\\tThe following are the mean percentage changes ( and SD ) in BMD over @ months : at L@-L@ , @ + / -@ in the Caltrate D group and @ + / -@ in the Rocaltrol + Caltrate D group ( P = @ , by ANCOVA ) ; at the femoral neck , @ + / -@ in the Caltrate D group and @ + / -@ in the Rocaltrol + Caltrate D group ( P = @ , by ANCOVA ) ; and in the trochanter , @ + / -@ in the Caltrate D group and @ + / -@ in the Rocaltrol + Caltrate D group ( P = @ , by ANCOVA ) .\\n',\n"," 'RESULTS\\tThe stand and maximal forward reach test ( SMFRT ) was significantly enhanced in both groups during the @ months of treatment , but no significant differences were found between these two groups .\\n',\n"," 'RESULTS\\tNo severe adverse event related to these medications occurred throughout the study .\\n',\n"," 'CONCLUSIONS\\tTreatment with Rocaltrol plus Caltrate D or Caltrate D for @ months in elderly Chinese postmenopausal women effectively increased BMD at the lumbar spine .\\n',\n"," 'CONCLUSIONS\\tRocaltrol plus Caltrate D was more effective at the lumbar spine than Caltrate D alone .\\n',\n"," '\\n',\n"," '###10401802\\n',\n"," 'OBJECTIVE\\tTo assess differences through grade @ in diet , physical activity , and related health indicators of students who participated in the Child and Adolescent Trial for Cardiovascular Health ( CATCH ) school and family intervention from grades @ through @ .\\n',\n"," 'METHODS\\tFollow-up of the @-center , randomized , controlled field trial with @ intervention and @ control elementary schools .\\n',\n"," 'METHODS\\tWe studied @ ( @ % ) of the initial CATCH cohort of @ students from ethnically diverse backgrounds in California , Louisiana , Minnesota , and Texas at grades @ , @ , and @ .\\n',\n"," 'RESULTS\\tSelf-reported daily energy intake from fat at baseline was virtually identical in the control ( @ % ) and intervention ( @ % ) groups .\\n',\n"," 'RESULTS\\tAt grade @ , the intake for controls remained at @ % , while the intake for the intervention group declined to @ % ( P < @ ) .\\n',\n"," 'RESULTS\\tAt grade @ , the between-group differential was maintained ( @ % vs @ % , P = @ ) .\\n',\n"," 'RESULTS\\tIntervention students maintained significantly higher self-reported daily vigorous activity than control students ( P = @ ) , although the difference declined from @ minutes in grade @ to @ , @ , and @ minutes in grades @ , @ , and @ , respectively .\\n',\n"," 'RESULTS\\tSignificant differences in favor of the intervention students also persisted at grade @ for dietary knowledge and dietary intentions , but not for social support for physical activity .\\n',\n"," 'RESULTS\\tNo impact on smoking behavior or stages of contemplating smoking was detected at grade @ .\\n',\n"," 'RESULTS\\tNo significant differences were noted among physiologic indicators of body mass index , blood pressure , or serum lipid and cholesterol levels .\\n',\n"," 'CONCLUSIONS\\tThe original CATCH results demonstrated that school-level interventions could modify school lunch and school physical education programs as well as influence student behaviors .\\n',\n"," 'CONCLUSIONS\\tThis @-year follow-up without further intervention suggests that the behavioral changes initiated during the elementary school years persisted to early adolescence for self-reported dietary and physical activity behaviors .\\n',\n"," '\\n',\n"," '###8381146\\n',\n"," \"BACKGROUND\\tIntralesional vinblastine has been used to treat Kaposi 's sarcoma associated with acquired immunodeficiency syndrome ( AIDS-KS ) .\\n\",\n"," 'BACKGROUND\\tInjections are painful and anticipated response rates are not well documented .\\n',\n"," 'OBJECTIVE\\tEleven homosexual men were studied to evaluate the efficacy and pain associated with intralesional vinblastine with or without @ % bicarbonate buffered lidocaine ( BBL ) .\\n',\n"," 'METHODS\\tSix lesions on each patient were selected and treated with either vinblastine , vinblastine mixed with BBL , or vinblastine @ minutes after BBL injection .\\n',\n"," 'METHODS\\tControl lesions received BBL , saline , or no treatment .\\n',\n"," 'METHODS\\tPatients recorded injection pain on a visual analog scale .\\n',\n"," 'RESULTS\\tThere was a complete or partial clinical response in @ % of vinblastine-treated lesions .\\n',\n"," 'RESULTS\\tPain scores for BBL , vinblastine , and the mixture of BBL and vinblastine were not statistically different .\\n',\n"," 'CONCLUSIONS\\tIntralesional vinblastine is effective therapy for AIDS-KS .\\n',\n"," 'CONCLUSIONS\\tLocal anesthesia does not reduce efficacy of treatment , or reduce the pain experienced by the patient .\\n',\n"," '\\n',\n"," '###21863462\\n',\n"," \"BACKGROUND\\tAlthough lumbar spinal fusion has been performed for more than @years , few studies have examined rehabilitation strategies for spinal fusion patients , and there is only sparse information about the patient 's activity level after surgery .\\n\",\n"," \"BACKGROUND\\tThe Canadian Occupational Performance Measure ( COPM ) is a standardized semi-structured interview , developed to identify patients ' problems in relation to activities of daily living ( ADL ) .\\n\",\n"," ...]"]},"metadata":{},"execution_count":91}]},{"cell_type":"code","source":["def preprocess_text_with_line_numbers(filename):\n","  \"\"\"Returns a list of dictionaries of abstract line data.\n","\n","  Takes in filename, reads its contents and sorts through each line,\n","  extracting things like the target label, the text of the sentence,\n","  how many sentences are in the current abstract and what sentence number\n","  the target line is.\n","\n","  Args:\n","      filename: a string of the target text file to read and extract line data\n","      from.\n","\n","  Returns:\n","      A list of dictionaries each containing a line from an abstract,\n","      the lines label, the lines position in the abstract and the total number\n","      of lines in the abstract where the line is from. For example:\n","\n","      [{\"target\": 'CONCLUSION',\n","        \"text\": The study couldn't have gone better, turns out people are kinder than you think\",\n","        \"line_number\": 8,\n","        \"total_lines\": 8}]\n","  \"\"\"\n","  input_lines = get_lines(filename) # get all lines from filename\n","  abstract_lines = \"\" # create an empty abstract\n","  abstract_samples = [] # create an empty list of abstracts\n","\n","  # Loop through each line in target file\n","  for line in input_lines:\n","    if line.startswith(\"###\"): # check to see if line is an ID line\n","      abstract_id = line\n","      abstract_lines = \"\" # reset abstract string\n","    elif line.isspace(): # check to see if line is a new line\n","      abstract_line_split = abstract_lines.splitlines() # split abstract into separate lines\n","\n","      # Iterate through each line in abstract and count them at the same time\n","      for abstract_line_number, abstract_line in enumerate(abstract_line_split):\n","        line_data = {} # create empty dict to store data from line\n","        target_text_split = abstract_line.split(\"\\t\") # split target label from text\n","        line_data[\"target\"] = target_text_split[0] # get target label\n","        line_data[\"text\"] = target_text_split[1].lower() # get target text and lower it\n","        line_data[\"line_number\"] = abstract_line_number # what number line does the line appear in the abstract?\n","        line_data[\"total_lines\"] = len(abstract_line_split) - 1 # how many total lines are in the abstract? (start from 0)\n","        abstract_samples.append(line_data) # add line data to abstract samples list\n","\n","    else: # if the above conditions aren't fulfilled, the line contains a labelled sentence\n","      abstract_lines += line\n","\n","  return abstract_samples"],"metadata":{"id":"jn_rCmyIDHfI"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["train_data = preprocess_text_with_line_numbers(data_dir + \"train.txt/train.txt\")\n","val_data = preprocess_text_with_line_numbers(data_dir + \"dev.txt\") # dev is another name for validation set\n","test_data = preprocess_text_with_line_numbers(data_dir + \"test.txt\")\n","len(train_data), len(val_data), len(test_data)"],"metadata":{"id":"vfm_ous2xa15","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1702840903205,"user_tz":-180,"elapsed":5891,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"08947522-5a69-4ee5-e093-b69c5733a2a9"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["(2211861, 28932, 29493)"]},"metadata":{},"execution_count":93}]},{"cell_type":"code","source":["import pandas as pd\n","train_df = pd.DataFrame(train_data)\n","val_df = pd.DataFrame(val_data)\n","test_df = pd.DataFrame(test_data)\n","train_df.head(14)"],"metadata":{"id":"o2aL8ptgx-A9","colab":{"base_uri":"https://localhost:8080/","height":714},"executionInfo":{"status":"ok","timestamp":1702840905358,"user_tz":-180,"elapsed":2156,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"a8964c93-b04f-4881-92dd-91d4d8bef7a8"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["         target                                               text  \\\n","0    BACKGROUND  the emergence of hiv as a chronic condition me...   \n","1    BACKGROUND  this paper describes the design and evaluation...   \n","2       METHODS  this study is designed as a randomised control...   \n","3       METHODS  the intervention group will participate in the...   \n","4       METHODS  the program is based on self-efficacy theory a...   \n","5       METHODS  participants will access the program for a min...   \n","6       METHODS  primary outcomes are domain specific self-effi...   \n","7       METHODS  secondary outcomes include : depression , anxi...   \n","8       METHODS  data collection will take place at baseline , ...   \n","9   CONCLUSIONS  results of the positive outlook study will pro...   \n","10   BACKGROUND                                           actrn@ .   \n","11   BACKGROUND  the aim of this study was to evaluate the effi...   \n","12      METHODS  a total of @ patients suffering from thyroid o...   \n","13      METHODS  patients were randomized into two groups : gro...   \n","\n","    line_number  total_lines  \n","0             0           10  \n","1             1           10  \n","2             2           10  \n","3             3           10  \n","4             4           10  \n","5             5           10  \n","6             6           10  \n","7             7           10  \n","8             8           10  \n","9             9           10  \n","10           10           10  \n","11            0           11  \n","12            1           11  \n","13            2           11  "],"text/html":["\n","  <div id=\"df-4e1720ec-ff20-4708-91b5-0f03eb832462\" class=\"colab-df-container\">\n","    <div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>target</th>\n","      <th>text</th>\n","      <th>line_number</th>\n","      <th>total_lines</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>0</th>\n","      <td>BACKGROUND</td>\n","      <td>the emergence of hiv as a chronic condition me...</td>\n","      <td>0</td>\n","      <td>10</td>\n","    </tr>\n","    <tr>\n","      <th>1</th>\n","      <td>BACKGROUND</td>\n","      <td>this paper describes the design and evaluation...</td>\n","      <td>1</td>\n","      <td>10</td>\n","    </tr>\n","    <tr>\n","      <th>2</th>\n","      <td>METHODS</td>\n","      <td>this study is designed as a randomised control...</td>\n","      <td>2</td>\n","      <td>10</td>\n","    </tr>\n","    <tr>\n","      <th>3</th>\n","      <td>METHODS</td>\n","      <td>the intervention group will participate in the...</td>\n","      <td>3</td>\n","      <td>10</td>\n","    </tr>\n","    <tr>\n","      <th>4</th>\n","      <td>METHODS</td>\n","      <td>the program is based on self-efficacy theory a...</td>\n","      <td>4</td>\n","      <td>10</td>\n","    </tr>\n","    <tr>\n","      <th>5</th>\n","      <td>METHODS</td>\n","      <td>participants will access the program for a min...</td>\n","      <td>5</td>\n","      <td>10</td>\n","    </tr>\n","    <tr>\n","      <th>6</th>\n","      <td>METHODS</td>\n","      <td>primary outcomes are domain specific self-effi...</td>\n","      <td>6</td>\n","      <td>10</td>\n","    </tr>\n","    <tr>\n","      <th>7</th>\n","      <td>METHODS</td>\n","      <td>secondary outcomes include : depression , anxi...</td>\n","      <td>7</td>\n","      <td>10</td>\n","    </tr>\n","    <tr>\n","      <th>8</th>\n","      <td>METHODS</td>\n","      <td>data collection will take place at baseline , ...</td>\n","      <td>8</td>\n","      <td>10</td>\n","    </tr>\n","    <tr>\n","      <th>9</th>\n","      <td>CONCLUSIONS</td>\n","      <td>results of the positive outlook study will pro...</td>\n","      <td>9</td>\n","      <td>10</td>\n","    </tr>\n","    <tr>\n","      <th>10</th>\n","      <td>BACKGROUND</td>\n","      <td>actrn@ .</td>\n","      <td>10</td>\n","      <td>10</td>\n","    </tr>\n","    <tr>\n","      <th>11</th>\n","      <td>BACKGROUND</td>\n","      <td>the aim of this study was to evaluate the effi...</td>\n","      <td>0</td>\n","      <td>11</td>\n","    </tr>\n","    <tr>\n","      <th>12</th>\n","      <td>METHODS</td>\n","      <td>a total of @ patients suffering from thyroid o...</td>\n","      <td>1</td>\n","      <td>11</td>\n","    </tr>\n","    <tr>\n","      <th>13</th>\n","      <td>METHODS</td>\n","      <td>patients were randomized into two groups : gro...</td>\n","      <td>2</td>\n","      <td>11</td>\n","    </tr>\n","  </tbody>\n","</table>\n","</div>\n","    <div class=\"colab-df-buttons\">\n","\n","  <div class=\"colab-df-container\">\n","    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-4e1720ec-ff20-4708-91b5-0f03eb832462')\"\n","            title=\"Convert this dataframe to an interactive table.\"\n","            style=\"display:none;\">\n","\n","  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n","    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n","  </svg>\n","    </button>\n","\n","  <style>\n","    .colab-df-container {\n","      display:flex;\n","      gap: 12px;\n","    }\n","\n","    .colab-df-convert {\n","      background-color: #E8F0FE;\n","      border: none;\n","      border-radius: 50%;\n","      cursor: pointer;\n","      display: none;\n","      fill: #1967D2;\n","      height: 32px;\n","      padding: 0 0 0 0;\n","      width: 32px;\n","    }\n","\n","    .colab-df-convert:hover {\n","      background-color: #E2EBFA;\n","      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","      fill: #174EA6;\n","    }\n","\n","    .colab-df-buttons div {\n","      margin-bottom: 4px;\n","    }\n","\n","    [theme=dark] .colab-df-convert {\n","      background-color: #3B4455;\n","      fill: #D2E3FC;\n","    }\n","\n","    [theme=dark] .colab-df-convert:hover {\n","      background-color: #434B5C;\n","      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","      fill: #FFFFFF;\n","    }\n","  </style>\n","\n","    <script>\n","      const buttonEl =\n","        document.querySelector('#df-4e1720ec-ff20-4708-91b5-0f03eb832462 button.colab-df-convert');\n","      buttonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","\n","      async function convertToInteractive(key) {\n","        const element = document.querySelector('#df-4e1720ec-ff20-4708-91b5-0f03eb832462');\n","        const dataTable =\n","          await google.colab.kernel.invokeFunction('convertToInteractive',\n","                                                    [key], {});\n","        if (!dataTable) return;\n","\n","        const docLinkHtml = 'Like what you see? Visit the ' +\n","          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n","          + ' to learn more about interactive tables.';\n","        element.innerHTML = '';\n","        dataTable['output_type'] = 'display_data';\n","        await google.colab.output.renderOutput(dataTable, element);\n","        const docLink = document.createElement('div');\n","        docLink.innerHTML = docLinkHtml;\n","        element.appendChild(docLink);\n","      }\n","    </script>\n","  </div>\n","\n","\n","<div id=\"df-4f229dfc-620d-4faa-b034-c51fb003228d\">\n","  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-4f229dfc-620d-4faa-b034-c51fb003228d')\"\n","            title=\"Suggest charts\"\n","            style=\"display:none;\">\n","\n","<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","     width=\"24px\">\n","    <g>\n","        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n","    </g>\n","</svg>\n","  </button>\n","\n","<style>\n","  .colab-df-quickchart {\n","      --bg-color: #E8F0FE;\n","      --fill-color: #1967D2;\n","      --hover-bg-color: #E2EBFA;\n","      --hover-fill-color: #174EA6;\n","      --disabled-fill-color: #AAA;\n","      --disabled-bg-color: #DDD;\n","  }\n","\n","  [theme=dark] .colab-df-quickchart {\n","      --bg-color: #3B4455;\n","      --fill-color: #D2E3FC;\n","      --hover-bg-color: #434B5C;\n","      --hover-fill-color: #FFFFFF;\n","      --disabled-bg-color: #3B4455;\n","      --disabled-fill-color: #666;\n","  }\n","\n","  .colab-df-quickchart {\n","    background-color: var(--bg-color);\n","    border: none;\n","    border-radius: 50%;\n","    cursor: pointer;\n","    display: none;\n","    fill: var(--fill-color);\n","    height: 32px;\n","    padding: 0;\n","    width: 32px;\n","  }\n","\n","  .colab-df-quickchart:hover {\n","    background-color: var(--hover-bg-color);\n","    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n","    fill: var(--button-hover-fill-color);\n","  }\n","\n","  .colab-df-quickchart-complete:disabled,\n","  .colab-df-quickchart-complete:disabled:hover {\n","    background-color: var(--disabled-bg-color);\n","    fill: var(--disabled-fill-color);\n","    box-shadow: none;\n","  }\n","\n","  .colab-df-spinner {\n","    border: 2px solid var(--fill-color);\n","    border-color: transparent;\n","    border-bottom-color: var(--fill-color);\n","    animation:\n","      spin 1s steps(1) infinite;\n","  }\n","\n","  @keyframes spin {\n","    0% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","      border-left-color: var(--fill-color);\n","    }\n","    20% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    30% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","      border-right-color: var(--fill-color);\n","    }\n","    40% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    60% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","    }\n","    80% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-bottom-color: var(--fill-color);\n","    }\n","    90% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","    }\n","  }\n","</style>\n","\n","  <script>\n","    async function quickchart(key) {\n","      const quickchartButtonEl =\n","        document.querySelector('#' + key + ' button');\n","      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n","      quickchartButtonEl.classList.add('colab-df-spinner');\n","      try {\n","        const charts = await google.colab.kernel.invokeFunction(\n","            'suggestCharts', [key], {});\n","      } catch (error) {\n","        console.error('Error during call to suggestCharts:', error);\n","      }\n","      quickchartButtonEl.classList.remove('colab-df-spinner');\n","      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n","    }\n","    (() => {\n","      let quickchartButtonEl =\n","        document.querySelector('#df-4f229dfc-620d-4faa-b034-c51fb003228d button');\n","      quickchartButtonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","    })();\n","  </script>\n","</div>\n","\n","    </div>\n","  </div>\n"]},"metadata":{},"execution_count":94}]},{"cell_type":"code","source":["train_df.target.value_counts()"],"metadata":{"id":"kOTgWZd4COXy","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1702840905359,"user_tz":-180,"elapsed":9,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"6fbcb423-d31d-4cdf-e352-594c1fb8cab6"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["RESULTS        766271\n","METHODS        722586\n","CONCLUSIONS    339714\n","BACKGROUND     196689\n","OBJECTIVE      186601\n","Name: target, dtype: int64"]},"metadata":{},"execution_count":95}]},{"cell_type":"code","source":["train_df.target.value_counts()"],"metadata":{"id":"PqS8fkkeyAfK","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1702840906276,"user_tz":-180,"elapsed":923,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"de1c8286-b24d-4d79-c67a-75115dc18eef"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["RESULTS        766271\n","METHODS        722586\n","CONCLUSIONS    339714\n","BACKGROUND     196689\n","OBJECTIVE      186601\n","Name: target, dtype: int64"]},"metadata":{},"execution_count":96}]},{"cell_type":"code","source":["train_sentences = train_df[\"text\"].tolist()\n","val_sentences = val_df[\"text\"].tolist()\n","test_sentences = test_df[\"text\"].tolist()\n","len(train_sentences),len(val_sentences),len(test_sentences)"],"metadata":{"id":"U4Xxye_5yB6z","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1702840906276,"user_tz":-180,"elapsed":12,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"a23d5442-1be1-48f7-a817-e99258cc4bc6"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["(2211861, 28932, 29493)"]},"metadata":{},"execution_count":97}]},{"cell_type":"code","source":["from sklearn.preprocessing import LabelEncoder\n","label_encoder = LabelEncoder()\n","train_labels_encoded = label_encoder.fit_transform(train_df[\"target\"].to_numpy())\n","val_labels_encoded = label_encoder.transform(val_df[\"target\"].to_numpy())\n","test_labels_encoded = label_encoder.transform(test_df[\"target\"].to_numpy())\n","\n","train_labels_encoded"],"metadata":{"id":"NPtysdNwzETi","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1702840906276,"user_tz":-180,"elapsed":8,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"6f3ece7f-d9e7-4181-d2f1-dcf594a817cc"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["array([0, 0, 2, ..., 4, 4, 4])"]},"metadata":{},"execution_count":98}]},{"cell_type":"code","source":["num_classes = len(label_encoder.classes_)\n","class_names = label_encoder.classes_\n","num_classes, class_names"],"metadata":{"id":"EoJ7uWbbzFXN","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1702840906276,"user_tz":-180,"elapsed":5,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"cd09038c-18ec-4a48-e4c0-25d7965ea9ca"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["(5,\n"," array(['BACKGROUND', 'CONCLUSIONS', 'METHODS', 'OBJECTIVE', 'RESULTS'],\n","       dtype=object))"]},"metadata":{},"execution_count":99}]},{"cell_type":"code","source":["max_tokens = 68000"],"metadata":{"id":"4_jK5Sy2zZ7m"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["from tensorflow.keras.layers import TextVectorization\n","\n","\n","text_vectorizer = TextVectorization(max_tokens=max_tokens,\n","                                    output_sequence_length=55)"],"metadata":{"id":"ih16nYFhzbo-"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["text_vectorizer.adapt(train_sentences)"],"metadata":{"id":"5riYG_dhzdKU"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["\n","import random\n","target_sentence = random.choice(train_sentences)\n","print(f\"Text:\\n{target_sentence}\")\n","print(f\"\\nLength of text: {len(target_sentence.split())}\")\n","print(f\"\\nVectorized text:\\n{text_vectorizer([target_sentence])}\")"],"metadata":{"id":"L3uqW4--zyMF"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["token_embed = layers.Embedding(input_dim=len(rct_20k_text_vocab), # length of vocabulary\n","                               output_dim=128,\n","                               mask_zero=True,\n","                               name=\"token_embedding\")\n","\n","print(f\"Sentence before vectorization:\\n{target_sentence}\\n\")\n","vectorized_sentence = text_vectorizer([target_sentence])\n","print(f\"Sentence after vectorization (before embedding):\\n{vectorized_sentence}\\n\")\n","embedded_sentence = token_embed(vectorized_sentence)\n","print(f\"Sentence after embedding:\\n{embedded_sentence}\\n\")\n","print(f\"Embedded sentence shape: {embedded_sentence.shape}\")"],"metadata":{"id":"iI1sRap4zwXa"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["\" \".join(list(train_sentences[0]))"],"metadata":{"id":"U4iU7rRL2mfz"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["def split_chars(text):\n","  return \" \".join(list(text))"],"metadata":{"id":"U4bHYe-p2czF"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["train_chars = [split_chars(sentence) for sentence in train_sentences]\n","val_chars = [split_chars(sentence) for sentence in val_sentences]\n","test_chars = [split_chars(sentence) for sentence in test_sentences]\n","test_chars[:2]"],"metadata":{"id":"HLef4Wil0yNw"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["chars_lens = [len(sentence) for sentence in train_sentences]\n","mean_char_len = np.mean(chars_lens)\n","per95 = int(np.percentile(chars_lens,95))\n","\n","per95"],"metadata":{"id":"SgAwMP7E0yqJ"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["numchartok = 70 #add 2 for space and out of vocab\n","char_vectorizer = TextVectorization(\n","    max_tokens = numchartok,\n","    output_sequence_length = 290,\n","    #standardize = \"lower_and_strip_punctuation\",\n","    name = \"char_vectorizer\"\n",")"],"metadata":{"id":"sAsiBZOD0y8n"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["char_vectorizer.adapt(train_chars)"],"metadata":{"id":"GAanBb5e2cww"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["random_train_chars = random.choice(train_chars)\n","vectorized_chars = char_vectorizer([random_train_chars])\n","print(f\"the text is {len(random_train_chars)} and it is \\n {random_train_chars},\\n and the vectorized is {len(vectorized_chars[0])} and the text is \\n {vectorized_chars}\")"],"metadata":{"id":"0S9Bm0HZ2cs1"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["char_embed = layers.Embedding(input_dim = len(char_vocab),\n","                              output_dim = 25,\n","                              mask_zero = True,\n","                              name = \"char_embed\")"],"metadata":{"id":"rKVKVWnk2cks"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":[],"metadata":{"id":"sTsA-95N2c7R"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["train_total_lines_one_hot = tf.one_hot(train_df[\"total_lines\"].to_numpy(), depth=20)\n","val_total_lines_one_hot = tf.one_hot(val_df[\"total_lines\"].to_numpy(), depth=20)\n","test_total_lines_one_hot = tf.one_hot(test_df[\"total_lines\"].to_numpy(), depth=20)\n","\n","train_total_lines_one_hot.shape, train_total_lines_one_hot[:10]"],"metadata":{"id":"vy6atWRp0Fyb"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["\n","train_line_numbers_one_hot = tf.one_hot(train_df[\"line_number\"].to_numpy(), depth=15)\n","val_line_numbers_one_hot = tf.one_hot(val_df[\"line_number\"].to_numpy(), depth=15)\n","test_line_numbers_one_hot = tf.one_hot(test_df[\"line_number\"].to_numpy(), depth=15)"],"metadata":{"id":"R8hafZxO0FNu"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":[],"metadata":{"id":"GMvokwIg2c4a"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["\n","token_inputs = layers.Input(shape=[], dtype=\"string\", name=\"token_inputs\")\n","token_embeddings = tf_hub_embedding_layer(token_inputs)\n","token_outputs = layers.Dense(128, activation=\"relu\")(token_embeddings)\n","token_model = tf.keras.Model(inputs=token_inputs,\n","                             outputs=token_outputs)\n","\n","char_inputs = layers.Input(shape=(1,), dtype=\"string\", name=\"char_inputs\")\n","char_vectors = char_vectorizer(char_inputs)\n","char_embeddings = char_embed(char_vectors)\n","char_bi_lstm = layers.Bidirectional(layers.LSTM(32))(char_embeddings)\n","char_model = tf.keras.Model(inputs=char_inputs,\n","                            outputs=char_bi_lstm)\n","\n","line_number_inputs = layers.Input(shape=(15,), dtype=tf.int32, name=\"line_number_input\")\n","x = layers.Dense(32, activation=\"relu\")(line_number_inputs)\n","line_number_model = tf.keras.Model(inputs=line_number_inputs,\n","                                   outputs=x)\n","\n","total_lines_inputs = layers.Input(shape=(20,), dtype=tf.int32, name=\"total_lines_input\")\n","y = layers.Dense(32, activation=\"relu\")(total_lines_inputs)\n","total_line_model = tf.keras.Model(inputs=total_lines_inputs,\n","                                  outputs=y)\n","\n","combined_embeddings = layers.Concatenate(name=\"token_char_hybrid_embedding\")([token_model.output,\n","                                                                              char_model.output])\n","z = layers.Dense(256, activation=\"relu\")(combined_embeddings)\n","z = layers.Dropout(0.5)(z)\n","\n","z = layers.Concatenate(name=\"token_char_positional_embedding\")([line_number_model.output,\n","                                                                total_line_model.output,\n","                                                                z])\n","\n","output_layer = layers.Dense(5, activation=\"softmax\", name=\"output_layer\")(z)\n","\n","mainclf = tf.keras.Model(inputs=[line_number_model.input,\n","                                 total_line_model.input,\n","                                 token_model.input,\n","                                 char_model.input],\n","                         outputs=output_layer)"],"metadata":{"id":"WhE_RW6S2c1X"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":[],"metadata":{"id":"yPjvXg8U0RIa"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["mainclf.summary()"],"metadata":{"id":"fDwRn2Is3Zbi"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["from tensorflow.keras.utils import plot_model\n","plot_model(mainclf)"],"metadata":{"id":"9jsFj8g13cPI"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["early_stopping = tf.keras.callbacks.EarlyStopping(monitor=\"val_loss\",\n","                                                  patience=5,\n","                                                  verbose = 1)\n","\n","\n","checkpoint_path = \"/content/drive/Othercomputers/My Laptop/code/MacDeepL/Skim-lit/Fulldatacheckpoints/\"\n","model_checkpoint = tf.keras.callbacks.ModelCheckpoint(checkpoint_path,\n","                                                      save_best_only=True,\n","                                                      monitor=\"val_loss\",\n","                                                      verbose = 1)\n","reduce_lr = tf.keras.callbacks.ReduceLROnPlateau(monitor=\"val_loss\",\n","                                                 factor=0.2, # multiply the learning rate by 0.2 (reduce by 5x)\n","                                                 patience=2,\n","                                                 verbose=1, # print out when learning rate goes down\n","                                                 min_lr=1e-7)"],"metadata":{"id":"FanJ44Bv3m_T"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["train_pos_char_token_data = tf.data.Dataset.from_tensor_slices((train_line_numbers_one_hot,\n","                                                                train_total_lines_one_hot,\n","                                                                train_sentences,\n","                                                                train_chars))\n","train_pos_char_token_labels = tf.data.Dataset.from_tensor_slices(train_labels_one_hot)\n","train_pos_full_char_token_dataset = tf.data.Dataset.zip((train_pos_char_token_data, train_pos_char_token_labels))\n","train_pos_full_char_token_dataset = train_pos_full_char_token_dataset.batch(32).prefetch(tf.data.AUTOTUNE)\n","\n","val_pos_char_token_data = tf.data.Dataset.from_tensor_slices((val_line_numbers_one_hot,\n","                                                              val_total_lines_one_hot,\n","                                                              val_sentences,\n","                                                              val_chars))\n","val_pos_char_token_labels = tf.data.Dataset.from_tensor_slices(val_labels_one_hot)\n","val_pos_full_char_token_dataset = tf.data.Dataset.zip((val_pos_char_token_data, val_pos_char_token_labels))\n","val_pos_full_char_token_dataset = val_pos_full_char_token_dataset.batch(32).prefetch(tf.data.AUTOTUNE)\n","\n","train_pos_full_char_token_dataset, val_pos_full_char_token_dataset"],"metadata":{"id":"WB-BHzqn3m7Z"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["\n","mainclf.compile(loss=tf.keras.losses.CategoricalCrossentropy(label_smoothing=0.2), # add label smoothing (examples which are really confident get smoothed a little)\n","                optimizer=tf.keras.optimizers.Adam(),\n","                metrics=[\"accuracy\"])"],"metadata":{"id":"3boQ9mwh8QjD"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["\n","history_mainclf = mainclf.fit(train_pos_char_token_dataset,\n","                              steps_per_epoch=int( len(train_pos_full_char_token_dataset)),\n","                              epochs=100,\n","                              validation_data=val_pos_char_token_dataset,\n","                              validation_steps=int(0.1 * len(val_pos_full_char_token_dataset)),\n","                              callbacks=[model_checkpoint,\n","                                         early_stopping])"],"metadata":{"id":"CHGFc2LS3mxi"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["len(train_line_numbers_one_hot)"],"metadata":{"id":"UANuqPpZ8S3x"},"execution_count":null,"outputs":[]},{"cell_type":"markdown","source":["#testing\n"],"metadata":{"id":"HoZGgYjbFDnv"}},{"cell_type":"code","source":["test_pos_char_token_data = tf.data.Dataset.from_tensor_slices((test_line_numbers_one_hot,\n","                                                               test_total_lines_one_hot,\n","                                                               test_sentences,\n","                                                               test_chars))\n","test_pos_char_token_labels = tf.data.Dataset.from_tensor_slices(test_labels_one_hot)\n","test_pos_char_token_dataset = tf.data.Dataset.zip((test_pos_char_token_data, test_pos_char_token_labels))\n","test_pos_char_token_dataset = test_pos_char_token_dataset.batch(32).prefetch(tf.data.AUTOTUNE)\n","\n","# Check shapes\n","test_pos_char_token_dataset"],"metadata":{"id":"CME2ZqaUCU6_"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["test_pred_probs = loaded_model.predict(test_pos_char_token_dataset,\n","                                       verbose=1)\n","test_preds = tf.argmax(test_pred_probs, axis=1)\n","test_preds[:10]"],"metadata":{"id":"VCKpAqxnFAxy"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["loaded_model_test_results = calculate_results(y_true=test_labels_encoded,\n","                                              y_pred=test_preds)\n","loaded_model_test_results"],"metadata":{"id":"QXUSBEGlFB4f"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["\n","test_pred_classes = [label_encoder.classes_[pred] for pred in test_preds]\n","test_pred_classes"],"metadata":{"id":"2RI_aLCgFLFO"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["import json\n","# Download and open example abstracts (copy and pasted from PubMed)\n","!wget https://raw.githubusercontent.com/mrdbourke/tensorflow-deep-learning/main/extras/skimlit_example_abstracts.json\n","\n","with open(\"skimlit_example_abstracts.json\", \"r\") as f:\n","  example_abstracts = json.load(f)\n","\n","example_abstracts"],"metadata":{"id":"LOHPHkzVFgP_","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1702821649817,"user_tz":-180,"elapsed":722,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"eab924cf-ca3a-4dae-db7f-3707f9e1317c"},"execution_count":null,"outputs":[{"output_type":"stream","name":"stdout","text":["--2023-12-17 14:00:12--  https://raw.githubusercontent.com/mrdbourke/tensorflow-deep-learning/main/extras/skimlit_example_abstracts.json\n","Resolving raw.githubusercontent.com (raw.githubusercontent.com)... 185.199.108.133, 185.199.109.133, 185.199.110.133, ...\n","Connecting to raw.githubusercontent.com (raw.githubusercontent.com)|185.199.108.133|:443... connected.\n","HTTP request sent, awaiting response... 200 OK\n","Length: 6737 (6.6K) [text/plain]\n","Saving to: skimlit_example_abstracts.json\n","\n","skimlit_example_abs 100%[===================>]   6.58K  --.-KB/s    in 0s      \n","\n","2023-12-17 14:00:12 (52.6 MB/s) - skimlit_example_abstracts.json saved [6737/6737]\n","\n"]},{"output_type":"execute_result","data":{"text/plain":["[{'abstract': 'This RCT examined the efficacy of a manualized social intervention for children with HFASDs. Participants were randomly assigned to treatment or wait-list conditions. Treatment included instruction and therapeutic activities targeting social skills, face-emotion recognition, interest expansion, and interpretation of non-literal language. A response-cost program was applied to reduce problem behaviors and foster skills acquisition. Significant treatment effects were found for five of seven primary outcome measures (parent ratings and direct child measures). Secondary measures based on staff ratings (treatment group only) corroborated gains reported by parents. High levels of parent, child and staff satisfaction were reported, along with high levels of treatment fidelity. Standardized effect size estimates were primarily in the medium and large ranges and favored the treatment group.',\n","  'source': 'https://pubmed.ncbi.nlm.nih.gov/20232240/',\n","  'details': 'RCT of a manualized social treatment for high-functioning autism spectrum disorders'},\n"," {'abstract': \"Postpartum depression (PPD) is the most prevalent mood disorder associated with childbirth. No single cause of PPD has been identified, however the increased risk of nutritional deficiencies incurred through the high nutritional requirements of pregnancy may play a role in the pathology of depressive symptoms. Three nutritional interventions have drawn particular interest as possible non-invasive and cost-effective prevention and/or treatment strategies for PPD; omega-3 (n-3) long chain polyunsaturated fatty acids (LCPUFA), vitamin D and overall diet. We searched for meta-analyses of randomised controlled trials (RCT's) of nutritional interventions during the perinatal period with PPD as an outcome, and checked for any trials published subsequently to the meta-analyses. Fish oil: Eleven RCT's of prenatal fish oil supplementation RCT's show null and positive effects on PPD symptoms. Vitamin D: no relevant RCT's were identified, however seven observational studies of maternal vitamin D levels with PPD outcomes showed inconsistent associations. Diet: Two Australian RCT's with dietary advice interventions in pregnancy had a positive and null result on PPD. With the exception of fish oil, few RCT's with nutritional interventions during pregnancy assess PPD. Further research is needed to determine whether nutritional intervention strategies during pregnancy can protect against symptoms of PPD. Given the prevalence of PPD and ease of administering PPD measures, we recommend future prenatal nutritional RCT's include PPD as an outcome.\",\n","  'source': 'https://pubmed.ncbi.nlm.nih.gov/28012571/',\n","  'details': 'Formatting removed (can be used to compare model to actual example)'},\n"," {'abstract': 'Mental illness, including depression, anxiety and bipolar disorder, accounts for a significant proportion of global disability and poses a substantial social, economic and heath burden. Treatment is presently dominated by pharmacotherapy, such as antidepressants, and psychotherapy, such as cognitive behavioural therapy; however, such treatments avert less than half of the disease burden, suggesting that additional strategies are needed to prevent and treat mental disorders. There are now consistent mechanistic, observational and interventional data to suggest diet quality may be a modifiable risk factor for mental illness. This review provides an overview of the nutritional psychiatry field. It includes a discussion of the neurobiological mechanisms likely modulated by diet, the use of dietary and nutraceutical interventions in mental disorders, and recommendations for further research. Potential biological pathways related to mental disorders include inflammation, oxidative stress, the gut microbiome, epigenetic modifications and neuroplasticity. Consistent epidemiological evidence, particularly for depression, suggests an association between measures of diet quality and mental health, across multiple populations and age groups; these do not appear to be explained by other demographic, lifestyle factors or reverse causality. Our recently published intervention trial provides preliminary clinical evidence that dietary interventions in clinically diagnosed populations are feasible and can provide significant clinical benefit. Furthermore, nutraceuticals including n-3 fatty acids, folate, S-adenosylmethionine, N-acetyl cysteine and probiotics, among others, are promising avenues for future research. Continued research is now required to investigate the efficacy of intervention studies in large cohorts and within clinically relevant populations, particularly in patients with schizophrenia, bipolar and anxiety disorders.',\n","  'source': 'https://pubmed.ncbi.nlm.nih.gov/28942748/',\n","  'details': 'Effect of nutrition on mental health'},\n"," {'abstract': \"Hepatitis C virus (HCV) and alcoholic liver disease (ALD), either alone or in combination, count for more than two thirds of all liver diseases in the Western world. There is no safe level of drinking in HCV-infected patients and the most effective goal for these patients is total abstinence. Baclofen, a GABA(B) receptor agonist, represents a promising pharmacotherapy for alcohol dependence (AD). Previously, we performed a randomized clinical trial (RCT), which demonstrated the safety and efficacy of baclofen in patients affected by AD and cirrhosis. The goal of this post-hoc analysis was to explore baclofen's effect in a subgroup of alcohol-dependent HCV-infected cirrhotic patients. Any patient with HCV infection was selected for this analysis. Among the 84 subjects randomized in the main trial, 24 alcohol-dependent cirrhotic patients had a HCV infection; 12 received baclofen 10mg t.i.d. and 12 received placebo for 12-weeks. With respect to the placebo group (3/12, 25.0%), a significantly higher number of patients who achieved and maintained total alcohol abstinence was found in the baclofen group (10/12, 83.3%; p=0.0123). Furthermore, in the baclofen group, compared to placebo, there was a significantly higher increase in albumin values from baseline (p=0.0132) and a trend toward a significant reduction in INR levels from baseline (p=0.0716). In conclusion, baclofen was safe and significantly more effective than placebo in promoting alcohol abstinence, and improving some Liver Function Tests (LFTs) (i.e. albumin, INR) in alcohol-dependent HCV-infected cirrhotic patients. Baclofen may represent a clinically relevant alcohol pharmacotherapy for these patients.\",\n","  'source': 'https://pubmed.ncbi.nlm.nih.gov/22244707/',\n","  'details': 'Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection'}]"]},"metadata":{},"execution_count":2}]},{"cell_type":"code","source":["import pandas as pd"],"metadata":{"id":"pjNrFNsHAjiJ"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["# See what our example abstracts look like\n","abstracts = pd.DataFrame(example_abstracts)\n","abstracts"],"metadata":{"id":"ntvPjpMaFhvd","colab":{"base_uri":"https://localhost:8080/","height":365},"executionInfo":{"status":"ok","timestamp":1702821651068,"user_tz":-180,"elapsed":789,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"414c5e8b-1dd3-48af-c379-961041ac1bf8"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["                                            abstract  \\\n","0  This RCT examined the efficacy of a manualized...   \n","1  Postpartum depression (PPD) is the most preval...   \n","2  Mental illness, including depression, anxiety ...   \n","3  Hepatitis C virus (HCV) and alcoholic liver di...   \n","\n","                                      source  \\\n","0  https://pubmed.ncbi.nlm.nih.gov/20232240/   \n","1  https://pubmed.ncbi.nlm.nih.gov/28012571/   \n","2  https://pubmed.ncbi.nlm.nih.gov/28942748/   \n","3  https://pubmed.ncbi.nlm.nih.gov/22244707/   \n","\n","                                             details  \n","0  RCT of a manualized social treatment for high-...  \n","1  Formatting removed (can be used to compare mod...  \n","2               Effect of nutrition on mental health  \n","3  Baclofen promotes alcohol abstinence in alcoho...  "],"text/html":["\n","  <div id=\"df-ea0f3dbd-dbbc-404a-a8de-122bef092741\" class=\"colab-df-container\">\n","    <div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>abstract</th>\n","      <th>source</th>\n","      <th>details</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>0</th>\n","      <td>This RCT examined the efficacy of a manualized...</td>\n","      <td>https://pubmed.ncbi.nlm.nih.gov/20232240/</td>\n","      <td>RCT of a manualized social treatment for high-...</td>\n","    </tr>\n","    <tr>\n","      <th>1</th>\n","      <td>Postpartum depression (PPD) is the most preval...</td>\n","      <td>https://pubmed.ncbi.nlm.nih.gov/28012571/</td>\n","      <td>Formatting removed (can be used to compare mod...</td>\n","    </tr>\n","    <tr>\n","      <th>2</th>\n","      <td>Mental illness, including depression, anxiety ...</td>\n","      <td>https://pubmed.ncbi.nlm.nih.gov/28942748/</td>\n","      <td>Effect of nutrition on mental health</td>\n","    </tr>\n","    <tr>\n","      <th>3</th>\n","      <td>Hepatitis C virus (HCV) and alcoholic liver di...</td>\n","      <td>https://pubmed.ncbi.nlm.nih.gov/22244707/</td>\n","      <td>Baclofen promotes alcohol abstinence in alcoho...</td>\n","    </tr>\n","  </tbody>\n","</table>\n","</div>\n","    <div class=\"colab-df-buttons\">\n","\n","  <div class=\"colab-df-container\">\n","    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-ea0f3dbd-dbbc-404a-a8de-122bef092741')\"\n","            title=\"Convert this dataframe to an interactive table.\"\n","            style=\"display:none;\">\n","\n","  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n","    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n","  </svg>\n","    </button>\n","\n","  <style>\n","    .colab-df-container {\n","      display:flex;\n","      gap: 12px;\n","    }\n","\n","    .colab-df-convert {\n","      background-color: #E8F0FE;\n","      border: none;\n","      border-radius: 50%;\n","      cursor: pointer;\n","      display: none;\n","      fill: #1967D2;\n","      height: 32px;\n","      padding: 0 0 0 0;\n","      width: 32px;\n","    }\n","\n","    .colab-df-convert:hover {\n","      background-color: #E2EBFA;\n","      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","      fill: #174EA6;\n","    }\n","\n","    .colab-df-buttons div {\n","      margin-bottom: 4px;\n","    }\n","\n","    [theme=dark] .colab-df-convert {\n","      background-color: #3B4455;\n","      fill: #D2E3FC;\n","    }\n","\n","    [theme=dark] .colab-df-convert:hover {\n","      background-color: #434B5C;\n","      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","      fill: #FFFFFF;\n","    }\n","  </style>\n","\n","    <script>\n","      const buttonEl =\n","        document.querySelector('#df-ea0f3dbd-dbbc-404a-a8de-122bef092741 button.colab-df-convert');\n","      buttonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","\n","      async function convertToInteractive(key) {\n","        const element = document.querySelector('#df-ea0f3dbd-dbbc-404a-a8de-122bef092741');\n","        const dataTable =\n","          await google.colab.kernel.invokeFunction('convertToInteractive',\n","                                                    [key], {});\n","        if (!dataTable) return;\n","\n","        const docLinkHtml = 'Like what you see? Visit the ' +\n","          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n","          + ' to learn more about interactive tables.';\n","        element.innerHTML = '';\n","        dataTable['output_type'] = 'display_data';\n","        await google.colab.output.renderOutput(dataTable, element);\n","        const docLink = document.createElement('div');\n","        docLink.innerHTML = docLinkHtml;\n","        element.appendChild(docLink);\n","      }\n","    </script>\n","  </div>\n","\n","\n","<div id=\"df-1b2e7f95-bfd7-427a-b3bd-be625c5ad2a7\">\n","  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-1b2e7f95-bfd7-427a-b3bd-be625c5ad2a7')\"\n","            title=\"Suggest charts\"\n","            style=\"display:none;\">\n","\n","<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","     width=\"24px\">\n","    <g>\n","        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n","    </g>\n","</svg>\n","  </button>\n","\n","<style>\n","  .colab-df-quickchart {\n","      --bg-color: #E8F0FE;\n","      --fill-color: #1967D2;\n","      --hover-bg-color: #E2EBFA;\n","      --hover-fill-color: #174EA6;\n","      --disabled-fill-color: #AAA;\n","      --disabled-bg-color: #DDD;\n","  }\n","\n","  [theme=dark] .colab-df-quickchart {\n","      --bg-color: #3B4455;\n","      --fill-color: #D2E3FC;\n","      --hover-bg-color: #434B5C;\n","      --hover-fill-color: #FFFFFF;\n","      --disabled-bg-color: #3B4455;\n","      --disabled-fill-color: #666;\n","  }\n","\n","  .colab-df-quickchart {\n","    background-color: var(--bg-color);\n","    border: none;\n","    border-radius: 50%;\n","    cursor: pointer;\n","    display: none;\n","    fill: var(--fill-color);\n","    height: 32px;\n","    padding: 0;\n","    width: 32px;\n","  }\n","\n","  .colab-df-quickchart:hover {\n","    background-color: var(--hover-bg-color);\n","    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n","    fill: var(--button-hover-fill-color);\n","  }\n","\n","  .colab-df-quickchart-complete:disabled,\n","  .colab-df-quickchart-complete:disabled:hover {\n","    background-color: var(--disabled-bg-color);\n","    fill: var(--disabled-fill-color);\n","    box-shadow: none;\n","  }\n","\n","  .colab-df-spinner {\n","    border: 2px solid var(--fill-color);\n","    border-color: transparent;\n","    border-bottom-color: var(--fill-color);\n","    animation:\n","      spin 1s steps(1) infinite;\n","  }\n","\n","  @keyframes spin {\n","    0% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","      border-left-color: var(--fill-color);\n","    }\n","    20% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    30% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","      border-right-color: var(--fill-color);\n","    }\n","    40% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    60% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","    }\n","    80% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-bottom-color: var(--fill-color);\n","    }\n","    90% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","    }\n","  }\n","</style>\n","\n","  <script>\n","    async function quickchart(key) {\n","      const quickchartButtonEl =\n","        document.querySelector('#' + key + ' button');\n","      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n","      quickchartButtonEl.classList.add('colab-df-spinner');\n","      try {\n","        const charts = await google.colab.kernel.invokeFunction(\n","            'suggestCharts', [key], {});\n","      } catch (error) {\n","        console.error('Error during call to suggestCharts:', error);\n","      }\n","      quickchartButtonEl.classList.remove('colab-df-spinner');\n","      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n","    }\n","    (() => {\n","      let quickchartButtonEl =\n","        document.querySelector('#df-1b2e7f95-bfd7-427a-b3bd-be625c5ad2a7 button');\n","      quickchartButtonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","    })();\n","  </script>\n","</div>\n","\n","  <div id=\"id_7b2d031e-585f-490e-af0d-4cc5021b51b4\">\n","    <style>\n","      .colab-df-generate {\n","        background-color: #E8F0FE;\n","        border: none;\n","        border-radius: 50%;\n","        cursor: pointer;\n","        display: none;\n","        fill: #1967D2;\n","        height: 32px;\n","        padding: 0 0 0 0;\n","        width: 32px;\n","      }\n","\n","      .colab-df-generate:hover {\n","        background-color: #E2EBFA;\n","        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","        fill: #174EA6;\n","      }\n","\n","      [theme=dark] .colab-df-generate {\n","        background-color: #3B4455;\n","        fill: #D2E3FC;\n","      }\n","\n","      [theme=dark] .colab-df-generate:hover {\n","        background-color: #434B5C;\n","        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","        fill: #FFFFFF;\n","      }\n","    </style>\n","    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('abstracts')\"\n","            title=\"Generate code using this dataframe.\"\n","            style=\"display:none;\">\n","\n","  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","       width=\"24px\">\n","    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n","  </svg>\n","    </button>\n","    <script>\n","      (() => {\n","      const buttonEl =\n","        document.querySelector('#id_7b2d031e-585f-490e-af0d-4cc5021b51b4 button.colab-df-generate');\n","      buttonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","\n","      buttonEl.onclick = () => {\n","        google.colab.notebook.generateWithVariable('abstracts');\n","      }\n","      })();\n","    </script>\n","  </div>\n","\n","    </div>\n","  </div>\n"]},"metadata":{},"execution_count":4}]},{"cell_type":"code","source":["# Create sentencizer - Source: https://spacy.io/usage/linguistic-features#sbd\n","from spacy.lang.en import English\n","nlp = English() # setup English sentence parser\n","\n","# New version of spaCy\n","sentencizer = nlp.add_pipe(\"sentencizer\") # create sentence splitting pipeline object\n","\n","# Old version of spaCy\n","# sentencizer = nlp.create_pipe(\"sentencizer\") # create sentence splitting pipeline object\n","# nlp.add_pipe(sentencizer) # add sentence splitting pipeline object to sentence parser\n","\n","# Create \"doc\" of parsed sequences, change index for a different abstract\n","doc = nlp(example_abstracts[0][\"abstract\"])\n","abstract_lines = [str(sent) for sent in list(doc.sents)] # return detected sentences from doc in string type (not spaCy token type)\n","abstract_lines"],"metadata":{"id":"W2y-mwGUFjD7","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1702821672669,"user_tz":-180,"elapsed":21610,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"27b84d43-fd1b-4706-9190-0c48cbc51b04"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["['This RCT examined the efficacy of a manualized social intervention for children with HFASDs.',\n"," 'Participants were randomly assigned to treatment or wait-list conditions.',\n"," 'Treatment included instruction and therapeutic activities targeting social skills, face-emotion recognition, interest expansion, and interpretation of non-literal language.',\n"," 'A response-cost program was applied to reduce problem behaviors and foster skills acquisition.',\n"," 'Significant treatment effects were found for five of seven primary outcome measures (parent ratings and direct child measures).',\n"," 'Secondary measures based on staff ratings (treatment group only) corroborated gains reported by parents.',\n"," 'High levels of parent, child and staff satisfaction were reported, along with high levels of treatment fidelity.',\n"," 'Standardized effect size estimates were primarily in the medium and large ranges and favored the treatment group.']"]},"metadata":{},"execution_count":5}]},{"cell_type":"code","source":["# Get total number of lines\n","total_lines_in_sample = len(abstract_lines)\n","\n","# Go through each line in abstract and create a list of dictionaries containing features for each line\n","sample_lines = []\n","for i, line in enumerate(abstract_lines):\n","  sample_dict = {}\n","  sample_dict[\"text\"] = str(line)\n","  sample_dict[\"line_number\"] = i\n","  sample_dict[\"total_lines\"] = total_lines_in_sample - 1\n","  sample_lines.append(sample_dict)\n","sample_lines"],"metadata":{"id":"4rz92SmbFkLN","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1702821672669,"user_tz":-180,"elapsed":23,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"adc36ee7-4a6f-4535-b9e6-8160df795121"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["[{'text': 'This RCT examined the efficacy of a manualized social intervention for children with HFASDs.',\n","  'line_number': 0,\n","  'total_lines': 7},\n"," {'text': 'Participants were randomly assigned to treatment or wait-list conditions.',\n","  'line_number': 1,\n","  'total_lines': 7},\n"," {'text': 'Treatment included instruction and therapeutic activities targeting social skills, face-emotion recognition, interest expansion, and interpretation of non-literal language.',\n","  'line_number': 2,\n","  'total_lines': 7},\n"," {'text': 'A response-cost program was applied to reduce problem behaviors and foster skills acquisition.',\n","  'line_number': 3,\n","  'total_lines': 7},\n"," {'text': 'Significant treatment effects were found for five of seven primary outcome measures (parent ratings and direct child measures).',\n","  'line_number': 4,\n","  'total_lines': 7},\n"," {'text': 'Secondary measures based on staff ratings (treatment group only) corroborated gains reported by parents.',\n","  'line_number': 5,\n","  'total_lines': 7},\n"," {'text': 'High levels of parent, child and staff satisfaction were reported, along with high levels of treatment fidelity.',\n","  'line_number': 6,\n","  'total_lines': 7},\n"," {'text': 'Standardized effect size estimates were primarily in the medium and large ranges and favored the treatment group.',\n","  'line_number': 7,\n","  'total_lines': 7}]"]},"metadata":{},"execution_count":6}]},{"cell_type":"code","source":["import tensorflow as tf"],"metadata":{"id":"vMtXbIJIAy84"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["# Get all line_number values from sample abstract\n","test_abstract_line_numbers = [line[\"line_number\"] for line in sample_lines]\n","# One-hot encode to same depth as training data, so model accepts right input shape\n","test_abstract_line_numbers_one_hot = tf.one_hot(test_abstract_line_numbers, depth=15)\n","test_abstract_line_numbers_one_hot"],"metadata":{"id":"tbhbJNPtF9s1","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1702821672670,"user_tz":-180,"elapsed":21,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"eab5c3ce-e3dd-48fd-f793-71590cb91c5a"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["<tf.Tensor: shape=(8, 15), dtype=float32, numpy=\n","array([[1., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0.],\n","       [0., 1., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0.],\n","       [0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0.],\n","       [0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0.],\n","       [0., 0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0.],\n","       [0., 0., 0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0., 0.],\n","       [0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0.],\n","       [0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0.]],\n","      dtype=float32)>"]},"metadata":{},"execution_count":8}]},{"cell_type":"code","source":["# Get all total_lines values from sample abstract\n","test_abstract_total_lines = [line[\"total_lines\"] for line in sample_lines]\n","# One-hot encode to same depth as training data, so model accepts right input shape\n","test_abstract_total_lines_one_hot = tf.one_hot(test_abstract_total_lines, depth=20)\n","test_abstract_total_lines_one_hot"],"metadata":{"id":"BM2Kq6E8Fu4W","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1702821672670,"user_tz":-180,"elapsed":17,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"7a5a36bd-f3a6-46da-c3d5-bd03f142ba04"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["<tf.Tensor: shape=(8, 20), dtype=float32, numpy=\n","array([[0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0.,\n","        0., 0., 0., 0.],\n","       [0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0.,\n","        0., 0., 0., 0.],\n","       [0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0.,\n","        0., 0., 0., 0.],\n","       [0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0.,\n","        0., 0., 0., 0.],\n","       [0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0.,\n","        0., 0., 0., 0.],\n","       [0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0.,\n","        0., 0., 0., 0.],\n","       [0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0.,\n","        0., 0., 0., 0.],\n","       [0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0.,\n","        0., 0., 0., 0.]], dtype=float32)>"]},"metadata":{},"execution_count":9}]},{"cell_type":"code","source":["def split_chars(text):\n","  return \" \".join(list(text))"],"metadata":{"id":"uldT7DMIBEoy"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["# Split abstract lines into characters\n","abstract_chars = [split_chars(sentence) for sentence in abstract_lines]\n","abstract_chars"],"metadata":{"id":"taxi3C53Fu1a","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1702821672670,"user_tz":-180,"elapsed":13,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"c01bcf90-0f0b-4569-f270-f0a08324cccc"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["['T h i s   R C T   e x a m i n e d   t h e   e f f i c a c y   o f   a   m a n u a l i z e d   s o c i a l   i n t e r v e n t i o n   f o r   c h i l d r e n   w i t h   H F A S D s .',\n"," 'P a r t i c i p a n t s   w e r e   r a n d o m l y   a s s i g n e d   t o   t r e a t m e n t   o r   w a i t - l i s t   c o n d i t i o n s .',\n"," 'T r e a t m e n t   i n c l u d e d   i n s t r u c t i o n   a n d   t h e r a p e u t i c   a c t i v i t i e s   t a r g e t i n g   s o c i a l   s k i l l s ,   f a c e - e m o t i o n   r e c o g n i t i o n ,   i n t e r e s t   e x p a n s i o n ,   a n d   i n t e r p r e t a t i o n   o f   n o n - l i t e r a l   l a n g u a g e .',\n"," 'A   r e s p o n s e - c o s t   p r o g r a m   w a s   a p p l i e d   t o   r e d u c e   p r o b l e m   b e h a v i o r s   a n d   f o s t e r   s k i l l s   a c q u i s i t i o n .',\n"," 'S i g n i f i c a n t   t r e a t m e n t   e f f e c t s   w e r e   f o u n d   f o r   f i v e   o f   s e v e n   p r i m a r y   o u t c o m e   m e a s u r e s   ( p a r e n t   r a t i n g s   a n d   d i r e c t   c h i l d   m e a s u r e s ) .',\n"," 'S e c o n d a r y   m e a s u r e s   b a s e d   o n   s t a f f   r a t i n g s   ( t r e a t m e n t   g r o u p   o n l y )   c o r r o b o r a t e d   g a i n s   r e p o r t e d   b y   p a r e n t s .',\n"," 'H i g h   l e v e l s   o f   p a r e n t ,   c h i l d   a n d   s t a f f   s a t i s f a c t i o n   w e r e   r e p o r t e d ,   a l o n g   w i t h   h i g h   l e v e l s   o f   t r e a t m e n t   f i d e l i t y .',\n"," 'S t a n d a r d i z e d   e f f e c t   s i z e   e s t i m a t e s   w e r e   p r i m a r i l y   i n   t h e   m e d i u m   a n d   l a r g e   r a n g e s   a n d   f a v o r e d   t h e   t r e a t m e n t   g r o u p .']"]},"metadata":{},"execution_count":11}]},{"cell_type":"code","source":["max_tokens = 60000"],"metadata":{"id":"-Uz-gamgED93"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["\n","from tensorflow.keras.layers import TextVectorization\n","\n","\n","text_vectorizer = TextVectorization(max_tokens=max_tokens,\n","                                    output_sequence_length=55)"],"metadata":{"id":"jGXKH-2oEBu6"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["from tensorflow.keras import layers\n","\n","import tensorflow_hub as hub\n","tf_hub_embedding_layer = hub.KerasLayer(\"https://tfhub.dev/google/universal-sentence-encoder/4\",\n","                                        trainable=False,\n","                                        name=\"universal_sentence_encoder\")\n","numchartok = 70 #add 2 for space and out of vocab\n","char_vectorizer = TextVectorization(\n","    max_tokens = numchartok,\n","    output_sequence_length = 290,\n","    #standardize = \"lower_and_strip_punctuation\",\n","    name = \"char_vectorizer\"\n",")\n","char_vocab = char_vectorizer.get_vocabulary()\n","char_embed = layers.Embedding(input_dim = len(char_vocab),\n","                              output_dim = 25,\n","                              mask_zero = True,\n","                              name = \"char_embed\")"],"metadata":{"id":"wiBbzYqTC-pJ"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["\n","token_inputs = layers.Input(shape=[], dtype=\"string\", name=\"token_inputs\")\n","token_embeddings = tf_hub_embedding_layer(token_inputs)\n","token_outputs = layers.Dense(128, activation=\"relu\")(token_embeddings)\n","token_model = tf.keras.Model(inputs=token_inputs,\n","                             outputs=token_outputs)\n","\n","char_inputs = layers.Input(shape=(1,), dtype=\"string\", name=\"char_inputs\")\n","char_vectors = char_vectorizer(char_inputs)\n","char_embeddings = char_embed(char_vectors)\n","char_bi_lstm = layers.Bidirectional(layers.LSTM(32))(char_embeddings)\n","char_model = tf.keras.Model(inputs=char_inputs,\n","                            outputs=char_bi_lstm)\n","\n","line_number_inputs = layers.Input(shape=(15,), dtype=tf.int32, name=\"line_number_input\")\n","x = layers.Dense(32, activation=\"relu\")(line_number_inputs)\n","line_number_model = tf.keras.Model(inputs=line_number_inputs,\n","                                   outputs=x)\n","\n","total_lines_inputs = layers.Input(shape=(20,), dtype=tf.int32, name=\"total_lines_input\")\n","y = layers.Dense(32, activation=\"relu\")(total_lines_inputs)\n","total_line_model = tf.keras.Model(inputs=total_lines_inputs,\n","                                  outputs=y)\n","\n","combined_embeddings = layers.Concatenate(name=\"token_char_hybrid_embedding\")([token_model.output,\n","                                                                              char_model.output])\n","z = layers.Dense(256, activation=\"relu\")(combined_embeddings)\n","z = layers.Dropout(0.5)(z)\n","\n","z = layers.Concatenate(name=\"token_char_positional_embedding\")([line_number_model.output,\n","                                                                total_line_model.output,\n","                                                                z])\n","\n","output_layer = layers.Dense(5, activation=\"softmax\", name=\"output_layer\")(z)\n","\n","loaded_model = tf.keras.Model(inputs=[line_number_model.input,\n","                                 total_line_model.input,\n","                                 token_model.input,\n","                                 char_model.input],\n","                         outputs=output_layer)"],"metadata":{"id":"kTkNjUM7CxCq"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["from tensorflow.keras.models import load_model\n","loadcheck = \"/content/drive/Othercomputers/My Laptop/code/MacDeepL/Skim-lit/basiccheckpoints/\"\n","loaded_model =  load_model(loadcheck)"],"metadata":{"id":"F6Z4MyvsBLiZ"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["import tensorflow.strings.as_bytes as b"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":314},"id":"kW55hXenGsqm","executionInfo":{"status":"error","timestamp":1702822110360,"user_tz":-180,"elapsed":7,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"576e56d6-24db-4f58-c670-873184595442"},"execution_count":null,"outputs":[{"output_type":"error","ename":"ModuleNotFoundError","evalue":"ignored","traceback":["\u001b[0;31m---------------------------------------------------------------------------\u001b[0m","\u001b[0;31mModuleNotFoundError\u001b[0m                       Traceback (most recent call last)","\u001b[0;32m<ipython-input-23-8d9c901de040>\u001b[0m in \u001b[0;36m<cell line: 1>\u001b[0;34m()\u001b[0m\n\u001b[0;32m----> 1\u001b[0;31m \u001b[0;32mimport\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mstrings\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mas_bytes\u001b[0m \u001b[0;32mas\u001b[0m \u001b[0mb\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m","\u001b[0;31mModuleNotFoundError\u001b[0m: No module named 'tensorflow.strings.as_bytes'","","\u001b[0;31m---------------------------------------------------------------------------\u001b[0;32m\nNOTE: If your import is failing due to a missing package, you can\nmanually install dependencies using either !pip or !apt.\n\nTo view examples of installing some common dependencies, click the\n\"Open Examples\" button below.\n\u001b[0;31m---------------------------------------------------------------------------\u001b[0m\n"],"errorDetails":{"actions":[{"action":"open_url","actionText":"Open Examples","url":"/notebooks/snippets/importing_libraries.ipynb"}]}}]},{"cell_type":"code","source":["test_abstract_pred_probs = loaded_model.predict(x=(test_abstract_line_numbers_one_hot,\n","                                                   test_abstract_total_lines_one_hot,\n","                                                   tf.constant(abstract_lines),\n","                                                   tf.strings.as_bytes(abstract_chars)))\n","test_abstract_pred_probs"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":279},"id":"MgAAKn9FGUWw","executionInfo":{"status":"error","timestamp":1702822059678,"user_tz":-180,"elapsed":479,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"9d843bb6-8bd8-4474-f966-0f6366ceb9da"},"execution_count":null,"outputs":[{"output_type":"error","ename":"AttributeError","evalue":"ignored","traceback":["\u001b[0;31m---------------------------------------------------------------------------\u001b[0m","\u001b[0;31mAttributeError\u001b[0m                            Traceback (most recent call last)","\u001b[0;32m<ipython-input-21-593dfd1ecf09>\u001b[0m in \u001b[0;36m<cell line: 1>\u001b[0;34m()\u001b[0m\n\u001b[1;32m      2\u001b[0m                                                    \u001b[0mtest_abstract_total_lines_one_hot\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      3\u001b[0m                                                    \u001b[0mtf\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mconstant\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mabstract_lines\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m----> 4\u001b[0;31m                                                    tf.strings.as_bytes(abstract_chars)))\n\u001b[0m\u001b[1;32m      5\u001b[0m \u001b[0mtest_abstract_pred_probs\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n","\u001b[0;31mAttributeError\u001b[0m: module 'tensorflow._api.v2.strings' has no attribute 'as_bytes'"]}]},{"cell_type":"code","source":["# Make predictions on sample abstract features\n","%%time\n","test_abstract_pred_probs = loaded_model.predict(x=(test_abstract_line_numbers_one_hot,\n","                                                   test_abstract_total_lines_one_hot,\n","                                                   tf.constant(abstract_lines),\n","                                                   tf.constant(abstract_chars)))\n","test_abstract_pred_probs"],"metadata":{"id":"Draxi6vqFuy5","colab":{"base_uri":"https://localhost:8080/","height":1000},"executionInfo":{"status":"ok","timestamp":1702821899536,"user_tz":-180,"elapsed":29654,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"30151056-30a1-4f33-e9dd-ceb1c9aa14e3"},"execution_count":null,"outputs":[{"output_type":"error","ename":"InvalidArgumentError","evalue":"ignored","traceback":["\u001b[0;31m---------------------------------------------------------------------------\u001b[0m","\u001b[0;31mInvalidArgumentError\u001b[0m                      Traceback (most recent call last)","\u001b[0;32m<timed exec>\u001b[0m in \u001b[0;36m<module>\u001b[0;34m\u001b[0m\n","\u001b[0;32m/usr/local/lib/python3.10/dist-packages/keras/src/utils/traceback_utils.py\u001b[0m in \u001b[0;36merror_handler\u001b[0;34m(*args, **kwargs)\u001b[0m\n\u001b[1;32m     68\u001b[0m             \u001b[0;31m# To get the full stack trace, call:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     69\u001b[0m             \u001b[0;31m# `tf.debugging.disable_traceback_filtering()`\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 70\u001b[0;31m             \u001b[0;32mraise\u001b[0m \u001b[0me\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mwith_traceback\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mfiltered_tb\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;32mfrom\u001b[0m \u001b[0;32mNone\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     71\u001b[0m         \u001b[0;32mfinally\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     72\u001b[0m             \u001b[0;32mdel\u001b[0m \u001b[0mfiltered_tb\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n","\u001b[0;32m/usr/local/lib/python3.10/dist-packages/tensorflow/python/eager/execute.py\u001b[0m in \u001b[0;36mquick_execute\u001b[0;34m(op_name, num_outputs, inputs, attrs, ctx, name)\u001b[0m\n\u001b[1;32m     51\u001b[0m   \u001b[0;32mtry\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     52\u001b[0m     \u001b[0mctx\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mensure_initialized\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 53\u001b[0;31m     tensors = pywrap_tfe.TFE_Py_Execute(ctx._handle, device_name, op_name,\n\u001b[0m\u001b[1;32m     54\u001b[0m                                         inputs, attrs, num_outputs)\n\u001b[1;32m     55\u001b[0m   \u001b[0;32mexcept\u001b[0m \u001b[0mcore\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_NotOkStatusException\u001b[0m \u001b[0;32mas\u001b[0m \u001b[0me\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n","\u001b[0;31mInvalidArgumentError\u001b[0m: Graph execution error:\n\nDetected at node model_5/char_embed/embedding_lookup defined at (most recent call last):\n  File \"/usr/lib/python3.10/runpy.py\", line 196, in _run_module_as_main\n\n  File \"/usr/lib/python3.10/runpy.py\", line 86, in _run_code\n\n  File \"/usr/local/lib/python3.10/dist-packages/colab_kernel_launcher.py\", line 37, in <module>\n\n  File \"/usr/local/lib/python3.10/dist-packages/traitlets/config/application.py\", line 992, in launch_instance\n\n  File \"/usr/local/lib/python3.10/dist-packages/ipykernel/kernelapp.py\", line 619, in start\n\n  File \"/usr/local/lib/python3.10/dist-packages/tornado/platform/asyncio.py\", line 195, in start\n\n  File \"/usr/lib/python3.10/asyncio/base_events.py\", line 603, in run_forever\n\n  File \"/usr/lib/python3.10/asyncio/base_events.py\", line 1909, in _run_once\n\n  File \"/usr/lib/python3.10/asyncio/events.py\", line 80, in _run\n\n  File \"/usr/local/lib/python3.10/dist-packages/tornado/ioloop.py\", line 685, in <lambda>\n\n  File \"/usr/local/lib/python3.10/dist-packages/tornado/ioloop.py\", line 738, in _run_callback\n\n  File \"/usr/local/lib/python3.10/dist-packages/tornado/gen.py\", line 825, in inner\n\n  File \"/usr/local/lib/python3.10/dist-packages/tornado/gen.py\", line 786, in run\n\n  File \"/usr/local/lib/python3.10/dist-packages/ipykernel/kernelbase.py\", line 377, in dispatch_queue\n\n  File \"/usr/local/lib/python3.10/dist-packages/tornado/gen.py\", line 250, in wrapper\n\n  File \"/usr/local/lib/python3.10/dist-packages/tornado/gen.py\", line 748, in __init__\n\n  File \"/usr/local/lib/python3.10/dist-packages/tornado/gen.py\", line 786, in run\n\n  File \"/usr/local/lib/python3.10/dist-packages/ipykernel/kernelbase.py\", line 361, in process_one\n\n  File \"/usr/local/lib/python3.10/dist-packages/tornado/gen.py\", line 234, in wrapper\n\n  File \"/usr/local/lib/python3.10/dist-packages/ipykernel/kernelbase.py\", line 261, in dispatch_shell\n\n  File \"/usr/local/lib/python3.10/dist-packages/tornado/gen.py\", line 234, in wrapper\n\n  File \"/usr/local/lib/python3.10/dist-packages/ipykernel/kernelbase.py\", line 539, in execute_request\n\n  File \"/usr/local/lib/python3.10/dist-packages/tornado/gen.py\", line 234, in wrapper\n\n  File \"/usr/local/lib/python3.10/dist-packages/ipykernel/ipkernel.py\", line 302, in do_execute\n\n  File \"/usr/local/lib/python3.10/dist-packages/ipykernel/zmqshell.py\", line 539, in run_cell\n\n  File \"/usr/local/lib/python3.10/dist-packages/IPython/core/interactiveshell.py\", line 2975, in run_cell\n\n  File \"/usr/local/lib/python3.10/dist-packages/IPython/core/interactiveshell.py\", line 3030, in _run_cell\n\n  File \"/usr/local/lib/python3.10/dist-packages/IPython/core/async_helpers.py\", line 78, in _pseudo_sync_runner\n\n  File \"/usr/local/lib/python3.10/dist-packages/IPython/core/interactiveshell.py\", line 3257, in run_cell_async\n\n  File \"/usr/local/lib/python3.10/dist-packages/IPython/core/interactiveshell.py\", line 3473, in run_ast_nodes\n\n  File \"/usr/local/lib/python3.10/dist-packages/IPython/core/interactiveshell.py\", line 3553, in run_code\n\n  File \"<ipython-input-19-bb52a3ac20c4>\", line 1, in <cell line: 1>\n\n  File \"/usr/local/lib/python3.10/dist-packages/google/colab/_shell.py\", line 334, in run_cell_magic\n\n  File \"/usr/local/lib/python3.10/dist-packages/IPython/core/interactiveshell.py\", line 2473, in run_cell_magic\n\n  File \"<decorator-gen-54>\", line 2, in time\n\n  File \"/usr/local/lib/python3.10/dist-packages/IPython/core/magic.py\", line 187, in <lambda>\n\n  File \"/usr/local/lib/python3.10/dist-packages/IPython/core/magics/execution.py\", line 1335, in time\n\n  File \"<timed exec>\", line 1, in <module>\n\n  File \"/usr/local/lib/python3.10/dist-packages/keras/src/utils/traceback_utils.py\", line 65, in error_handler\n\n  File \"/usr/local/lib/python3.10/dist-packages/keras/src/engine/training.py\", line 2655, in predict\n\n  File \"/usr/local/lib/python3.10/dist-packages/keras/src/engine/training.py\", line 2440, in predict_function\n\n  File \"/usr/local/lib/python3.10/dist-packages/keras/src/engine/training.py\", line 2425, in step_function\n\n  File \"/usr/local/lib/python3.10/dist-packages/keras/src/engine/training.py\", line 2413, in run_step\n\n  File \"/usr/local/lib/python3.10/dist-packages/keras/src/engine/training.py\", line 2381, in predict_step\n\n  File \"/usr/local/lib/python3.10/dist-packages/keras/src/utils/traceback_utils.py\", line 65, in error_handler\n\n  File \"/usr/local/lib/python3.10/dist-packages/keras/src/engine/training.py\", line 590, in __call__\n\n  File \"/usr/local/lib/python3.10/dist-packages/keras/src/utils/traceback_utils.py\", line 65, in error_handler\n\n  File \"/usr/local/lib/python3.10/dist-packages/keras/src/engine/base_layer.py\", line 1149, in __call__\n\n  File \"/usr/local/lib/python3.10/dist-packages/keras/src/utils/traceback_utils.py\", line 96, in error_handler\n\n  File \"/usr/local/lib/python3.10/dist-packages/keras/src/engine/functional.py\", line 515, in call\n\n  File \"/usr/local/lib/python3.10/dist-packages/keras/src/engine/functional.py\", line 672, in _run_internal_graph\n\n  File \"/usr/local/lib/python3.10/dist-packages/keras/src/utils/traceback_utils.py\", line 65, in error_handler\n\n  File \"/usr/local/lib/python3.10/dist-packages/keras/src/engine/base_layer.py\", line 1149, in __call__\n\n  File \"/usr/local/lib/python3.10/dist-packages/keras/src/utils/traceback_utils.py\", line 96, in error_handler\n\n  File \"/usr/local/lib/python3.10/dist-packages/keras/src/layers/core/embedding.py\", line 272, in call\n\nindices[7,0] = 9 is not in [0, 2)\n\t [[{{node model_5/char_embed/embedding_lookup}}]] [Op:__inference_predict_function_104955]"]}]},{"cell_type":"code","source":["# Turn prediction probabilities into prediction classes\n","test_abstract_preds = tf.argmax(test_abstract_pred_probs, axis=1)\n","test_abstract_preds"],"metadata":{"id":"Ck-FH8QsFuv8"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["# Turn prediction class integers into string class names\n","test_abstract_pred_classes = [label_encoder.classes_[i] for i in test_abstract_preds]\n","test_abstract_pred_classes"],"metadata":{"id":"DOvcVqKgFutN"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["# Visualize abstract lines and predicted sequence labels\n","for i, line in enumerate(abstract_lines):\n","  print(f\"{test_abstract_pred_classes[i]}: {line}\")"],"metadata":{"id":"gaudNK6IFuSh"},"execution_count":null,"outputs":[]},{"cell_type":"markdown","source":["#try\n"],"metadata":{"id":"buvknA1SIC8a"}},{"cell_type":"code","source":["import json\n","# Download and open example abstracts (copy and pasted from PubMed)\n","!wget https://raw.githubusercontent.com/mrdbourke/tensorflow-deep-learning/main/extras/skimlit_example_abstracts.json\n","\n","with open(\"skimlit_example_abstracts.json\", \"r\") as f:\n","  example_abstracts = json.load(f)\n","\n","example_abstracts"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"MzJ9fxfPIETY","executionInfo":{"status":"ok","timestamp":1702840379270,"user_tz":-180,"elapsed":11,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"c6f55809-4cf0-4ab6-ece5-5be5b4442d75"},"execution_count":null,"outputs":[{"output_type":"stream","name":"stdout","text":["--2023-12-17 19:12:21--  https://raw.githubusercontent.com/mrdbourke/tensorflow-deep-learning/main/extras/skimlit_example_abstracts.json\n","Resolving raw.githubusercontent.com (raw.githubusercontent.com)... 185.199.111.133, 185.199.109.133, 185.199.108.133, ...\n","Connecting to raw.githubusercontent.com (raw.githubusercontent.com)|185.199.111.133|:443... connected.\n","HTTP request sent, awaiting response... 200 OK\n","Length: 6737 (6.6K) [text/plain]\n","Saving to: skimlit_example_abstracts.json\n","\n","\r          skimlit_e   0%[                    ]       0  --.-KB/s               \rskimlit_example_abs 100%[===================>]   6.58K  --.-KB/s    in 0s      \n","\n","2023-12-17 19:12:22 (86.0 MB/s) - skimlit_example_abstracts.json saved [6737/6737]\n","\n"]},{"output_type":"execute_result","data":{"text/plain":["[{'abstract': 'This RCT examined the efficacy of a manualized social intervention for children with HFASDs. Participants were randomly assigned to treatment or wait-list conditions. Treatment included instruction and therapeutic activities targeting social skills, face-emotion recognition, interest expansion, and interpretation of non-literal language. A response-cost program was applied to reduce problem behaviors and foster skills acquisition. Significant treatment effects were found for five of seven primary outcome measures (parent ratings and direct child measures). Secondary measures based on staff ratings (treatment group only) corroborated gains reported by parents. High levels of parent, child and staff satisfaction were reported, along with high levels of treatment fidelity. Standardized effect size estimates were primarily in the medium and large ranges and favored the treatment group.',\n","  'source': 'https://pubmed.ncbi.nlm.nih.gov/20232240/',\n","  'details': 'RCT of a manualized social treatment for high-functioning autism spectrum disorders'},\n"," {'abstract': \"Postpartum depression (PPD) is the most prevalent mood disorder associated with childbirth. No single cause of PPD has been identified, however the increased risk of nutritional deficiencies incurred through the high nutritional requirements of pregnancy may play a role in the pathology of depressive symptoms. Three nutritional interventions have drawn particular interest as possible non-invasive and cost-effective prevention and/or treatment strategies for PPD; omega-3 (n-3) long chain polyunsaturated fatty acids (LCPUFA), vitamin D and overall diet. We searched for meta-analyses of randomised controlled trials (RCT's) of nutritional interventions during the perinatal period with PPD as an outcome, and checked for any trials published subsequently to the meta-analyses. Fish oil: Eleven RCT's of prenatal fish oil supplementation RCT's show null and positive effects on PPD symptoms. Vitamin D: no relevant RCT's were identified, however seven observational studies of maternal vitamin D levels with PPD outcomes showed inconsistent associations. Diet: Two Australian RCT's with dietary advice interventions in pregnancy had a positive and null result on PPD. With the exception of fish oil, few RCT's with nutritional interventions during pregnancy assess PPD. Further research is needed to determine whether nutritional intervention strategies during pregnancy can protect against symptoms of PPD. Given the prevalence of PPD and ease of administering PPD measures, we recommend future prenatal nutritional RCT's include PPD as an outcome.\",\n","  'source': 'https://pubmed.ncbi.nlm.nih.gov/28012571/',\n","  'details': 'Formatting removed (can be used to compare model to actual example)'},\n"," {'abstract': 'Mental illness, including depression, anxiety and bipolar disorder, accounts for a significant proportion of global disability and poses a substantial social, economic and heath burden. Treatment is presently dominated by pharmacotherapy, such as antidepressants, and psychotherapy, such as cognitive behavioural therapy; however, such treatments avert less than half of the disease burden, suggesting that additional strategies are needed to prevent and treat mental disorders. There are now consistent mechanistic, observational and interventional data to suggest diet quality may be a modifiable risk factor for mental illness. This review provides an overview of the nutritional psychiatry field. It includes a discussion of the neurobiological mechanisms likely modulated by diet, the use of dietary and nutraceutical interventions in mental disorders, and recommendations for further research. Potential biological pathways related to mental disorders include inflammation, oxidative stress, the gut microbiome, epigenetic modifications and neuroplasticity. Consistent epidemiological evidence, particularly for depression, suggests an association between measures of diet quality and mental health, across multiple populations and age groups; these do not appear to be explained by other demographic, lifestyle factors or reverse causality. Our recently published intervention trial provides preliminary clinical evidence that dietary interventions in clinically diagnosed populations are feasible and can provide significant clinical benefit. Furthermore, nutraceuticals including n-3 fatty acids, folate, S-adenosylmethionine, N-acetyl cysteine and probiotics, among others, are promising avenues for future research. Continued research is now required to investigate the efficacy of intervention studies in large cohorts and within clinically relevant populations, particularly in patients with schizophrenia, bipolar and anxiety disorders.',\n","  'source': 'https://pubmed.ncbi.nlm.nih.gov/28942748/',\n","  'details': 'Effect of nutrition on mental health'},\n"," {'abstract': \"Hepatitis C virus (HCV) and alcoholic liver disease (ALD), either alone or in combination, count for more than two thirds of all liver diseases in the Western world. There is no safe level of drinking in HCV-infected patients and the most effective goal for these patients is total abstinence. Baclofen, a GABA(B) receptor agonist, represents a promising pharmacotherapy for alcohol dependence (AD). Previously, we performed a randomized clinical trial (RCT), which demonstrated the safety and efficacy of baclofen in patients affected by AD and cirrhosis. The goal of this post-hoc analysis was to explore baclofen's effect in a subgroup of alcohol-dependent HCV-infected cirrhotic patients. Any patient with HCV infection was selected for this analysis. Among the 84 subjects randomized in the main trial, 24 alcohol-dependent cirrhotic patients had a HCV infection; 12 received baclofen 10mg t.i.d. and 12 received placebo for 12-weeks. With respect to the placebo group (3/12, 25.0%), a significantly higher number of patients who achieved and maintained total alcohol abstinence was found in the baclofen group (10/12, 83.3%; p=0.0123). Furthermore, in the baclofen group, compared to placebo, there was a significantly higher increase in albumin values from baseline (p=0.0132) and a trend toward a significant reduction in INR levels from baseline (p=0.0716). In conclusion, baclofen was safe and significantly more effective than placebo in promoting alcohol abstinence, and improving some Liver Function Tests (LFTs) (i.e. albumin, INR) in alcohol-dependent HCV-infected cirrhotic patients. Baclofen may represent a clinically relevant alcohol pharmacotherapy for these patients.\",\n","  'source': 'https://pubmed.ncbi.nlm.nih.gov/22244707/',\n","  'details': 'Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection'}]"]},"metadata":{},"execution_count":71}]},{"cell_type":"code","source":["# Create sentencizer - Source: https://spacy.io/usage/linguistic-features#sbd\n","from spacy.lang.en import English\n","nlp = English() # setup English sentence parser\n","\n","# New version of spaCy\n","sentencizer = nlp.add_pipe(\"sentencizer\") # create sentence splitting pipeline object\n","\n","# Old version of spaCy\n","# sentencizer = nlp.create_pipe(\"sentencizer\") # create sentence splitting pipeline object\n","# nlp.add_pipe(sentencizer) # add sentence splitting pipeline object to sentence parser\n","\n","# Create \"doc\" of parsed sequences, change index for a different abstract\n","doc = nlp(example_abstracts[0][\"abstract\"])\n","abstract_lines = [str(sent) for sent in list(doc.sents)] # return detected sentences from doc in string type (not spaCy token type)\n","abstract_lines"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"IKW3Mk26INU7","executionInfo":{"status":"ok","timestamp":1702840385086,"user_tz":-180,"elapsed":5820,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"a283bc4b-47c7-4ef9-c3cb-58350573c5fc"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["['This RCT examined the efficacy of a manualized social intervention for children with HFASDs.',\n"," 'Participants were randomly assigned to treatment or wait-list conditions.',\n"," 'Treatment included instruction and therapeutic activities targeting social skills, face-emotion recognition, interest expansion, and interpretation of non-literal language.',\n"," 'A response-cost program was applied to reduce problem behaviors and foster skills acquisition.',\n"," 'Significant treatment effects were found for five of seven primary outcome measures (parent ratings and direct child measures).',\n"," 'Secondary measures based on staff ratings (treatment group only) corroborated gains reported by parents.',\n"," 'High levels of parent, child and staff satisfaction were reported, along with high levels of treatment fidelity.',\n"," 'Standardized effect size estimates were primarily in the medium and large ranges and favored the treatment group.']"]},"metadata":{},"execution_count":72}]},{"cell_type":"code","source":["# Get total number of lines\n","total_lines_in_sample = len(abstract_lines)\n","\n","# Go through each line in abstract and create a list of dictionaries containing features for each line\n","sample_lines = []\n","for i, line in enumerate(abstract_lines):\n","  sample_dict = {}\n","  sample_dict[\"text\"] = str(line)\n","  sample_dict[\"line_number\"] = i\n","  sample_dict[\"total_lines\"] = total_lines_in_sample - 1\n","  sample_lines.append(sample_dict)\n","sample_lines"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"XZuIroUhIWBq","executionInfo":{"status":"ok","timestamp":1702840385087,"user_tz":-180,"elapsed":15,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"1c98a64d-0b9d-45c0-b170-5d107e5ec3fe"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["[{'text': 'This RCT examined the efficacy of a manualized social intervention for children with HFASDs.',\n","  'line_number': 0,\n","  'total_lines': 7},\n"," {'text': 'Participants were randomly assigned to treatment or wait-list conditions.',\n","  'line_number': 1,\n","  'total_lines': 7},\n"," {'text': 'Treatment included instruction and therapeutic activities targeting social skills, face-emotion recognition, interest expansion, and interpretation of non-literal language.',\n","  'line_number': 2,\n","  'total_lines': 7},\n"," {'text': 'A response-cost program was applied to reduce problem behaviors and foster skills acquisition.',\n","  'line_number': 3,\n","  'total_lines': 7},\n"," {'text': 'Significant treatment effects were found for five of seven primary outcome measures (parent ratings and direct child measures).',\n","  'line_number': 4,\n","  'total_lines': 7},\n"," {'text': 'Secondary measures based on staff ratings (treatment group only) corroborated gains reported by parents.',\n","  'line_number': 5,\n","  'total_lines': 7},\n"," {'text': 'High levels of parent, child and staff satisfaction were reported, along with high levels of treatment fidelity.',\n","  'line_number': 6,\n","  'total_lines': 7},\n"," {'text': 'Standardized effect size estimates were primarily in the medium and large ranges and favored the treatment group.',\n","  'line_number': 7,\n","  'total_lines': 7}]"]},"metadata":{},"execution_count":73}]},{"cell_type":"code","source":["# Get all line_number values from sample abstract\n","test_abstract_line_numbers = [line[\"line_number\"] for line in sample_lines]\n","# One-hot encode to same depth as training data, so model accepts right input shape\n","test_abstract_line_numbers_one_hot = tf.one_hot(test_abstract_line_numbers, depth=15)\n","test_abstract_line_numbers_one_hot"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"Qm_uywB0IY9L","executionInfo":{"status":"ok","timestamp":1702840385087,"user_tz":-180,"elapsed":14,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"1396f9a7-d1f0-4133-86b6-efa50e3c3922"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["<tf.Tensor: shape=(8, 15), dtype=float32, numpy=\n","array([[1., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0.],\n","       [0., 1., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0.],\n","       [0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0.],\n","       [0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0.],\n","       [0., 0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0., 0., 0.],\n","       [0., 0., 0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0., 0.],\n","       [0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0.],\n","       [0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0.]],\n","      dtype=float32)>"]},"metadata":{},"execution_count":74}]},{"cell_type":"code","source":["import tensorflow as tf"],"metadata":{"id":"jfQL0MbpIbxY"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["# Get all total_lines values from sample abstract\n","test_abstract_total_lines = [line[\"total_lines\"] for line in sample_lines]\n","# One-hot encode to same depth as training data, so model accepts right input shape\n","test_abstract_total_lines_one_hot = tf.one_hot(test_abstract_total_lines, depth=20)\n","test_abstract_total_lines_one_hot"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"ZPdBnoVJIeI_","executionInfo":{"status":"ok","timestamp":1702840385087,"user_tz":-180,"elapsed":9,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"211b80d4-190d-443f-b0b4-46f5548812f9"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["<tf.Tensor: shape=(8, 20), dtype=float32, numpy=\n","array([[0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0.,\n","        0., 0., 0., 0.],\n","       [0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0.,\n","        0., 0., 0., 0.],\n","       [0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0.,\n","        0., 0., 0., 0.],\n","       [0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0.,\n","        0., 0., 0., 0.],\n","       [0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0.,\n","        0., 0., 0., 0.],\n","       [0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0.,\n","        0., 0., 0., 0.],\n","       [0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0.,\n","        0., 0., 0., 0.],\n","       [0., 0., 0., 0., 0., 0., 0., 1., 0., 0., 0., 0., 0., 0., 0., 0.,\n","        0., 0., 0., 0.]], dtype=float32)>"]},"metadata":{},"execution_count":76}]},{"cell_type":"code","source":["# Split abstract lines into characters\n","abstract_chars = [split_chars(sentence) for sentence in abstract_lines]\n","abstract_chars"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"GHmiPpVQIi5M","executionInfo":{"status":"ok","timestamp":1702840385670,"user_tz":-180,"elapsed":4,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"9c58cd7e-8b02-4fef-d527-cd40ad5747e8"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["['T h i s   R C T   e x a m i n e d   t h e   e f f i c a c y   o f   a   m a n u a l i z e d   s o c i a l   i n t e r v e n t i o n   f o r   c h i l d r e n   w i t h   H F A S D s .',\n"," 'P a r t i c i p a n t s   w e r e   r a n d o m l y   a s s i g n e d   t o   t r e a t m e n t   o r   w a i t - l i s t   c o n d i t i o n s .',\n"," 'T r e a t m e n t   i n c l u d e d   i n s t r u c t i o n   a n d   t h e r a p e u t i c   a c t i v i t i e s   t a r g e t i n g   s o c i a l   s k i l l s ,   f a c e - e m o t i o n   r e c o g n i t i o n ,   i n t e r e s t   e x p a n s i o n ,   a n d   i n t e r p r e t a t i o n   o f   n o n - l i t e r a l   l a n g u a g e .',\n"," 'A   r e s p o n s e - c o s t   p r o g r a m   w a s   a p p l i e d   t o   r e d u c e   p r o b l e m   b e h a v i o r s   a n d   f o s t e r   s k i l l s   a c q u i s i t i o n .',\n"," 'S i g n i f i c a n t   t r e a t m e n t   e f f e c t s   w e r e   f o u n d   f o r   f i v e   o f   s e v e n   p r i m a r y   o u t c o m e   m e a s u r e s   ( p a r e n t   r a t i n g s   a n d   d i r e c t   c h i l d   m e a s u r e s ) .',\n"," 'S e c o n d a r y   m e a s u r e s   b a s e d   o n   s t a f f   r a t i n g s   ( t r e a t m e n t   g r o u p   o n l y )   c o r r o b o r a t e d   g a i n s   r e p o r t e d   b y   p a r e n t s .',\n"," 'H i g h   l e v e l s   o f   p a r e n t ,   c h i l d   a n d   s t a f f   s a t i s f a c t i o n   w e r e   r e p o r t e d ,   a l o n g   w i t h   h i g h   l e v e l s   o f   t r e a t m e n t   f i d e l i t y .',\n"," 'S t a n d a r d i z e d   e f f e c t   s i z e   e s t i m a t e s   w e r e   p r i m a r i l y   i n   t h e   m e d i u m   a n d   l a r g e   r a n g e s   a n d   f a v o r e d   t h e   t r e a t m e n t   g r o u p .']"]},"metadata":{},"execution_count":77}]},{"cell_type":"code","source":["import tensorflow as tf\n","loaded_model = tf.keras.models.load_model('/content/drive/Othercomputers/My Laptop/MacDeepL/Skim-lit/nmodelmain')\n","loaded_model.summary()"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"6cJxXPNjMmtm","executionInfo":{"status":"ok","timestamp":1702880193291,"user_tz":-180,"elapsed":31086,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"cf939229-2cd7-4cd8-a342-3ac6ffb03c71"},"execution_count":2,"outputs":[{"output_type":"stream","name":"stdout","text":["Model: \"model_4\"\n","__________________________________________________________________________________________________\n"," Layer (type)                Output Shape                 Param #   Connected to                  \n","==================================================================================================\n"," char_inputs (InputLayer)    [(None, 1)]                  0         []                            \n","                                                                                                  \n"," token_inputs (InputLayer)   [(None,)]                    0         []                            \n","                                                                                                  \n"," char_vectorizer (TextVecto  (None, 290)                  0         ['char_inputs[0][0]']         \n"," rization)                                                                                        \n","                                                                                                  \n"," universal_sentence_encoder  (None, 512)                  2567978   ['token_inputs[0][0]']        \n","  (KerasLayer)                                            24                                      \n","                                                                                                  \n"," char_embed (Embedding)      (None, 290, 25)              700       ['char_vectorizer[0][0]']     \n","                                                                                                  \n"," dense_1 (Dense)             (None, 128)                  65664     ['universal_sentence_encoder[0\n","                                                                    ][0]']                        \n","                                                                                                  \n"," bidirectional (Bidirection  (None, 64)                   14848     ['char_embed[0][0]']          \n"," al)                                                                                              \n","                                                                                                  \n"," token_char_hybrid_embeddin  (None, 192)                  0         ['dense_1[0][0]',             \n"," g (Concatenate)                                                     'bidirectional[0][0]']       \n","                                                                                                  \n"," line_number_input (InputLa  [(None, 15)]                 0         []                            \n"," yer)                                                                                             \n","                                                                                                  \n"," total_lines_input (InputLa  [(None, 20)]                 0         []                            \n"," yer)                                                                                             \n","                                                                                                  \n"," dense_4 (Dense)             (None, 256)                  49408     ['token_char_hybrid_embedding[\n","                                                                    0][0]']                       \n","                                                                                                  \n"," dense_2 (Dense)             (None, 32)                   512       ['line_number_input[0][0]']   \n","                                                                                                  \n"," dense_3 (Dense)             (None, 32)                   672       ['total_lines_input[0][0]']   \n","                                                                                                  \n"," dropout (Dropout)           (None, 256)                  0         ['dense_4[0][0]']             \n","                                                                                                  \n"," token_char_positional_embe  (None, 320)                  0         ['dense_2[0][0]',             \n"," dding (Concatenate)                                                 'dense_3[0][0]',             \n","                                                                     'dropout[0][0]']             \n","                                                                                                  \n"," output_layer (Dense)        (None, 5)                    1605      ['token_char_positional_embedd\n","                                                                    ing[0][0]']                   \n","                                                                                                  \n","==================================================================================================\n","Total params: 256931233 (980.11 MB)\n","Trainable params: 133409 (521.13 KB)\n","Non-trainable params: 256797824 (979.61 MB)\n","__________________________________________________________________________________________________\n"]}]},{"cell_type":"code","source":["# Make predictions on sample abstract features\n","%%time\n","test_abstract_pred_probs = loaded_model.predict(x=(test_abstract_line_numbers_one_hot,\n","                                                   test_abstract_total_lines_one_hot,\n","                                                   tf.constant(abstract_lines),\n","                                                   tf.constant(abstract_chars)))\n","test_abstract_pred_probs"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"ESu9oMCEInT3","executionInfo":{"status":"ok","timestamp":1702840547033,"user_tz":-180,"elapsed":4081,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"b2469d49-fdea-4324-ba6f-141fc3f74415"},"execution_count":null,"outputs":[{"output_type":"stream","name":"stdout","text":["1/1 [==============================] - 4s 4s/step\n","CPU times: user 3.61 s, sys: 23.2 ms, total: 3.63 s\n","Wall time: 3.58 s\n"]},{"output_type":"execute_result","data":{"text/plain":["array([[0.2823349 , 0.08950289, 0.08736741, 0.49124002, 0.04955484],\n","       [0.07398733, 0.03794192, 0.7527627 , 0.10632225, 0.02898582],\n","       [0.06801202, 0.02267802, 0.7319966 , 0.07871886, 0.09859453],\n","       [0.13231558, 0.18081692, 0.5210675 , 0.09576359, 0.07003641],\n","       [0.0513235 , 0.05730627, 0.20246047, 0.04950066, 0.63940907],\n","       [0.02726303, 0.06320986, 0.666859  , 0.03457999, 0.20808807],\n","       [0.01692936, 0.06243039, 0.02179435, 0.02505794, 0.87378794],\n","       [0.01390455, 0.08042303, 0.06327089, 0.0256635 , 0.816738  ]],\n","      dtype=float32)"]},"metadata":{},"execution_count":80}]},{"cell_type":"code","source":["test_abstract_preds = tf.argmax(test_abstract_pred_probs, axis=1)\n","test_abstract_preds"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"hpziCJ0RNZH1","executionInfo":{"status":"ok","timestamp":1702840553191,"user_tz":-180,"elapsed":380,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"d2c75588-ccc8-4d62-908c-ba6c67109278"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["<tf.Tensor: shape=(8,), dtype=int64, numpy=array([3, 2, 2, 2, 4, 2, 4, 4])>"]},"metadata":{},"execution_count":81}]},{"cell_type":"code","source":["test_abstract_pred_classes = [label_encoder.classes_[i] for i in test_abstract_preds]\n","test_abstract_pred_classes"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"lEr0n4c0NZ88","executionInfo":{"status":"ok","timestamp":1702840556736,"user_tz":-180,"elapsed":409,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"69481f2e-c14a-456d-f8e8-6ae1567f22b6"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["['OBJECTIVE',\n"," 'METHODS',\n"," 'METHODS',\n"," 'METHODS',\n"," 'RESULTS',\n"," 'METHODS',\n"," 'RESULTS',\n"," 'RESULTS']"]},"metadata":{},"execution_count":82}]},{"cell_type":"code","source":["for i, line in enumerate(abstract_lines):\n","  print(f\"{test_abstract_pred_classes[i]}: {line}\")"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"al8lBJ8WNb6c","executionInfo":{"status":"ok","timestamp":1702840706581,"user_tz":-180,"elapsed":4,"user":{"displayName":"Usman Khan","userId":"08807198114584804058"}},"outputId":"f70a6ba0-5df2-4b67-88ab-91978a20ff30"},"execution_count":null,"outputs":[{"output_type":"stream","name":"stdout","text":["OBJECTIVE: This RCT examined the efficacy of a manualized social intervention for children with HFASDs.\n","METHODS: Participants were randomly assigned to treatment or wait-list conditions.\n","METHODS: Treatment included instruction and therapeutic activities targeting social skills, face-emotion recognition, interest expansion, and interpretation of non-literal language.\n","METHODS: A response-cost program was applied to reduce problem behaviors and foster skills acquisition.\n","RESULTS: Significant treatment effects were found for five of seven primary outcome measures (parent ratings and direct child measures).\n","METHODS: Secondary measures based on staff ratings (treatment group only) corroborated gains reported by parents.\n","RESULTS: High levels of parent, child and staff satisfaction were reported, along with high levels of treatment fidelity.\n","RESULTS: Standardized effect size estimates were primarily in the medium and large ranges and favored the treatment group.\n"]}]},{"cell_type":"code","source":[],"metadata":{"id":"Z_kpWtxXNqW3"},"execution_count":null,"outputs":[]}],"metadata":{"colab":{"provenance":[],"collapsed_sections":["YlfChAzUwPmA","HoZGgYjbFDnv"],"mount_file_id":"12m6JlnEn5rJLKp0pYFT-BmIrnFxIUS1I","authorship_tag":"ABX9TyOY5SCPB6WgVhFURiiF116d"},"kernelspec":{"display_name":"Python 3","name":"python3"},"language_info":{"name":"python"}},"nbformat":4,"nbformat_minor":0}